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inTroduCTion and ouTline oF The TheSiS
Coronary heart disease is the most frequent cause of death in the Western society.1 Coronary 
arteriography, a technique to visualize morphologic characteristics of the coronary arteries, 
has provided an objective basic standard of diagnosis and fundamentally changed our ap-
proach to the patient with suspected coronary artery disease. 
The advent of conventional coronary angiography towards the end of the 1950s allowed in-vi-
vo assessment of coronary stenoses due to atherosclerosis.2 The introduction of this diagnostic 
technique allowed the development of rational treatment modalities such as coronary artery 
bypass surgery (CABG) and, subsequently, percutaneous coronary intervention, roughly one 
and two decades later respectively.3-5 The timeline and introduction of conventional coronary 
angiography in clinical practice including some landmark clinical studies is shown in Figure 
1.2,3,5-9
Until the end of the 1980s the general belief prevailed that acute myocardial infarction or 
unstable angina pectoris were the consequence of high-grade coronary stenoses, lesions that 
could be depicted by conventional coronary angiography. However, several data occasioned 
a reassessment of this central dogma of clinical cardiology. Angiographic studies obtained 
before acute myocardial infarction and those obtained during the infarction revealed that 
the atherosclerotic lesions that gave rise to occlusive thrombosis did not cause high-grade 
stenoses in many cases.10-12 A number of “regression trials” in the early 1990s showed that 
lipid lowering therapy had a minimal effect on the degree of high-grade coronary stenoses. 
Yet, these studies revealed a consistent decrease in acute coronary events.13 Autopsy studies 
among patients with sudden cardiac death have shown that the vast majority of these acute 
clinical events occur as a result of plaque rupture at sites with noncritical luminal narrow-
ing.14-16 Finally, in patients with stable angina pectoris percutaneous revascularization of high-
grade coronary stenoses in addition to optimal medical therapy does not reduce the rates of 
death and myocardial infarction as compared to optimal medical therapy alone.17 
Non-invasive imaging of the coronary arteries has been an important challenge over the last 
15 years and started off in the early 1990s using magnetic resonance imaging and elec-
tron beam computed tomography (EBCT).18-20 The introduction of multislice CT technology 
in 1998 set the stage for a rapid technological development that resulted in a significant 
improvement in image quality, thereby favoring computed tomography coronary angiography 
(CTCA) as the preferred technique for noninvasive coronary artery imaging.21 CTCA avoids 
catheter-related complications, is less costly and importantly helps us to refocus our eyes on 
the central manifestation of coronary artery disease, atherosclerotic involvement of the coro-
nary artery wall.22 The subsequent improvements in multi-slice CT technology and the first 
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CTCA studies reporting on the natural history of coronary artery disease are summarized on 
the same timeline in Figure 1.23 
The aims of this thesis are multiple: first, to validate CTCA as a diagnostic technique to identify 
and characterize coronary atherosclerotic plaque using intravascular ultrasound and optical 
coherence tomography as reference intravascular imaging tests; second, to explore the spec-
trum of patients with possible native vessel coronary artery disease in whom CTCA might be 
clinically useful; third, to assess the clinical value of CTCA in patients who underwent previous 
coronary artery stenting. 
Part 1 addresses the role of CTCA in the diagnostic work-up of patients with suspected coro-
nary artery disease, illustrates the potential of CTCA to overcome the inherent limitations of 
Figure 1. Historical overview: the development of coronary angiography. Invasive and non-invasive assessment. The numbers in 
between brackets are referring to the references in the text. PTCA denotes percutaneous transluminal coronary angioplasty; RCT 
denotes randomized clinical trial. 
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conventional coronary angiography and highlights how the information provided by CTCA 
can aid in planning or performing coronary and non-coronary intervention (Chapter 2). Part 
2 addresses the potential of CTCA to visualize the early stages of coronary artery disease 
where “ luminographic” involvement is still absent or minimal. The design and the results of 
the Integrated Biomarker and Imaging Study (IBIS), a multimodality imaging and biomarker 
study that aimed to characterize subclinical coronary atherosclerotic disease, are discussed 
(Chapters 3-5). Part 3 describes the diagnostic performance of 64-slice CTCA to detect ob-
structive coronary artery disease in a wide clinical spectrum of patients, ranging from those 
presenting with stable angina pectoris to patients admitted with acute coronary syndrome 
without ST-segment elevation (Chapters 6 and 7, interlude 2). Of particular value is the diag-
nostic performance of 64-slice CTCA in patients with a low-to-intermediate pretest likelihood 
of significant CAD (Chapters 8 and 9). There are two fundamentally different approaches to 
assess coronary artery disease, anatomical and functional. We address this important topic by 
combining anatomical information, using CTCA, with functional data (Chapters 10 and 11, 
interlude 3). Angiographic assessment of complex coronary pathology such as bifurcation le-
sions and chronic total occlusions is sometimes suboptimal and might be a reason to refer a 
patient for an alternative imaging technique. We evaluated the value of CTCA in these lesion 
subsets (Chapters 12 and 13, interlude 4). In addition, we provide our initial experience with 
the integration of CT data in the cathlab for the purpose of percutaneous coronary interven-
tions using magnetic navigation (Chapter 14). Part 4 deals with in-vivo CT coronary stent 
imaging. Both the technical knowledge required to obtain good visualisation of the lumen 
inside the stent as well as the possible clinical application are discussed. Part 5 summarises 
the current findings and touches upon the future steps that are being taken to accommodate 
CTCA as a diagnostic tool in clinical cardiology.
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aBSTraCT
Computed tomography coronary angiography is considered an appropriate diagnostic test for 
evaluation of symptomatic patients with a low-to-intermediate pre-test likelihood of coronary 
artery disease. A negative CT scan reliably rules out the presence of coronary artery disease, 
has a favourable prognostic value and might therefore significantly impact on the need for 
invasive coronary angiography. Those patients with significant atherosclerotic disease on CT 
benefit from further functional assessment to decide upon the appropriate therapeutic ap-
proach. Beyond this gatekeeper function, computed tomography coronary angiography over-
comes the inherent 2-dimensional limitations of the catheter-based approach and might be 
valuable as a complementary technique in patients with complex coronary artery disease.
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inTroduCTion
Although in-vivo assessment of the coronary arteries only became feasible towards the end 
of the 1950s, its introduction revolutionized the practice of cardiology.1 Less than half a cen-
tury later a noninvasive alternative, computed tomography coronary angiography (CTCA), 
became available.2,3 The high diagnostic accuracy of CTCA both for the detection and the 
exclusion of hemodynamically significant (> 50% stenosis) coronary artery stenosis is now well 
established. Ongoing advances in scan technology have resulted in the current generation 
of 64-slice CT scanners that allow accurate assessment of clinically relevant segments of the 
coronary tree (vessels with a diameter of 1.5 mm or more) within 10 seconds, a breath hold 
that is comfortable for the vast majority of patients. The technique still has limitations, notably 
the challenges posed by extensive calcification or irregular cardiac rhythms, and does not yet 
provide the same spatial and temporal resolution as its invasive counterpart. However, its 3-di-
mensional (3-D) nature offers insights into both lesion and vessel characteristics that cannot 
be obtained with conventional 2-D angiography, and that may prove valuable in planning and 
guiding interventional procedures.
In current practice, invasive coronary angiography (ICA) is the initial imaging procedure per-
formed to confirm or exclude obstructive coronary disease as a cause of chest pain and 
to triage patients towards percutaneous or surgical revascularization. These procedures are 
often performed by cardiologists who are not trained in percutaneous coronary intervention 
(PCI). Not infrequently, when these studies are reviewed by an interventional cardiologist and 
a cardiac surgeon with a view to planning the best revascularization strategy, they are deemed 
Figure 1. Invasive coronary angiogram of the right coronary artery. (a) Normal appearance of the vessel at initial catheterization. 
(b) A repeat coronary angiogram was scheduled 2 weeks later in order to perform an intravascular ultrasound. This resulted in a 
proximal dissection of the vessel (arrowheads).
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to be suboptimal. Additional projections to assess overlapped lesions, to determine the exact 
anatomy of bifurcating or ostial lesions, or to clarify the hemodynamic significance of lesions 
are deemed to be necessary to determine if revascularization is indicated or to determine the 
best revascularization strategy. CTCA has the potential to replace ICA in a significant propor-
tion of patients especially those with a low or intermediate probability of coronary disease at 
initial presentation.4,5 Higher risk patients could be referred directly to centers where ad hoc 
PCI could be performed where indicated. This approach should theoretically reduce the inher-
ent risks of peripheral and coronary arterial injury that can occur during ICA. (Figure 1) 
 This article aims to critically evaluate the potential of CTCA to alter the management of 
patients with suspected coronary disease, to illustrate the potential of CTCA to overcome the 
inherent limitations of ICA, and to highlight how the information provided by CTCA can aid in 
planning or performing coronary and non-coronary interventions.
CT Coronary angiography: CurrenT STaTuS
As a new diagnostic imaging tool CTCA has been systematically validated against ICA, the 
gold standard technique, to assess for the presence or absence of obstructive CAD. By default, 
Reference No. of 
patients
excluded 
segments, % (n)
Sensitivity, 
%
Specificity, 
%
PPV, % NPV, %
Ehara68 67 8 (82/966) 98 86 98 86
Ghostine69 66 0 (0/990) 97 95 93 97
Leber70 45 0 (0/798) 88 85 88 85
Leschka71 67 0 (0/1005) 100 100 100 100
Meijboom72 70 0 (0/1003) 100 92 82 100
Meijboom73 104 0 (0/1525) 100 75 96 100
Mollet74 51 0 (0/725) 100 92 97 100
Muhlenbruch75 51 5 (39/765) 98 50 94 75
Nikolaou76 68 10 (97/1020) 97 79 86 96
Oncel77 80 0 (0/1200) 100 100 100 100
Pugliese78 35 0 (0/494) 100 90 96 100
Raff79 70 12 (130/1065) 95 90 93 93
Ropers80 81 4 (45/1128) 96 91 83 98
Schuijf81 60 1 (12/854) 94 97 97 93
Mean 3 (405/13538)
Weighted mean 98 87 93 95
Table 1. Patient-based diagnostic performance of 64-slice CT coronary angiography to detect significant coronary artery disease 
(≥ 50% lumen diameter stenosis). PPV, positive predictive value; NPV, negative predictive value.
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the patients that have been included in these validation studies almost invariably had a high 
pretest-probability of significant CAD as all of them had an indication for ICA based on clini-
cal grounds. Although coronary artery imaging is feasible with 4-slice and 16-slice technol-
ogy a substantial proportion of the coronary tree cannot be fully evaluated due to insufficient 
spatial and temporal resolution. However, current 64-slice and dual-source CT technology 
has substantial improvement in image quality so as to reduce the percentage of otherwise 
non-diagnostic coronary segments to less than 5%. The diagnostic performance of 64-slice 
CT scanners in patients with native vessel disease is presented in Table 1. The diagnostic per-
formance obtained with dual-source CT is summarized in Table 2.
diagnoSTiC work-up oF paTienTS wiTh 
SuSpeCTed Coronary arTery diSeaSe: 
CurrenT STaTuS and FuTure perSpeCTive
Due to its invasive nature, ICA should ideally be reserved for patients in whom the likelihood 
of proceeding to coronary revascularization is high. Current guidelines recommend the use 
of noninvasive stress testing as a first-line test before proceeding to a catheter-based as-
sessment of the coronary anatomy.6,7 However, in daily practice, the approach to patients 
with suspected or proven stable coronary artery disease is different. The majority of patients 
undergoing coronary revascularization do not have objectively demonstrated ischemia.8 Re-
cent surveys demonstrate that up to 20% of all coronary angiograms are reported as be-
ing normal.9 Furthermore, only around a third of patients undergoing ICA are referred for 
revascularization.10 Mason Sones suggested, at the dawn of coronary angiography, that its 
major role would be to exclude significant coronary disease as a cause of chest pain and it 
is therefore not surprising that today ICA is still widely used for this purpose.11 The frequent 
Reference No. of 
patients
Non-diagnostic 
segments, % (n)
Sensitivity,
 %
Specificity, 
%
PPV, % NPV, %
Scheffel82 30 1.4 (6/420) 96 97 86 99
Weustink83 100 6 (89/1489) 99 87 96 95
Leber84 88 0 (0/1216) 95 90 74 99
Ropers85 100 3.7 (51/1394) 98 81 79 98
Alkadhi86 150 1.9 (39/2059) 97 87 83 97
Scheffel87 120 1.7 (30/1803) 100 93 94 100
Mean 2.6
Weighted mean 98 88 86 98
Table 2. Patient-based diagnostic performance of dual-source CT coronary angiography to detect significant coronary artery 
disease (≥ 50% lumen diameter stenosis). PPV, positive predictive value; NPV, negative predictive value. 
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recourse to ICA in patients with a low-to-intermediate pretest probability of disease reflects 
the diagnostic uncertainty related to inconclusive noninvasive stress testing in patients with 
unexplained chest pain.12 A normal nuclear scan or dobutamine stress echocardiogram has a 
well documented favorable prognostic value.13-16 However, it does not definitively exclude the 
presence of significant coronary artery disease as a cause of unexplained chest pain. Standard 
single photon emission computed tomography (SPECT) and positron emission tomography 
imaging rely on normalization of acquired data to the region of the myocardium with maximal 
perfusion, although this area of perfusion may not, in fact, be normal and may provide false 
negative results particularly in patients with significant three-vessel or left main disease.17,18 
Stress echocardiography has limited sensitivity for the detection of single-vessel disease. This 
makes it a useful tool for clarifying prognosis but less useful for excluding coronary disease as 
a cause of symptoms.19 
Current 64-slice CT scanners have been shown, in numerous studies, to have high sensitiv-
ity and specificity for the exclusion of significant coronary artery disease. In this regard it is 
important to note that the prognosis of a patient with a normal scan result appears to be 
very favorable.20-22 As a result, a CT-based approach seems most useful in patients with a low 
to intermediate pre-test likelihood of CAD, in whom it is deemed necessary to evaluate the 
coronary anatomy.23 Most clinicians would advocate ICA, in an interventional center, as the 
preferred strategy in patients with a high pre-test likelihood of CAD, because of the additional 
Figure 2. Flow chart showing current diagnostic work-up of patients with suspected stable coronary artery disease. Multiple non-
invasive functional tests are available, such as exercise stress testing, nuclear scintigraphy, stress echocardiography and magnetic 
resonance imaging. When exercise is well tolerated and the rest ECG is normal, exercise electrocardiography is the first choice 
test. Low tolerability for physical stress and/or electrocardiographic abnormalities at rest are good reasons to choose an imaging 
technique combined with pharmacological stress instead. Documentation of myocardial ischemia is the preferred situation to 
proceed with invasive coronary angiography (ICA). However, an inconclusive stress test or findings that are discordant with clinical 
presentation are often sufficient reason to perform an ICA to reduce level of uncertainty. 
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option, in patients with suitable anatomy and who have been appropriately pretreated, to 
perform an ad hoc therapeutic intervention.
Figure 2 summarizes the current work-up of patients presenting with chest discomfort in whom 
stable angina is suspected. A careful history and clinical examination remains the cornerstone 
of the diagnostic assessment.7 Stress testing whether or not combined with an imaging modal-
ity, using echocardiography, SPECT, or magnetic resonance imaging, is usually recommended 
as the next step in order to document the presence and severity of myocardial ischemia. The 
demonstration of ischemia is an important consideration for further management as its pres-
ence impacts on the prognosis of a given patient.24 Recent guidelines and trial data endorse 
this strategy before proceeding to an invasive assessment of coronary anatomy and eventual 
revascularization.25-27 The exact place of CTCA within the current diagnostic work-up of CAD 
Figure 3. Potential algorithm incorporating CT coronary angiography (CTCA) into the existing diagnostic armamentarium of 
noninvasive functional tests. Patients are triaged for further testing based on the pre-test likelihood of coronary artery disease. 
Patients with a low-to-intermediate likelihood are ideal candidates for noninvasive anatomical imaging. Patients with high pretest 
likelihood preferably undergo a functional test before referral for invasive coronary angiography. CAD, coronary artery disease; 
LM, left main.
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has not yet been fully defined. Its high negative predictive value makes it most useful as a 
rule-out-test for the presence of clinically relevant CAD. For the purpose of exclusion of CAD, 
CTCA is most effective when used for the symptomatic patient with a low or intermediate pre-
test likelihood of significant CAD.4 A negative CTCA would preclude the need for further di-
agnostic testing and therefore represents a strong addition to the diagnostic armamentarium. 
A possible diagnostic algorithm incorporating the advantages of CTCA is presented in Figure 
3. As a morphological test, CTCA has limited value for predicting the hemodynamic impact 
of overt CAD. Head-to-head comparisons with nuclear perfusion data and invasive measure-
ments of coronary flow performed in the catheterization laboratory show that about half of 
coronary lesions graded as ≥50% diameter stenosis by CTCA do not induce ischemia under 
stress.28,29 Patients with a high pre-test likelihood of CAD therefore continue to benefit most 
from an approach providing functional information, using stress imaging tests. Patients in the 
low-to-intermediate range, who exhibit significant anatomical disease on CTCA, preferably 
undergo a combined approach with a subsequent functional test to reveal the physiological 
relevance of the coronary narrowing. Referral to the catheterization laboratory for further 
invasive assessment and definitive exclusion of the functional severity of a specific epicardial 
stenosis, using fractional flow reserve (FFR), might be the preferred approach for patients with 
significant left main- or multivessel CAD on CTCA, due to underestimation of the extent of 
ischemia by non-invasive functional tests.18,30 
limiTaTionS oF invaSive Coronary angiography
ICA is only a reliable technique when it provides optimal images, which include appropriate, 
non-standard projections, to clarify ambiguities and images after the intracoronary injection 
of nitrate, where necessary.31 In the hands of less experienced operators, or of operators who 
do not perform PCI, this is often not achieved.32,33 Furthermore, contrary to the general belief, 
ICA does not always prove to be the gold standard technique for the visualization of the coro-
nary anatomy even in the hands of an expert angiographer.34 Indeed, the intrinsic limitations 
of an imaging technique that is inherently 2-dimensional make it sometimes impossible to ac-
curately assess the presence or severity of a coronary narrowing especially where the anatomy 
is complex.35 (Figures 4 and 5) 
Complex Anatomy
Failure to visualize or to understand the anatomical course of a coronary artery has become 
a frequent reason to refer a patient for an alternative imaging technique. Coronary anomalies 
are the prototype example where the cardiac catheterization findings often are inconclusive 
or result in a prolonged procedure with excessive use of contrast material. (Figure 6) In this 
regard, cardiac CT is becoming the investigation of choice to depict the complex 3-D course 
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of coronary arteries and their rela-
tion to surrounding structures.36,37 In 
experienced centers, coronary mag-
netic resonance angiography pres-
ents an excellent alternative and 
offers the additional advantages 
of not using ionizing radiation and 
contrast material.38
Figure 4. (a) Invasive coronary angiogram (ICA) of the right coronary artery (RCA). The diagnostic catheter (arrow) is obscuring 
the ostium of the vessel. The distal segment has significant stenoses (arrowheads). (b) ICA of the left coronary artery, showing a 
significant narrowing in the proximal left anterior descending coronary artery (arrowhead). The distal part of the left main coro-
nary artery (arrow) was judged to have atheroma without significant narrowing. A straight anteroposterior view (inset), which was 
performed when the patient was scheduled for a percutaneous coronary intervention, clearly shows a severe stenosis at this level 
(arrowhead).
Figure 5. Corresponding CT coronary angiogram. 
(a) Curved multiplanar reconstruction of the right 
coronary artery confirming the stenoses in the dis-
tal segment (arrows). The ostium (inset) also shows 
a high-grade stenosis (arrowheads), which was not 
visualized on the invasive coronary angiogram. (b) 
Multiplanar reconstruction of the proximal seg-
ments of the left coronary artery, clearly showing 
significant stenoses in the distal part of the left 
main coronary artery (large arrow), the proximal 
left anterior descending coronary artery (small ar-
rows) and the large intermediate branch (arrow-
heads). Ao, indicates ascending aorta. 
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Moreover, CTCA can pro-
vide accurate information 
to facilitate the subsequent 
therapeutic approach in 
other difficult anatomical 
settings, such as ostial le-
sions, lesions at bifurcations 
or in the left main artery, 
and chronic total occlusions
Ostial Lesions
Catheter-based imaging of 
coronary ostial disease can 
be technically challenging 
because of difficulties in ob-
taining adequate contrast 
opacification while keep-
ing the catheter outside the 
ostium. More often, the os-
tium is not properly assessed 
due to deep catheter intu-
bation. (Figure 7) Failure to 
recognize catheter-induced 
spasm, a condition that typi-
cally affects the right coronary artery may lead to inappropriate intervention. (Figure 8) These 
caveats are not an issue in cardiac CT. Indeed, in our experience CTCA has become the pre-
ferred imaging tool for re-assessment of suspected ostial pathology in patients whose initial 
ICA has been inconclusive. 
Bifurcations 
Coronary atherosclerosis exhibits a predilection for areas of low shear stress, typically at bifur-
cation sites. Plaque build-up usually is already extensive in these areas before it is detected on 
ICA. Currently, PCI for bifurcation pathology involves up to 20% of attempted lesion subsets.39 
PCI of bifurcation lesions remains quite challenging and the most effective treatment strategy 
remains as yet undefined. Important determinants of the chosen approach are the distribution 
of plaque in main vessel and side branch, as well as the degree of angulation between both 
branches. Coronary bifurcations are notoriously difficult to examine completely by ICA de-
spite multiple angiographic projections, due to factors such as vessel overlap and foreshorten-
ing.40 Cardiac CT offers accurate 3-D information and is not subject to the limitations of ICA. 
Figure 6. Anomalous origin of the right coronary artery (RCA). (a) An aortogram 
was performed to localize the origin of the RCA, whose contours are faintly visible 
(arrowheads). (b) Non-selective injection confirms its origin (arrowheads) in the left 
coronary cusp. (c, d, e) CT coronary angiogram clearly showing the anomalous origin 
(arrowheads) and course of the RCA.
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(Figure 9) CTCA reliably assesses 
the plaque distribution across the 
bifurcation and in contrast to ICA 
allows a more precise assessment 
of coronary bifurcation angles.41,42 
These advantages are of potential 
benefit for deciding on an ad-
equate treatment strategy. 
Left Main Coronary Artery
Evaluation of the left main (LM) 
coronary artery on ICA combines 
the difficulties that arise when as-
sessing both ostial and bifurca-
tion disease. Indeed, ostial lesions 
of the left anterior descending or 
circumflex arteries frequently in-
volve the distal LM bifurcation. 
Despite its clinical significance, 
LM disease may not be accurately 
evaluated by ICA alone.43,44 CTCA 
overcomes the limitations of ICA 
and can be a clinically useful, ad-
junctive method to evaluate ostial 
and distal bifurcation LM coronary 
artery disease where the results of 
ICA are ambiguous. (Figure 10) 
Chronic Total Occlusions
Coronary chronic total occlusions 
(CTOs) are found in up to 50% 
of patients with significant coro-
nary artery disease, but PCI is at-
tempted in only a fraction of these 
lesions.45 The relatively low pro-
cedural success rate compared 
to PCI of non-occluded coronary 
arteries and the higher risk of pro-
cedural-related complications in 
Figure 7. Patient with a true os-
tial stenosis of the right coronary 
artery. (a) Initial invasive coronary 
angiogram showing the stenosis 
(arrow). (b) These findings are 
confirmed (arrow) when the pa-
tient was rescheduled to undergo 
a percutaneous coronary inter-
vention. The contrast injection 
this time was nonselective, as 
is obvious from the appearance 
of contrast in the right coronary 
cusp (arrowheads), to minimize 
the chances of catheter-induced 
spasm. (c) A significant ostial lesion (arrow) is seen on the corresponding CT 
coronary angiogram. (d, e, f, g) Cross-sectional intravascular ultrasound (d 
and f) and CT (e and g) images, clearly showing the significant narrowing 
of the lumen (d and e). The extent of disease (e, arrows) in the vessel wall is 
quite obvious on CT and the residual lumen area (arrowheads) is very small. 
(f, g) Corresponding cross-sections at the reference site (panel c, arrowhead), 
distal to the stenosis.
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case of failed recanalization account for 
the rather low rate of attempted PCI.46 
Several angiographic features have been 
identified as predictors for successful 
recanalization, and the presence or ab-
sence of these can influence the deci-
sion regarding whether PCI is attempted 
or the patient is referred for bypass sur-
gery.47 CTCA not only assesses the lumi-
nal impact of atherosclerosis, but also visualizes the disease process in the coronary artery wall 
and by consequence in occluded parts of the coronary arteries. (Figure 11) Independent pre-
dictors of PCI failure for CTOs, are the length of the occlusion and the presence of heavy cal-
cifications within the occluded segment: 
both variables are more precisely defined 
by CTCA as compared to CCA.48 Prepro-
cedural evaluation of CTOs by means of 
CTCA is becoming routine in several institutions as it provides the interventional cardiologist 
a roadmap that appears to be helpful in the selection of the guidewire for crossing the oc-
clusion.49,50 This is important as differentiating the nature of the occluding plaque whether 
it is soft (lipid-rich) or hard (fibrocalcific), will have an impact on device selection and clini-
Figure 8. Patient who was referred to undergo a percu-
taneous coronary intervention for an ostial stenosis of 
the right coronary artery. (a) Initial angiographic image 
showing the coronary narrowing (arrowhead). (b, with 
inset) On cardiac CT the vessel had a normal appear-
ance. (c) A repeat coronary angiogram confirmed the CT 
findings. (d) On intravascular ultrasound the ostium was 
indeed widely patent with only minimal intimal thickening 
(arrowheads).
Figure 9. (a) Invasive coronary angiogram showing a sig-
nificant bifurcation lesion (large arrow) of the left anterior 
descending coronary artery with the first diagonal branch 
(D1). Also note the limited contrast enhancement (small 
arrows) in what looks like a small side branch. (b) Three-
dimensional reconstruction of the heart with CT showing 
the bifurcation lesion. The dense spot within the lesion 
(arrowhead) corresponds to calcification. The branch 
that was faintly visible angiographically, can now clearly 
be recognized without interference of overlapping ves-
sels as the intermediate branch (arrows). (c) 3-mm thick 
maximum intensity projection clearly showing the calci-
fied (arrowhead) and non-calcified plaque components 
causing the lumen narrowing. (d) After wiring the inter-
mediate branch its true dimension can be well appreci-
ated (arrows).(A full color version of this illustration can 
be found in the color section)
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cal outcome.51 Also the 3-D visualization 
of the course of the occluded vessel part 
enables the interventional cardiologist to 
steer the guidewire towards the direction 
of the distal vessel beyond the occlusion. 
(Figure 12) 
Plaque imaging
CTCA has provided non-invasive confirmation of the fact, often reiterated by surgeons and pa-
thologists, that ICA greatly underestimates the extent of coronary atherosclerotic disease. The 
fundamental difference between ICA and CTCA is the basic image format. While ICA provides 
high-resolution imaging, it only provides a 2-D representation of the coronary artery lumen. 
CTCA overcomes the limitations of silhouette imaging and reveals details of the distribution 
and composition of atherosclerosis within the vessel wall. (Figure 13) 
It is not yet clear whether a targeted 
interventional approach, a systemic 
pharmacological approach, or a hybrid 
Figure 10. (a) Invasive coronary angiogram (ICA) of 
the left coronary artery in a female patient with atypi-
cal chest pain who presented with ventricular fibrillation 
during a bicycle stress test. Although not visible there 
was a suspicion of ostial left main disease because of 
the absence of contrast back flow in the coronary sinus. 
(b and c) The CT coronary angiogram clearly shows a 
severe ostial narrowing (arrowheads). (d) A non-selective 
repeat ICA confirms the CT findings (arrowhead). (e and 
f) A percutaneous coronary intervention was performed: 
shown are the positioning and deployment of the stent. 
(g) Postprocedural coronary angiogram.
Figure 11. Patient with recurrent angina after previ-
ous coronary bypass graft surgery, including a venous 
graft to the right coronary artery (RCA) and left in-
ternal mammary artery (LIMA) to the left anterior de-
scending coronary artery. At initial invasive coronary 
angiography the origin of the left coronary artery ap-
peared occluded. (a) Cardiac CT scan, coronal view, 
indeed showing a short occlusion (arrowheads) of the 
left main stem. (b) Three-dimensional reconstruction 
of the heart showing the patent LIMA (arrow) and ve-
nous graft to the RCA (arrowheads). (c) Contrast injec-
tion after wiring of the LIMA (arrow) results in opaci-
fication of the native coronary artery up to the distal 
part of the left main stem. (d) Six-month angiographic 
result after successful PCI (inset) of the left main stem. 
(A full color version of this illustration can be found in 
the color section).
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approach to the treatment of plaques, 
identified as being at high-risk of causing 
future adverse events, will prevail. How-
ever, visualization and characterization of coronary plaques with CTCA is feasible and may 
provide us a novel way of assessing the coronary atherosclerotic disease process. A role for 
CTCA in identifying high-risk plaque or in natural history studies that use novel compounds to 
alter plaque burden or characteristics may emerge in the future. Currently, no data is avail-
able that show a patient 
benefit from using CTCA 
as a tool for risk stratifi-
cation in asymptomatic 
individuals. 
 
Figure 12. (a) Invasive coronary angiogram, showing a 
chronic total occlusion of the right coronary artery. Si-
multaneous contrast injection in the left coronary artery 
shows filling of the distal part of the RCA (arrow) through 
collaterals. (b) Antegrade attempt at recanalising the 
RCA shows movement of the wire into smaller branches 
supplying the right ventricle (arrowhead). To facilitate the 
direction of the antegrade wire, a second wire (arrows) 
was positioned retrograde through the collateral system. 
(c, d, e and f) The CT images provide a roadmap to show 
which direction the wire should go. Clearly shown are the 
small right ventricular branches (c, e and f, arrowhead), 
the path of the occluded vessel in the sagittal plane (d, 
small arrows) and frontal plane (e, small arrow). The dis-
tal part of the RCA (d and e, large arrow) is filled with 
contrast through collaterals. (A full color version of this 
illustration can be found in the color section).
Figure 13. (a) Invasive coronary angiogram 
showing “lumen irregularities” (arrowheads) 
and thus indirect signs of atherosclero-
sis proximal to the origin of the first septal 
branch (arrow). (b) Corresponding CT coro-
nary angiogram, maximum intensity projec-
tion, showing atherosclerosis (arrowheads) in 
its earlier stages, i.e.outward remodeling of 
the vessel without lumen impairment, proxi-
mal to the take-off of the first septal branch 
(arrow). (c) Intravascular ultrasound of the 
left main stem clearly showing plaque build-
up in the intimal layer (arrowheads).
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TherapeuTiC uSe oF CardiaC CT imaging
Guidance During Complex Percutaneous Coronary Interventions
In addition to its diagnostic value, cardiac CT images may also facilitate the performance of 
PCI. This is currently being investigated by integration of CTCA datasets into magnetic naviga-
tion systems.52 Precise control of the direction of a guidewire or a device in three-dimensional 
space offers a means to access difficult lesions and tortuous vessels that are often challenging 
to approach with conventional methods.53,54 (Figure 14) 
Percutaneous Treatment of Valvular Heart Disease
In addition to the investigation of the coronary arteries, cardiac CT systems can be used to 
assess the dimensions of the aortic root, left ventricular function, and disease of the large 
extra-cardiac arteries. Percutaneous aortic valve replacement (PAVR) is an emerging technol-
ogy in the management of patients with severe aortic stenosis who are felt to be unsuitable 
for surgical management.55,56 These percutaneous heart valves are routinely implanted via a 
transfemoral arterial access using large diameter sheaths (18 to 24 French). There is limited 
experience with this technology to date; however, in the few centers that offer this therapeutic 
option, CT scans are routinely used to evaluate the size of the aortic annulus and iliac arteries 
to ensure appropriate sizing of the prosthesis as to ensure that the 18-to-24 French system can 
safely negotiate the peripheral arterial system. (Figure 15) 
Figure 14. (a) Invasive coronary angiogram, show-
ing a chronic total occlusion (arrow) of the circum-
flex artery (CX). Only the very distal part of the 
vessel is visible through collaterals (arrowheads) 
(b) Corresponding CT image (curved multiplanar 
reconstruction): compared to the angiographic in-
formation the occlusion appears much shorter and 
consists of non calcified tissue. (c) The CT dataset 
has been uploaded in the navigation software; 
the course of the CX, including the path of the 
occlusion, is marked by a green line overlay. (d) 
The course of the CX has been marked as a yellow 
line. The rectangular that is present in panel c and 
d marks the location of the wire tip in the vessel. 
The inset in panel d represents the perpendicular 
cross-sectional view of the vessel allowing the op-
erator to steer the guidewire in the desired direc-
tion. (A full color version of this illustration can be 
found in the color section).
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limiTaTionS oF CTCa: a noTe oF CauTion
Ongoing refinements in CT scan technology have brought this cardiac imaging tool to a 
point where accurate noninvasive assessment of coronary anatomy is feasible. As for any new 
technology being considered for clinical use, an important consideration is the incremental 
information provided by a new modality in comparison to existing standard assessments. Con-
tinuing increases in the cost of health care and the increasing use of cardiac imaging tests in 
particular, underscore the need for a test to be cost-effective before changing existing diagnos-
tic pathways.57,58 While acknowledging the need for further scientific evidence, several societ-
ies have issued guidelines describing the optimal use of cardiac CT in an appropriate clinical 
context.23,59 In general, CTCA proves most valuable for clinical situations where one seeks to 
confidently establish the absence of coronary artery disease. Initial studies have highlighted 
the potential of CTCA to be cost-effective in this regard.60 Determination of the target patient 
population is just one of the determinants of a successful cardiac CT program. Other factors, 
such as adequate heart rate control, the body mass index of the patient, and the extent of 
coronary artery calcification, are equally important and contribute to the “ readability” of a 
scan.61,62 A cardiac CT scan is not entirely limited to the heart, but also includes the adjacent 
thoracic structures. Non-cardiac findings requiring clinical or radiological follow-up are re-
ported in up to 25% of patients undergoing cardiac CT and emphasize the need for a multidis-
ciplinary approach.63 The potential increase in cancer risk due to CT-related ionizing radiation 
is an important limiting factor and is providing impetus for the development of dose-saving 
algorithms and new scanning protocols that will reduce the effective radiation dose to the level 
Figure 15. Eighty-three year-old woman with symptom-
atic severe aortic valve stenosis who was considered a 
candidate for percutaneous aortic valve replacement. (a) 
The thoraco-abdominal CT scan revealed severe calcifi-
cations (arrows) of the abdominal aorta and iliac arteries. 
(b) CT image, coronal view, showing the severe calcifica-
tions of the aortic valve (arrowheads). (c) Because of the 
expected difficult femoral access, the valve replacement 
was successfully performed through the left subclavian 
artery. The arrows are showing the borders of the freshly 
implanted aortic valve, which consists of an equine peri-
cardial valve mounted on a stainless steel bioprosthesis.
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of ICA.64-66 Finally, state-of-the-art cardiac CT imaging and interpretation requires adequate 
training both in cardiovascular disease and radiology imaging; ideally, at least 6 months active 
participation in a joint cardiology and radiology program in a dedicated teaching hospital.5,67 
ConCluSion
CTCA is a promising technique that has the potential to radically alter the diagnostic pathways 
we currently employ in patients with suspected coronary disease. Based on current knowledge, 
the use of CTCA as a diagnostic test is considered appropriate for clinical scenarios where one 
seeks to confidently exclude the presence of CAD. The more widespread use of CTCA, replac-
ing more costly diagnostic imaging modalities, in particular ICA and nuclear imaging studies, 
could result in substantial cost savings for the health care system. The cost-effectiveness of 
CTCA is currently being evaluated in large clinical trials. 
ICA remains the preferred option for the patient with typical angina as it provides the option 
of ad hoc intervention. As illustrated in this review, complementary coronary imaging using 
CTCA might be of value in certain circumstances to clarify whether surgery or PCI is a better 
option or to provide specific information that might aid in planning PCI. This complementary 
role of cardiac CT imaging already results in so-called “reverse referrals”, i.e. patients initially 
referred for ICA are subsequently referred for CTCA. 
Finally, although CTCA is finding its place as a diagnostic tool in clinical cardiology, it is criti-
cal to ensure that those performing it have adequate training in the technique and adhere to 
guidelines issued by professional societies.
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aBSTraCT
Death or myocardial infarction, the most serious clinical consequences of atherosclerosis, 
often result from plaque rupture at non-flow limiting lesions. Current diagnostic imaging with 
coronary angiography only detects large plaques that already impinge on the lumen and 
cannot accurately identify those that have a propensity to cause unheralded events. Accurate 
evaluation of the composition or of the biomechanical characteristics of plaques with invasive 
or non-invasive methods, alone or in conjunction with assessment of circulating biomark-
ers, could help identify high-risk patients, thus providing the rationale for aggressive treat-
ments in order to reduce future clinical events. The IBIS (Integrated Biomarker and Imaging 
Study) study is a prospective, single-center, non-randomized, observational study conducted 
in Rotterdam. The aim of the IBIS study is to evaluate both invasive (quantitative coronary 
angiography, intravascular ultrasound (IVUS) and palpography) and non-invasive (multislice 
spiral computed tomography) imaging techniques to characterize non-flow limiting coronary 
lesions. In addition, multiple classical and novel biomarkers will be measured and their levels 
correlated with the results of the different imaging techniques. A minimum of 85 patients up 
to a maximum of 120 patients will be included. This paper describes the study protocol and 
methodological solutions that have been devised for the purpose of comparisons among sev-
eral imaging modalities. It outlines the analyses that will be performed to compare invasive 
and non-invasive imaging techniques in conjunction with multiple biomarkers to characterize 
non-flow limiting subclinical coronary lesions. 
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BaCkground
Although coronary atherosclerosis is common, clinical events are relatively rare and not lin-
early related to either the extent or severity of atherosclerosis. The majority of acute coronary 
events arise from non-flow limiting lesions and are often the first clinical manifestation of pre-
viously subclinical atherosclerosis [1-5]. These observations, among others, led to the concept 
of the vulnerable atherosclerotic plaque, a plaque that has a high probability of causing a 
clinical event [6-8]. The most common post-mortem histological features in such plaques are 
the presence of a thin fibrous cap, a lipid-rich core, and infiltration by inflammatory cells [9-
14]. Less common pathological substrates for fatal clinical events are plaque erosion, nodular 
calcification and intraplaque hemorrhage [9,15]. 
Coronary angiography is the standard technique to define the presence and to assess the 
extent of coronary atherosclerosis; however, it can only detect plaques that impinge on the 
lumen. Given the diffuse nature of coronary atherosclerosis and the phenomenon of arterial 
remodeling, an extensive amount of plaque can be present yet go undetected on angiogra-
phy [16,17]. To detect potentially vulnerable plaque before it impinges on the lumen, other 
diagnostic modalities are needed [18-20]. Furthermore, accurate evaluation of the composi-
tion or biomechanical characteristics of such plaques could aid in the detection of high-risk 
lesions. 
Several circulating plasma biomarkers related to increased inflammatory burden, platelet ac-
tivation or endothelial activation correlate with the risk of cardiovascular events both in pa-
tients who have previously had an acute coronary event and in apparently healthy individuals 
[21-28] . Despite these epidemiological results, little data exist on the relation between cir-
culating biomarkers and local biomechanical or other structural characteristics of coronary 
plaques. 
The aim of the IBIS study is to characterize non-flow limiting subclinical coronary lesions by 
invasive and non-invasive imaging techniques in conjunction with multiple biomarkers.
meThodS
Patients and Study Protocol
From March to November 2003 we enrolled 90 patients in IBIS a prospective, single cen-
ter, non-randomized, observational study. No formal sample size calculations have been per-
formed. Follow-up will be completed in summer 2004. Patients 18 years of age or older 
were eligible for inclusion if (1) they presented with stable angina pectoris, documented silent 
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ischaemia or an acute coronary syndrome (unstable angina pectoris, non ST segment eleva-
tion or ST segment elevation myocardial infarction) and (2) they underwent successful percu-
taneous coronary intervention (PCI) of one or more lesions in the native coronary circulation. 
Successful PCI was defined as attainment of residual diameter stenosis <20% (visual assess-
ment), TIMI 3 flow and no residual dissection. Exclusion criteria are listed in table 1. Patients 
who met all the inclusion criteria and none of the exclusion criteria were enrolled. The study 
was performed in accordance with the principles set out in the Declaration of Helsinki and 
was approved by the Medical Ethics Committee of the Erasmus MC. All patients gave written 
informed consent.
A coronary artery, other than the vessel that was the target for percutaneous coronary inter-
vention (PCI), was designated as “the study vessel”. In order of preference, the left anterior 
descending artery (LAD), right coronary artery (RCA) or circumflex artery (CX, including large 
intermediate branches) were selected. In addition, interrogation of the PCI vessel could be 
undertaken at the discretion of the investigator. All invasive imaging procedures (coronary 
angiography, IVUS and palpography) were performed immediately after the PCI procedure or 
the morning following the PCI (where PCI was performed for STEMI). MSCT was preferably 
performed prior to invasive imaging; otherwise it was done within 21 days after PCI. Blood 
samples were obtained, whenever possible, prior to PCI from the arterial sheath before ad-
ministration of unfractionated heparin. In order to correlate the different imaging techniques, 
a region of interest (ROI) in the study vessel was defined. This was based on the MSCT scan; 
Figure 1. The region of 
interest (ROI) within the 
study vessel, in this ex-
ample the LAD, as deter-
mined by MSCT (A) is ap-
propriately matched with 
the angiographic (B) and 
IVUS (C) image. This ROI 
is demarcated by clear 
distal (in this example the 
first diagonal branch) and 
proximal (in this example 
the ostium of the Cx) 
anatomical landmarks. 
LAD = left anterior de-
scending artery; Cx = 
circumflex artery; diag = 
diagonal branch.
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a side branch was chosen as the distal boundary of the region of interest and a second side 
branch, or the ostium of the vessel, as the proximal boundary. An example is provided in Fig-
ure 1. 
Clinical follow-up visits were scheduled at 3 and 6 months. At each visit, an ECG and blood 
samples for biomarker analysis were obtained and data collected on clinical events. At 6 
months, repeat MSCT was performed, followed by repeat invasive imaging procedures on 
the study vessel. Whenever clinically-driven angiography was performed before the 3-month 
follow-up, patients were asked to return for the previously scheduled angiogram at 6 months. 
When angiography was performed after 3 months follow-up, this angiogram was consid-
ered as the final follow-up angiogram. All different invasive imaging techniques (angiography, 
IVUS, palpography) were repeated at follow-up; when PCI of the “study vessel” was indicated 
at follow-up, the imaging procedures were performed before intervention. Patients who failed 
to attend the follow-up visits were contacted by phone or by letter or information was obtained 
General and clinical criteria
a. Braunwald class IA, IIA, IIIA (unstable angina caused by non¬cardiac illness)
b. Pregnant women or women of childbearing potential who do not use adequate contraception
c. Known allergies to aspirin, clopidogrel bisulfate (Plavix ®), Ticlopidine (Ticlid ®), heparin, stainless steel, 
copper or a sensitivity to contrast media, which cannot be adequately premedicated
d. Life expectancy of less than one year or factors making clinical and/or angiographic follow-up difficult
e. Planned coronary bypass surgery or major non-cardiac surgery
f. Impaired renal function (creatinine >2 mg/dl or ≥ 150 mmol/L)
g. A history of bleeding diathesis or coagulopathy
h. Previous disabling stroke within the past year
Criteria related to invasive imaging
a. Severe 3-vessel coronary artery and/or left main disease with ≥ 50% stenosis
b. Minimal lumen diameter <2mm in the segments to be analyzed within the study vessel
c. Diameter stenosis >70% or total occlusion of the study vessel
d. In case the study-vessel has been stented previously more than 1/3 (outside the length of the stent plus 
5mm proximal and distal to the stent) of the study vessel should be available for examination
e. Ejection fraction ≤ 30%
f. Moderate to severe tortuosity (moderate: 2 bends >75° or one bend > 90°) of the proximal vessel in the 
segment(s) to be analyzed
g. Known tendency to coronary vasospasm
Criteria related to non-invasive imaging 
a. Heart rate>70 beats/minute 1 hour after administration of an oral beta-blocker 
b. Contra-indication to iodinated contrast material (e.g. known allergy, serum creatinine ≥150 mmol/L, 
thyroid disorders) 
c. Inability to hold breath for 20 seconds
d. Irregular heart rate (e.g. atrial fibrillation or very frequent PVCs)
Table 1. Exclusion criteria
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through the general practitioner, the patient’s next of kin or referring cardiologist. The patient 
was considered lost to follow-up if all these avenues were unsuccessful. 
Coronary Angiography
Conventional selective coronary angiography was performed with standard techniques. In 
order to obtain accurate and reproducible quantitative coronary angiographic (QCA) mea-
surements, each angiogram was preceded by the intra-coronary injection of nitrates (1-3 mg 
isosorbide dinitrate) and the catheter tip was cleared of contrast. QCA analysis was performed 
by the core laboratory using the Cardiovascular Angiography Analysis System II algorithm 
(CAAS II), as previously described in detail [29]. 
QCA: Definitions
The mean and minimal lumen diameters of the ROI were measured in all individual suitable 
projections. The average of these values for all available projections was calculated to provide 
an overall mean and minimal luminal diameter for the ROI diameter. A plaque was defined 
as luminal narrowing that resulted in ≥20% diameter stenosis within the ROI with respect to 
the interpolated reference diameter. The reproducibility for QCA has previously been reported 
[30]. An additional qualitative analysis will be performed on the pre-intervention angiogram(s) 
to assess the presence and severity of atherosclerosis, based on angiography, in the study 
population in order to allow comparison of the “total plaque burden” on angiography with that 
on MSCT. All segments of the coronary tree were analyzed by an independent experienced 
cardiologist. Each segment was classified as normal (smooth or tapering borders), as ather-
omatous without an identifiable plaque (<20% diameter stenosis visually), as atheromatous 
with a distinct but <50% stenosis, as atheromatous with a >50% stenosis but without occlu-
sion or as occluded. 
IVUS Imaging
The IVUS catheter used was a commercially available mechanical sector scanner with a 30- 
or 40-MHz transducer (UltracrossTM 2.9F 30 MHz catheter or CVIS AtlantisTM SR Pro 2.5F 40 
MHz catheter, Boston Scientific Corporation, Santa Clara, USA), connected to the GalaxyTM 
ultrasound console from Boston Scientific. Using an automated pullback device, the trans-
ducer was withdrawn at a continuous speed of 0.5 mm/s. Cine runs before and during contrast 
injection were performed to define the position of the IVUS catheter before the pullback was 
started. IVUS data were acquired after the intracoronary administration of isosorbide dinitrate 
and the data were stored on S- VHS videotape. The videotapes were digitized on a computer 
system, transformed into the DICOM medical image standard and stored on an IVUS Picture 
Archiving and Communications System (PACS). 
Rationale and Methods of the Integrated Biomarker and Imaging Study (IBIS): Combining Invasive and Non-Invasive Imaging 
with Biomarkers to Detect Subclinical Atherosclerosis and Assess Coronary Lesion Biology
53
Quantitative Coronary Ultrasound (QCU) Analysis
QCU analysis was performed by the core laboratory using validated software (Curad, ver-
sion 3.1, Wijk bij Duurstede, the Netherlands), which allows semi-automated detection of 
luminal and external elastic membrane boundaries in reconstructed longitudinal planes (L-
mode views) [31]. Due to catheter motion during the cardiac cycle, non-gated IVUS pullbacks 
result in a sawtooth-appearance of the coronary segment on the longitudinal views and thus 
interfere with the contour detection algorithms used in most QCU software packages. This 
phenomenon can also lead to inaccurate measurements. In order to obtain a smooth ap-
pearance of the vessel wall structures in the longitudinal views, the IntelligateTM image-based 
gating method was applied [32, 33]. This validated technique eliminates catheter-induced im-
age artefacts, by retrospectively selecting end-diastolic frames, thus resulting in more reliable 
volumetric measurements. Assuming a heart rate of 60 beats per minute and given a pull-
back speed of 0.5 mm/sec, the IntelligateTM method selects 2 IVUS frames per mm for data 
analysis. After performing QCU, the borders of the external elastic membrane (EEM) and the 
lumen-intima interface enclose a volume that was defined as the coronary plaque plus media 
volume (Figure 2). The intra- and interobserver variability in our institution for measurements 
of lumen, EEM and plaque+media cross-sectional area has been reported in a previous study 
[34]. Because of recent adjustments and improvements in the whole IVUS imaging chain, 
from catheter until final analysis, the observer-related variability data will again be determined 
for a subset of patients included in the IBIS study [33, 35].
IVUS plaque characterization: Computer-aided grey-scale analysis
In addition to plaque volume, IVUS also provides information on plaque echogenicity, a poten-
tial source of information on plaque composition. The acoustic characterization of a coronary 
plaque has been investigated by in vitro and in vivo studies that support a role for echogenicity 
as a predictor of histological plaque composition [18, 36-39]. In the present study, we used a 
computer-aided grey scale value analysis program for plaque characterization [40]. Using the 
Figure 2. Longitudinal view (A) of the ROI on IVUS, as obtained by the IntelligateTM method [33]. The tissue between the external 
elastic membrane (EEM), depicted in green, and the lumen-intima interface, depicted in red, is defined as the coronary plaque plus 
media volume. For the purpose of this study, significant coronary plaque was defined as a plaque that occupied >50% of the area 
within the EEM. This is indicated in the longitudinal view by P1 (plaque 1) and P2 (plaque 2) and shown in a cross-sectional image 
of P2 (B). LII = lumen-intima interface. (A full color version of this illustration can be found in the color section).
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mean grey level of the 
adventitia as a thresh-
old, 5 main tissue types 
can be characterized 
(Figure 3): (1) hy-
poechogenic tissue has 
a mean grey level lower 
than that of the adven-
titia, (2) hyperecho-
genic tissue, defined as 
tissue with a mean grey 
value higher than that 
of the adventitia, (3) 
calcified tissue, defined 
as a tissue with a mean 
grey value higher than 
that of the adventitia 
with associated acous-
tic shadowing, (4) un-
known tissue, defined as tissue shadowed by calcification and (5) “upper” tissue, defined as 
tissue that has a mean grey value higher than the mean adventitial intensity plus two times its 
standard deviation but is not typical calcified tissue with acoustic shadowing. An example of a 
recording illustrating some of the types of tissue described is presented in Figure 4. 
Plaque Size and Composition by IVUS: Definitions 
For the purpose of the IBIS protocol, significant plaque was defined as the presence of echo-
lucent media and echogenic plaque area that resulted in a ≥50% reduction in the cross-
sectional area circumscribed by the external elastic membrane (EEM). Plaque composition 
was classified, as defined previously, based on tissue echogenicity. Plaque within the ROI was 
considered calcified if it contained calcium in at least 2 consecutive cross-sections (0.5mm < 
calcified plaque <1mm) and was scored in a binary fashion.
Palpography 
Intravascular palpography is a new parametric imaging technique based on IVUS that as-
sesses the local mechanical properties of the vessel wall and plaque. The underlying principle 
is that soft material will deform more compared with hard material when force is applied to 
the tissue. The naturally occurring pulsatile arterial pressure provides the force. The relative 
deformability of coronary plaque components can be estimated by measuring the relative 
displacements of radiofrequency (RF) signals, recorded during IVUS acquisition, at 2 differ-
Figure 3. Panel A shows a histogram of the distribution of the grey level intensities of the 
pixels in the adventitia, which is located outside the EEM contour, in all the cross-sections of 
the ROI. In order to obtain a reliable reference value, parts of the adventitia with reduced 
intensity, due to acoustic shadowing, are excluded. When the distribution of the grey values 
in the histogram follows a normal distribution, shown here as a red line, the ultrasound 
images can be reliably used for image based tissue characterization. An example of a cal-
cified plaque with acoustic shadowing of the adventitia is provided in panel B and C. The 
non-shadowed part of the adventitia is colored white (panel C). (A full color version of this 
illustration can be found in the color section).
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ent pressure levels [41]. Post-processing of RF signals derives data regarding deformation of 
the tissue and allows the construction of a “strain” image in which “harder” (low strain) and 
“softer” regions (high strain) can be identified. The local strain is displayed color-coded from 
blue for 0% strain via red to yellow for 2% strain as a complementary image to the IVUS echo-
gram (Figure 5) [42]. The resolution of the strain measurement in the radial direction is 200 
µm. In vitro and in vivo studies have validated the technique and found higher strain values 
in fatty as compared to fibrous plaques [19, 41, 43]. A recent in vitro study demonstrated the 
diagnostic potential of palpography to identify thin cap fibroatheromas [42]. 
Figure 5. A, the intravascular palpogram is superimposed on the IVUS image. This technique measures the deformation of the 
underlying vessel wall and plaque in the radial direction. The resulting strain values are plotted as a color-coded contour at the 
lumen vessel boundary. 
B is an example of a plaque with a low strain on the surface. C shows a plaque with high strain. (A full color version of this illustra-
tion can be found in the color section).
Figure 4. Examples of tissue types as de-
fined by the computer-aided grey scale 
analysis program. Panels a, d and g show 
the delineation of the lumen-intima (red), 
EEM (green) and adventitia (blue). Panels 
b, e and h are the corresponding cross sec-
tions and depict the different tissue types 
in different colors: red structures are hy-
poechogenic; green spots are hyperecho-
genic. Panel h also explains the principle of 
unknown tissue, colored yellow: tissue that 
cannot be characterized due to acoustic 
shadowing from calcium.
The histograms (c, f, i panels) are divided 
in three portions, each portion showing the 
main tissue type of the plaque. Panel c, the 
majority of the plaque is located in the left 
portion of the histogram and is therefore 
hypoechogenic. Panel f, example of a hy-
perechogenic plaque. Panel i, example of a 
mainly hypoechogenic plaque, with a rim of 
calcium. (A full color version of this illustra-
tion can be found in the color section).
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All data in IBIS were acquired using a 20 MHz Jovus Avanar F/X IVUS catheter (Volcano, 
Rancho Cordova, CA, USA), which was connected to an InVision Gold IVUS console. Record-
ings were obtained at a pullback speed of 1 mm/sec using a mechanical pullback device 
(Trackback II, Volcano, Rancho Cordova, CA, USA). Simultaneously, the ECG and intraluminal 
pressure signals were recorded. Acquisition was done with a custom made dedicated worksta-
tion connected to the digital interface of the IVUS machine. Each acquisition was stored on 
a separate DVD. Processing and analysis of the data was done independently by observers 
unaware of the results of the other techniques. The reproducibility of three-dimensional pal-
pography at our institution has been recently reported [44]. 
Palpography: Definitions
The strain value that best discriminates a plaque at risk of rupture has a threshold of 1.26% 
[42]. Strain values were classified according to the ROC classification (ROtterdam Classifica-
tion) as low strain spots (ROC I: 0.0 - <0.6%), moderate strain spots (ROC II: 0.6 - <0.9%), 
medium strain spots (ROC III: 0.9 - <1.2%), or high strain spots (ROC IV: >1.2%). 
Multislice Spiral Computed Tomography (MSCT)
Intravenous contrast injection with multislice coronary tomography allows non-invasive visual-
ization of coronary arteries including visualization and evaluation of non-calcified and calcified 
plaques [45, 46]. Patients with resting heart rates >65 beats/minute received a single oral 
dose of 100 mg metoprolol (SelokeenÒ, AstraZeneca Pharmaceuticals, UK), one hour prior 
to the MSCT scan. All scans were performed using a true 16-row detector MSCT scanner 
(Sensation 16, Straton) with a gantry rotation time of 375 ms. Other scan parameters were: 
16 x 0.75 detector collimation, table feed 3.0 mm/rotation, tube voltage 120 kV, tube current 
500-600 mAs. A bolus of 140 ml Iodixanol with an Iodine content of 320 mgI/ml (Visipaque 
320, Amersham Health, UK) was intravenously injected in an antecubital vein at 4 ml/s. A bo-
lus tracking technique was used to synchronize the arrival of contrast material inside the coro-
nary arteries and the start of the scan: a ROI was positioned inside the ascending aorta and 
the mean density within the ROI was monitored at intervals of 1.25 ms after the start of the 
injection. The patient was instructed, via an automated prerecorded message, to perform a 
breath hold when the mean density reached a predefined threshold (+100 HU), and the scan 
started 4 s later. All data were acquired during a single breath hold of 20 seconds, and images 
were reconstructed using retrospective ECG gating. An image reconstruction algorithm was 
used, which uses data obtained in half gantry rotation time resulting in a temporal resolution 
of up to 188 ms. To obtain motion-free images, standard reconstruction windows were select-
ed during the mid-to-end diastolic phase (350, 400, and 450 ms prior to the next R-wave), but 
additional image reconstruction windows were explored when deemed necessary. The dataset 
with least motion-artefacts was selected and loaded into an off-line workstation (Leonardo, 
Siemens, Forchheim, Germany). Then, a ROI in the study vessel was selected on multiplanar 
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reconstructed (MPR) images, 
using easily identified anatom-
ic landmarks (sidebranches 
or the ostium). Thereafter, the 
dataset was loaded into a semi- 
automated vessel-tracking soft- 
ware program and a central 
lumen line was created throughout the ROI. Ten, twenty, or thirty cross-sectional MPR images 
(depending on the length of the ROI) were reconstructed orthogonal to this central lumen 
line, and used for image analysis. A cardiologist and a radiologist, unaware of the results of 
other imaging modalities, independently evaluated the cross-sectional images. Disagreements 
were resolved by consensus. The image quality of all cross-sectional images was classified as 
reliable, adequate, or unreliable. Images with unreliable image quality were excluded from 
further analysis. 
MSCT: Definitions
Reliable cross-sectional MSCT images were visually evaluated for the presence of plaque; 
plaque was further classified based on size - as small, medium, or large- and composition 
- non-calcified, calcified, or mixed. A plaque was defined as a visually apparent abnormal 
space-occupying lesion, within the wall of the coronary artery that was clearly distinguishable 
both from the adjacent epicardial fat and from the coronary lumen. The mean Hounsfield 
unit (HU) of a plaque was defined as the average HU of the individual cross-sections with 
plaque.
Plaque size was further classified, based on their measured maximal thickness, as small (<1 
mm), medium (1-2 mm), or large (>2 mm). Plaque was defined as calcified if it contained 
high-density (>130 HU) components (Figure 6). Plaque tissue with both calcified and non-
calcified components was classified as mixed. HU of non-calcified and calcified tissue com-
ponents were measured in all cross-sections with medium and large plaques by positioning 
a ROI as far as possible from the lumen and adjacent epicardial fat. The k-values in our 
institution for inter- and intra-observer agreement regarding plaque size, using the 16-row 
detector MSCT scanner, have been determined in a group of 78 patients and are 72% and 
74% respectively.
Figure 6. (A), using the same region of 
interest as in Figure 1, different plaque 
types can be identified on MSCT. (B), 
cross-section at location 1, showing 
noncalcified plaque (23 HU). 
(C), cross-section at location 2, showing 
calcified plaque (579 HU).
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Finally, the total plaque burden of the entire coronary tree was assessed on MSCT. All coronary 
segments were assessed. Where not possible (vessel <2mm, vessel segment distal to an ap-
parent total occlusion, motion or other artefact rendering interpretation unreliable), this was 
noted. Plaque was defined as mentioned above and was further classified as non-calcified, 
mixed, or calcified. Where MSCT was performed after the intervention, evaluation of plaque 
burden in the stented segments was obviously not possible. In these patients, an independent 
observer assessed the preintervention coronary angiogram as follows: the segments that had 
been stented were scored, by imputation. The segment(s) that were the site of the culprit le-
sion were classified as having a large plaque. In some patients, segments that were stented 
had no significant stenosis on angiography. This mainly reflected our practice of stenting from 
“normal” to “normal” with drug-eluting-stents; in other situations, multiple stents were im-
planted to cover a dissection or to protect a compromised side branch. These segments were 
considered as non-assessable for the presence of plaque. Qualitative assessment for calcium 
was performed, as described above, in all stented segments.
IVUS Virtual Histology (IVUS-VH): an IBIS Substudy
IVUS VH is an intravascular ultrasound derived technique that analyses the radiofrequency 
component of the reflected ultrasound signal. As compared with standard IVUS, this imaging 
modality has the potential for more detailed assessment of different plaque components. In 
preliminary in vitro studies, four plaque types (fibrous, fibrolipidic, lipid core and calcium) as 
defined by histology could be correlated with a specific spectrum of the radiofrequency signal 
[47, 48]. The different plaque components are assigned colour codes: fibrous, fibrolipidic, 
lipid core and calcified regions are labelled green, light green, red and white, respectively 
(Figure 7). This technique, given its ability to identify lipid-rich plaques, could be of great value 
in identifying potentially vulnerable plaque. 
Figure 7. Atheroma morpholo-
gy by IVUS (A) and IVUS virtual 
histology (VH) (B). 
A, Concentric plaque with soft 
(-) and fibrous (+) components. 
B, The same cross-section in 
IVUS VH shows that this plaque 
has a more heterogeneous 
composition: fibrous (green), 
fibrolipidic (light green), lipid 
core (red) and calcified (white) 
components can be identified. 
(A full color version of this il-
lustration can be found in the 
color section).
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IVUS VH derives its data from the RF output of a conventional IVUS console and is ECG-gated 
for accurate data analysis. Since validation of the technique so far only exists for a 30 MHz sys-
tem, the same 30 MHz IVUS catheter, used for the acquisition of the IVUS data, was utilized. 
The RF and ECG signal were transferred from the Boston Scientific console to a dedicated 
IVUS VH (Volcano) platform. The IVUS VH data were stored on a CD-ROM and sent to the 
Imaging Core Lab at Cardialysis for offline analysis by one independent observer.
IVUS Virtual Histology: Definitions and Endpoints
In analogy with QCU, the tissue in between the EEM and lumen-intima interface was defined 
as the coronary plaque plus media. Classification of the coronary plaque into its 4 compo-
nents within the ROI was assessed independently from the media. Since IVUS VH was not 
incorporated at the start of the IBIS protocol, the results of this technique will only be reported 
as a substudy. The primary endpoints of this substudy are: (1) the volumetric correlation with 
QCU, (2) the correlation of the different plaque components with clinical presentation and 
biomarkers, (3) the correlation between plaque composition and strain pattern observed on 
palpography. Furthermore, the design of the IBIS study provides the means to address chang-
es in plaque composition.
Biomarker and Blood Analysis
Cardiac enzymes (including troponin), hemoglobin, hematocrit, red blood cell (RBC) count, 
white blood cell (WBC) count, platelet count, urea, creatinine, total cholesterol, HDL choles-
terol (HDL-C) and triglycerides were analyzed by the local laboratory. Plasma concentration of 
LDL cholesterol (LDL-C) was calculated by the use of the Friedewald formula [LDL-C= total 
cholesterol minus HDL-C minus (triglycerides/5)]. 
Plasma and sera used for biomarker analysis was centrifugally separated within 30 minutes 
of draw and stored at -70C. Analytes were measured using commercial ELISA kits from R&D 
Systems except where noted. Plasma high sensitivity interleukin 6 (hs IL-6), tumor necrosis 
factor alpha (TNFa), serum high sensitivity C-reactive protein (hsCRP- Diagnostic Systems 
Laboratories), lipoprotein phospholipase A2 (LpPLA2- GSK), ultrasensitive pregnancy asso-
ciated plasma protein A (PAPP-A-Diagnostic Systems Laboratory), matrix metalloproteinase 
9 (MMP-9), soluble CD40L (sCD40L- Bender MedSystems) and monocyte chemoattratact 
protein (MCP-1), were measured in the Human Biomarker Centre, GlaxoSmithKline, using 
protocols provided by the manufacturer. Results from the standardized ELISA assays were 
measured on a MRX Revelation microplate reader with 4.2 software. Plasma LpPLA2 activity 
assay measures the proportional release of aqueous 3H acetate resulting from the enzymatic 
cleavage of the 3H acetyl-platelet activating factor substrate using methodology developed at 
GlaxoSmithKline. All simple analyses were done in batches representing the three time points 
(baseline, 3 and 6 months follow-up). Internally developed matrix matched or kit provided 
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controls were incorporated to ensure consistency in the assay performance. NT pro BNP was 
measured in EDTA plasma by Quest Diagnostics using a two-site electrochemiluminescent as-
say. The lipoprotein subclass distribution was analyzed by Liposciences Inc. using NMR based 
technology. The analysis provided to us for the IBIS trial used the newest NMR LipoProfile II 
methodology.
In addition, serum batched by patient sets from all baseline and follow-up visits, were mea-
sured using an analyte defined (closed format) protein chip. Protein chips provide capability 
for the analysis of between 10 to 157 different chemokines, cytokines and growth factors de-
pending on the platform. Our analyses to date include the ZyomyxTM protein chip. The limits 
of quantification for the above analytes are as follows: 2.5 uIU/mL for PAPP-A, 0.18 ng/mL for 
MMP-9, 0.0048 mg/L for CRP, 6.31 pg/mL for MCP-1, 0.78 ng/mL for sCD40L, 0.057 pg/mL 
for IL-6, 0.88 pg/mL for TNF-α, and 3.92 nmols/min/mL for LpPLA2 activity.
Figure 8. Integration of the different imaging modalities, used in IBIS, into one graph provides a more comprehensive view on 
coronary atherosclerosis. Visualizing the same coronary artery segment, it becomes clear that the coronary angiogram grossly un-
derestimates the coronary plaque burden: a significant amount of plaque on IVUS (plaque/ EEM ratio > 50%) and MSCT (plaque 
thickness > 2mm) produces only a mild lumen reduction on angiography. The palpogram provides additional information on the 
plaque surface: in this patient two high strain areas (ROC 4) were identified. The ROI is shown in the x-axis (in this patient 22 
mm). The percent EEM-area reduction (on IVUS) and diameter reduction (on angiography) is depicted on the left y-axis. The right 
y-axis visualizes the plaque thickness in mm (MSCT) and the ROC score (palpography). Distal and proximal indicate the distal and 
proximal reference point in the coronary artery, with respect to the coronary ostium. (A full color version of this illustration can be 
found in the color section).
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Off-line Analysis of Imaging Techniques: 
Principles and Resolution of Problems
No previous study has attempted to identify and characterize either coronary atherosclerosis 
or potentially vulnerable coronary plaques with such a wide range of invasive and non-invasive 
imaging techniques (Figure 8) in conjunction with multiple analyses of classic and novel bio-
markers. 
In the present study all imaging techniques were analyzed independently. The QCA and 
QCU were performed by an independent Core Lab (Cardialysis) using standard operating 
procedures and validated methodology. The IVUS based tissue echogenicity, palpography, 
and MSCT analyses were performed independently by the research groups that developed or 
refined the techniques in our institution. 
Ideally, we aimed to study a common ROI ≥30 mm long for all techniques. This was possible 
for the majority of patients but specific difficulties related to each technique required either a 
redefinition of the original ROI, before database lock, or the use of a shorter ROI within the 
initially defined region, in some patients. For all patients, the initial ROI was to be determined 
on MSCT. However, in some cases the landmarks on MSCT were not identifiable on IVUS. 
This primarily occurred in the RCA when the ostium was chosen as a landmark on MSCT but 
was not reliably identified on IVUS because the distal tip of the guiding catheter was within 
the coronary artery. In a few cases, the ROI could not be determined on MSCT. This was 
mainly related to uninterpretable images due to artefact related to high heart rates, irregular 
heart rates, or cardiac motion (exclusively in the RCA). Finally, in some cases, MSCT was not 
performed. 
Imaging Techniques: Parameters Measured at Baseline
IVUS 
Mean plaque area in the ROI as defined by QCU was used for comparisons among imaging 
techniques and for exploratory analyses on the relation between clinical and biological vari-
ables and the extent of subclinical atheroma in the ROI. To this end, mean plaque area (MPA) 
was calculated as the difference between mean total vessel area (ATV) and mean total lumen 
area (ATL). Total plaque volume (TPV) was calculated as the sum of the differences between 
external elastic membrane (EEM) and lumen areas across all frames in the region of interest 
[49] .The plaque variables we measured and their definitions are presented in Table 2. Calci-
fied plaque was measured in the ROI based on the presence or absence of calcium in each 
5 mm segment. 
Chapter 3
62
MSCT
The ROI was subdivided into 5 mm segments. Each 5 mm segment was classified as plaque 
free or as containing a small, medium, or large plaque. Each plaque was classified as non-
calcified, calcified, or mixed. Finally the longitudinal extent of calcium was expressed as an 
integer score based on the presence or absence of calcium in each 5 mm segment.
Comparison of QCU with MSCT
Based on QCU derived measurements of coronary atheroma (i.e. plaque and media), the abil-
ity of MSCT to detect coronary plaques resulting in ≥50% EEM area reduction and to detect 
calcification was assessed. To ensure that the same plaques were assessed by the different 
techniques and to allow correlations, the ROI within the study vessel was subdivided into 5 
mm segments as outlined above. The QCU and MSCT data were compared in corresponding 
5 mm segments in the ROI. 
Using these definitions, the ability of MSCT to detect plaque (binary classification; plaque 
present or absent) was compared with that of IVUS (binary classification, coronary plaque 
area ≥50% of the area enclosed by the EEM, yes/no). The effect of the presence or absence 
of calcium detected on IVUS on the specificity and sensitivity of MSCT plaque detection was 
also assessed, using a binary classification: calcium present/absent on MSCT or IVUS within 
the 5 mm segments. 
QCA
The overall mean and minimal lumen diameters of the ROI were measured. The number of 
plaques, defined as luminal narrowing that resulted in ≥20% diameter stenosis within the 
ROI, was also assessed. 
Volumetric variables (mm³)
Absolute plaque volume (mm3 )
 Total plaque volume (TPV) = ∑ (EEMCSA – LUMENCSA) 
Relative (percent) plaque volume (%)
 Relative plaque volume (RPV) = ∑ (EEMCSA – LUMENCSA) x 100
  EEMCS
Area variables (mm2)
 Mean plaque area (MPA) = Mean total vessel area (ATV) – mean total lumen area (ATL)
Table 2. IVUS coronary plaque measurements
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Tissue Echogenicity
The major variables measured using the tissue echogenicity program were absolute hypo-
echogenic and hyper-echogenic plaque volume (mm3). Other variables measured, defined in 
the methods section, were upper volume and unknown volume (mm3). These variables were 
also assessed for contiguous 5 mm segments within the ROI. 
Palpography
The number of ROC III and IV scores was measured in the ROI and in individual 10 mm seg-
ments of the ROI (ROC 3/4 density). 
Safety 
The occurrence of Major Adverse Cardiac and Cerebral Events (MACCE) was assessed after 
the procedure, at discharge, and at 3 and 6 months, as were the individual components: 
death, MI, revascularization by PCI or CABG, hospitalization for ischaemia and/or anginal 
symptoms, and stroke. They were classified, where possible, as related to the “study vessel”, 
the PCI vessel, or a non-PCI/non-study-vessel. The definition of myocardial infarction was 
identical to that defined in the ACC/ESC joint document on the redefinition of myocardial 
infarction [50]. Major bleeding and vascular complications were also prospectively recorded 
using standard definitions [51]. 
Statistics
For the comparison between and within techniques for each patient, for each analysis tech-
nique, and each time point, the same ROI, selected by the Core Lab, will be studied. Compari-
sons between techniques and within techniques (baseline versus follow-up) will be performed 
with use of either two-by-two tables (sensitivity, specificity) for qualitative outcomes or linear 
regression analysis (regression coefficient, scatter plots) for quantitative outcomes. For the 
analysis on a per patient level, including biomarkers, clinical parameters, and imaging tech-
nique results, the data will be summarized by vessel (ROI) and for 5 mm increments of the 
ROI. For each 5mm increment in each technique it was judged whether or not plaque could be 
detected. On the vessel level, plaque was defined as plaque in any of the 5 mm increments of 
the ROI. Circulating biomarkers will be correlated with imaging endpoints using the univariate 
Pearson correlation coefficients. We will also use Box and Whisker plots to compare biomarker 
distributions in predefined subgroups of the study population (diabetic status, anginal status, 
etc). Statistical analyses will be performed with use of SAS Version 8.
Discussion
Coronary atherosclerosis remains one of the major causes of mortality and morbidity in the 
Western Hemisphere. Advances in medical research have resulted in the introduction of new 
pharmacological agents that have significantly contributed to our ability to decrease the risk 
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of clinical events related to atherosclerosis. Furthermore, the discipline of interventional car-
diology has evolved from an experimental technology that was an option in highly selected 
patients to a discipline that complements and may soon largely replace coronary artery bypass 
surgery. 
In parallel, advances in our understanding of the mechanisms underlying atherosclerosis have 
clearly demonstrated that clinical events are not necessarily related to the severity of luminal 
narrowing in large epicardial coronary arteries. The potential contribution of a low-grade 
inflammation, infectious agents, genetic factors, and other putative mechanisms to the occur-
rence of atherosclerosis-related clinical events is the subject of intense investigation.
Finally, the recognition that death or myocardial infarction is often related to plaque rupture 
at the site of non-flow limiting subclinical atherosclerosis has evolved into the concept of the 
vulnerable atherosclerotic plaque. Post-mortem studies have shown that plaque rupture at the 
site of thin-cap fibroatheromas is the most common mechanism that leads to death from ath-
erosclerosis. However, it has also been clearly shown that such ruptures often remain clinically 
silent and contribute to lesion progression. As atherosclerosis is a diffuse process that involves 
many vascular beds and several sites within the coronary vasculature, better identification of 
plaque compositional characteristics is needed. The quest to identify reliable technique(s) to 
detect plaques that are at high risk of causing future clinical events is currently the subject 
of intense research activity. Ideally, biomarkers in peripheral blood, singly or in combination, 
could be used to identify patients at risk for new or recurrent clinical events such as sudden 
death or acute myocardial infarction. Appropriate non-invasive or invasive techniques could 
then be used to further refine risk stratification. 
Figure 9. Schematic outline of the remodeling 
process in coronary atherosclerosis, as assessed 
by IVUS. In theory nine remodeling patterns can 
be defined, as depicted. Determinants of the 
coronary artery lumen diameter are the change in 
plaque size and the process of vascular remodel-
ing, which is the change in the size of an artery 
over time. The change in the vascular lumen is 
indicated in the figure by the + (increase), - (de-
crease) or = (unchanged) signs.
By taking into account the, still to be determined, 
observer related variability of the IVUS data in this 
study, as indicated by the (hypothetical) dotted 
lines, the natural history of the remodeling pro-
cess can be defined for the IBIS population. The 
shaded box in grey indicates a change of 5 mm2 
along the x- and y-axis.
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The aim of the IBIS study is to evaluate the feasibility and safety of both invasive (quantita-
tive coronary angiography, intravascular ultrasound with tissue echogenicity and palpography) 
and non-invasive (multislice spiral computed tomography) imaging techniques to characterize 
non-flow limiting coronary lesions. The performance of MSCT to identify and characterize cor-
onary plaque will be directly compared with that of IVUS, the current gold standard. Multiple 
classical and novel biomarkers will be measured and their levels will be correlated with the 
results of the different imaging techniques. In addition, the potential utility of novel techniques 
such as tissue echogenicity and palpography will be evaluated.
Beyond these specific goals, the longitudinal character of the IBIS study will be utilized to as-
sess the natural history of arterial remodeling (Figure 9). Serial studies, like IBIS, that measure 
changes in vessel area at the same site over time are the ideal way to assess the remodeling 
process since they are not subjected to the limitations of using a reference site [52, 53]. A few 
IVUS studies with serial long-term (≥ 12 months) follow-up in patients with atherosclerotic 
coronary artery disease have recently been reported [54, 55].They substantiate the earlier 
knowledge that changes in the arterial lumen correlate more closely with the direction and 
magnitude of the remodeling process than with plaque size. 
Study Limitations
We used 2 different IVUS catheters in the present study. During the first 3 months of patient 
inclusion IVUS imaging was done using a 40-MHz catheter; all subsequent baseline and all 
follow-up analyses were done using the 30-MHz system. This approach was driven by the 
decision to include IVUS VH as an additional imaging technique 3 months after the start of 
the IBIS study. Ideally, the same IVUS catheter used at baseline should again be selected for 
the follow-up procedure. However, since both IVUS catheters were operated on the same 
display system (GalaxyTMconsole, Boston Scientific), this should not affect IVUS measurements 
[35].
Plaque assessment by MSCT was based on visual evaluation. While automated programs 
with the possibility of manual contour correction, such as used for QCA and IVUS, are under 
development for MSCT imaging, none are currently available for use.
IVUS examinations performed with a 40-MHz IVUS catheter will not be used for evaluation by 
IVUS VH since validation only exists for the 30-MHz system.
Where the initial ROI on MSCT could not be used for correlation with the other imaging 
techniques due to a problem with the identification of the landmarks, a new ROI was defined 
on MCST by the Core Lab in conjunction with an independent cardiologist, familiar with but 
not involved in the analysis of the various techniques. Where MSCT was not performed or 
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could not be interpreted, a ROI was defined on IVUS using proximal and distal anatomic 
landmarks. 
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aBSTraCT  
Objectives
Our purpose was to assess non-invasive imaging in detection of subclinical atherosclerosis and 
to examine novel invasive modalities to describe prevalence and temporal changes in putative 
characteristics of  “high-risk” plaques.
Background
Conventional coronary imaging cannot identify “high-risk” lesions. 
Methods
Conventional (quantitative angiography and intravascular ultrasound [IVUS]) and novel im-
aging (IVUS-based palpography and gray scale echogenicity) were performed at baseline 
and 6 months later in 67 patients with diverse clinical presentations. Different imaging tech-
niques were compared within a common segment defined by multislice computed tomogra-
phy (MSCT).
Results
Compared with IVUS, the sensitivity, specificity, and positive and negative predictive value of 
MSCT for detecting significant plaque was 86%, 69%, 90%, and 61% respectively. In coronary 
arteries with <50% stenosis, there were no temporal changes in luminal and plaque dimen-
sions measured by quantitative coronary angiography or IVUS; however, a significant reduc-
tion in abnormal strain pattern was detected on palpography (density high strain spots/cm: 1.6 
± 1.5 vs. 1.2 ± 1.4, p = 0.0123). These changes were mainly related to significant changes 
in patients who presented with ST-segment elevation myocardial infarction. The assessment 
of plaque echogenicity showed no temporal changes. There were no correlations between 
circulating biomarkers and quantifiable imaging parameters.
Conclusions
Mild angiographic disease is associated with large atherosclerotic plaques on MSCT. Conven-
tional invasive coronary imaging reveals static luminal and plaque dimensions on standard 
medical therapy with plaque hypoechogenicity remaining unchanged over the 6-month pe-
riod. By contrast, palpography measurements of strain correlate with clinical presentation and 
significantly decrease on standard medical therapy. Novel imaging modalities, such as pal-
pography, may provide insights into plaque biology and might eventually serve as intermediate 
end points in interventional trials.
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inTroduCTion
Atherosclerosis is a systemic disease in which the clinical sequelae only weakly correlate with 
its extent or severity. Furthermore, sudden death or acute coronary syndromes are frequently 
the first manifestation of previously subclinical atherosclerosis, and the majority of such events 
(i.e. 60-70%) occur as a result of plaque rupture at sites with noncritical luminal narrowing 
(1-5). Pathologic studies have correlated specific coronary plaque characteristics with fatal 
ischemic events, but conventional imaging techniques, such as quantitative angiography and 
quantitative intravascular ultrasound (IVUS) cannot reliably identify high-risk, rupture-prone, 
plaques prospectively (6). Thus, development of novel coronary imaging modalities to detect 
structural and compositional plaque characteristics has been the subject of intensive preclini-
cal and clinical research (7,8). In parallel with the advances in novel invasive imaging, non-
invasive multislice computed tomographic angiography (MSCTA) has matured to the extent 
that it can reliably identify flow-limiting coronary lesions in relatively unselected patients.
The aim of this study was four-fold: 1/ to determine the potential of MSCTA in the detection 
of subclinical, non-flow limiting coronary atherosclerosis; 2/ to assess the prevalence of high-
risk characteristics in such plaques with two novel IVUS-based imaging modalities (palpogra-
phy and echogenicity plaque characterization); 3/ to assess temporal changes in IVUS-based 
plaque characteristics of high-risk lesions; and 4/ we attempted to relate changes in imaging 
parameters to changes in systemic biomarker levels.
meThodS
Study Design and Patient Selection
This was a prospective, observational, single-center pilot study.  The study design has been 
described in detail elsewhere (9). Briefly, patients with stable angina, unstable angina, non-
ST-segment elevation or ST-segment elevation myocardial infarction (STEMI), referred for 
percutaneous coronary intervention (PCI), were eligible for inclusion. Major clinical exclusion 
criteria included significant renal dysfunction (creatinine > 2 mg/dl), prior coronary interven-
tion in the region of interest (ROI), life expectancy < 1 year, or factors that made follow-up 
difficult. Major imaging-related exclusion criteria included coronary anatomy that precluded 
safe IVUS examination of a suitable ROI or criteria that precluded acquisition of diagnostic 
noninvasive angiographic images (irregular heart rhythm or inability to hold breath for 20 s). 
Between March 2003 and November 2003, 90 consecutive patients were enrolled and follow-
up was completed in summer 2004. The study vessel was preferably a non-intervened artery. 
At the discretion of the operator, a second artery could be studied. The ROI was defined on 
the basis of MSCTA, using landmarks, such as branches or the vessel origin. At six months 
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follow-up, patients underwent repeat invasive imaging. The medical ethics committee of the 
Erasmus Medical Center Rotterdam approved the study protocol, and all patients provided 
written informed consent.
Quantitative Coronary Angiography and IVUS
Quantitative angiographic analyses were performed by a core laboratory (Cardialysis, Rot-
terdam, the Netherlands) with the use of edge-detection techniques (CAAS II, Pie Medical, 
Maastricht, the Netherlands). Mean and minimum luminal diameters and diameter stenosis 
were measured in at least two, preferentially orthogonal, projections, and averaged.
The IVUS was performed with commercially available catheters (30 MHz, Ultracross, or 40 
MHz, Atlantis SR Pro, Boston Scientific, Santa Clara, California) using standard procedures 
with an automated pullback device (0.5 mm/s) (10). Data were stored on videotape, trans-
formed into the Digital Imaging and Communication in Medicine (DICOM) image standard, 
and archived. Quantitative analysis was performed by the core laboratory with validated soft-
ware (Curad, version 3.1, Wijk bij Duurstede, the Netherlands) and retrospective image-based 
gating (11). The borders of the external elastic membrane (EEM) and of the lumen were 
traced. The enclosed area was defined as the coronary plaque plus media area (subsequently 
referred to as plaque area). Significant plaque was defined as a plaque that occupied 50% or 
more of the cross-sectional vessel area circumscribed by the EEM. Other IVUS measurements 
included length of the ROI, lumen volume, and vessel volume. Plaque volume (PV) was calcu-
lated as vessel volume minus lumen volume. The interobserver variability was determined by 
re-analyzing the baseline and follow-up IVUS recordings of 16 patients by a different core lab 
analyst. Sixteen patients (32 recordings) were randomly selected among recordings that ful-
filled the following two criteria: 1) ROI ≥30 mm long, and 2) both pullbacks were performed 
with the same type of IVUS catheter (30 MHz catheter).
Novel IVUS-Based Plaque Imaging: Echogenicity 
We used a computer-aided, gray-scale value analysis program for plaque characterization(12). 
Based on the mean gray level (brightness) of the adventitia, plaque was classified as brighter 
(hyperechogenic) or less bright (hypoechogenic) than the adventitia. Calcified plaque was de-
fined as plaque brighter than the adventitia with associated acoustic shadowing. The variables 
measured in the previously defined ROI included hypoechogenic PV and hyperechogenic PV 
(mm3) and relative plaque echogenicity, calculated as (hypoechogenic plaque volume/ sum of 
hypoechogenic and hyperechogenic plaque volume) x 100. For the comparison with MSCT, 
plaque within the ROI was considered calcified if it contained calcium in at least 2 consecutive 
cross-sections corresponding to an IVUS segment with a length of at least 0.5mm.
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Novel IVUS-Based Plaque Imaging: Palpography
Palpography is an IVUS-based technique that assesses the local mechanical properties of the 
coronary plaque. The technique measures the relative displacements of backscattered ra-
diofrequency signals, recorded during IVUS acquisition, at two different blood pressure levels 
to detect differences in deformability or strain of various plaque components. As such, lipid-
rich plaques will deform more and thus show a higher strain value compared with calcified 
or fibrous plaques (13). Palpography data were acquired during an IVUS pullback (1 mm/s) 
with a commercially available catheter (20 MHz Jovus Avanar, Volcano, Rancho Cordova, 
California).  With previously described and validated methodology, plaque strain values were 
assigned a ROtterdam Classification (ROC) score ranging from 1 to 4 (ROC 1: 0% to 0.6%; 
ROC 2: 0.6% to <0.9%; ROC 3: 0.9% to <1.2%; ROC 4: >1.2%) (13-16). The parameters 
measured included the number of ROC 3 or 4 spots in the ROI and the density of ROC 3/4 
spots, defined as the total number of ROC 3 and 4 scores that were counted in all cross sec-
tions that were acquired at 1-mm intervals in the whole ROI. This number was divided by the 
length of the ROI and multiplied by 10 to normalize to the pullback length.
 MSCTA 
All scans were performed on a 16-row detector scanner (Sensation 16, Straton, Siemens, 
Forchheim, Germany). The scan protocol and image reconstruction parameters were recently 
published (17). The dataset with least motion artifacts was loaded on an off-line workstation 
(Leonardo, Siemens) and the ROI identified on multiplanar reconstructions, on the basis of 
anatomic landmarks. Datasets were loaded on a semi-automated vessel-tracking software 
program and a central lumen line created throughout the ROI. Ten through 30 cross sections 
were reconstructed orthogonal to the center of the lumen and analyzed independently by two 
observers. Disagreements were resolved by consensus. Plaque was defined as an abnormal 
mass within the artery wall, clearly distinguishable from epicardial fat and the coronary lumen. 
On the basis of manually measured maximal thickness, plaques were classified as small (<1 
mm), medium (1 to 2 mm), or large (>2 mm). Calcification was defined by the presence of 
high-density components (>130 Hounsfield units).
Lipoprotein Levels and Biomarkers
Plasma concentrations of total cholesterol, high-density lipoprotein cholesterol (HDL-C), and 
triglycerides were measured in the local laboratory. The Friedewald formula was used to de-
rive low-density lipoprotein cholesterol (LDL-C) levels (18). Blood samples for additional bio-
marker analysis were stored at –70°C. Serum C-reactive protein (Diagnostic Systems Labora-
tories, Webster, Texas), plasma interleukin 6, and tumor necrosis factor-alpha (R&D Systems, 
Minneapolis, Minnesota) were measured in the Human Biomarker Center (GlaxoSmithKline, 
Philadelphia, Pennsylvania) on the basis of protocols provided by the manufacturer. Lipopro-
tein associated phospholipase A2 activity assay was measured by the proportional release of 
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aqueous 3H acetate resulting from the enzymatic cleavage of the 3H acetyl-platelet activating 
factor substrate (100 µmol/l). N-terminal pro brain natriuretic peptide was measured with use 
of a two-site electrochemiluminescent assay. 
Definition of Events and Follow-Up for Major Adverse Cardiac Events 
The occurrence of major adverse cardiovascular events was assessed after the procedure, 
at discharge, and at three and six months, as were the individual components: death, myo-
cardial infarction (MI), revascularization by PCI or coronary artery bypass graft surgery, 
hospital stay for ischaemia and/or anginal symptoms, and stroke. The diagnosis of MI was 
consistent with the American College od Cardiology/European Society of Cardiology definition 
(19). 
Statistical Analysis
Discrete variables are presented as counts and percentages. Continuous variables are pre-
sented as means ± SD, unless otherwise indicated. Comparisons between quantitative out-
comes were performed with use of scatter plots and linear regression analysis (regression 
coefficient). When appropriate, biomarker analyses were performed after natural logarithmic 
transformation. Correlations 
between imaging end points 
and circulating biomarkers 
were assessed, and univari-
ate Pearson correlation co-
efficients were calculated. 
Comparisons among patient 
subgroups, grouped by clini-
cal presentation, with find-
ings on palpography and on 
echogenicity, were performed 
at both vessel and patient 
level. In the latter case, the 
imaging findings from two 
ROIs in the same patient 
were averaged. Differences 
in means among groups 
were analyzed by a two-
sample t-test. A value p < 
0.05 (two-sided) was indica-
tive of statistical significance. 
No formal hypotheses were 
Figure 1. Flow chart detailing number of patients at baseline and follow-up. Values 
in parentheses reflect number of vessels examined with different imaging modalities. 
IVUS = intravascular ultrasound; QCA = quantitative coronary angiography. 
77
Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled with Assessment of Changes in Plaque Characteristics 
Using Novel Invasive Imaging Modalities. The Integrated Biomarker and Imaging Study (IBIS)
tested in this exploratory study; 
therefore p-values are given as 
such, without any correction for 
multiplicity of testing. Statistical 
analyses were performed using 
the Statistical Analysis System 
software version 8.2 (SAS Insti-
tute, Cary, North Carolina).
reSulTS
Patient Population
A flow diagram detailing the 
number of patients undergoing 
multimodality coronary imaging 
is presented in Figure 1. Sixty-
seven patients underwent serial 
invasive imaging of non-culprit 
segments of coronary artery at 
baseline and 196 ± 19 days lat-
er. Nine patients had one or both 
IVUS recordings that were not 
further analyzable, owing to arti-
fact or use of an incorrect scale. 
An additional three patients could 
not be analyzed for IVUS echo-
genicity, owing to extensive cal-
cification overshadowing a large 
part of the adventitia, which is 
used as a reference for the inter-
pretation of gray-scale values of 
surrounding tissue. Reasons for 
inaccurate palpogram readings 
(n = 18) were related to exten-
sive catheter motion during data 
acquisition. Baseline character-
istics of patients who completed 
the study are shown in Table 1. 
Demographics and Clinical History Patients (n =67)
Male 57 (85)
Age (yrs) 58 + 11 
Previous myocardial infarction 27 (40) 
Previous coronary bypass surgery 1 (1)
Previous percutaneous coronary intervention 11 (16)
History of diabetes 6 (9)
History of stroke 1 (1)
Family history of coronary disease 36 (54)
Hypertension* 29 (43)
Hypercholesterolemia† 57 (85)
Previous smoker 23 (34)
Current smoker 26 (39)
Medication at inclusion
   Aspirin 59 (88)
   Clopidogrel 38 (57)
   ACE-I/AT2 20 (30)
   Beta-blocker 44 (66)
   Statin therapy 48 (72)
Medication at 6 months follow-up
   Aspirin 61 (91)
   Clopidogrel 63 (94)
   ACE-I/AT2 34 (51)
   Beta-blocker 50 (75)
   Statin therapy 66 (99)
Clinical Status at enrolment 
   Stable angina 32 (48)
   Unstable angina or non-STEMI 21 (31)
   STEMI 14 (21)
Extent of Disease‡ 
   Non significant disease 4 (6)
   Single-vessel disease 36 (53.7)
   Two-vessel disease 21 (31.3)
   Three-vessel disease 3 (4.5)
   Left main stem (plus two-vessel) disease 3 (4.5)
Table 1. Baseline characteristics of patients with invasive follow-up evaluation
Categorical data are presented as n (%) and continuous data as mean values 
± SD. *Blood pressure >160/95 mmHg or treatment for hypertension, †Total 
cholesterol >215 mg/dL or treatment for hypercholesterolemia. ‡Significant 
disease was defined as >50% (visual estimate) stenosis in a major epicardial 
vessel or in branches > 2.5 mm diameter. 
ACE-I  =  angiotensin-converting enzyme inhibitor; AT2  =  angiotensin-II re-
ceptor antagonist; STEMI  = ST-segment elevation myocardial infarction. 
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They were comparable to those of the entire cohort of 84 patients enrolled at baseline (not 
shown).  Almost all patients (99%) received treatment with a statin within the 6-month study 
period, mainly as a result of starting treatment in the group who presented initially with STEMI 
(treatment started in 13 of 14 STEMI patients). Mean total cholesterol, LDL-C, HDL-C, and 
triglyceride values for patients who completed the study are presented in Table 2. 
Total choles-
terol, mg/dL
LDL choles-
terol, mg/dL 
HDL choles-
terol, mg/dL 
Triglycerides, 
mg/dL
Entire cohort (n=64)                                                                              
      Baseline 176.8±48 113±44.7 39.7±13.7 143.1±83.9
      Follow-up 171.1±31.8 104.5±29.6 44.1±14.4 165.9±82.3
      Change -5.9±51 -10.6±44.6 4.3±9 21.1±79.9
      P value NS NS 0.001 0.008
STEMI (n=13)
      Baseline 210±37.5 145±32.8 43.5±12 143.4±68.6
      Follow-up 166.7±34.6 102.6±30.9 39.9±10.3 162.5±67.6
      Change -40.9±39.2 -36.1±41.1 -3.3±6.1 27.2±58.5
      P value 0.003 0.006 NS NS
UA or NSTEMI (n=21)
      Baseline 167.1±45.2 107.8±36.4 36.8±11.6 144.5±81
      Follow-up  169.9±26.6 100.2±25.1 47.2±15.7 152.7±87.1
      Change  7.5±54 -4.6±39.6 9.6±6.5 5.9±80.7
      P value NS NS <0.001 NS
Stable angina  (n=30)
      Baseline 169.2±49 102.7±49 40±15.7 142±94
      Follow-up 174.2±34.4 108.2±32.4 44.1±15.3 176.1±87.4
      Change 3.6±47.8 -2.3±46.3 4.5±9.2 28.1±89.5
      P value NS NS 0.026 0.014
Table 2. Changes in lipid parameters
HDL = high-density lipoprotein; LDL = low-density lipoprotein; STEMI  = ST-segment elevation myocardial infarction; UA = 
unstable angina.
entire region of interest 5-mm subsegments
Sensitivity 44/51 (86, 74-93) 136/185 (74, 67-79)
Specificity 11/16 (69, 44-86) 140/192 (73, 66-79)
Positive predictive value 44/49 (90, 78-96) 136/188 (72, 66-78)
Negative predictive value 11/18 (61, 39-80) 140/189 (74, 67-80)
Table 3. Accuracy of multislice computed tomography for the detection of significant coronary plaque*: comparison with IVUS for 
the entire region of interest and for its 5 mm subsegments
Values are n (%, 95% confidence interval). *Significant plaque on intravascular ultrasound (IVUS) was defined as mean plaque area 
obstruction {(Vesselarea - Lumenarea / Vesselarea) x 100} > 50%, or the presence of calcium on 2 consecutive slices on IVUS.
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MSCTA Versus IVUS at Baseline
MSCTA and IVUS were compared, at baseline, in 61 patients (67 vessels). The sensitivity and 
specificity of MSCTA to detect significant plaque identified on IVUS (> 50% EEM area obstruc-
tion or the presence of calcification on two consecutive slices) was calculated for the entire ROI 
and for 5-mm sub-segments (Table 3). The sensitivity, specificity, positive and negative predic-
tive values of MSCTA for detection of any significant plaque was 86%, 69%, 90%, and 61%, re-
spectively. The sensitivity of MSCTA to detect plaque was 60% (30/50) for small (<1mm), 76% 
(80/105) for medium (1 to 2 mm), and 79% (26/33) for large (>2 mm) plaques. 
Reproducibility of IVUS Measurements
Interobserver variability for IVUS analysis (n= 32 pullbacks) showed no systematic error and 
good reproducibility. Mean differences in area (mm2) measurements were: 0.04 ± 0.56 for 
EEM, 0.02 ± 0.50 for lumen, and –0.06 ± 0.59 for plaque. The mean difference in PV (mm3) 
was –2.43 ± 22.
Conventional Imaging: Quantitative Coronary Angiography and IVUS 
There were no statistically significant changes in the angiographic variables measured in the 
ROI (Table 4). Likewise, IVUS-derived measurements remained unchanged in matched seg-
ments (Table 5). Figure 2 illustrates the spread of the individual data points for PV. When 
Length (mm) Mean Diam-
eter (mm)
Minimal Diam-
eter (mm)
Diameter 
Stenosis (%)
Entire cohort (n=67)
      Baseline 27.2±13.1 2.78±0.6 2.31±0.6 25±11
      Follow-up 27.2±13.1 2.84±0.8 2.38±0.7 25±11
      Change 0.0±2.5 0.06±0.4 0.06±0.4 0.0±8
      p value NS NS NS NS
Table 4. Quantitative angiographic parameters (n=67)
Values are mean ± SD.
Variable Length 
(mm)
Lumen 
volume (mm3)
Vessel 
volume (mm3)* 
Total Plaque 
Volume (mm3)†
Hypo Volume 
(mm3)‡
Hyper Volume 
(mm3)§
Baseline   29.3±14.4 285±161 481±250 195±117 171±104 15±11
Follow-up 29.2±14.2 279±161 469±243 190±107 177±98 12±14
Change -0.1±1.6 -7±52 -12±61 -5.2±33 6±53 -3±13
p-value NS NS NS NS NS NS
Values are mean ± SD. *Vessel volume denotes the volume circumscribed by the external elastic membrane. †Total plaque volume 
denotes Vesselvolume-Lumenvolume including echolucent media. ‡Hypo volume = hypoechogenic plaque volume. §Hyper volume 
= hyperechogenic plaque volume.
Table 5. Quantitative IVUS (n = 58) and echogenicity (n = 55) parameters
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patients were grouped 
according to initial di-
agnosis (i.e., STEMI, 
unstable angina, stable 
angina), there were no 
significant changes in 
either angiographic or 
IVUS measurements 
between baseline and 
follow-up (data not 
shown).
Novel IVUS-
Based Imaging
Temporal changes in 
plaque characteristics 
on the basis of IVUS-
based palpography 
and echogenicity are 
shown in Tables 5 and 6. At baseline, the predominant plaque component was hypoecho-
genic tissue (91.6% of PV). There was no significant change in the absolute volume of hy-
poechogenic or hyperechogenic plaque over the course of the study. On palpography, both 
the absolute number of high-strain spots (grade 3/4) in the ROI (p = 0.009) and their density 
per cm (p = 0.012) decreased significantly between baseline and follow-up. This decrease in 
the overall population was largely driven by changes in the subgroup of patients with STEMI; 
this group had both the highest number of high-strain spots at baseline and the most marked 
relative decrease during follow-up, compared with patients with other clinical presentations. 
At 6-month follow-up, the density of high-strain spots (1.2 ± 1.4/cm) was comparable among 
clinical subgroups. Representative imaging findings are presented in Figure 3.
Correlation of Biomarkers with Imaging Techniques
Not surprisingly, several inflammatory mediators (C-reactive protein, interleukin-6, IL-6, li-
poprotein-associated phospholipase A2 and a marker of hemodynamic stress (NT-proBNP) 
decreased over time, particularly in patients presenting with acute coronary syndromes. There 
were no significant correlations noted between circulating biomarkers and imaging param-
eters (data not shown). Among lipid parameters (total cholesterol, LDL-C, HDL-C, and trig-
lycerides), a correlation with the change in IVUS-derived plaque area was only noted for the 
change in HDL-C (Pearson correlation coefficient -0.37, p < 0.05, data not shown).
Figure 2. Bland-Altman plot of the intravascular ultrasound data on plaque volume. The 
green (top) and blue (bottom) line indicate the borders of 2 x SD. 
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Adverse Events 
One patient died 2 weeks after inclusion, because of a second MI. All imaging procedures 
were performed without complications. 
 
diSCuSSion
The major findings of the study were four-fold. First, using IVUS as a gold standard, non-
invasive MCSTA can identify atherosclerotic plaque, in vessels with only minimal angiographic 
disease, with high sensitivity and moderate specificity. Second, further investigation of such 
plaque with novel IVUS-based imaging techniques (palpography and echogenicity) showed 
that features potentially indicative of vulnerable plaques are both widespread and highly prev-
alent. Third, although conventional imaging with quantitative coronary angiography and IVUS 
demonstrates no significant changes in lumen or plaque dimensions, the biomechanical prop-
erties of the plaques, assessed by palpography, showed significant changes over a relatively 
Palpography
Number of high strain spots Density of high strain spots
Total population (n=52) 
      Baseline 4.8±4.5 1.6±1.5
      Follow-up 3.6±4.4 1.2±1.4
      p value 0.009 0.0123
STEMI   (n=12)
      Baseline 7.2 ± 5.8 2.3 ± 1.8
      Follow-up 3.8±4.6 1.1±1.4
      p value 0.003 0.0003
UA or non-STEMI (n=16)
      Baseline 4.1±3.9 1.8±1.8
      Follow-up 3.1±3.5 1.4±1.7
      p value 0.17 0.29
Stable Angina  (n=24)
      Baseline 4.0±4.0 1.2±1.1
      Follow-up 3.8±4.9 1.2±1.1
      p value 0.69 0.56
Table 6. Plaque characterization with palpography (n= 49 patients/ 52 vessels). 
Values are expressed using the total number and density of high strain spots, given as mean ± SD. Density refers to the number 
of Rotterdam Classification 3/4 spots per 10 mm of vessel. STEMI = ST-segment elevation myocardial infarction; UA = unstable 
angina. 
Chapter 4
82
short period. Finally, circulating levels of measured biomarkers showed no significant correla-
tions with focal imaging end points identified by conventional and novel imaging modalities. 
Subclinical Atherosclerosis: Role of Noninvasive Imaging
The development of noninvasive angiography with MSCTA can be used to reliably identify 
significant epicardial coronary atherosclerosis (20). Recent studies have shown its potential 
for detecting non-obstructive coronary plaques in highly selected patients (21,22). Our results 
Figure 3. Example of multimodality coro-
nary imaging of the proximal left anterior 
descending coronary artery. (A, B) Region 
of interest (ROI) is defined by the ostium 
of the left anterior descending and a large 
septal branch, as marked by white lines on 
the conventional angiogram (A) and arrow-
heads on multislice computed tomography 
maximum intensity projection reconstruc-
tion (B). (C) Gated longitudinal intravascu-
lar ultrasound (IVUS) reconstruction. The 
vertical lines mark the boundaries of the 
ROI. The red line indicates the lumen-inti-
ma interface and the green line the exter-
nal border of the plaque plus echolucent 
media. (D, E) Representative color-coded 
cross-sectional palpograms that are super-
imposed on the IVUS image. Strain values 
are color-coded from 0% (blue) to 2% (yel-
low), as shown on the vertical scale. (D) 
Shows non-deformable eccentric plaque 
with calcification and acoustic shadowing. 
The blue line around the lumen indicates a 
non-deformable plaque with 0% strain. In 
the regions without plaque, the gray color 
indicates that no strain value can be mea-
sured. (E) Shows eccentric partly calcified 
plaque with a high strain (yellow) spot on 
one shoulder of the plaque (nine o’clock). 
On the other shoulder (four o’clock) the 
blue color (0% strain) indicates that the 
plaque is not deformable in this region. 
(F, G) Representative color-coded echo-
genicity cross-sections. Hypoechogenic 
tissue is represented in red and hyper-
echogenic tissue in green. (F) Shows a 
cross section with a relatively large hyper-
echogenic area. The white spots visible 
most likely represent thick fibrous tissue 
and not calcification, as there was no 
acoustic shadowing on the correspond-
ing IVUS images (not shown). (G) Shows 
a cross section, which predominantly con-
tains hypoechogenic tissue. (H) Multislice 
computed tomography reconstruction and 
(inset) a cross section in an area with calci-
fied plaque (arrows). (A full color version of 
this illustration can be found in the color 
section).
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extend these findings by showing that non-obstructive coronary plaque can be detected, in 
an arbitrarily selected ROI, with moderately high sensitivity and specificity in a broader patient 
population; however, when examined in more detail, with novel invasive techniques, we found 
that putative “high-risk” characteristics (i.e. hypoechogenic plaques with a high-strain pattern) 
were very common. This observation provides additional arguments to support recommenda-
tions discouraging the indiscriminate use of noninvasive coronary imaging to detect subclini-
cal atherosclerosis at the present time (23). 
Subclinical Atherosclerosis: Insights from Novel Invasive Techniques
We have previously validated the potential of palpography to identify thin-capped fibroathero-
mas in vitro (13,14,24,25). Subsequently, we showed that the number of high-strain spots 
in culprit epicardial vessels was correlated with clinical presentation (16). The present study 
extends these findings by demonstrating that, within arbitrarily selected segments of non-
culprit vessels, high-strain areas were quite common, despite only mild angiographic disease. 
The most marked changes occurred in patients with an acute MI, most of who were statin-
naïve (93%) at the time of the initial presentation. Although acute MI patients had a higher 
extent of high-strain spots, all subgroups were comparable six months later, regardless of the 
initial presentation. Interestingly, the persistence of abnormal strain patterns might reflect the 
inadequacy of standard medical care. This hypothesis would be consistent with recent data 
that indicate the need for intensive intervention for LDL-C (<70 mg/dl) and inflammation (C-
reactive protein <2 mg/l) to achieve the best clinical outcomes in the course of therapy with 
statins in post-ACS patients (26,27). 
Prior studies suggest that gray-scale echogenicity is related to the histological components 
of carotid and coronary plaques (28-30). Although carotid plaque echogenicity can be as-
sessed noninvasively, assessment of coronary plaque echogenicity requires invasive techniques 
and has been restricted to research settings. In the present study, we used a quantitative 
computer-assisted index of echogenicity, on the basis of gray-scale values of adventitia, and 
demonstrated that hypoechogenic tissue was the predominant plaque component. We found 
no significant change in absolute hypoechogenic or hyperechogenic PV over the average six 
months. Our findings differ from the observations of Schartl et al. (31), who found a small but 
significant increase in the hyperechogenic plaque component;  however, their study had a lon-
ger follow-up period and patients had intensive, carefully monitored, statin therapy. A recent 
study conducted at our institution suggested that the changes in plaque echogenicity require 
a much longer period to occur (more than 2 years) (32). Accordingly, the high preponderance 
of hypoechogenic plaque (>90% of the PV) coupled with the lack of significant change during 
the short-term follow-up suggests that plaque echogenicity lacks the discrimination necessary 
either for risk stratification or as a surrogate measure of plaque composition on serial stud-
ies. 
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Study Limitations
This observational study has limitations. First, our patient population was intentionally het-
erogeneous and the study was underpowered to correlate compositional imaging end points 
with clinical outcomes. Although follow-up was incomplete (67/84, 80%), it compares fa-
vorably with recent serial IVUS studies (33,34). Moreover, baseline characteristics of the 67 
patients with completed follow-up were the same as in the overall study population. Second, 
the present study did not demonstrate changes in plaque size. By contrast, recently published 
studies demonstrated regression of coronary atherosclerosis in patients with acute coronary 
syndromes treated with aggressive statin regimen (34). In contrast, in those with stable coro-
nary artery disease maximal dose of atorvastatin given for 18 months only halted plaque 
growth (33). Potential explanation for these disparate results may be due to different duration 
of follow-up (6 vs. 18 months), underlying index event (stable vs. acute coronary syndrome), 
or suboptimal intensity of statin treatment noted in many IBIS patients that reflects slow adop-
tion of current guidelines into clinical practice settings. With these caveats, however, data 
from recent trials, such as Reversing Atherosclerosis with Aggressive Lipid Lowering (REVER-
SAL) and Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT), indicate 
that intensive treatment with statins affects plaque size and event rates, respectively (33,35). 
Third, although our results underscore the heterogeneity of coronary atheroma, much larger 
studies are needed to ultimately define the role of novel plaque imaging techniques in clini-
cal practice. Fourth, our attempt to relate circulating biomarkers to coronary plaque imaging 
in an arbitrarily selected ROI can only be regarded as exploratory. We did not further discuss 
this possible interaction because the correlations we found were weak. Fifth, the suboptimal 
spatial and temporal resolution of the 16-slice MSCT scanner precludes accurate assessment 
of coronary artery segments <2 mm. Although the ROI as selected by MSCT was chosen ran-
domly, distal coronary segments are inevitably underrepresented. The same argument holds 
true, however, for IVUS examination of the coronary tree, where for safety reasons only the 
larger coronary segments are targeted for interrogation.
    
ConCluSionS
Mild angiographic disease is associated with large atherosclerotic plaques identified with non-
invasive MSCTA. This study also confirms that conventional invasive imaging modalities fre-
quently reveal static luminal and plaque dimensions, whereas novel IVUS-based plaque pal-
pography can detect significant alterations in coronary plaque characteristics over a relatively 
short time interval. Our results highlight the dynamic changes in the strain of coronary plaques 
that are remote from the culprit lesions, particularly in patients with MI. Whether the persis-
tence of a high-strain pattern is a harbinger of cardiovascular events remains to be determined 
in future much larger studies. The novel imaging modalities used in this study provide insights 
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into plaque biology, whereas temporal changes detected with these modalities might eventu-
ally serve as intermediate end points in interventional trials.
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inTroduCTion
Invasive coronary angiography remains the standard of reference for the assessment of ad-
vanced coronary artery disease, which is typically characterized by significant narrowing of 
the coronary lumen and provides the necessary road map for defining the type and extent 
of coronary revascularization (percutaneous coronary intervention or coronary artery bypass 
graft surgery). Unfortunately, "luminographic" involvement is a late manifestation of coronary 
artery disease since a large amount of atherosclerotic plaque accumulates in the vessel wall 
before affecting the coronary artery lumen1,2. Identification of the earlier stages of coronary 
artery disease is critically important, as it has been shown that the majority of acute coronary 
events, manifesting as acute myocardial infarction or sudden cardiac death, are initiated by 
sudden rupture and subsequent thrombosis of atherosclerotic plaques that are not causing 
significant stenosis3. In vivo visualization of the extent of the angiographically invisible coronary 
atherosclerotic process was initially demonstrated by intravascular ultrasound (IVUS), another 
invasive imaging technique4. Non-invasive alternatives for imaging of the coronary arteries 
became available one decade ago. Coronary imaging by magnetic resonance imaging as first 
demonstrated in the early 1990s looked very promising5. However, long acquisition times and 
insufficient spatial resolution limit its clinical usefulness for the assessment of coronary artery 
disease6. By contrast, rapid developments in computed tomography (CT) techniques have pro-
vided the necessary spatial and temporal resolution for coronary imaging. As a result, cardiac 
CT is emerging as the preferred non-invasive imaging tool that has the ability to visualize both 
the coronary artery lumen and vessel wall. In this chapter we describe the potential of cardiac 
CT for coronary plaque imaging and relate this feature to the current possibilities of optical 
coherence tomography (OCT).
CT Technology
A CT scanner consists of an x-ray tube that rotates around the patient, with images collected by 
a row of detectors on the opposite side (Figure 1). The patient is continuously moved through 
the X-ray field while data are digi-
tally recorded from the detectors. 
The resulting X-ray projection data 
form a helix or spiral, hence the 
description ’spiral-CT’. While CT 
has been available for clinical use 
since the early 1970s, it has been 
poorly suited to cardiac imaging 
until a few years ago. Indeed, ac-
curate non-invasive assessment of 
the coronary arteries poses several Figure 1. Frontal (A) and side (B) view of a CT scanner.
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difficulties. First, high spatial resolution is required for accurate visualization of their small size 
and tortuous three-dimensional anatomy. Second, sufficient temporal resolution is needed to 
minimize artifacts related to rapid coronary motion. Third, the scan must be performed within 
a single short breath hold to avoid respiratory motion artifacts. To obtain motion-free images 
data are typically obtained during the diastolic phase of the cardiac cycle. Image acquisition 
must therefore be synchronized to the cardiac cycle using electrocardiogram (ECG) gating. In 
most instances retrospective ECG gating is used. This means that data are acquired during 
the whole cardiac cycle. After data acquisition, different reconstruction windows during the 
diastolic phase of the heart can be explored to obtain images with the lowest number of mo-
tion artifacts. Heart-rate-lowering drugs are generally recommended for patients with a resting 
heart rate above 70 beats/minute7.  
Two types of CT scanners, electron-beam CT (EBCT) and multislice CT (MSCT), exist for non-
invasive cardiac imaging. EBCT offers better temporal resolution, but MSCT scanners provide 
higher spatial resolution, shorter scan time and higher signal-to-noise ratio and are currently 
the preferred CT imaging modality. MSCT scanners enable the simultaneous acquisition of 
multiple sections per rotation of the X-ray tube, hence the terminology ’multislice’ spiral CT. 
Current 64-slice CT scanners allow data acquisition by up to 64 detector rows in one rotation. 
They feature a temporal resolution of 165 ms and isotropic (i.e., equal voxel dimensions in x, 
y, and z axes) through plane spatial resolution of 0.4 mm8. 
Plaque Evaluation and Characterization
Based on clinical grounds the presence of coronary artery disease in a patient is usually noted 
if there is a history of angina pectoris, myocardial infarction or coronary revascularization. 
Current diagnostic work-up of patients with suspicion of coronary artery disease targets the 
detection of myocardial ischemia due to flow-limiting coronary stenoses. However, this ap-
proach identifies coronary atherosclerosis only in an advanced development stage and falls 
short in identifying a large group of patients who present with acute coronary syndromes, such 
as unstable angina, myocardial infarction or sudden cardiac death, that are often the first clin-
ical manifestation of coronary artery disease. Rupture or erosion with concomitant thrombosis 
of non-obstructive coronary plaques is the most frequent cause of these acute cardiac events 
(Figure 2)9. Pathological studies have identified several characteristics of plaques at increased 
risk for thrombosis, the so-called vulnerable plaque: they typically present eccentric remodel-
ing, contain a large lipid core and are covered by a very thin fibrous cap showing an abundance 
of macrophages in the shoulder regions of the plaque10. Once vulnerable plaques have rup-
tured and resulted in an acute coronary syndrome, survival is diminished. Early identification 
and prophylactic stabilization of vulnerable plaque(s) may therefore play an important role in 
future strategies to prevent acute coronary syndromes. Coronary angiography, the reference 
standard for the identification of obstructive coronary artery disease, provides little or no infor-
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mation on the actual extent 
of the atherosclerotic process 
or on the composition of the 
atherosclerotic plaque11. As a 
result, coronary angiography 
cannot be used for the detec-
tion of vulnerable plaque(s). 
Unlike conventional angiog-
raphy, coronary CT has the ability to depict the vessel wall and coronary plaque irrespective 
of the amount of lumen involvement, thus allowing assessment of both non-flow limiting and 
flow-limiting plaques12. 
CT Stenosis Detection
MSCT and to a lesser extent EBCT provide the necessary spatial and temporal resolution for 
accurate detection of significant obstructive coronary artery disease. Early reports using four-
slice MSCT showed promising results. However, this technique was not robust enough, owing 
to its relatively long scan time and limited resolution, resulting in a number of non-evaluable 
coronary segments as high as 43%13. The diagnostic accuracy of CT coronary angiography 
significantly improved with 16-slice and the latest 64-slice MSCT, allowing reliable evaluation 
of coronary artery segments up to 1.5 mm in diameter8,14-16. The reported results depend 
largely on patient selection and several factors including elevated heart rates or severe coro-
nary calcification cause suboptimal image quality, making it sometimes difficult to correctly as-
sess the coronary arteries. Consequently, patients with arrhythmias are generally excluded and 
heart-rate-lowering medication is routinely administered for heart rates above 65-70 bpm. 
CT Plaque Imaging
EBCT and non-enhanced MSCT can accurately detect coronary calcium17,18. Because arterial 
calcification almost always represents atherosclerosis, detection of coronary artery calcium 
by means of CT is a reliable, non-invasive tool for determining the presence of coronary 
Figure 2. Patient with acute coronary 
syndrome showing a thrombotic suboc-
clusive lesion of the circumflex coronary 
artery (CX) on conventional coronary an-
giography (A, arrow). Volume-rendered 
(B) and multiplanar reformatted (D) CT 
image confirm the presence of a suboc-
clusive non-calcified plaque (arrows). On 
intravascular ultrasound (C) this lesion is 
hypechogenic in composition. The speck-
led appearance within the lumen is com-
patible with thrombus. (A full color ver-
sion of this illustration can be found in the 
color section).
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atherosclerosis. The amount of coronary 
calcium is closely correlated with the to-
tal atherosclerotic plaque burden and 
strongly predicts future cardiac events 
(Figure 3)19. Higher amounts of calcium 
are associated with a higher likelihood of adverse coronary events. At a population level, the 
coronary calcium score provides incremental value compared with traditional risk factors such 
as the Framingham Risk Score for predicting future cardiac events, and is therefore suggested 
as an adjunctive risk-stratification tool in intermediate-risk patients20, 21. However, up to 20% of 
patients presenting an acute coronary event may have mildly calcified or non-calcified culprit 
lesions and thus are not identified by coronary calcium scoring (Figure 4)22. 
Contrast-enhanced MSCT is able to 
detect calcified and non-calcified 
coronary plaques. Based on the tis-
sue-specific X-ray attenuation char-
acteristics, it is possible to differenti-
ate between fibrous tissue, lipid and 
calcium23-27. CT also has the abil-
Figure 3. A 51-year-old man presented with an acute 
coronary syndrome with transient ST-segment depres-
sion in the anterior ECG leads. On conventional coronary 
angiography mild wall irregularities in the proximal left 
anterior descending coronary artery (LAD) were noted 
(A). Coronary artery calcifications in the proximal part 
of the left coronary artery (C) and right coronary artery 
(D) were detected on non-enhanced MSCT confirming 
the presence of coronary atherosclerosis. Total Agatston 
calcification score was 292. The calcified plaque in the 
LAD was non-obstructive as illustrated on MSCT coro-
nary angiography (white arrow,E). Volume-rendered CT 
image (white arrow,B) confirms the presence of a calci-
fied plaque in the proximal LAD. CX, circumflex coro-
nary artery. (A full color version of this illustration can be 
found in the color section).
Figure 4. 40-year-old patient presenting with two 
episodes of non-ST-segment elevation myocardial 
infarction in a 1-month time interval. Convention-
al coronary angiography (A) and non-enhanced 
MSCT (B) were normal. However, MSCT coronary 
angiography revealed a large non-calcified plaque 
without lumen obstruction in the proximal left an-
terior descending coronary artery (LAD) (C, black 
arrowheads). (D)Cross-sectional CT image with 
arrowheads indicating the non-calcified plaque 
occupying the vessel wall. CX, circumflex coronary 
artery.
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ity to detect coronary segments with 
positive remodeling that can harbor 
substantial amounts of plaque with-
out significant luminal stenosis12. The 
clinical relevance of this information is 
unclear and is the subject of ongoing 
studies. In addition, several limitations 
have to be taken into account: report-
ed data were exclusively obtained in patients with high CT-image quality and are restricted 
to larger advanced plaques in sufficiently large coronary artery segments (at least 2 mm in 
diameter). Furthermore, lipid-rich and fibrous plaque shows overlapping CT attenuation char-
acteristics and makes accurate subclassification of non-calcified plaques difficult. 
OCT Plaque Characterization
OCT is an invasive imaging modality that can visualize the structure of normal and athero-
sclerotic coronary arteries with ultrahigh resolution (Figure 5)28. Compared to MSCT, OCT 
Figure 5. Comparison of intravascular OCT with 
findings on conventional coronary angiography, 
MSCT and intravascular ultrasound (IVUS). OCT was 
performed on the left anterior descending coronary 
artery (LAD) proximal to the first septal branch (S1). 
Angiographically (A) and on multislice computed 
tomography coronary angiography (B with inset, C) 
this part of the vessel has a normal appearance. The 
cross-sectional IVUS (D) and OCT images (E, F) show 
a normal appearance of the vessel wall except for 
some minimal thickening of the intima. CX, circum-
flex coronary artery.
Figure 6. Normal appearance of 
the right coronary artery (RCA) on 
conventional coronary angiogra-
phy (CCA) 6 months after implan-
tation of three overlapping stents. 
Hypoattenuating circular tissue 
is clearly present on the cross-
sectional computed tomography 
image of the proximal part of the 
RCA (cross-section B). Neointimal 
tissue growth within the stent is 
much better appreciated on intra-
vascular OCT, also in the more dis-
tal part of the RCA (A and B). Ar-
rowheads indicate the stent struts. 
Some minor stent malapposition 
can be appreciated at 5 o’clock 
(OCT cross-sectional image, A, ar-
rowheads). (A full color version of 
this illustration can be found in the 
color section).
OCT Plaque Characterization: Comparison to Multislice Computed Tomography
95
allows much more detailed analysis of different coronary structures such as presence of in-
stent intimal hyperplasia or advanced plaque characterization (Figure 6)29. Indeed, lipid-rich 
plaques have some unique differing OCT features compared to fibrous plaques (Figure 7). 
The high-resolution capacity of OCT offers the potential to detect some of the key features of 
the vulnerable plaque in vivo: a large lipid pool, a thin fibrous cap, and the accumulation of 
macrophages near the fibrous cap30. 
ConCluSionS
MSCT of the heart is a rapidly developing technology. In a selected patient population, current 
64-slice CT scanners allow comprehensive non-invasive coronary imaging, including assess-
ment of luminal stenosis and detection of non-obstructive atherosclerotic plaque. The high 
negative predictive value makes MSCT most suitable for exclusion of obstructive coronary 
plaques in patients with a low or intermediate likelihood of coronary artery disease. Beyond the 
detection of stenosis, MSCT may prove useful to identify high-risk coronary plaque character-
istics. The possibility that MSCT can be used as an initial non-invasive technique to establish, 
in a high-risk individual, the presence and location of a possible high-risk lesion is currently in-
vestigated in a prospective study that will correlate MSCT coronary plaque characteristics with 
the propensity for future adverse coronary events. Ultimately, non-invasive imaging techniques 
such as MSCT might help targeting the use of invasive imaging modalities such as OCT in the 
search of patients at risk for acute coronary syndromes and sudden cardiac death31, 32. 
Figure 7. Non-calcified plaque as visualized 
with MSCT in the proximal part of the left an-
terior descending coronary artery (LAD) (A 
and C, arrowheads). The optical coherence 
tomography (OCT) cross-sectional image (B, 
arrowheads) with uniform highly reflective tis-
sue is compatible with fibrous plaque. By con-
trast, lipid-rich plaques are visualized as low 
reflective structures within the arterial wall. 
This distinction in plaque appearance cannot 
be appreciated on MSCT, which uniformly 
depicts a non-calcified plaque as a structure 
within the range of 10-100 Hounsfield units. 
Also, the appearance of the plaque has much 
less image resolution as compared with OCT 
(see cross-sectional CT image in D, arrow-
heads). (A full color version of this illustration 
can be found in the color section).
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Summary
Background 
A 43-year-old woman with a 2-hour history of chest pain presented with an anterior infaction 
and was referred for primary percutaneous coronary intervention.
Investigations 
Physical examination, electrocardiography, laboratory tests, coronary angiography, abdomi-
nal angiography, cardiac CT, histology, immunohistochemistry, intravascular ultrasound.
Diagnosis 
ST-segment elevation anterior myocardial infarction
Management 
Coronary angiography, antithrombotic therapy, statin, angiotensin-converting enzyme inhibi-
tor, thrombectomy, coronary artery bypass graft surgery 
 
how Should i TreaT?
Presentation of the case
A 43-year-old woman with no previous cardiac history presented with a 2 hour history of 
central chest pain with radiation to the left arm unresponsive to sublingual nitroglycerin. A 
pre-hospital electrocardiogram (ECG) showed  ST-segment elevation in the precordial anterior 
leads consist with an evolving anterior infarction and was referred to our hospital for primary 
percutaneous coronary intervention (PCI). On admission to the coronary care unit (CCU), 
the pain had almost completely resolved. A 12-lead ECG showed persistent, but to a lesser 
degree, ST-segment elevation in all precordial leads (V1 to V6), including the inferior leads 
(II, III and aVF). 
The woman was from African origin and had a history of sickle cell disease. She had arte-
rial hypertension, which was treated with a thiazide diuretic, and a positive family history of 
premature coronary artery disease. She reported no history of diabetes or dyslipidemia, and 
was a non-smoker. Her blood pressure on admission was 135/ 65 mm Hg, and on physical 
examination there were no signs of heart failure. 
Aspirin (300 mg), unfractionated heparin (5000 IU), and nitroglycerine as a continuous in-
travenous infusion had been administered in the ambulance. Clopidogrel bisulfate (600 mg 
bolus) was added in the CCU. Coronary angiography showed a significant stenosis with fresh 
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thrombotic material in the left main coronary artery (LMCA) that extended towards the ostium 
of the left anterior descending artery (LAD) (Figure 1). The angiographic appearance of left 
circumflex artery (LCX), large intermediate branch (IB) and dominant right coronary artery 
(RCA) was unremarkable with normal epicardial flow, but the flow in the LAD was mildly im-
paired (TIMI flow, grade 2) . 
At this stage, it was unclear what would be the optimal treatment strategy. It was deemed too 
high risk to performing a PCI due to the location of the thrombus and the complexity of the 3 
major epicardial vessels. Any attempt of thrombotic aspiration had the risk of possible embo-
lization towards the 3 distal run-off vessels. An early consultation with our surgical colleagues 
suggested that ideally, coronary artery bypass graft surgery (CABG) would carry the least risk, 
but preferably not in the acute phase of a MI. 
Since the patient was now completely pain free following catheterisation and there was spon-
taneous reperfusion of the infarct-related-vessel(s), it was decided for aggressive anticoagu-
lant and anti-platelet therapy. On a regime of aspirin, clopidogrel, unfractionated heparin, 
and IV eptifibatide, a glycoprotein IIb/ IIIa receptor antagonist, the patient’s clinical condi-
tion stabilised. The CK values peaked at 454 U/l (CKMB mass of 47.6 U/l) 16 hours af-
ter admission. But one day after admission she developed a spontaneous bleeding of the 
right iliopsoas muscle  accompanied by fall in haemoglobin level from 6 to 4.3 mmol/l. 
The treatment with eptifibatide was stopped and she was transfused 2 units of packed red 
blood cells. On selective abdominal angiography there was no obvious bleeding focus. The 
patient underwent a CT coronary angiography (CTCA) 3 days later to re-evaluate the left 
main stem and other coronary arteries. The CT scan showed a persistent severe narrowing 
of the LMCA with normal appearance of the other coronary vessels (Figure 2). Assessment of 
the total coronary calcium burden did not reveal any calcium. The invasive coronary angio-
Figure 1. (A) Normal appearance of the right coronary artery. (B) Large filling defect (arrows) in the left main extending into the 
proximal left anterior descending artery.
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gram that was repeated the same day confirmed these findings. By this stage, the CK level 
had normalised (134 U/l). 
how Could i TreaT?
The invited experts opinion
The Interventionalist point of view
David Antoniucci, MD
Division of Cardiology, Careggi Hospital, florence, Italy
Despite the lack of the typical signs of fat embolism syndrome, the hypothesis of fat embolism 
in a young woman with sickle cell disease as the cause of an acute myocardial infarction with 
persistent nonocclusive thrombosis of the left main should be considered. Again, there is no 
angiographic evidence of atherosclerosis or spontaneous coronary dissection as the cause of 
thrombosis. It could be useful to see the distal bed of the left anterior descending artery, since 
ST segment elevation in both precordial and inferior leads associated with a subsequent small 
infarct suggest a persistent occlusive embolism of the distal left anterior descending artery. It 
has been hypothesised that fat emboli may reach the systemic arterial circulation via a patent 
foramen ovale or other intracardiac or pulmonary arteriovenous shunts (1) and appropriate 
investigations to identify these pathologies should be performed (ECHO, CT scan). The lack of 
any visible effect after three days of aggressive antiplatelet and anticoagulant treatment makes 
stronger the suspicion that the mass in the left main cannot be a thrombus. Another possible 
role of sickle cell disease in this case is that the thrombosis may be the result of endothelial 
Figure 2. Axial (A) and coronal (B) CT image showing the thrombus in the LMCA. The thrombus extends towards the LAD. The 
IB and CX are not affected. CX, circumflex artery; IB, intermediate branch; LAD, left anterior descending artery; LMCA, left main 
coronary artery.
Myocardial Infarction in a Patient with Sickle Cell Trait. Treatment Dilemmas and Imaging Findings at Follow-Up. 
103
damage attributable to shear injury by sickle cells and resulting prothrombotic state. At this 
stage, my strategy would be to perform an IVUS examination in order to exclude the possibil-
ity of coronary atherosclerotic disease or spontaneous dissection complicated by thrombosis. 
Again, there is the possibility that IVUS virtual histology could define the characteristics of the 
mass going into the left main. In the case of a fat embolism diagnosis, I think that the best 
strategy is the surgical removal of the material, since all endoluminal techniques (thrombec-
tomy devices, atherectomy devices, aspiration devices also with large catheters such as the 
Proxis used as an aspiration catheter without proximal occlusion of the vessel) seem likely to 
be unsuccessful in removal the entire material, while the risk of distal occlusive embolisation is 
high. Conversely, if the mass is a thrombus, the treatment should be endoluminal and should 
include rheolytic thrombectomy before stenting, or thrombectomy alone if IVUS doesn’t show 
any disrupted plaque or dissection. Whatever the nature of the mass going into the left main 
and the chosen treatment (endoluminal or surgical treatment), in my opinion there is the indi-
cation for acute exchange transfusion before treatment in order to decrease the haemoglobin 
S level to less than 30%. It has been shown that hyper-transfusion may prevent sickling and 
decrease the pro-coagulant state of sickle cell disease (2).
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The Surgeon’s point of view
David P. Taggart, MD(Hons), PhD, fRCS
university of Oxford, Oxford, united Kingdom
This is a particularly interesting and unusual case of left main stem (LMS) stenosis. The opti-
mal method of revascularisation (between surgery and stents) will be influenced by how gen-
eral recommendations for LMS stenosis are influenced by key features specific to this patient 
including:
–  Young woman (43 years old)
–  Presentation with established acute infarct with ST elevation and enzyme rise
–  Complex left main stem stenosis involving ostium, shaft and extending to proximal LAD 
and containing thrombus (may require IVUS confirmation)
–  Normal intermediate, obtuse marginal and right coronary artery
–  Significant bleed on anti-platelet medication
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Additional information required to determine optimal treatment decision:
–  Precise extent and complexity of LMS stenosis can be delineated by IVUS
–  Assessment of left ventricular function (good, moderate, poor) to guide risk of surgery
–  Any other contraindication to surgery such as significantly impaired renal function
The case for and against stents:
In general outcomes with stents in LMS stenosis are critically dependent on
–  the precise anatomic location and complexity (including calcification) of the lesion
–  the simultaneous presence of multivessel coronary artery disease (in up to 80% of 
patients).
Up to 90% of LMS stenosis involve the distal segment of the artery and extend into the proxi-
mal coronary arteries (1) and such bifurcation or trifurcation lesions are at notoriously high 
risk of restenosis with both bare metal stents and drug eluting stents (2). The angiographic 
appearance in this patient suggests diffuse involvement of the left main including extension to 
the LAD (if there is uncertainty this can be confirmed with IVUS). Furthermore -and ominous-
ly- restenosis in this critical location, even with drug eluting stents, is frequently asymptomatic 
and therefore mandates intensive and possibly serial angiographic follow up (3). 
In contrast, a recent multicentre retrospective registry of 147 patients with non-bifurcation 
LMS appears to be safe and effective with restenosis of <1% at 6-month angiographic follow-
up, major adverse clinical event rates of 7%, and a cumulative cardiac mortality of 2.7% at a 
median follow-up of around two and a half years (4). However even in this series the authors 
pointed out that there were four late unexplained deaths (4) raising the spectre of late stent 
thrombosis. If stenting is advocated then the relative merits of drug eluting (DES) and bare 
metal stents (BMS) need to be considered. While DES reduce the rate of restenosis it is in-
creasingly likely that they will require lifelong dual anti platelet medication. In view of a previ-
ous significant bleed in this patient DES may be contraindicated.
The case for and against CABG
Both randomised trials and Registry data show that CABG offers the most durable and proven 
treatment for LMS stenosis (1). In contrast to the location of stents, placing the bypass grafts 
to the mid coronary vasculature has two important beneficial prognostic implications (1): 
–  the complexity and location of LMS stenosis (as well as its frequently associated proximal 
multivessel coronary artery disease) are irrelevant
–  the grafts offer prophylaxis against the development of new disease in the proximal 
coronary vasculature
And the current results of CABG in LMS stenosis are reassuring. The Society of Cardiothoracic 
Surgery in the UK reported a mortality of 3% for all 5,003 patients undergoing CABG for LMS 
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stenosis including high risk and urgent cases (5) and two recent British studies reported excel-
lent two year survival rates of 94% and 95% (6,7). As for all cardiac surgical procedures the 
mortality is strongly influenced by co-morbidities; for example Ellis et al reported that three 
year mortality for CABG in LMS stenosis varied from 4% in low risk patients to 40% in those 
with significant and multiple co-morbidities (8). The fact that this patient has had a recent in-
farct would significantly increase the immediate risk of surgery with the risk decreasing rapidly 
after two weeks and towards normal elective risk within six weeks assuming that the ventricle 
is not significantly impaired. The survival benefit of CABG is increased by the use of an IMA 
graft to the left anterior descending coronary artery and may be further magnified by the use 
of a second IMA graft. The angiographic patency of both IMA placed to left sided coronary 
vessels is over 95% at one week and at seven years and may translate into a significant survival 
benefit (9). In a systematic review of over 15,000 CABG patients matched for age, gender, 
diabetes and left ventricular function, the HR for death was 0.82 with bilateral vs single IMA 
grafts (NNT of 13-16) (9). And the use of bilateral IMA grafts appears safe; the ART trial of 
bilateral versus single IMA (10) grafts reported an overall 30-day mortality of 1% in over 3,100 
patients [Taggart DP; unpublished observations].
Recommendation
If the patient remains stable, she should be kept in hospital to undergo CABG in 10-14 days 
(assuming LV function is at least moderate) as this offers the best prospect of a good long-
term outcome and particularly in view of her young age. An initial strategy of stenting, to defer 
surgery, carries risk because of an increased risk of death before crossover to CABG occurs. 
CABG should be performed with three bypass grafts because of the diffuse nature of LMS dis-
ease and ideally should be done with both IMA grafts to the two best left sided vessels. If the 
patient is unstable or has sustained significant myocardial damage (when risks of CABG would 
be high) then an initial strategy of stenting is reasonable but mandates intensive – including 
angiographic – follow-up. In view of previous significant bleed then a bare metal stent might 
be favoured to avoid the need for dual antiplatelet medication.
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how did i TreaT?
Actual treatment and management of the case
The patient was deemed eligible for enrollment in the SYNTAX study, a multicenter, prospec-
tive study, randomising patients with de novo 3-vessel disease and/or left main disease to 
undergo either PCI or CABG. She was randomized to the CABG-arm of the study and eight 
days after admission she underwent uneventful revascularization of the LAD using the left 
internal mammary artery graft, and of the intermediate branch using the right internal mam-
mary artery graft. A small aortotomy was performed to remove the focal lesion in the LMCA, 
which was sent  for pathologic evaluation (Figure 3). She made an uneventful recovery and 
was discharged 8 days later on 100 mg aspirin, 100 mg metoprolol, 40 mg atorvastatin, 4 
mg perindopril once daily, and oral iron supplements. To re-assess the surgical result, a re-
peat cardiac CT scan was performed 6 months later, which showed a patent LMCA without 
residual stenosis and occlusion of both bypass grafts (Figure 4a). A repeat invasive angiogram 
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showed the LIMA to be hypoplastic with 
competitive filling from the native coro-
nary circulation (Figure 4b); the RIMA 
graft was occluded early on in its course 
(Figure 4c). 
Intravascular ultrasound (IVUS) showed 
the persistence of a large noncalcified 
plaque in the LMCA, that was clearly pres-
ent on CT but not visible angiographically 
(Figures 5a and b). IVUS radiofrequency 
data analysis (RDA) and optical coher-
ence tomography (OCT) showed this 
plaque to have a fibrous composition 
(Figures 5c and d). Serology revealed 
that the patient was heterozygous for 
the hemoglobin S gene without any 
other  pro-thrombophilic condition. 
Figure 3. (A) Tangential cut of fibrotic initima with at-
tached thrombus that is being organized in view of the in-
growth of fibroblasts (arrow) and capillaries (arrowhead) 
(hematoxylin and eosine, original magnification 50 x). 
(B) Same area stained for CD31 shows diffuse staining 
of thrombotic material including platelets and capillaries. 
(C) Same area stained for CD34, highlighting the growth 
of capillaries into the thrombus. (D) Same area stained for 
CD68, showing numerous histiocytic cells/macrophages 
scattered throughout the intima and the thrombus. (E) 
Same area stained for desmin showing the absence of 
smooth muscle cells in the intima. (A full color version of 
this illustration can be found in the color section).
Figure 4. (A) Three-dimensional volume-rendered CT 
image showing the occlusion of the LIMA (left internal 
mammary artery graft) [arrowhead] at the level of the 
right ventricular outflow tract. The RIMA (right inter-
nal mammary artery graft) is also occluded: its previ-
ous course is still marked by vascular clips (arrows). 
(B, C) Corresponding invasive angiogram showing 
the LIMA graft to be hypoplastic with only minimal 
contrast filling distally (arrowheads) and an occlusion 
of the RIMA in its proximal part (arrow). (D) Invasive 
coronary angiogram showing a normal appearance 
of the left main coronary artery (arrowheads).  (A full 
color version of this illustration can be found in the 
color section).
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An overview of the relevant laboratory tests performed since hospital admission is provided in 
Table 1. Since she remains asymptomatic, her medical therapy was continued.
Figure 5. (A) Intravascular ultrasound 
of the distal left main coronary artery 
showing a large noncalcified plaque, 
extending from the 6 to 12 o’clock po-
sition. (B) This plaque is also visible on 
the corresponding CT image (arrows). 
The previous connection of the right 
internal mammary artery graft to 
the intermediate branch is indicated 
by the vascular clip (arrowhead). (C) 
Radiofrequency data analysis (RDA) 
showed that the plaque was predomi-
nantly fibrous in nature. (D) Optical 
coherence tomography (OCT) also 
showed features consistent with a fi-
brous plaque with a high reflectivity, 
homogenous and finely textured ap-
pearance (arrows). (A full color ver-
sion of this illustration can be found in 
the color section).
Variable Normal range first admission 6 months follow-up
Total cholesterol (mmol/la) <4.1 4.0 2.2
HDL cholesterol (mmol/la) >1.0 1.5 1.2
LDL cholesterol (mmol/la) <3.4 2.3 0.9
Triglycerides (mmol/lb) <1.7 0.3 0.6
Antitrombine III (IU/ml) 0.8-1.2 0.84
Factor II (E/ml) 0.8-1.25 0.93
Factor V Leiden Absent Absent
Protein C activity (IU/ml) 0.7-1.4 0.48
Protein S activity (IU/ml) 0.7-1.4 0.38
Antiphospholipid antibodiesc Absent absent
a For conversion to mg/dl divide by 0.0259. b For conversion to mg/dl divide by 0.0113. 
c Antiphospholipid antibodies: consisting of anticardiolipin, anti-beta2-glycoprotein I and lupus anticoagulant antibodies. 
Table 1. Results of laboratory tests.
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Discussion of diagnosis
The occurrence of an acute MI in a female patient of relatively young age, i.e., less than 45 
years, is quite unusual and represents only ~ 2% of the women diagnosed with a heart attack 
each year.1 Except for arterial hypertension and a positive family history of premature coronary 
artery disease our patient did not have other risk factors that would put her at risk for devel-
oping an acute MI. Using the Framingham-risk score her 10-year risk for developing a major 
coronary event was calculated as less than 1%.2 Illicit drug uses, which our patient denied, is 
a well recognized precipitating factor in this age group and should be scrutinized. Coronary 
calcium, as measured and quantified by cardiac CT, documents the presence of coronary 
atherosclerosis and adds precision to the risk estimate of cardiac events based on traditional 
risk factors.3 The risk of cardiac events in patients without coronary calcification is very low, 
i.e. 0.1% per year.4,5 However, the absence of coronary calcium does not exclude the presence 
of atherosclerotic disease. In fact, it is not unusual to find a calcium score of zero in relatively 
young patients (i.e. below the age of 60) who present with an acute coronary event.6 Plaque 
rupture and ensuing thrombosis most often occurs in non-calcified coronary lesions. CTCA al-
lows the identification of these so-called soft plaques provided they are sufficiently large. This 
case illustrates this concept and is a nice in-vivo illustration of plaque erosion with thrombosis 
occurring  in an atherosclerotic lesion with non-calcified morphology. Coronary plaque erosion 
is a less frequent cause of coronary thrombosis and typically occurs in relatively young and 
female patients.7 As compared to the classical rupture-prone plaques, this type of vulnerable 
plaque typically lacks a large lipid core but instead is composed of smooth muscle cells and 
proteoglycan-rich extracellular matrix. 
Patients with sickle cell disease, who are homozygous for the abnormal hemoglobin S, can 
present with cardiac problems, including the occurrence of acute MI.8 In contrast to athero-
sclerotic disease, coronary thrombosis with obstruction usually affects the small arteries and 
it is rare to find abnormalities of the large epicardial vessels. Furthermore, heterozygosity 
for the sickle cell gene (sickle cell trait) usually does not result in clinical manifestations.  Al-
though the pathogenesis of the acute cardiac event in this case is related to atherosclerotic 
disease, the abundance of endothelial cells within the removed thrombus-like material in the 
left main stem, fits with the histopathologic findings of patients with sickle cell disease.9 Fac-
tors such as endothelial dysfunction and increased platelet activation, which are well described 
in patients with sickle cell disease, might have contributed to the sequence of events in this 
patient.10
Current 64-slice and dual-source 64-slice CT scanners offer sufficient resolution to provide  re-
liable non-invasive access to the different cardiac anatomical structures. Of particular value is 
the direct way of looking at coronary artery disease by revealing the presence of disease in the 
vessel wall and lumen and the robustness in visualizing larger vessel structures such as bypass 
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grafts, which sometimes are difficult to depict by invasive coronary angiography. The cardiac 
CT scan in this case accurately reflected the course of the disease by showing the presence 
and subsequent disappearance of the large plaque with luminal narrowing in the LMCA and 
the occlusion of the bypass grafts at six months follow-up.
Treatment and management
Primary PCI using stents performed within 90 minutes of first medical contact is the preferred 
treatment strategy for patients with STEMI who present within 12 hours of symptom onset.11 
However, up to 5% of patients with STEMI who undergo emergency cardiac catheterization 
are not deemed suitable for PCI but undergo CABG instead.12 The main reason to select 
CABG as the preferred reperfusion strategy in patients with acute MI is the presence of left 
main disease or other unfavourable anatomy for PCI. In selected patients, in particular acute 
MI patients with an occlusion of the left main stem and/or hemodynamic instability, the per-
cutaneous approach is often pursued. In the current case, spontaneous reperfusion of the 
infarct-related artery had occurred, which gave the opportunity to reconsider the different 
therapeutic options. The presence of unprotected left main disease is considered a surgical 
indication, thus surgery would have been the preferred therapeutic approach.13 
However, several advancements in the field of interventional cardiology, such as the advent of 
drug-eluting stents (DES), have improved the outcome of patients with more complex coro-
nary disease and are challenging the results of CABG. Large randomised trials currently un-
derway comparing PCI using DES with CABG for LMCA disease such as the SYNergy between 
percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study and 
the COMparison of Bypass surgery and AngioplasTy using SES in patients with LMCA disease 
(COMBAT) study, will better define the role of PCI in this particular group of patients.14 
When CABG is deemed necessary in a patient with STEMI, the timing of surgery becomes 
important. Recent studies have demonstrated that, as for PCI, CABG is preferably performed 
within 6 hours of symptom onset or alternatively to delay surgery for at least 24 hours and 
preferentially 7 days. In-hospital mortality becomes excessively high within the 6 to 24 hour 
time interval and there is general consensus to avoid this critical period whenever possible.15
The third option would have been to perform an isolated percutaneous or surgical resection 
of the thrombotic material. Percutaneous thrombectomy has not been shown to be effective 
in randomized studies, although there might be a niche application for this practice in lesions 
with a large thrombus load.16 In this case, the thrombotic lesion was removed surgically in 
combination with the implantation of 2 bypass grafts. As documented by the CT scan and 
confirmed angiographically, both grafts became functionally and/or anatomically occluded. 
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This is not an unexpected finding since it is well documented that bypass grafts often occlude 
when they are attached to native coronary arteries with only mild or moderate stenoses.17
ConCluSion
Primary PCI is advocated as the preferred therapy for patients with STEMI.  However, a patient-
specific approach is necessary and cardiac surgery remains an appropriate choice in patients 
with unfavourable coronary lesion anatomy. In the latter situation, bypass grafts are not always 
needed and become unnecessary in the case of non-flow limiting coronary lesions.
This case furthermore demonstrates the possibilities of cardiac CT as a non-invasive imaging 
tool to visualize disease-related issues of native coronary arteries and bypass grafts.   
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aBSTraCT
Background
The diagnostic performance of the latest 64-slice CT scanner, with increased temporal (165 
ms) and spatial (0.4 mm3) resolution, to detect significant stenoses in the clinically relevant 
coronary tree is unknown.
Methods and Results
We studied 52 patients (34 men, mean age 59.6±12.1 years) with atypical chest pain, stable 
or unstable angina pectoris, or non-ST-segment elevation myocardial infarction scheduled for 
diagnostic conventional coronary angiography. All patients had stable sinus rhythm. Patients 
with initial heart rates ≥70 bpm received ß-blockers. Mean scan-time was 13.3±0.9 sec-
onds. The CT scans were analysed by 2 observers unaware of the results of invasive coronary 
angiography, which was used as the standard of reference. All available coronary segments, 
regardless of size, were included in the evaluation. Lesions with ≥50 % luminal narrowing 
were considered significant stenoses. 
Invasive coronary angiography demonstrated the absence of significant disease in 25% (13/52), 
single-vessel disease in 31% (16/52), and multi-vessel disease in 45% (23/52) of patients. 
One unsuccessful CT-scan was classified as inconclusive. Ninety-four significant stenoses were 
present in the remaining 51 patients. Sensitivity, specificity, and positive and negative predic-
tive value of CT for the detection of significant stenoses on a segment-by-segment analysis 
were 99% (93 of 94, 95% CI: 94 to 99), 95% (601 of 631, 95% CI: 93 to 96), 76% (93 of 123, 
95% CI: 67 to 89), and 99% (601 of /602, 95% CI: 99 to100), respectively. 
Conclusions
Noninvasive 64-slice CT coronary angiography accurately detects coronary stenoses in pa-
tients in sinus rhythm and presenting with atypical chest pain, stable or unstable angina, or 
non-ST-segment elevation myocardial infarction.
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inTroduCTion
Spiral Computed Tomography (CT) coronary angiography has emerged rapidly, thanks to 
technical improvements as a sensitive diagnostic modality1-12. The newest generation spiral 
CT scanners are significantly improved. They feature 64 slices and thinner detectors, and the 
X-ray tube permits higher X-ray output and faster tube rotation. These improvements result 
in high-quality, nearly motion-free, isotropic image quality. Data are acquired during a single 
breathhold of ≈13 seconds. We report the diagnostic performance of 64-slice CT coronary 
angiography in 52 patients with atypical chest pain, stable or unstable angina, or non-ST-
segment elevation myocardial infarction referred for diagnostic invasive coronary angiography 
to assess the extent and severity of coronary stenoses in the clinically relevant coronary tree.
meThodS
Study Population
During a period of 6 weeks, we studied 70 consecutive patients scheduled for diagnostic con-
ventional coronary angiography who fulfilled the following criteria: sinus heart rhythm, able to 
breath hold for 15 seconds, and no previous percutaneous coronary intervention or coronary 
bypass surgery. Eighteen patients were excluded because of the logistical inability to perform 
a CT-scan before the conventional angiogram (n=9), presence of arrhythmia (n=4), impaired 
renal function (serum creatinine >120 mmol/L) (n=4), and known contrast allergy (n=1). 
Thus, the study population comprised 52 patients (34 male, mean age 59.6±12.1 years). 
Our institutional review board approved the study protocol and all patients gave informed 
consent.
Patient Preparation
Patients with heart rates above 70 bpm received, unless they had known overt heart failure or 
ECG AV conduction abnormalities, a single oral dose of 100 mg metoprolol 45 minutes before 
the scan. Patients with heart rates above 80 bpm received an additional single oral dose of 1 
mg lorazepam.
Scan Protocol and Image Reconstruction
All patients were scanned with a 64-slice CT scanner (Sensation 64, Siemens) equipped with 
a new feature in multislice CT technology, so-called z-axis flying focus technology13. The cen-
tral 32 detector rows acquire 0.6-mm slices, and the flying focus spot switches back and forth 
between 2 z-positions between each reading. Two slices per detector row are acquired, which 
results in a higher oversampling rate in the z axis, thereby reducing artifacts related to the 
spiral acquisition and improving spatial resolution down to 0.4 mm3 13. Angiographic scan 
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parameters included the following: number of slices per rotation, 32 x 2; individual detector 
width, 0.6 mm; rotation time, 330 ms; table feed, 3.8 mm per rotation; tube voltage, 120 
kV; tube current, 900 mA; and no prospective X-ray tube modulation. Calcium scoring pa-
rameters (similar unless indicated) were a tube current 150 mA and prospective X-ray tube 
modulation. The radiation exposure for CT coronary angiography with this scan protocol was 
calculated as 15.2 to 21.4 mSv (for men and women, respectively)using dedicated software 
(WinDose, Institute of Medical Physics). The radiation exposure of calcium scoring using a 
comparable scan protocol (including prospective x-ray tube modulation) on a 16-slice scanner 
was calculated as 1.3 to -1.7 mSv (for men and women, respectively)15. 
A bolus of 100 mL contrast material (iomeprol, Iomeron 400) was injected through an arm 
vein at a flow rate of 5 mL/s. A bolus-tracking technique was used to synchronize the arrival 
of contrast in the coronary arteries with the initiation of the scan. To monitor the arrival of 
contrast material, axial scans were obtained at the level of the ascending aorta with a delay 
of 10 seconds after the start of the contrast injection. The scan was automatically started 
when a threshold of 100 Hounsfield units was reached in a region of interest positioned in the 
ascending aorta.
Images were reconstructed using ECG gating to obtain optimal, motion-free image quality. 
Data sets were reconstructed immediately after the scan following a stepwise pattern. Initially, 
a single data set was reconstructed during the mid- to end-diastolic phase (350 ms before 
the next R wave). Image quality was assessed on a per-segment level. In case of insufficient 
image quality of ≥1 coronary segments, additional data sets were reconstructed (300, 400, 
and 450 ms before the next R wave). In case of persistent artifacts related to coronary mo-
tion, a second reconstruction approach was carried out, including reconstruction of data sets 
both during the mid- to end-diastolic phase (between 60% and 70% of the R-R interval) and 
the end-systolic phase (between 25% and 35% of the R-R interval). If necessary, multiple data 
sets of a single patient were used separately to obtain optimal image quality of all available 
coronary segments. The reconstruction algorithm uses data from a single heartbeat, obtained 
during half-x-ray tube rotation, resulting in a temporal resolution of 165 ms. 
Quantitative Coronary Angiography 
All scans were performed within 2 weeks of the conventional diagnostic angiogram. A single 
observer unaware of the multislice CT results identified coronary segments using a 17-seg-
ment modified AHA classification14 (right coronary artery: 1, proximal; 2, mid; 3, distal; 4a, 
posterior descending; 4b postero-lateral; left main coronary artery: 5; left anterior descending 
coronary artery: 6, proximal; 7, mid; 8, distal; 9, first diagonal; 10, second diagonal; circum-
flex coronary artery: 11, proximal; 12, first marginal; 13, mid; 14, second marginal; 15, distal; 
16, intermediate branch). All segments, regardless of size, were included for comparison with 
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CT coronary angiography. Segments were classified as normal (smooth parallel or tapering 
borders), as having nonsignificant disease (luminal irregularities or <50% stenosis), or as 
having significant stenoses. Stenoses were evaluated in 2 orthogonal views and classified as 
significant if the mean lumen diameter reduction was ≥50% using a validated quantitative 
coronary angiography (QCA) algorithm (CAAS, Pie Medical). 
CT Image Evaluation
All scans were analysed independently by a radiologist and a cardiologist who were unaware 
of the results of conventional coronary angiography and used an offline workstation (Leon-
ardo, Siemens). Total calcium scores of all patients were calculated using dedicated software 
and expressed as Agatston scores. The Agatston score is a commonly used scoring method 
that calculates the total amount of calcium based on the basis of the number, areas, and peak 
Hounsfield units of the detected calcified lesions16. 
All available coronary segments were visually scored for the presence of significant stenosis. 
Maximum-intensity projections were used to identify coronary lesions and (curved) multi-pla-
nar reconstructions to classify lesions as significant or nonsignificant. Disagreement between 
observers was resolved by consensus. 
Image quality was evaluated on a per-segment basis and classified as good (defined as ab-
sence of any image-degrading artifacts related to motion, calcification, or noise), adequate 
(presence of image-degrading artifacts but evaluation possible with moderate confidence), 
or poor (presence of image-degrading artifacts and evaluation possible only with low confi-
dence). 
Statistical Analysis
The diagnostic performance of CT coronary angiography for the detection of significant le-
sions in coronary arteries with QCA as the standard of reference is presented as sensitivity, 
specificity, positive and negative predictive value and positive and negative likelihood ratios 
with the corresponding exact 95% CIs. Comparison between CT coronary angiography and 
QCA was performed on 3 levels: segment by segment, vessel by vessel (no or any disease per 
vessel), and patient by patient (no or any disease per patient). We performed an additional 
sensitivity analysis after random selection of a single segment per patient to explore the effect 
of nesting; repeated assessments (segment by segment and vessel by vessel) within the same 
patient were made that were not independent observations. Intraobserver and interobserver 
variability for the detection of significant coronary stenosis was determined by k statistics. 
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reSulTS
Patient characteristics are shown in Table 1. Seventy-three percent of the patients (38 of 52) 
received a ß-blocker and, 31% (16 of 52) also received lorazepam. The mean heart rate in 
these patients dropped within 45 minutes from 68.2±10.2 to 57.8±6.8 bpm. The mean scan 
time was 13.3±0.6 seconds. One 
unsuccessful CT scan was classified 
as inconclusive because the develop-
ment of ventricular bigeminy during 
the angiography scan. 
A single data set for the assessment of 
significant stenoses was used in 69%, 
2 data sets in 27%, and 3 data sets in 
4% of patients to obtain optimal im-
age quality of on a per-segment level. 
Data sets reconstructed during the 
end-systolic phase were used in 27% 
of patients (14/51). Image quality was 
classified as good in 90%, moderate 
in 7%, and poor in 3% of coronary 
segments. Reasons for poor image 
quality were motion artifacts (60%, 12 
of 20), severe calcifications (20%, 4 
of 20), or low contrast-to-noise ratio 
(20%, 4 of 20).
Diagnostic Performance of 64-Slice CT Coronary 
Angiography: Segment-by-Segment Analysis
A total of 725 segments were included for comparison with QCA. Potentially, 17 segments 
per patient can be present for analysis. However, 142 segments were not visualized on the 
conventional angiogram because of variations in coronary anatomy (absence of an intermedi-
ate branch or hypoplastic, nondominant coronary arteries in which not all segments could be 
identified; 102 segments), and the presence of a proximal occlusion and poorly filled distal 
segments by collaterals (40 segments). 
Interobserver and intraobserver variability for detection of significant lesions had k values of 
0.73 and 0.79, respectively. The diagnostic performance of CT coronary angiography for de-
tecting significant lesions on a segment-based analysis is detailed in Table 2. One significant 
Symptoms
Atypical chest pain 6 (12)
Stable angina pectoris 32 (63)
Unstable angina pectoris 3 (6)
Non-ST-elevation myocardial infarction 11 (22)
Risk factors
Hypertension 17 (33)
Hypercholesterolemia 36 (71)
Diabetes Mellitus 7 (14)
Smoking 15 (29)
Family history of acute coronary syndrome 13 (26)
Obese (body mass index ≥30 kg/m2) 14 (28)
Calcium score, median (interquartile range)* 231 (15-736)
Conventional angiography
Absence of coronary artery disease 7 (13)
Nonsignificant disease 6 (12)
Single-vessel disease 16 (31)
Multivessel disease 23 (45)
Table 1. Patient characteristics (n=52)
N=52. Value are n (%) unless otherwise indicated.
* Agatston-score
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stenosis (lumen diameter reduction: 52%) located at the mid part of the LAD was detected 
with CT, but the severity of the stenosis was underestimated and classified as nonsignificant. 
Thirty nonsignificant lesions were detected with CT, but the severity of these stenoses was 
overestimated, resulting in incorrect classification as significant stenoses on the CT scan. 
Conventional angiography revealed only wall irregularities in 8 and nonsignificant stenoses in 
the remaining 22 lesions (mean lumen reduction: 34.7±7.9%; range, 23 to 49%). The vast 
majority (83%, 25 of 30) of these segments were calcified. The presence of coronary calcium 
N Sensitivity, % Specificity, % PPV, % NPV, % +LR -LR
Segment-based analysis
All segments 725 99 (94-98) 95 (93-96) 76 (67-89) 100 (99-100) 20.81 0.01
Proximal segments 204 100 (89-100) 97 (93-98) 83 (67-97) 100 (97-100) 29.00 0.00
Mid segments 142 97 (83-99) 94 (88-97) 81 (63-96) 99 (94-99) 15.47 0.04
Distal segments 121 100 (68-100) 97 (92-99) 73 (39-98) 100 (96-100) 37.67 0.00
Side branches 258 100 (87-100) 94 (90-96) 65 (48-85) 100 (98-100) 16.57 0.00
LM 51 100 (21-100) 100 (93-100) 100 (92-100) 100 (2-100) ∞ 0.00
LAD 230 97 (85-100) 92 (88-95) 69 (53-86) 99 (96-99) 12.68 0.03
LCx 235 100 (88-100) 97 (94-99) 83 (66-97) 100 (98-100) 34.33 0.00
RCA 209 100 (89-100) 95 (91-97) 77 (60-95) 100 (97-100) 19.89 0.00
Patient-based analysis
All segments 51 100 (91-100) 92 (67-99) 97 (86-99) 100 (73-100) 13.00 0.00
Table 2. Diagnostic Performance and Predictive Value of 64-slice CT Coronary Angiography for the Detection of ≥50% Stenoses 
on QCA
PPV indicates positive predictive value, NPV, negative predictive value; +LR, positive likelihood ratio; -LR, negative likelihood 
ratio; LM, left main coronary artery; LCx, circumflex coronary artery; and RCA: right coronary artery. For segment-based analysis, 
analysis of 725 segments visualized on the conventional angiogram and classified according to a 17-segment modified AHA clas-
sification was performed. Segments were further classified on the basis of their location within the coronary tree (proximal, mid, or 
distal segments of the main coronary artery arteries or side branches) and their location within a single vessel (LM, LAD, LCx, or 
RCA). For patient-based analysis, analysis of 51 patients was performed. Values in parentheses represent 95% Cls.
Calcium 
Score
n
Mean (±SD) 
Agatston Score
TP TN fP fN
Sensitivity, 
%
Specificity, 
%
Positive 
PV,%
Negative 
PV, %
0-10 12 0 ± 0 8 171 2 0 100 (63-100) 99 (95-99) 80 (44-98) 100 (97-100)
11-400 21 174 ± 122 36 240 13 0 100 (90-100) 95 (91-97) 73 (58-88) 100 (98-100)
401-1000 12 718 ± 166 31 129 10 1 97 (83-98) 93 (87-96) 76 (59-89) 99 (95-99)
>1000 6 1731 ± 621 18 61 5 0 100 (81-100) 92 (83-97) 78 (56-96) 100 (94-100)
Table 3. Influence of Coronary Calcification on Diagnostic Accuracy of 64-slice CT Coronary Angiography on a Segment-Based 
Analysis.
TP indicates true positive; TN, true negative; FP, false positive; FN, false negative; PV, predictive value; Values in parentheses 
represent 95% CIs.
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induced overestimation of the sever-
ity of these lesions on the CT scan 
(Table 3). Agreement between CT 
coronary angiography and QCA on 
a per-segment level was very good 
(k value, 0.83).
After random selection of a single 
segment per patient, the sensitivity 
for detecting significantly diseased 
vessels was 100% (13 of 13, 95% CI, 75 to 100), specificity was 95% (36 of 38; 95% CI, 82 to 
99), positive predictive value was 87% (13 of 15; 95% CI, 59 to 99), and negative predictive 
value was 100% (36 of 36; 95% CI, 90 to 100).
Diagnostic Performance of 64-slice CT Coronary 
Angiography: Vessel-by-Vessel Analysis
The diagnostic performance of CT coronary angiography for detectng significant lesions on 
a vessel-based analysis is detailed in Table 2. One significantly diseased LAD was incorrectly 
classified as nonsignificantly diseased on the CT scan. Sensitivity for the detection of sig-
nificantly diseased LAD was 96% and 100% in all other main coronary arteries. Agreement 
between CT coronary angiography and QCA on a per-vessel level was very good (k value: 
0.85).
Diagnostic Performance of 64-Slice CT Coronary 
Angiography: Patient-by-Patient Analysis 
The diagnostic performance of CT coronary angiography for detecting significant lesions on 
a patient-based analysis is detailed in Table 2. Twelve patients with either an angiographically 
normal coronary angiogram (n=7) or with non-significant disease (n=5) were correctly identi-
fied with CT. However, 1 patient with only wall irregularities on the conventional angiogram 
Figure 1a, CT coronary angiogram and corre-
sponding conventional angiogram of the right 
coronary artery (RCA) in a patient presenting with 
stable angina pectoris and a calcium (Agatston) 
score of 79. The arrow indicates a significant lesion 
located at the mid RCA. Cross-sectional CT images 
show a large noncalcific plaque (b) and a normal 
coronary lumen proximal and distal of the lesion (a, 
c). Note that the volume-rendered images (colored 
images) provide an excellent anatomical overview 
of the coronary arteries but should not be used to 
score the presence and degree of coronary stenos-
es.
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was incorrectly classified 
as having single-vessel 
disease on the CT scan. 
All 38 patients with sig-
nificant coronary artery 
disease on conventional 
angiography were cor-
rectly identified on the CT 
scan (Figure 1 and, 2).
However, in 7 patients 
with single-vessel disease 
also, another lesion was 
detected and its severity 
was overestimated which 
resulted in incorrect clas-
sification as having mul-
tivessel disease on CT 
coronary angiography. 
Agreement between CT 
coronary angiography 
and QCA on a per-patient 
(no or any disease) level 
was very good (k value, 
0.95); agreement be-
tween both techniques to 
classify patients as having 
no, single-vessel, or mul-
tivessel disease was good 
(k value, 0.72).
Figure 1b, Volume-rendered CT image (colored image) providing an overview of the 
coronary anatomy and showing a small (lumen diameter, 1.5 mm) intermediate branch 
(IMB). A detailed curved multiplanar reconstructed (cMPR) CT image reveals the pres-
ence of a significant stenosis (arrowhead) located at the proximal IMB, which was con-
firmed on the conventional angiogram (CA). The patient was correctly classified as hav-
ing 2-vessel disease on the CT scan. MIP indicates maximum-intensity projection; PDA, 
posterior descending coronary artery; RCA, right coronary artery. 
Figure 2. Volume-rendered CT im-
age (colored image) providing an 
overview of the coronary anatomy 
and suggesting a significant steno-
sis of the proximal LAD (indicated 
by the arrow). More detailed analy-
sis using different CT postprocess-
ing techniques (maximum-intensity 
projections [MIP] and curved multi-
planar reconstructions [cMPR]) con-
firms the presence of a significant 
stenosis, which corresponds with the 
conventional angiogram (CA).
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diSCuSSion
Recent reports demonstrated that earlier-generation multislice CT scanners showed promise 
for noninvasive detection of coronary stenoses.1-12 The reported diagnostic values were high 
but one should bear in mind that the calculated sensitivity and specificity were based on ana-
lyzable coronary segments rather than on those of all examined coronary segments. In fact, 
the most recent reports of 16-slice CT coronary angiography excluded 6% to 17% of the avail-
able coronary segments, and only a few included all available segments. In addition, only the 
larger parts of the coronary tree were examined; smaller parts with a diameter of <1.5 mm 
or 2 mm were excluded from analysis. Most recently, Leschka et al17 presented the first study 
exploring the diagnostic performance of 64-slice CT coronary angiography. They evaluated 
all available coronary segments ≥1.5 mm and reported a high sensitivity and specificity for 
detecting significant lesions using a 64-slice CT scanner with a rotation time of 375 ms. 
The newest 64-slice CT scanners have a shorter rotation time (330 ms) and offer not only a 
shorter scan time and a higher spatial resolution but also a higher temporal resolution com-
pared with previous scanner generations. Multislice CT coronary angiography of the clinically 
relevant coronary segments, as designated by the AHA classification, is now possible. We 
found that significant coronary stenoses were detected using the latest 64-slice CT scanner 
with a sensitivity of 99% and a specificity of 95% compared with conventional invasive diag-
nostic coronary angiography. All but 1 patients with angiographically normal coronary angio-
grams were correctly identified, rendering the CT-technique highly reliable to identify patients 
with no significant coronary obstruction. Furthermore, all patients with significant coronary 
artery disease were correctly diagnosed, and only a single coronary lesion was missed on the 
CT scan. In addition, we found good agreement between CT coronary angiography and QCA 
in the classification of patients with no, single-vessel, or multivessel disease. Our results were 
obtained in patients with a wide spectrum of clinical settings, including atypical chest pain, 
stable or unstable angina, or non-ST-segment elevation, who had varying degrees of coronary 
artery disease, ranging from normal coronary angiograms to obstructive disease of 1, 2 or 3 
vessels.
We did not include patients with ST-segment elevation myocardial infarction; these patients 
should undergo immediate percutaneous intervention without delay, and the role of CT in 
these patients is highly questionable. In our study the specificity was somewhat lower because 
we tended to overestimate the severity of a lesion on the CT scan, resulting in a number of 
false-positive outcomes, rather than underestimating the lesion severity and thereby “missing” 
lesions, which may have serious consequences in a symptomatic patient population. 
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Study Limitations
The estimated radiation dose during CT coronary angiography (15.2 to 21.4 mSv for men 
and women, respectively) is a cause of concern and higher than the radiation dose associated 
with conventional coronary angiography. The radiation exposure can be reduced by technical 
adjustments such as prospective x-ray tube current modulation. This technique reduces the ra-
diation exposure by ≈ 50% in patients with low heart rates15 but is sensitive to arrhythmia and 
limits the possibility to reconstruct datasets during the end-systolic phase. This proved useful 
in 27% of our patients. Persistent irregular heart rhythm such as atrial fibrillation and frequent 
extrasystoles preclude multislice coronary angiography. Motion artifacts caused by mild ar-
rhythmia (e.g. a single ventricular extrasystole) can be diminished by manual repositioning 
the reconstruction windows. Severe coronary calcification obscures the coronary lumen and 
can lead to overestimation of severity of lesions due to blooming artifacts, resulting in a lower 
specificity in patients with high calcium scores. The presence of coronary calcifications also 
severely limits the applicability of QCA algorithms. In fact, no software able to detect and 
quantify coronary stenoses has been adequately validated yet. 
When evaluating the diagnostic performance of CT coronary angiography on 3 levels (seg-
ment by segment, vessel by vessel, and patient by patient), we made repeated assessments 
within the same patient. However, we performed a sensitivityanalysis after random selection of 
a single segment per patient and found values that are in line with the values obtained after 
clustering all available segments. This finding suggests that the nesting of observations within 
a single patient did not have an important impact on the estimates of the diagnostic perfor-
mance of CT for detecting significant stenoses in present study. 
Patients with initial heart rates >70 bpm received prescan medication, reducing the mean 
heart rate to 57 bpm. Future improvements in temporal resolution should diminish motion ar-
tifacts related to high heart rates, which could make the administration of prescan ß-blockers 
unnecessary. 
 
ConCluSionS
Our results show that noninvasive 64-slice CT coronary angiography is a reliable technique 
to detect coronary stenoses in patients with sinus rhythm presenting with atypical chest pain, 
stable or unstable angina pectoris, or non-ST-segment elevation myocardial infarction and 
suggest that this noninvasive technique can now be considered as an alternative to invasive 
diagnostic coronary angiography in selected patients. 
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aBSTraCT
Background
A high diagnostic accuracy of 64-slice CT coronary angiography (CTCA) has been reported in 
selected patients with stable angina pectoris, but only scant information is available in patients 
with non-ST elevation acute coronary syndrome (ACS).
Objectives
To study the diagnostic performance of 64-slice CTCA in patients with non-ST elevation ACS.
Patients and methods
64-slice CTCA was performed in 104 patients (mean (SD) age 59 (9) years) with non-ST el-
evation ACS. Two independent, blinded observers assessed all coronary arteries for stenosis, 
using conventional quantitative angiography as a reference. Coronary lesions with ≥50 % 
luminal narrowing were classified as significant. 
Results
Conventional coronary angiography demonstrated the absence of significant disease in 15% 
(16/104) of patients, and the presence of single-vessel disease in 40% (42/104) and multives-
sel disease in 44% (46/104) of patients. Sensitivity for detecting significant coronary stenoses 
on a patient-by-patients analysis was 100% (88/88; 95% CI 95 to 100), specificity 75% (12/16; 
95% CI 47 to 92), and positive and negative predictive values were 96% (88/92; 95% CI 89 to 
99) and 100% (12/12; 95% CI 70 to 100), respectively. 
Conclusion
64-slice CTCA has a high sensitivity to detect significant coronary stenoses, and is reliable 
to exclude the presence of significant coronary artery disease in patients who present with a 
non-ST elevation ACS. 
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inTroduCTion
Patients with a non-ST elevation acute coronary syndrome (ACS) are usually stratified into 
high and low risk for progression to myocardial infarction or death on the basis of their clinical 
presentation, ECG changes, biomarkers, electrical or hemodynamical instability, and pres-
ence of diabetis mellitus.1 An invasive management strategy, including conventional coronary 
angiography (CCA) and revascularization, is recommended in high-risk patients, whereas a 
conservative strategy with ischemia-guided revascularization is recommended in low-risk pa-
tients.1-3 We investigated the feasibility and diagnostic accuracy of 64-slice CT coronary an-
giography (CTCA) in 104 patients with non-ST elevation ACS as a first step to evaluate the 
potential decision-making role of CT in this patient cohort. 
meThodS
Study Population
Over a 12-month period we included 104 patients presenting with unstable angina pectoris 
or non-ST-segment elevation myocardial infarction. They were stratified as either high or low 
risk group according to the current European guidelines, on the basis of baseline character-
istics, troponin rise or ECG changes.1 High-risk patients and low-risk patients with a positive 
or inconclusive exercise ECG test or high suspicion for obstructive coronary artery disease 
(CAD underwent both CTCA and CCA. Furthermore, patients presenting with a ST-segment 
elevation myocardial infarction were not included, but were immediately referred for direct 
percutaneous coronary intervention (PCI). No patients with previous history of PCI or coronary 
artery bypass graft (CABG), impaired renal function (serum creatinine>120 µmol/l), known 
intolerance to iodinated contrast material and atrial fibrillation were included. All patients un-
derwent CCA, which was the standard of reference. The institutional review board of Erasmus 
MC Rotterdam approved the study and all subjects gave informed consent. 
Patient Preparation
Patients with a heart rate >65 bpm before the examination received additional beta-blockers 
(50/100mg Metoprolol), and all were given thorough breath-hold instructions. 
Scan Protocol 
All scans were made with a 64-slice CT scanner, which had a gantry rotation time of 330 ms, 
a temporal resolution of 165 ms, and a spatial resolution of 0.4 mm3 (Sensation 64, Siemens, 
Forchheim, Germany). Initially, a calcium scan was performed using standardized scan pa-
rameters 64×0.6 mm collimation, 330 ms rotation time, 3.8 mm/rotation table feed, 120 kV 
tube voltage, 150 mA tube current and prospective x ray tube modulation. Then the CTCA 
Chapter 7
134
was completed, which had similar parameters except for a higher tube current of 900 mA 
and absence of x-ray tube modulation. The radiation exposure for CTCA using this scan pro-
tocol was calculated as 15.2-21.4 (male/female) mSv using dedicated software (WinDose®, 
Institute of Medical Physics, Erlangen, Germany). The radiation exposure for calcium scoring 
using a comparable scan protocol (including prospective x ray tube modulation) on a 16-slice 
scanner was calculated as 1.3-1.7 (male/female) mSv.4 
A bolus of 80-100 ml of contrast material (400 mgI/mL; Iomeron, Bracco, Milan, Italy) was 
injected intravenously in an antecubital vein at a flow rate of 5 ml/s. A bolus-tracking tech-
nique was used to synchronise the arrival of contrast in the coronary arteries, and the scan 
was started once the contrast attenuation in a preselected region of interest in the ascending 
aorta had reached a predefined threshold of +100 HU. 
Image Reconstruction
Images were obtained during a half x ray tube rotation, resulting in an effective temporal reso-
lution of 165 ms. Datasets were reconstructed immediately after the scan. To obtain optimal 
image quality, datasets were reconstructed in the mid-to-end diastolic phase using retrospec-
tive ECG gating with an absolute reverse or percentage technique as described previously by 
Mollet.5 In case of impaired image quality due to motions artefacts or breathing artefacts ad-
ditional reconstructions were made in the end-systolic phase. 
Quantitative Coronary Angiography
All CT scans were carried out within 1-2 days of performing CCA. One experienced cardiolo-
gist, blinded to the results of CTCA, identified and analyzed all coronary segments, using a 
17-segment modified American Heart Association classification.6 
All segments, regardless of size, were included for comparison with CTCA. Segments were 
classified as normal (smooth parallel or tapering borders), as having non-significant disease 
(wall irregularities or <50% stenosis) or having significant disease (stenosis ≥50%). Stenoses 
were evaluated in the worst view, and were classified as significant if the reduction in lumen di-
ameter exceeded 50 % of that measured by the validated quantitative coronary angiographic 
(QCA) algorithm (CAAS, Pie Medical, Maastricht, the Netherlands). 
CT Image Evaluation
One observer analyzed total calcium scores of all patients using the appropriate software 
(Syngo, Calcium Scoring, Siemens Fonchheim, Germany), expressing results as an Agatston 
score.7 Two experienced observers, a radiologist and a cardiologist, all unaware of the results 
of CCA, evaluated the CTCA datasets on an offline workstation (Leonardo, Siemens, Forch-
heim, Germany). The axial slices were initially evaluated for the presence of significant seg-
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mental disease and, additionally, multiplanar and curved multiplanar reconstructed images 
were used. Segments located distally to a chronic total occlusion were excluded because of 
poor distal filling by collaterals. Interobserver disagreements were resolved by a third reader. 
Statistical Analysis
The diagnostic performance of CTCA for detecting significant stenoses in the coronary arter-
ies using QCA as the standard of reference is presented in terms of sensitivity, specificity, posi-
tive predictive value and negative predictive values with the corresponding 95% CIs. Positive 
(sensitivity/ [1-specificity]) and negative ([1-sensitivity]/specificity) likelihood ratios are given. 
The likelihood ratio incorporates both the sensitivity and specificity of a test and provides a 
direct estimate of how much a test result will change the odds of having a disease. Post-test 
odds can be calculated by multiplying the pre-test odds by the likelihood ratios. Comparison 
between CTCA and QCA was performed on three levels of analysis: patient by patient, vessel 
by vessel and segment by segment. To investigate the effect of nesting, an additional sensitivity 
analysis was done; repeated assessments (segment by segment and vessel by vessel) within 
the same patient were made, which were not independent observations. Interobserver and 
intraobserver variabilities for the detection of significant coronary stenosis and agreement 
between techniques to classify patients as having no, single or multi-vessel disease were de-
termined using k statistics.
reSulTS
Table 1 shows the patient demographics. In all, 86% (89/104) the patients received oral ß-
blockers as treatment for ACS. Additional ß-blockers were administered in 63% (65/104) of 
patients, and the mean (SD) heart rate dropped within 60 min from 66 (9) to 60 (8) bpm in 
these patients. The mean (SD) scan time was 12.3 (1.2) s. As a first step, all datasets were 
reconstructed in the mid-to-end diastolic phase. In 34% (35/104) of cases, additional higher 
quality end-systolic reconstructions were used.
Diagnostic performance of 64-slice CT coronary 
angiography: patient-by-patient analysis
The prevalence of significant CAD, defined as having at least one ≥ 50% stenosis per patient 
was 85%. Tabel 2 details the diagnostic performance of CTCA for detecting significant stenos-
es on a patient-based analysis. The diagnostic accuracy of patients in the low- and high-risk 
groups were similar. 
Twelve patients with either an angiographically normal CCA (n=4) or with non-significant 
disease (n=8) were correctly identified with CT. However, two patients with only wall irregu-
larities on the CCA were incorrectly classified as having single-vessel disease on the CT scan 
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Low risk High risk
n 33 71
Mean (SD) age, range (years) 58 ± 7 (38-75) 59 ± 10 (30-84)
Males 23 (70) 52 (73)
Mean (AD) calcium score* 473.9 ± 738.2 440.0 ± 513.6
Mean (SD) BMI† 25.8 ± 3.6 26.5 ± 3.7
Recurrent ischemia ‡ - 49 (71)
Early postinfarct unstable angina - 9 (13)
Elevated troponin levels -    55 (78)
Diabetes Mellitus - 9 (13)
Normal ECG 21 (64) -
ECG with negative or flat T-waves 12 (36) -
Positive exercise ECG test 23 (70) -
Inconclusive exercise ECG test 3 (9)
Highly suspicious for obstructive CAD 7 (21)
Traditional risk factors
 Hypertension 17 (52) 37 (52)
 Hypercholesterolemia 22 (67) 40 (56)
 Diabetes mellitus 0 (0) 9 (13)
 Smoker 14 (42) 35 (49)
 Ex-smoker 2 (6) 2 (3)
 Family history of CAD 24 (73) 32 (45)
 Obese † 8 (24) 15 (21)
 Previous myocardial infarction 1 (3) 17 (24)
Conventional angiography
 Absence of coronary disease 2 (6) 2 (3)
 Nonsignificant disease 3 (9) 9 (13)
 Single-vessel disease 15 (45) 27 (38)
 Two-vessel disease 10 (30) 26 (37)
 Three-vessel disease 3 (9) 7 (10)
Table 1. Patient demographics (n=104)
BMI, body mass index; CAD coronary artery disease. 
Values are n (%) unless otherwise indicated 
According to European Society for Cardiology guidelines, patients were stratified into high and 
low-risk groups, which give a risk estimate for progression to myocardial infarction or death. 
which give a risk estimate for progression to myocardial infarction or death.
* Agatston score
† BMI≥ 30 kg/m²
‡ Recurrent ischemia defined as either recurrent chest pain or dynamic ST-segment changes 
  (in particular ST-segment depression, or transient ST-segment elevation) 
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and two patients as having multi-vessel disease. All 88 patients with significant CAD on CCA 
were correctly identified on the CT-scan (figs 1 and 2). However, in 23 patients with single-
vessel disease on CCA, CTCA overestimated the severity of additional lesions, which resulted 
in incorrect classification as having multi-vessel disease on CTCA. In all, 27 patients in the 
low-risk group underwent PCI, 1 underwent CABG and 5 were treated medically. In the high-
risk group, 55 underwent PCI, 5 underwent CABG and 11 were treated medically. Agreement 
Figure 1. This patient with prior history of a mitral valve plasty for endocarditis was admitted with a non-ST segment elevation 
myocardial infarction. A volume-rendered CT coronary angiography image (A) reveals the anatomy of the right coronary artery. 
Two curved multiplanar reconstructed images (C, D) disclose a significant stenosis (arrow) in the proximal right coronary artery, 
which was corroborated by conventional coronary angiography (B). 
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between CTCA and QCA on a per-patient (no or any disease) level was very good (k value 
0.84), whereas agreement between techniques to classify patients as having no, single-, and 
multi-vessel disease was moderate (k value 0.55).
Diagnostic Performance of 64-Slice CT Coronary 
Angiography: Vessel-By-Vessel Analysis
Table 2 details the diagnostic performance of CTCA for the detection of significant lesions in 
a vessel-based analysis. Two significantly diseased right coronary arteries and one diseased 
circumflex coronary artery were incorrectly classified as non-significantly diseased on the CT-
scan. Of a total of 416 vessels, 59 non-obstructive vessels were overestimated and scored as 
false positives. Agreement between CTCA and QCA on a per-vessel level was good (k value: 
0.70).
Diagnostic Performance of 64-slice CT Coronary 
Angiography: Segment-By-Segment Analysis
A total of 1525 segments were included for comparison with QCA. Potentially, 17 segments 
per patient can be present for analysis. A total of 243 segments were not visualized on the 
Figure 2. A maximum intensity 
projected CT coronary angiog-
raphy image shows a large non-
calcified plaque in the proximal 
segment of the right coronary 
artery (A). Two curved multi-
planar reconstructed images 
(C, D) disclose the high-grade 
stenosis, confirmed by conven-
tional coronary angiography 
(B).
64-slice CT Coronary Angiography in Patients with Non-ST Elevation Acute Coronary Syndrome
139
Pr
ev
al
en
ce
 o
f 
di
se
as
e,
 %
n
T
P
T
N
fP
fN
k
Se
ns
iti
vi
ty
,
%
 (
95
%
 C
I)
Sp
ec
ifi
ci
ty
,
%
 (
95
%
 C
I)
PP
V,
%
 (
95
%
 C
I)
N
PV
,
%
 (
95
%
 C
I)
+
LR
- 
LR
 A
ll 
pa
tie
nt
s
85
10
4
88
12
4
0
0.
84
10
0 
(9
5-
10
0)
75
 (
47
-9
2)
96
 (
89
-9
9)
10
0 
(7
0-
10
0)
4.
00
0.
00
 H
ig
h 
ris
k
   
85
71
60
8
3
0
0.
82
10
0 
(9
3-
10
0)
73
 (
39
-9
3)
95
 (
86
-9
9)
10
0 
(6
0-
10
0)
3.
67
0.
00
 L
ow
 r
is
k
85
33
28
4
1
0
  0
.8
7
10
0 
(8
5-
10
0)
 8
0 
(3
0-
99
)
93
 (
80
-1
00
)
10
0 
(4
0-
10
0)
5.
00
 0
.0
0 
Ve
ss
el
 b
as
ed
 a
na
ly
si
s
  A
ll 
ve
ss
el
s
35
41
6
14
1
21
4
58
3
0.
70
98
 (
94
-9
9)
79
 (
73
-8
3)
71
 (
64
-7
7)
99
 (
96
-1
00
)
4.
59
0.
03
  R
C
A
48
10
4
48
39
15
2
0.
68
96
 (
85
-9
9)
72
 (
58
-8
3)
76
 (
64
-8
6)
95
 (
82
-9
9)
3.
46
0.
06
  L
M
3
10
4
3
98
3
0
0.
65
10
0 
(3
1-
10
0)
97
 (
91
-9
9)
50
 (
14
-8
6)
10
0 
(9
5-
10
0)
33
.6
7
0.
00
  L
A
D
47
10
4
49
32
23
0
0.
57
10
0 
(9
1-
10
0)
58
 (
44
-7
1)
68
 (
56
-7
8)
10
0 
(8
7-
10
0)
2.
39
0.
00
  C
X
39
10
4
40
46
17
1
0.
66
98
 (
86
-1
00
)
73
 (
60
-8
3)
70
 (
56
-8
1)
98
 (
87
-1
00
)
3.
62
0.
03
Se
gm
en
t b
as
ed
 a
na
ly
si
s
  A
ll 
se
gm
en
ts
13
15
25
18
3
12
05
12
2
15
0.
68
92
 (
88
-9
6)
91
 (
89
-9
2)
60
 (
54
-6
5)
  9
9 
(9
8-
99
)
10
.0
5
0.
08
  P
ro
xi
m
al
14
41
6
58
31
2
44
2
0.
65
97
 (
87
-9
9)
88
 (
84
-9
1)
57
 (
47
-6
7)
99
 (
97
-1
00
)
7.
82
0.
04
  M
id
23
30
2
67
19
9
34
2
0.
71
97
 (
89
-9
9)
85
 (
80
-9
0)
66
 (
56
-7
5)
99
 (
96
-1
00
)
6.
65
0.
03
  D
is
ta
l
9
32
7
24
28
6
11
6
0.
71
80
 (
61
-9
2)
96
 (
93
-9
8)
69
 (
51
-8
3)
  9
8 
(9
5-
99
)
21
.6
0
0.
21
  S
id
e 
br
an
ch
8
48
0
34
40
8
33
5
0.
60
87
 (
72
-9
5)
92
 (
90
-9
5)
51
 (
38
-6
3)
99
 (
97
-1
00
)
11
.6
5
0.
14
Ta
bl
e 
2
. D
ia
gn
os
tic
 p
er
fo
rm
an
ce
 a
nd
 p
re
di
ct
iv
e 
va
lu
e 
of
 6
4
-S
lic
e 
C
T
C
A
 f
or
 t
he
 d
et
ec
tio
n 
of
 ≥
 5
0
%
 s
te
no
si
s 
on
 q
ua
nt
ita
tiv
e 
co
ro
na
ry
 a
ng
io
gr
ap
hy
C
TC
A
, 
C
T 
co
ro
na
ry
 a
ng
io
gr
ap
hy
; 
FN
, 
fa
ls
e 
ne
ga
tiv
e;
 F
P,
 f
al
se
 p
os
iti
ve
; 
LA
D
, 
le
ft
 a
nt
er
io
r 
de
sc
en
di
ng
 c
or
on
ar
y 
ar
te
ry
; 
LC
x,
 c
irc
um
fle
x 
co
ro
na
ry
 a
rt
er
y;
 L
M
, 
le
ft
 m
ai
n 
co
ro
na
ry
 a
rt
er
y;
 
+
LR
, p
os
iti
ve
 li
ke
lih
oo
d 
ra
tio
; 
-L
R
, n
eg
at
iv
e 
lik
el
ih
oo
d 
ra
tio
; 
N
PV
, n
eg
at
iv
e 
pr
ed
ic
tiv
e 
va
lu
e;
 P
PV
, p
os
iti
ve
 p
re
di
ct
iv
e 
va
lu
e;
 R
C
A
, r
ig
ht
 c
or
on
ar
y 
ar
te
ry
; 
T
P,
 t
ru
e 
po
si
tiv
e;
 T
N
, t
ru
e 
ne
ga
-
tiv
e.
A
cc
or
di
ng
 t
o 
th
e 
17
-s
eg
m
en
t 
m
od
ifi
ed
 A
m
er
ic
an
 H
ea
rt
 A
ss
oc
ia
tio
n 
(A
H
A
) 
cl
as
si
fic
at
io
n,
 1
52
5 
se
gm
en
ts
 a
nd
 4
16
 v
es
se
ls
 v
is
ua
lis
ed
 w
ith
 c
on
ve
nt
io
na
l c
or
on
ar
y 
an
gi
og
ra
ph
y 
w
er
e 
in
-
cl
ud
ed
 fo
r 
se
gm
en
t a
nd
 v
es
se
l a
na
ly
si
s.
 
Chapter 7
140
CCA. A total of 181 segments were excluded owing to 
variations in coronary anatomy, and 62 segments ow-
ing to the presence of a proximal occlusion and poorly 
filled distal segments by collaterals. All segments were 
included, irrespective of the presence of calcifications or 
poor image quality. Interobserver and intraobserver vari-
abilities for detection of a significant stenosis per seg-
ment had a k value of 0.69 and 0.73, respectively. Tabel 
2 details the performance of CTCA for detecting signifi-
cant stenoses. Agreement between CTCA and QCA on 
a per-segment level was good (k value 0.68).
Fifteen significant coronary stenoses were underestimat-
ed or missed and classified as non-significant. Most of 
these significant lesions (11/15) were located in distal 
segments or in side branches. In all, 123 non-significant 
lesions were detected with CTCA, but the severity of 
these stenoses was overestimated. This overestimation, 
in 67% (83/123) owing to heavy calcification, resulted 
in incorrect classification as significant stenoses on the 
CT scan. Patients were divided into tertiles based on the 
mean calcium score. The presence of calcium decreased 
the diagnostic accuracy (low calcium score 0.95, mid 
0.89 and high 0.88; table 3).
To exclude the possible confounding effect of nesting, 
random selection of a single segment per patient was 
performed. The diagnostic accuracy for detecting sig-
nificant CAD was a sensitivity 93% (13/14; 95% CI 64 
to 100), a specificity 93 % (84/90; 95% CI 93 to 97), a 
positive predictive value of 68% (13/19; 95% CI 43 to 
86) and a negative predictive value 99% (84/85; 95% 
CI 93 to 100).
diSCuSSion
Several recent reports about the diagnostic performance 
of 64-slice CTCA have shown a high sensitivity and neg-
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ative predictive value to detect or exclude the presence of significant coronary stenosis in 
patients scheduled for CCA.5,8-14 However, only scant information is available about the diag-
nostic performance of CTCA in a limited number of patients with ACS.5,8,15,16
In our study, the prevalence of obstructive CAD was 85% which was in keeping with previ-
ous reports evaluating ACS angina syndromes.2,3,17-19 In this high pre-test risk population we 
demonstrated a high diagnostic accuracy in patients with non-ST elevation ACS. In segments 
where interpretation was difficult owing to heavy calcification, there was a tendency for ob-
servers to score these as positive for significant stenosis in order to reduce the chance of miss-
ing an important lesion. This “defensive scoring” approach is also likely to be used in clinical 
practice when evaluating symptomatic patients. The high negative predictive value of the CT 
scan despite significant coronary calcification and the high prevalence of CAD demonstrates 
that significant CAD can be ruled out in this patients group.
Patients with non-segment elevation ACS classified as at high risk on the basis of baseline 
characteristics, troponin or ECG changes are best managed with an invasive strategy.1-3 These 
patients should generally have a CCA followed by revascularisation, if appropriate, in the first 
few days after admission to hospital. The role of CTCA in these patients is not just for the de-
tection of significant disease, the detailed delineation of coronary anatomy may also be useful 
to guide subsequent management. In this study, the agreement between CTCA and QCA in 
the classification of patients as having no, single or multivessel disease was moderate. This is 
due to the relatively high number of false positive segments scored predominantly because of 
calcification. In 41 out of the 104 patients, at least one vessel was overestimated as having 
a significant stenosis. Given this current limitation, CTCA may need to evolve further before 
it can more accurately guide future management, in particular either percutaneous or surgi-
cal revascularisation in these high-risk patients. At the moment, even though the results are 
promising, a clinical role of CTCA in these high-risk patients is not defined.
Currently, CTCA may be more suited in the low-risk non-segment-elevation ACS group. These 
patients, without recurrent chest pain or evidence of myocardial necrosis, are recommended 
to undergo a stress test after an observation period. CCA is recommended in these patients 
only if significant ischemia is demonstrated during stress testing.1 However, stress testing, 
particularly treadmill or bicycle stress testing may be inconclusive. The role of CTCA may be 
to replace the stress test as the first investigation in this population group. Given the excellent 
negative predictive value as demonstrated in this study, a negative CTCA would allow patients 
to be discharged and other non-cardiac causes of the presenting chest pain to be considered. 
Patients with non-obstructive CAD on CTCA would continue to be managed medically, includ-
ing appropriate secondary prevention, and the need for future stress testing or CCA would 
depend on further symptoms. 
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Patients with significant disease on CTCA in this patient group could be referred directly for 
CCA, particularly if there was left main disease, three-vessel or proximal segment disease of a 
main coronary artery. Patients with small-vessel disease (ie, distal disease < 2mm), equivocal 
lesions or uninterpretable scans could undergo a stress test to further guide the need for CCA. 
However, the use of sequential testing is controversial, as no data is available showing better 
test results than a stress test alone.
Limitations of the study
We did not include patients with severe ongoing ischemia, or hemodynamic or electrical in-
stability, to prevent further delays of revascularization treatment. Furthermore, inclusion com-
prised a non-consecutive group of patients. Owing to logistic reasons, it was not feasible to 
scan and include every patient presenting with a non-ST elevation ACS. Moreover, patients in 
the low-risk group with a negative exercise ECG test were not included, since these patients 
did not receive a CCA.
Heart rate reduction with ß-blockers is standard practice in patients presenting with a non-ST 
elevation ACS. Additional ß-blockers were given to reduce the heart rate even more in order 
to achieve optimal heart rate control. With the next generation dual-source CT scanners, 
scanning at higher heart rates will be possible owing to the improved temporal resolution of 
83 ms20,21.
The rather high radiation exposure of CTCA as compared to CCA is of concern.22,23 The radia-
tion exposure can be reduced by 40% using prospective x ray tube current modulation. How-
ever, this limits the possibility to reconstruct valuable datasets during the end-systolic phase. 
The presence of atrial fibrillation precludes the use of CTCA and was one of the exclusion 
criteria.
ConCluSionS 
The 64-slice CT angiography has a high sensitivity to detect significant coronary stenoses and 
is reliable to exclude the presence of significant CAD in patients who present with a non-ST 
elevation ACS. The role of CTCA in these patients, particularly in the low-risk group, needs to 
be further evaluated.
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Spontaneous Dissection of the Left 
Main Coronary Artery in a Patient 
with Osler-Weber-Rendu Disease 
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A 33 year old woman, with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu dis-
ease), presented to the hospital 48 hours after a prolonged episode of chest pain. The ECG, 
showing pathological Q waves in leads V1-V3, and inverted T waves in leads V1-V6, and 
cardiac enzymes confirmed the diagnosis of a semi-recent anterior myocardial infarction. 
Cardiac 64 row multislice computed tomography (panels A and B) revealed a dissection origi-
nating from the left main (LM) with antegrade extension along the course of the left anterior 
descending coronary artery (LAD) and re-entry distal to the first diagonal branch (D1). These 
findings were subsequently confirmed by coronary angiography and intravascular ultrasound 
(IVUS) (panels C and D). Both the LM and mid-LAD were successfully treated with a bare 
metal stent.
Spontaneous coronary artery dissection is a rare condition, the aetiology of which in general 
remains unclear. In this case it might be related to the fragility of the vessel wall, which char-
acterizes Osler-Weber-Rendu disease.
Figure Three dimensional (A) and multiplanar 
reconstructed (B) multislice computed tomog-
raphy image showing the false lumen (asterisk) 
with thrombus (t) within the LM artery. The 
dissection is accompanied by a large haema-
toma along the course of the LAD that com-
presses the lumen (arrows) distal to the origin 
of D1. (C) Coronary angiography confirms the 
LM dissection and critical narrowing of the mid 
LAD. (D) IVUS shows the false lumen (f) with 
thrombus (asterisk) and an intimal tear (arrow) 
corresponding to the distal re-entry point of the 
dissection. Angiographically the tear is visible 
as a “flap” within the lumen. (A full color ver-
sion of this illustration can be found in the color 
section).
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aBSTraCT
Objectives
We assessed the usefulness of 64-slice computed tomography coronary angiography (CTCA) 
to detect or rule out coronary artery disease (CAD) in patients with various estimated pretest 
probabilities of CAD.
Background
The pretest probability of the presence of CAD may impact on the diagnostic performance of 
CTCA.
Methods
Sixty-four-slice CTCA (Sensation 64, Siemens, Forchheim, Germany) was performed in 254 
symptomatic patients. Patients with heart rates ≥65 beats/min received beta-blockers before 
CTCA. The pretest probability for significant CAD was estimated by type of chest discomfort, 
age, gender, traditional risk factors and defined as high (≥71%), intermediate (31% to 70%), 
and low (≤30%).  Significant CAD was defined as the presence of at least 1 ≥50% coronary 
stenosis on quantitative coronary angiography, which was the standard of reference. No coro-
nary segments were excluded from analysis. 
Results
The estimated pretest probability of CAD in the high (n = 105), intermediate (n = 83), and 
low (n = 66) group was 87%, 53% and 13%, respectively. The diagnostic performance of the 
CT scan was different in the 3 subgroups. The estimated post-test probability of the presence 
of significant CAD after a negative CT scan was 17%, 0%, and 0%, and after a positive CT 
scan 96%, 88% and 68%, respectively. 
Conclusions
Computed tomography coronary angiopraphy is useful in symptomatic patients with a low or 
intermediate estimated pretest probability of having significant CAD, and a negative CT scan 
reliably rules out the presence of significant CAD. Computed tomography coronary angiopra-
phy  does not provide additional relevant diagnostic information in symptomatic patients with 
a high estimated pretest probability of CAD. 
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inTroduCTion
The estimated pretest probability of having significant coronary artery disease (CAD) in a 
study population should be taken into account in the evaluation of the diagnostic accuracy 
of computed tomography coronary angiography (CTCA) to detect or rule out the presence of 
coronary stenosis. The estimated pretest probability of having obstructive CAD in patients who 
present with chest pain is related to age, gender, type of chest discomfort, and traditional risk 
factors. The estimated pretest probability is lowest in younger female patients with nonanginal 
chest pain and highest in older male patients with typical angina (1).
The diagnostic performance of CTCA has mostly been tested in symptomatic patient popula-
tions with a high estimated pretest probability of having significant CAD, and a few studies 
have reported on the impact of different estimated pretest probabilities on the performance 
of CTCA (2). 
The purpose of this study was to evaluate the diagnostic performance and clinical usefulness 
of 64-slice CTCA in 254 patients with high, intermediate or low estimated pretest probability 
of having significant coronary stenosis.
meThodS
Study population
During a 24-month period, 254 patients presenting with typical angina pectoris, atypical an-
gina pectoris and nonanginal chest pain who were referred for conventional coronary angiog-
raphy (CCA) were included into the study. Typical angina was defined as having 3 character-
istics: 1) substernal discomfort, 2) that is precipitated by physical exertion or emotion and 3) 
relieved with rest or nitroglycerine within 10 min. Atypical angina pectoris was defined as hav-
ing 2 out of 3 of the definition characteristics. Nonanginal chest pain was characterized as 1 or 
absence of the described chest pain features. The estimated pretest probability for obstructive 
CAD was estimated using the Duke Clinical Score, which includes type of chest discomfort, 
age, gender, and traditional risk factors (3, 4).  Patients were categorized into a low (1% to 
30%), intermediate (31% to 70%), or high (71% to -99%) estimated pretest probability group 
of having significant CAD. No patients with previous history of percutaneous coronary inter-
vention, coronary artery bypass surgery, prior myocardial infarction, impaired renal function 
(serum creatinine >120 µmol/l), persistent arrhythmias or known allergy to iodinated contrast 
material, were included. Conventional coronary angiogram was performed before or after the 
CTCA and served as the standard of reference. The institutional review board of the Erasmus 
Medical Center Rotterdam approved the study, and all subjects gave informed consent. 
Chapter 8
150
Patient preparation
Patients with a heart rate exceeding 65 beats/min received additional beta-blockers (50/100mg 
Metoprolol) 1 h before the computed tomography (CT) examination. 
Scan protocol 
All scans were performed with a 64-slice CT scanner that features a gantry rotation time of 
330 ms, a temporal resolution of 165 ms and a spatial resolution of 0.4 mm3 (Sensation 
64, Siemens, Forchheim, Germany). A calcium scoring scan was performed with following 
parameters; 64 × 0.6 mm collimation, 330 ms rotation time, 120 kV tube voltage, 150 mAs 
tube current, 3.8 mm/rotation table feed, prospective electrocardiogram (ECG)  X-ray tube 
modulation. Afterwards, the CTCA was performed using identical parameters aside from a 
higher tube current between 850 and 960 mAs and without the use of prospective ECG X-ray 
tube modulation. The radiation exposure was estimated using dedicated software (ImPACT ®, 
version 0.99x, St. George’s Hospital, Tooting, London, United Kingdom). 
A bolus of 95 ml of contrast material (400 mgI/ml; Iomeron, Bracco, Milan, Italy) was injected 
intravenously in an antecubital vein at 5 ml/s, and a bolus-tracking technique was used to 
synchronize the arrival of contrast in the coronary arteries and the initiation of the scan. 
Image reconstruction
Datasets were reconstructed immediately after the scan after a stepwise approach as previ-
ously described (5, 6). If necessary, multiple datasets of a single patient were used separately 
in order to obtain optimal image quality for all available coronary segments. 
Quantitative coronary angiography (QCA)
All scans were carried out within 1 week before or after CCA. One experienced cardiolo-
gist, unaware of the results of CTCA, identified and analyzed all coronary segments, using a 
17-segment modified American Heart Assiciation classification. All segments, regardless of 
size, were included for comparison with CTCA. Segments were classified as normal (smooth 
parallel or tapering borders), as having non-significant disease (wall irregularities or <50% 
stenosis) or having significant disease (stenosis ≥50%). Stenoses were evaluated in the worst 
view, and classified as significant if the lumen diameter reduction exceeded ≥50% measured 
by validated QCA algorithm (CAAS, Pie Medical, Maastricht, the Netherlands). 
CT image evaluation
One observer analyzed total calcium scores of all patients using dedicated software. Two expe-
rienced observers, a radiologist and a cardiologist, unaware of the results of CCA, evaluated 
the CTCA data sets on an offline workstation (Leonardo, Siemens) using (curved) multiplanar 
reconstruction. Segments were scored positive for significant CAD if there was ≥ 50% diam-
151
64-slice Computed Tomography Coronary Angiography in Patients with High, Intermediate, 
or Low Pretest Probability of Significant Coronary Artery Disease
eter reduction of the lumen by visual assessment. Segments distal to a chronic total occlusion 
were excluded. Interobserver disagreements were resolved by a third reader. 
Statistical analysis
The diagnostic performance of CTCA for the detection of significant coronary artery stenoses 
as defined by QCA is presented as sensitivity, specificity, positive and negative predictive values 
with the corresponding 95% (CIs), and positive and negative likelihood ratios (LRs) were cal-
culated. Comparison between CTCA and QCA was performed on 3 levels: patient-by-patient, 
vessel-by-vessel and segment-by-segment analysis. A Mantel-Haenszel test was performed to 
evaluate the trend in sensitivity and specificity relative to the estimated pre-test probability for 
obstructive CAD.
Categorical characteristics are expressed as numbers and percentages, and compared be-
tween the 3 groups using the chi square test. Continuous variables are expressed as means 
(standard deviation) and compared with one-way analysis of variance followed by post-hoc 
Bonferroni correction to adjust for multiple comparisons. If not normally distributed, continu-
ous variables are expressed as medians (25th to 75th percentile range) and compared with 
Kruskal-Wallis test. 
An additional analysis was done to investigate the effect of nesting since repeated assess-
ments within the same patient were made that were not independent observations. A random 
selection of a single segment per patient was done, and the diagnostic accuracy for detecting 
significant artery disease was calculated. Interobserver and intraobserver variability for the de-
tection of significant coronary stenosis and agreement between techniques to classify patients 
as having no, single-, or multivessel disease was determined by ∙-statistics.
reSulTS
Patient demographics are shown in Table 1. Additional beta-blockers prior to CT scanning 
were administered in 74 % (188 of 254) of patients decreasing the mean heart rate from 71 
± 11 beats/min to 59 ± 8 beats/min. The mean scan time was 12.7 ± 1.6 s. Initially, all data-
sets were reconstructed in the mid- to end diastolic phase. In 34% of the cases (86 of 254), ad-
ditional higher quality reconstructions obtained during end systole were used for evaluation.
The estimated radiation exposure using prospective X-ray tube modulation for the calcium 
score in women and men was 1.8 and 1.4 mSv, respectively. The estimated radiation exposure 
for the contrast-enhanced scan without prospective X-ray tube modulation was 17.0 mSv in 
women and 13.4 mSv in men, which is in line with previous reports (7).
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Table 1 : Patient demographics (n=254)
Diagnostic performance of 64-slice CTCA: all patients with chest pain
The observed pretest probability of significant CAD, defined as having at least 1 ≥50% coro-
nary stenosis per patient was 50%. The diagnostic performance of CTCA for detecting sig-
nificant stenoses on a patient level is detailed in Table 2. Eighteen patients with angiographic 
Pretest Probability of Significant CAD
> 70% High 
(n =  105)
30-70% 
 Intermediate 
(n =  83)
< 30% Low 
(n =  66)
p Value
Typical angina 89 (85) 31 (37) 3 (4) < 0.0001
Atypical angina 16 (15) 29 (35) 21 (32)
Nonanginal chest pain 0 (0) 23 (28) 42 (64)
Men 97 (92) 47 (57) 27 (41)  < 0.0001
Age (yrs)* 63 ± 9 61 ± 8 50 ± 12  < 0.0001
BMI (kg/m²)* 27.5 ± 4.2 27.1 ± 4.8 26.7 ± 4.2 ns
Heart rate (beats/min)* 57 ± 8 60 ± 7 61 ± 7 < 0.01
Risk factors
   Hypertension† 68 (65) 43 (52) 30 (45) < 0.05
   Hypercholesterolemia‡ 71 (68) 52 (63) 14 (21) < 0.0001
   Diabetes mellitus§ 16 (15) 11 (13) 4 (6) ns
   Current smoker 32 (30) 16 (19) 16 (24) ns
   Previous smoker 14 (13) 6 (7) 4 (6) ns
   Family history of CAD|| 57 (54) 39 (47) 29 (44) ns
   Obesity¶ 32 (30) 21 (25) 13 (20) ns
Calcium score (Agatston score)# 354 (103-814) 134 (1-296) 0 (0-56) < 0.0001
Conventional coronary angiography
   Prevalence of obstructive CAD 82 (78) 32 (39) 12 (18) < 0.0001
   Absence of CAD 6 (6) 21 (25) 36 (55) < 0.0001
   Nonsignificant disease 17 (16) 30 (36) 18 (27)
   Single-vessel disease 42 (40) 22 (27)  9 (14)
   Multivessel disease 40 (38) 10 (12) 3 (5)
* Mean and standard deviation.  ‡ Blood pressure ≥ 140/90 mm Hg or treatment for hypertension. ‡Total cholesterol > 180 mg/
dl or treatment for hypercholesterolemia. §Treatment with oral anti-diabetic medication or insulin. ||Family history of coronary 
artery disease (CAD), having first- or second-degree relatives with premature CAD (age <55 years). ¶Body mass index (BMI) ≥ 30 
kg/m2. #Median and quartiles. Values are n (%) unless otherwise indicated. Categorical variables were tested with chi-square test. 
Continuous variables were tested with 1-way analysis of variance . If not normally distributed, continuous variables were compared 
with Kruskal-Wallis test. The p-values < 0.05 were considered statistically significant.  
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nonsignificant disease were incorrectly 
classified as having significant CAD by 
CT: 17 patients were scored as having 
single-vessel disease, and 1 patient was 
misinterpreted as having multivessel dis-
ease. Ninety-eight percent (124 of 126) 
of patients with significant CAD on CCA 
were correctly identified by CTCA (Fig. 
1). The 2 patients in whom the severity of disease was underestimated both showed significant 
lumen narrowing in the circumflex coronary artery (both 53% diameter reduction, one in the 
proximal and one in the midsegment). Forty patients with single-vessel disease were evaluated 
as having multivessel disease by CTCA due to overestimation of disease severity in other ves-
sels. Agreement between CTCA and QCA on a per-patient (no or any disease) level was very 
good (∙-value: 0.84), whereas agreement between techniques to classify patients as having 
no, single-, and multivessel disease was good (∙-value: 0.61).
Diagnostic performance of 64-slice CT coronary 
angiography: patient-by-patient analysis 
The analysis comprised 105 (43%) patients with a high estimated pretest probability for CAD, 
83 (33%) patients with an intermediate, and 66 (26%) patients with a low estimated pretest 
probability for CAD. The mean age between patients with high estimated probability and 
intermediate estimated probability group was significantly different from the mean age in the 
low probability group, and the median calcium score was significantly different in all 3 groups. 
The mean heart rate was significantly lower in the high estimated probability group compared 
with those seen in the intermediate and low estimated probability group (Table 1).
The diagnostic performance of CTCA was different in the patient groups with various esti-
mated pretest probabilities. The specificity showed a trend with a lower specificity in the high 
estimated pretest probability (p: < 0.05, sensitivity, p = NS).  The diagnostic impact of CTCA 
on the estimated pretest probability of having significant CAD is shown in Figure 2 and 3.
Figure 1. CTCA image of the right coronary artery. 
Volume-rendered computed tomography coronary an-
giography (CTCA) image (A) of the right coronary ar-
tery. A curved multiplanar reconstructed image (B) and 
a thick maximum-intensity projected image (C) disclose 
a significant coronary stenosis (arrow) in the mid right 
coronary artery, which was corroborated by conven-
tional coronary angiogram (D). Proximally and distally 
of the significant obstructed lesion, nonsignificant calci-
fied plaques can be seen (C)
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Diagnostic performance of 64-slice CT coronary 
angiography: vessel-by-vessel analysis
The diagnostic performance of CTCA for the detection of significant lesions on a vessel-based 
analysis is detailed in Table 2. Two significantly diseased right coronary arteries, 1 left anterior 
descending artery, and 5 diseased circumflex coronary arteries were incorrectly classified as 
non-significantly diseased by CTCA. Of a total of 1016 vessels, the severity of a lesion was 
overestimated in 97 nonobstructive vessels (false positives). The diagnostic performance of 
the CT scan was different in the 3 subgroups. The specificity showed a trend towards lower 
specificity in the high estimated pretest probability (p < 0.0001, sensitivity, p = NS). Agree-
ment between CTCA and QCA on a per-vessel level was good (∙-value: 0.71). 
Diagnostic performance of 64-slice CT coronary 
angiography: segment-by-segment analysis
Overall, 3647 (of 4318 potentially available segments) were included for comparison with 
QCA. Unavailable segments included 547 anatomically absent segments on CCA and 124 
segments distal to an occluded coronary segment. Segments were not excluded for reasons 
such as severe calcifications or poor image quality. The ∙-value for interobserver - and intrao-
bserver variability was 0.70 and 0.72, respectively. The diagnostic performance of CTCA for 
detecting significant stenoses is detailed in Table 2. Agreement between CTCA and QCA on a 
per-segment level was good (∙-value, 0.64).
The severity of 32 significant coronary stenoses was underestimated or missed and classified 
as nonsignificant by CTCA. Most of these significant lesions (24 of 32) were located in distal 
segments or in side branches. The severity of 193 nonsignificant lesions was overestimated 
Figure 3. Influence of CTCA on probability of obstruc-
tive CAD as a function of pretest probability. Using the 
positive and negative likelihood ratios obtained from 
Table 2, we calculated the estimated post-test prob-
abilities of CAD after positive and negative findings on 
CTCA from various estimated pre-test probabilities of 
CAD. Dashed lines = CTCA+; dotted lines = CTCA-. 
Abbreviations as in Figure 2.
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by CTCA. The diagnostic performance of the CT scan was different in the 3 subgroups with a 
lower sensitivity (p < 0.05) and a higher specificity (p < 0.0001) in the low pretest probability 
group.
Analysis on the randomly selected segments resulted in a sensitivity 92% (24 of 26; 95% CI 
73% to 99%), specificity 93% (212 of 228; 95% CI, 89% to 96%), positive predictive value 60% 
(16 of 40; 95% CI, 43% to 75%), negative predictive value 99% (212 of 214; 95% CI, 96% to 
100%). The effect of nesting is probably minimal as the result of this analysis is very similar to 
the results shown in the per-segment analysis (Table 2). 
diSCuSSion
The diagnostic performance of 64-slice CTCA to detect or rule out the presence of significant 
coronary stenosis has mainly been reported for patients with stable angina pectoris scheduled 
for invasive CCA, and these studies have shown that CTCA can reliably rule out significant 
CAD (5, 8-10). The majority of these patients presented with a high estimated pretest prob-
ability of having significant CAD, and only scant information is available on the diagnostic 
performance of 64-slice CTCA in patients with a low or intermediate estimated pretest prob-
ability of having significant CAD. 
In this study, we used the Duke Clinical Score, which incorporates clinical presentation of chest 
pain, age, gender and traditional risk factors, to estimate the pre-test probability of having 
significant CAD. Using the LRs of the tests, which were obtained in this study, post-test prob-
abilities were calculated.  
The pretest probability of CAD may impact of the diagnostic performance of the CT scan. 
Indeed, the diagnostic performance of CTCA in the 3 groups was different. The specificity was 
lower in the high pretest probability group compared with the low pretest probability group, 
whereas sensitivity was lower in the per-segment analysis in the low pretest probability group. 
This observation can probably be explained by the higher calcium scores in the higher prob-
ability groups, which tend to overestimate the severity of stenosis.
A negative CT-scan was present in 75% of the patients with a low estimated pretest probability 
and in approximately 50% of the patients with an intermediate estimated pretest probability. 
The negative predictive value of CTCA to exclude significant CAD was excellent in these 
patients, reducing the estimated post-test probability to zero. Thus, these patients would not 
need further downstream diagnostic tests. They may be candidates for secondary prevention 
measures, such as statin therapy in the presence of nonobstructive plaques or could be dis-
charged from further cardiac follow-up in the absence of any visible plaque. 
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A positive CT-scan occurred in approximately 25% and 50% of the patients with a low or in-
termediate estimated pretest probability, respectively. The number of false positive outcomes 
was rather high in these patients, which renders a positive CT scan rather unreliable for clinical 
decision making. In these patients it may be reasonable to proceed to invasive CCA in the case 
of left main disease, 3-vessel disease and in the presence of a critical stenosis in the proximal 
part of a major coronary artery. In case of vessel disease in distal vessels or side branches, 
equivocal lesions or uninterpretable scans, one may consider a non-invasive stress test to de-
termine the functional significance of a doubtful coronary stenosis. A negative functional test 
may overrule the clinical significance of a (false)-positive CT-scan and reduce the need for 
invasive coronary angiography. A positive functional test may further increase the probability 
of having significant CAD and should be followed by invasive coronary angiography and coro-
nary revascularisation if symptoms are not alleviated by the antianginal mediation. However, 
further studies are necessary to evaluate the diagnostic value of the combination of functional 
data from a stress test with the anatomical data provided by CTCA.
In the high estimated pretest probability group a negative CTCA reduced the estimated post-
test probability to 17%, whereas a positive CTCA increased the estimated post-test probability 
to as high as 96%. Given the high estimated pretest probability of significant CAD in this 
group, the majority of these symptomatic patients are likely to proceed to invasive CCA even if 
CTCA is negative, since the post-test probability of significant CAD was still >10%. Computed 
tomography coronary angiography, therefore, appears to be of limited clinical value in the 
evaluation of the high estimated pretest probability group. Assessment for the presence of 
myocardial ischemia with a functional test may be more appropriate in this situation. 
Study limitations
The studied patients were not a prospective, consecutive group of patients. However, selec-
tion was not based on particular patient demographics, but rather on the availability of the 64 
slice CT scanner for the examination of cardiac patients. The rather high estimated radiation 
exposure of 64-slice CTCA (17 to –13.4 mSv) as compared to CCA (3 to 6 mSv) is of concern 
(7). In this study we did not use prospective ECG X-ray tube modulation, which can signifi-
cantly reduce radiation exposure, but requires a regular heart rhythm and limits the possibility 
of reconstructing images in the end-systolic phase. In our study end-systolic data sets provided 
optimal image quality in 34% of patients.
Currently, there is no validated software available able to quantify the degree of stenoses. So 
far, the severity of coronary stenosis as assessed by CT is rather crudely visually estimated as 
more or less than 50% luminal diameter stenosis.
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aBSTraCT
Objectives
We studied the diagnostic performance of 64-slice CT coronary angiography (CTCA) to rule 
out or detect significant coronary stenosis in patients referred for valve surgery.
Background
Invasive conventional coronary angiography (CCA) is recommended in most of patients sched-
uled for valve surgery.
Methods
During a 6-month period, 145 patients were prospectively identified from a consecutive pa-
tient population scheduled for valve surgery. Thirty-five patients were excluded because of 
CTCA criteria: irregular heart rhythm (n = 26), impaired renal function (n = 5), and known 
contrast allergy (n = 4). General exclusion criteria were: hospitalization in community hos-
pital (n = 4), no need for CCA (n = 4), previous coronary artery bypass surgery (n = 1), or 
percutaneous coronary intervention (n = 4). Of the remaining 97 patients, 27 denied written 
informed consent. Thus, the study population comprised 70 patients (49 male, 21 female; 
mean age 63 ± 11years). 
Results
Prevalence of significant coronary artery disease, defined as having at least 1 ≥50% stenosis 
per patient, was 25.7%. Beta-blockers were administered in 71% and 64% received loraze-
pam. The mean heart rate dropped from 72.5 ± 12.4 to 59.5 ± 7.5 beats/min. The mean 
scan time was 12.8 ± 1.3 s. On a per-patient analysis, the sensitivity, specificity, and positive 
and negative predictive value were: 100% (18 of 18; 95% confidence interval [CI] 78 to 100), 
92% (48 of 52; 95% CI 81 to 98), 82% (18 of 22; 95% CI 59 to 94), 100% (48 of 48; 95% CI 
91 to 100), respectively.
Conclusions
The diagnostic accuracy of 64 slice CTCA for ruling out the presence of significant coronary 
stenoses in patients undergoing valve surgery is excellent and allows CTCA implementation as 
a gatekeeper for invasive CCA in these patients.
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inTroduCTion
Pre-operative detection of obstructive coronary artery disease (CAD) with conventional coro-
nary angiography (CCA) is recommended in most of patients scheduled for valve surgery (1). 
Although CCA is considered a safe procedure, it still carries a small but relevant risk for major 
(death, stroke, or vascular dissection) and minor (inguinal haematoma) complications (2). 
Furthermore, the catheterization procedure is rather expensive, as its invasive nature involves 
admission to a hospital or day-care facility and requires surveillance of an experienced team. 
A non-invasive, patient-friendly pre-operative work-up for these patients would be desirable.
The newest–generation 64 slice computed tomography (CT) scanner with improved spatial 
and temporal resolution shows excellent diagnostic accuracy to detect significant coronary 
artery lesions (3-6). In this study, we evaluated the clinical value of computed tomography 
coronary angiography (CTCA) in patients scheduled for elective valve surgery.
meThodS
Study population
During a 6-month period, we screened 145 consecutive patients scheduled for valve surgery. 
Patients were contacted before their final pre-operative appointment requesting them to con-
duct an additional CTCA. Thirty-five patients were excluded because of CTCA criteria and 13 
patients because of general criteria (Table 1). Of the remaining 97 patients, 27 denied written 
informed consent. Thus, the study population comprised 70 patients (49 male, 21 female; 
Screened patient population 145
      Atrial fibrillation/ severe arrhythmia 26
      Impaired renal function (serum creatinine > 120 mmol/l) 5
      Known contrast allergy 4
Patient population after CTCA exclusion criteria 110
      Hospitalisation in community hospital 4
      Percutaneous coronary intervention 4
      Coronary artery bypass graft 1
      No conventional angiogram 4
Patient population after general exclusion criteria 97
      Refusal of informed consent 27
Final patient population 70
Table 1. Patient inclusion
CTCA = computed tomography coronary angiogram.
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mean age 63 ± 11 years). The institutional review board of the Erasmus Medical Center Rot-
terdam approved the study, and all 70 subjects gave written informed consent. 
Patient preparation
Patients with an aortic stenosis and a good left ventricular function (LVF) with a heart rate 
exceeding 65 beats/min were given 50 mg metoprolol and 1 mg lorazepam 60 min before 
the CT scan. If the LVF was impaired, beta-blockers were withheld and only lorazepam was 
administered. Patients with other valve pathology and a heart rate above 65 and 70 beats/min 
were given 1 mg of lorazepam and 50 and 100 mg metoprolol, respectively. If the LVF was 
impaired in these patients, the doses of beta-blockers were reduced or not given. 
Scan protocol 
All scans were performed with a 64-slice CT scanner having a temporal resolution of 330 
ms and a spatial resolution of 0.4 mm3 (Sensation 64, Siemens, Forchheim, Germany). An-
giographic scan parameters were: number of slices per rotation, 32×2; individual detector 
width, 0.6 mm; table feed, 3.8 mm per rotation, tube voltage, 120 kV; tube current, 900 mAs. 
Prospective X-ray tube modulation was not used. Calcium scoring parameters (similar unless 
indicated) were a tube current of 150 mAs, and prospective X-ray tube modulation was used. 
The radiation exposure for CTCA with this scan protocol was calculated as 15.2 to 21.4 mSv 
(for men and women, respectively) using dedicated software (WinDose, Institute of Medical 
Physics, Erlangen, Germany), which is in line with previously reported X-ray radiation exposure 
(7,8).  The radiation exposure of calcium scoring (including prospective X-ray tube modula-
tion) was calculated as 1.3 to 1.7 mSv (for men and women, respectively) (9).
A bolus of 100 ml of contrast material (400 mgI/ml; Iomeron, Bracco, Milan, Italy) was in-
jected intravenously in an antecubital vein at 5 ml/s. A bolus-tracking technique was used to 
synchronize the arrival of contrast in the coronary arteries, and the scan was started once the 
contrast material in the ascending aorta reached a pre-defined threshold of +100 Hounsfield 
units.  
Image reconstruction
The post-processing technique to acquire the best possible image quality is previously de-
scribed by Mollet et al. (6). In short, images are obtained during a half X-ray tube rotation, 
resulting in an effective temporal resolution of 165 ms. Images were reconstructed with elec-
trocardiographic (ECG) gating to obtain nearly motion-free image quality. Optimal data sets 
were reconstructed in the mid- to end-diastolic phase. If non-diagnostic image quality was 
obtained, additional datasets were reconstructed in the end-systolic phase.
165
Pre-operative Computed Tomography Coronary Angiography to Detect Significant coronary 
Artery Disease in Patients Referred for Cardiac Valve Surgery
Quantitative coronary angiography (QCA)
All scans were carried out within 2 months after CCA. One experienced cardiologist, unaware 
of the results of CTCA, identified and analyzed all coronary segments, using a 17-segment 
modified American Heart Association (AHA) classification (10).
All segments, regardless of size, were included for comparison with CTCA. Segments were 
classified as normal (smooth parallel or tapering borders), as having non-significant disease 
(wall irregularities or <50% stenosis), or as having significant stenosis (stenosis ≥50%). 
Stenoses were evaluated in 2 orthogonal views, and were classified as significant if the mean 
lumen diameter reduction exceeded 50 % as measured by validated QCA algorithm (CAAS, 
Pie Medical, Maastricht, The Netherlands). 
CT image evaluation
One observer analyzed total calcium scores of all patients with dedicated software, and results 
were expressed as Agatston score (11). Two experienced observers, a radiologist and a cardi-
ologist, unaware of the results of CCA, evaluated the CTCA datasets on an offline workstation 
(Leonardo, Siemens, Forchheim, Germany). The axial slices were initially evaluated for the 
presence of significant segmental disease, and additionally (curved) multiplanar reformat-
ted reconstructions were used. Segments distal to a chronic total occlusion were excluded 
because of poor distal filling by collaterals. Inter-observer disagreements were resolved by 
consensus in a joint session. 
Statistical analysis
The diagnostic performance of CTCA for the detection of significant stenoses in the coronary 
arteries with QCA as the standard of reference is presented as sensitivity, specificity, positive 
and negative predictive values with the corresponding 95% confidence intervals (CIs). Positive 
(Sensitivity/[1-Specificity]) and negative ([1-Sensitivity]/Specificity) likelihood ratios are given. 
The likelihood ratio incorporates both the sensitivity and specificity of a test and provides a 
direct estimate of how much a test result will change the odds of having a disease. Post-test 
odds can be calculated by multiplying the pre-test odds by the likelihood ratios.
Comparison between CTCA and QCA was performed on 3 levels: patient-by-patient, vessel-
by-vessel and, segment-by-segment analysis. Furthermore, the relation of angina pectoris to 
angiographically significant CAD was analyzed.
A subanalysis was performed for patients with aortic stenosis compared to other valve pa-
thology and patients with or without angina pectoris. An unpaired 2-sided Student t test was 
performed to reveal possible differences in age, calcium score and heart rate during the CTCA 
between both groups. A p value <0.05 was considered statistically significant.
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Age (yrs)§ 63 ± 11 (35-80)
      Aortic stenosis (yrs)§ 68 ± 8 (44-80)
      Other valve pathology (yrs)§ 59 ± 11 (35-80)
Males 49/70 (70)
Symptoms
     Angina pectoris 21 (30)
     No angina pectoris 49 (70)
     Previous MI 5 (7)
Risk factors
     Hypertension 33 (47)
     Hypercholesterolemia 29 (41)
     Diabetes mellitus 2 (3)
     Smoker 15 (21)
     Ex-smoker 4 (6)
     Family history of CAD 26 (37)
     Obese (body mass index ≥ 30 kg/m²) 11 (16)
     Calcium score, median* 214,4
        Aortic stenosis, median* 391.9
        Other valve pathology, median* 116.6
Valve operation
     Aortic valve stenosis 31 (44)
     Mitral valve insufficiency 24 (34)
     Aortic valve insufficiency 9 (13)
     Mitral valve stenosis 2 (3)
     Pulmonary valve insufficiency 2 (3)
     Congenital aortic stenosis 2 (3)
     Tricuspid valve insufficiency 1 (1)
     Tricuspid valve stenosis 1 (1)
     Reoperation 6 (9)
Conventional angiography
     Absence of coronary disease 17 (24)
     Non-significant disease 35 (50)
     Single-vessel disease 11 (16)
     Multivessel disease 7 (10
Table 2.  Patient demographics (n=70)
Values are n (%) unless otherwise indicated. §Age ranges. *Agatston score.
CAD = coronary artery disease; MI = myocardial infarction.
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An additional sensitivity analysis was done to investigate the effect of nesting; repeated as-
sessments (segment by segment and vessel by vessel) within the same patient were made that 
were not independent observations. Interobserver and intraobserver variability for the detec-
tion of significant coronary stenosis was determined by ∙-statistics. 
reSulTS
Patient demographics are shown in 
Table 2. One patient had combined 
valve pathology: aortic stenosis and 
mitral regurgitation. Beta-blockers 
were administered in 71% of pa-
tients, and 64% received lorazepam. 
The mean heart rate in these pa-
tients dropped within 60 min from 
73 ± 12 to 60 ± 8 beats/min. The 
mean scan time was 12.8 ± 1.3 
s. Initially all datasets were recon-
structed in the mid- to end diastolic 
phase. In 30% of the cases (21 of /70), additional higher quality reconstructions from data of 
the end-systolic phase were used.
Diagnostic performance of 64-slice CT coronary 
angiography: patient-by-patient analysis
The diagnostic performance of CTCA for detecting significant stenoses on a patient-based 
analysis is detailed in Table 3. Computed tomography coronary angiography documented 
absence of significant disease in 48 patients, for an overall specificity per patient of 92 % (Fig. 
1). The severity of a stenosis was overestimated in 4 patients who were misclassified as having 
significant CAD. The CTCA correctly identified significant disease in all patients (18 of 70, 
prevalence 25.7%) with at least 1 significant stenosis, resulting in a sensitivity per patient of 
Figure 1. Three different types of post-processing 
techniques are shown: volume-rendered com-
puted tomography coronary angiogram (CTCA) 
images (A and B), a maximum-intensity projected 
image  (C), and 3 curved multiplanar reconstruct-
ed images (E, F, and G), which show a patent right 
coronary artery, which is confirmed by convention-
al coronary angiogram (CCA) (D). The bright white 
spots (C, E, and G) represent calcifications of the 
stenotic aortic valve. 
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100% (Fig. 2). An accurate determi-
nation of the presence or absence 
of significant CAD was made in 66 
of 70 patients (94%). In 3 out of 11 
patients with single-vessel disease, 
another stenosis was detected with 
CTCA. 
The severity of these stenoses was 
overestimated, which resulted in in-
correct classification as multivessel 
disease. Agreement between CTCA 
and QCA on a per-patient level was 
very good (∙ value, 0.86); agree-
ment between both techniques for 
classifying patients as having no, 
single-vessel or multivessel disease 
was good (∙ value, 0.78)
Diagnostic performance 
of 64-slice CT coronary 
angiography: vessel-
by-vessel analysis
The mean total per vessel calcium 
score for the left anterior descend-
ing coronary artery (LAD), right cor-
onary artery (RCA) and circumflex 
coronary artery (CX) were 96.72, 
47.89 and 40.22, respectively. The 
diagnostic performance of CTCA 
for detecting significant stenoses is 
detailed in Table 3. All vessels with 
significantly disease, as classified by QCA, were detected with CTCA. Of a total of 280 vessels, 
the severity of the stenoses in these 8 vessels, 6 in the LAD and 2 in the RCA, were overesti-
mated and scored as false positives. Agreement between CTCA and QCA on a per-vessel level 
was very good (∙ value, 0.85).
Figure 2. Volume-rendered CTCA image (A and B) reveal the anatomy 
of the left coronary artery. Two curved multiplanar reconstructed images 
(E and F) disclose a significant stenosis in the left anterior descending 
coronary artery, which was corroborated by CCA (C and D). Although the 
volume-rendered images provide an excellent overview of the coronary 
anatomy, they should not be used for the diagnostic assessment of pres-
ence of coronary stenoses. Abbreviations as in Figure 1. 
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Diagnostic performance of 64-slice CT coronary 
angiography: segment-by-segment analysis
A total of 1003 segments were included for comparison with QCA. Inter- and intraobserver 
variability for detection of a significant stenosis per segment had a ∙ value of 0.71 and 0.74, 
respectively. The diagnostic performance of CTCA for detecting significant stenoses is detailed 
in Table 3. Two significant stenoses were detected by CTCA, but the severity of the stenosis 
was underestimated. Both lesions were adjacent to a correctly detected stenosis. Eighteen 
non-significant stenoses were detected with CT, and the severity of the stenoses was overesti-
mated, resulting in false positive scores. Conventional coronary angiography revealed 5 wall 
irregularities and 13 non-significant stenoses, whereas the majority (83.3%, 15 of 18) of these 
segments was calcified. 
The presence of coronary calcium induced overestimation of the severity of these stenoses 
with the CT scan (Table 4). Agreement between CTCA and QCA on a per-segment level was 
good (∙ value, 0.76).
To exclude the possible confounding effect of nesting, random selection of a single segment 
per patient was done, and the diagnostic accuracy for detecting significant artery disease 
resulted in a sensitivity of 100 % (5 of 5; 95% CI 46 to 100), a specificity of 98 % (63 of 64; 
95% CI 90 to 100), a positive predictive value 83 % (5 of 6; 95% CI 36 to 99), and a negative 
predictive value 100 % (63 of 63; 95% CI 93 to 100).
Sub-analysis for patients with aortic stenosis versus other valve pathology
The sub-analysis comprised 31 patients with aortic stenosis and 39 with other valve pathology. 
The diagnostic performance of CTCA for detecting significant stenoses on a patient-based 
analysis in patients with and without aortic stenosis is detailed in Table 3. The average age (68 
vs. 59 yrs.; p = 0.0004) and calcium score (391.9 vs.116.6; p = 0.02) of patients with aortic 
stenosis were significantly higher than in patients not having aortic stenosis (Table 2). The 
heart rate during CTCA for both groups was the same (both 60 beats/min).
Table 4. Influence of coronary calcifications on diagnostic accuracy of 64-slice CTCA on a segment-based analysis
Values in parentheses represent 95% CIs. Abbreviations as in Table 1 and 3.
Calcium 
score
n 
(patients)
n 
(Segments)
Agatston-
Score, Mean 
(±SD) TP TN FP FN Kappa
Sensitivity, 
%
Specificity, 
%
PPV, 
%
NPV, 
%
0-10 23 338 0,3 ± 0,9 0 338 0 0 - - 100  (99-100) - 100 (99-100)
11-400 33 465 184 ± 131 15 443 7 0 0.80 100 (75-100) 98  (97-99) 68 (45-85) 100 (99-100)
401-1000 10 146 675 ± 23 16 124 5 1 0.82 94  (69-100) 96 (91-99) 76 (52-91) 99 (95-100)
>1000 4 54 1394 ± 273 3 44 6 1 0.40 75 (22-99) 88 (75-95) 33 (9-69) 98 (87-100)
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The relation of angina pectoris to significant CAD
The discordance between angina pectoris and the presence of significant CAD is displayed 
in Figure 3. Twenty-one patients had angina pectoris; 8 of these had significant obstructive 
disease. Moreover, 10 patients of 49 without angina pectoris did have significant stenoses. 
The diagnostic accuracy of angina pectoris was calculated, and the sensitivity, specificity, and 
positive and negative predictive values were 44% (8 of 18; 95% CI 22 to 67), 75% (39 of 52; 
95% CI 61 to 86), 38% (8 of 21; 95% CI 19 to 61) and 80%, (39 of 49; 95% CI 65 to 89), 
respectively.
diSCuSSion
The presence of concomitant obstructive CAD in patients undergoing cardiac valvular surgery 
worsens prognosis (12-14). Various studies have shown that combined valve and bypass sur-
gery of significant CAD reduced early and late mortality (13,15). Because aortic stenosis and 
CAD share common risk factors and occur with advancing age, and because mitral regurgita-
tion is often the consequence of CAD, concomitant, significant CAD is found in approximately 
one-third of these patients (16-19). Angina pectoris is present in 25% to 35% of patients with 
valvular heart disease. Angina pectoris is a poor predictor of obstructive CAD in patients with 
valvular disease because angina pectoris can have multiple causes, such as left ventricular 
enlargement, increased wall stress, or wall thickening with subendocardial ischemia (17,20). 
This was also shown in our study, and the low sensitivity of 44% and specificity of 75% is in 
keeping with the results observed in earlier reports. The value of non-invasive ECG stress test-
Figure 3. Discordance between angina pectoris and the presence of significant coronary artery disease.  FN =  false negative; 
FP =  false positive; TN =  true negative; TP =  true positive; other abbreviations as in Figure 1.
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ing to detect concomitant CAD is limited due to the presence of left ventricular hypertrophy 
and left bundle branch block in patients with valvular disease. Resting or exercise induced wall 
motion abnormalities and myocardial perfusion abnormalities, as seen with stress echo and 
nuclear tests, lack sufficient accuracy for reliable detection of concomitant CAD (21-24). 
Because of the poor predictive value of angina pectoris and the lack of accuracy of non-
invasive tests, the following guideline is recommended by the American College of Cardiology/
AHA committee; pre operative CCA is indicated in symptomatic patients and/or those with left 
ventricular dysfunction in men ≥35 years, pre-menopausal women ≥35 years with risk factors 
for CAD, and post-menopausal women (1). 
Non-invasive coronary angiography using 4- and 16-slice CT is a relatively recent develop-
ment. The early results were promising but lacked sufficient robustness to be useful in clinical 
practice, but the diagnostic performance of 64-slice CT scanners to detect coronary stenoses 
is very good in patients who have a high prevalence (more than 70%) of CAD. In these patients 
the negative predictive value of 64-slice CT -scanners is very high, allowing one to exclude 
the presence of significant CAD (3-6). However, there is little information about the diagnostic 
performance of CTCA in patients with a low or intermediate prevalence of CAD.
In our study, the prevalence of concomitant CAD was 25.7%. We found that significant coro-
nary stenoses were detected using a 64-slice CT scanner with a sensitivity of 100% and a 
specificity of 92% compared with CCA. A negative CT scan was correct in 92% (48 of 52) 
patients in ruling out significant disease, and all patients (18 of 18) with significant CAD were 
correctly diagnosed. The stenosis severity was overestimated in 4 patients using CTCA. Given 
the high reliability of CTCA, this would mean that CCA could have been avoided in 69% (48 
of 70) of patients, in 26% (18 of 70) a CCA was performed to confirm the CTCA diagnosis, 
and in 6% (4 of 70) an unnecessary CCA would have been performed on the basis of CTCA 
outcome.
Coronary calcium
The presence of calcium causes problems in the correct interpretation of the CTCA. Calcium 
creates blooming artifacts, which obscure the visualization of the underlying non-calcified 
plaque or lumen. Calcium tends to overestimate the severity of adjacent lesions, either be-
cause of the blooming effect itself or because, in the case of doubt or fear of “missing” a sig-
nificant stenosis a “defensive” scoring is exercised.  This has led to an ongoing debate whether 
a CTCA should be aborted when the calcium score exceeds a certain threshold. A generally 
accepted cutoff value is lacking, and proposed thresholds are arbitrarily chosen. Usually a 
chosen cutoff level is derived from the total calcium score. The total calcium score is some-
what misleading, because calcium distributed along the entire coronary tree would make the 
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interpretation of a CTCA examination relatively easy, whereas a single heavily calcified plaque 
would make interpretation doubtful. 
Recently, Gilard et al. (25) reported good accuracy of a 16-slice scanner in 55 patients re-
ferred for elective aortic valve surgery who had a mean calcium score of 609 ± 860. They 
used the Agatston score of ≥1000 as a cutoff point by showing that patients with this score 
had a higher frequency of non-interpretable segments. In our subgroup of patients with aortic 
stenosis we found, not unexpectedly, a higher calcium score. In this subgroup, the diagnostic 
accuracy of CTCA was lower because the extensive calcifications negatively influenced grad-
ing of stenoses and resulted in overestimation of the stenosis severity.
 
What would be the role of CTCA in patients referred for CCA before cardiac valve surgery? 
We do recommend to first obtaining a calcium score in all patients without atrial fibrillation, 
persistent irregular heart rhythm, or renal dysfunction. If the calcium score exceeds ≥ 1000, 
we would advice not to proceed with CTCA. If lower, patients may be advised to undergo 
CTCA. Patients with a scan negative for significant CAD can directly be referred for cardiac 
valve surgery. In case of doubt, and in the presence of significant CAD, a confirmative CCA is 
required to either confirm or refute the presence of significant CAD. 
Heart rate reduction in patients in patients with heart rates > 65 beats/min is part of the pro-
tocol used with current 64-slice CT scanners to increase image quality. Next-generation dual-
source CT scanners will allow scanning at higher heart rates because of the improved tem-
poral resolution of 83 ms, thereby avoiding the use of heart-rate reduction with beta-blockers 
(26,27). Especially, patients with severe aortic stenosis would benefit, since the administration 
of beta-blockers is limited. The radiation exposure can be decreased with the ultrafast dual-
source CT scanner during higher heart rates and use of X-ray tube modulation compared to 
64-slice CT scanning.
Study limitations
The presence of atrial fibrillation, which occurs frequently with mitral valve disease, precludes 
the use of CTCA and was indeed a significant reason for exclusion in our study. Only patients 
scheduled for elective valve surgery were screened, and patients in acute settings with he-
modynamic comprise were not studied. Since most patients were referred from community 
hospitals for valve surgery, the pre-operative diagnostic work-up, including the CCA, was per-
formed in many study patients. This may have created a bias, although the CT scoring was 
done blinded to the coronary angiogram. The rather high radiation exposure of CTCA as 
compared to CCA is of concern (7,8). The radiation exposure can be reduced by 50% with 
use of prospective X-ray tube current modulation (28). However, this limits the possibility to 
reconstructing valuable datasets during the end-systolic phase (29). In our study, we found 
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that in 30% of the patients, end-systolic phase reconstructions were useful and were of higher 
image quality than the mid- t o-end diastolic phase reconstructed images.
Conclusions 
The diagnostic accuracy of 64-slice CTCA for ruling out the presence of significant coronary 
lesions in patients undergoing elective valve surgery is excellent and allows CTCA implementa-
tion as a gatekeeper in these patients.
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aBSTraCT
Aims
To determine the adjunctive value of CT coronary angiography (CTCA) in the diagnostic work-
up of patients with typical angina pectoris.
Methods and results
CTCA was performed in 62 consecutive patients (45 male, mean age 58.8 ± 7.7 years) 
with typical angina undergoing diagnostic work-up including exercise-ECG and conventional 
coronary angiography. Only patients with sinus heart rhythm and ability to breath hold for 
20 s were included. Patients with initial heart rates ≥70 beats/min received ¯-blockers. We 
determined the post-test-likelihood ratios, to detect or exclude patients with significant (≥50% 
lumen diameter reduction) stenoses, of exercise-ECG and CTCA separately, and of CT per-
formed after exercise-ECG testing. 
The prevalence of patients with significant coronary artery disease (CAD) was 74%. Positive 
and negative likelihood ratios for exercise-ECG were 2.3 [95% confidence interval (CI): 1.0-
5.3] and 0.3 (95%CI: 0.2-0.7) and for CTCA 7.5 (95%CI: 2.1-27.1) and 0.0 (95%CI: 0.0-
8), respectively. CTCA increased the post-test probability of significant CAD after a negative 
exercise-ECG from 58 to 91%, and after a positive exercise-ECG from 89 to 99%, while CT 
correctly identified patients without CAD (probability 0%). 
Conclusion
Non-invasive CTCA is a potentially useful tool, in the diagnostic work-up of patients with typi-
cal angina pectoris, both to detect and to exclude significant CAD. 
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inTroduCTion
Stress-testing is useful in selecting patients for coronary angiography and can help guide sub-
sequent revascularization strategies. Current guidelines recommend stress-testing in the work-
up of patients with stable angina and a treadmill exercise-ECG is the first-choice stress-test in 
the majority of patients1-4. CT coronary angiography (CTCA) is a non-invasive technique that 
can reliably detect significant coronary stenoses in selected patient populations5-14. However, 
the value of CTCA in addition to exercise-ECG in the diagnostic work-up of patients with typi-
cal angina pectoris in the clinical setting is yet unknown.
We sought to establish the diagnostic value, to detect or exclude significant coronary artery 
disease (CAD), of exercise-ECG and CTCA, alone and in combination, in a consecutive cohort 
of patients with typical angina pectoris. 
meThodS
Study population
During a 1-year-period, we studied 62 (45 male, mean age 58.8 ± 7.7 years) consecutive 
patients who fulfilled all of the following criteria: first history of typical angina pectoris, and two 
specific CT criteria: sinus heart rhythm and ability to breath hold for ≥20 s. Of 103 patients 
eligible for inclusion, 41 patients were excluded with contra-indications (known allergy, serum 
creatinine >120 µmol/L, or thyroid disorders) to iodinated contrast (n = 4), baseline ECG 
abnormalities precluding reliable exercise-ECG interpretation (≥1 mm rest ST-depression, 
complete left bundle-branch block, n = 6), and inability to perform CTCA before conven-
tional angiography for logistic reasons (n = 23); eight patients refused to participate in the 
study. Patients were recruited in a community hospital where the diagnostic work-up including 
exercise-ECG and conventional coronary angiography (CCA) was performed. CTCA was per-
formed in a university hospital on an outpatient basis. The study complies with the Declaration 
of Helsinki. The institutional review boards of both hospitals approved the study protocol and 
all patients gave informed consent.
Patient preparation
Patients with a heart rate above 70 beats/min received a single oral dose of 100mg metoprolol 
≥45min before the scan, unless contraindicated (e.g. overt heart failure or chronic obstructive 
pulmonary disease).
Scan protocol, image reconstruction, and evaluation
All patients were scanned using a second generation 16-slice CT-scanner (Sensation16 
Straton®, Siemens, Forchheim, Germany). Scan parameters were: 16x0.75mm collimation, 
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rotation time 375ms, temporal resolution 188ms, table feed 3.0 mm/rotation, tube voltage 
120kV, 600mAs; tube modulation was not applied. Radiation exposure was estimated as 11.8-
16.3 mSv (WinDose®, Institute of Medical Physics, Erlangen, Germany). A bolus of 100ml 
contrast material (Iomeron®400, Bracco, Milan, Italy) was injected through an arm vein (4 
ml/s) using a bolus-tracking technique to initiate the CT-scan (mean scan time: 18.2 ± 1.0s). 
Datasets were reconstructed using ECG gating and high image quality was generally obtained 
when datasets were reconstructed during the mid-to-end diastolic phase. All available ≥2mm 
coronary branches were independently analysed by two observers, unaware of the results of 
CCA, using conventional post-processing techniques. Patients with at least 1 ≥50% stenosis 
were considered as having significant CAD on the CT-scan.
Quantitative coronary angiography (QCA)
All CT-scans were performed within 4 weeks of CCA. A single observer, unaware of the results 
of CTCA, determined the diameter of all coronary branches using a quantitative algorithm 
(CAAS, Pie Medical, Maastricht, The Netherlands). All ≥2mm branches were included for 
comparison with CT. Stenoses were evaluated in two orthogonal views, and classified as sig-
nificant if the mean lumen diameter reduction was ≥50%, which was considered as the stan-
dard of reference. Patients were labelled as having significant CAD if they had at least one 
significant coronary stenosis.
Exercise-ECG 
All exercise tests were performed prior to CT coronary angiography to avoid the influence of 
¯-blockers on the diagnostic accuracy of exercise-ECG. Exercise-ECG was performed using 
a cycle ergometer and a protocol starting with an initial workload of 25W, followed by incre-
ments of 25W every 2 min. Heart rate and blood pressure were recorded at rest and at the 
end of each stage of exercise. A 12-channel electrocardiogram was obtained each minute 
and 3-channel monitoring of cardiac rhythm was performed continuously.
Exercise-ECG examinations were classified as positive where there was horizontal or downslop-
ing ST-segment depression of ≥1mm at 80 ms after the J-point occurring during or after 
exercise15.
An exercise-ECG tests in patients who did not reach the reference exercise capacity normal-
ized for age, gender, and weight and which did not show a significant ST-segments depression 
were classified as inconclusive. 
Statistical analysis
Descriptive statistics were used to evaluate the diagnostic performance of exercise-ECG and 
CTCA to detect patients with significant CAD, including sensitivity, specificity, positive and 
negative predictive value, and positive and negative likelihood ratios. These diagnostic param-
eters were expressed with a 95% confidence interval (CI) calculated with binomial expansion. 
181
Adjunctive value of CT coronary angiography in the diagnostic work-up of patients with typical angina pectoris 
The pre-test likelihood was estimated using the Duke Clinical Score, which includes Diamond-
Forrester criteria and clinical variables that are known to have prognostic value 3,16,17. Post-
test likelihoods after exercise-ECG and CTCA were calculated using Bayes’ theorem (post-test 
odds = pre-test odds x likelihood ratio). Patient characteristics between included and excluded 
patients were compared using unpaired, two-sided T-test (continuous variables) or Pearson 
Chi-Square test (dichotomous variables). 
Prevalence of significant CAD was based on the presence of greater than or equal to one 
significant stenosis as determined by QCA, which was considered as the gold standard. Agree-
ment between CCA and CTCA was calculated using ∙-statistics. 
reSulTS
Patient characteristics of those included and excluded from the study are shown in Table 1. 
There were no significant differences between the two groups. Fifty percent (31/62) of the 
patients received a pre-scan ¯-blocker; mean heart rate during scanning was 59.3 ± 8.3 
beats/min. No contra-indications to ¯-blockers were present in patients presenting with high 
(≥70 beats/min) heart rates. One CT-examination was classified as inconclusive due to the 
presence of extensive motion artifacts (mean heart rate: 84 beats/min). CCA revealed absence 
of significant stenoses in 26% (16/62), single vessel disease in 32% (20/62), and multi-vessel 
disease in 42% (26/62) of patients. Thus, the prevalence of significant CAD was 74%. The 
pre-test likelihood was estimated as 81 ± 17% (see the statistical analysis section).
Diagnostic performance of exercise-ECG and CTCA 
Nine exercise-ECG tests were classified as inconclusive. Sensitivity of exercise-
ECG to detect significant CAD in the remaining 53 patients was 78% (95%CI: 62-
89), specificity was 67% (95%CI: 34-90), and positive and negative predictive val-
ue was 89% (95%CI: 73-96) and 47% (95%CI: 22-72), respectively. Sensitivity of 
CTCA to detect significant CAD in 61 patients (one patient was classified as inconclusive) was 
100% (95%CI: 92-100), specificity was 87% (95%CI: 59-98), and positive and negative pre-
dictive value was 96% (95%CI: 85-99) and 100% (95%CI: 75-100), respectively. Agreement 
between CCA and CTCA on a per-patient level was high (∙ -value: 0.91). 
Positive and negative likelihood ratios to detect or exclude significant CAD were; 2.3 (95%CI: 
1.0-5.3) and 0.3 (95%CI: 0.2-0.7) for exercise-ECG; 7.5 (95%CI: 2.1-27.1) and 0.0 (95%CI: 
0.0-∞) for CTCA, respectively. Figure 1 shows the diagnostic impact on the probability of sig-
nificant coronary artery disease of exercise-ECG. Figure 2 shows the diagnostic impact on the 
probability of significant coronary artery disease after CTCA.
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Diagnostic performance of CTCA in addition to 
exercise-ECG to detect significant stenoses
The prevalence of significant CAD after a positive exercise-ECG test of 89% (with an estimated 
post-test likelihood of 91%) was refined by CTCA to respectively 100% after a positive CT-scan 
[with an estimated post-test likelihood of 99%) and 0% after a negative CT-scan (with an esti-
mated post-test likelihood of 0%, (Figure 3)].
The prevalence of significant CAD after a negative exercise-ECG test of 53% (with an esti-
mated post-test likelihood of 58%) was refined by CTCA to respectively 90% after a positive 
CT-scan [with an estimated post-test likelihood of 91%, (Figure 4)] and 0% after a negative 
CT-scan (with an estimated post-test likelihood of 0%). The prevalence of significant CAD after 
CTCA in patients with an inconclusive exercise-ECG test was respectively 83% after a positive 
CT-scan [with an estimated post-test likelihood of 96%, (Figure 5)] and 0% after a negative 
CT-scan (with an estimated post-test likelihood of 0%). 
Included  patients 
(n = 62)
excluded patients 
(n = 41)
P-value
Mean age ( ± SD)1 60,4±9.3 59,5±9.2 0.643
Risk factors, n (%)
   Hypercholesterolemia2 43 (69) 27 (66) 0.589
   Systemic hypertension2 42 (68) 24 (59) 0.271
   Smoking2 25 (40) 18 (44) 0.797
   Family history of premature CAD2 23 (37) 17 (41) 0.728
   Obese (BMI ≥30)2 16 (26) 11 (27) 0.965
   Diabetes Mellitus2 8 (13) 4 (10) 0.597
Medication, n (%)
   Aspirin2 59 (95) 37 (90) 0.185
   ¯-blocker2 51 (82) 34 (84) 0.866
   ACE inhibitors / AT-II antagonist2 20 (32) 10 (24) 0.351
   Calcium-antagonist2 20 (32) 14 (34) 0.909
   Nitrates (systemic)2 18 (29) 9 (22) 0.385
   Statins2 43 (69) 28 (68) 0.773
Prevalence of significant CAD, n (%)2, 3 46 (74) 30 (75) 0.755
BMI, body mass index. 
P-values < 0.05 were considered significant.
1Calculated using unpaired T-test.
2Calculated using the Pearson Chi-Square test. 
3Based on the presence of a significant (≥50% lumen reduction) stenosis as determined by QCA
Table 1. Patient characteristics
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Figure 1. The diagnostic impact on the probability of significant CAD of exercise-ECG.
Figure 2. The diagnostic impact on the probability of significant CAD of CTCA
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Figure 4. Example of CT vs. CCA 
in a patient with single vessel dis-
ease and a negative exercise-ECG 
test. Volume-rendered CT images 
(coloured images) provide a nice 
anatomical overview of a domi-
nant right coronary artery (RCA). 
Maximum intensity projected 
(MIP) and two orthogonally curved 
multiplanar reconstructed (cMPR) 
CT images indicate the presence 
of a significant stenosis at the 
proximal RCA (arrowhead), which 
was confirmed on the convention-
al coronary angiogram (CCA).
Figure 3. The diagnostic impact on the probability of significant CAD of CTCA as an adjunct to exercise-ECG
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diSCuSSion
Exercise-ECG testing is safe, inexpensive, and widely available. Current guidelines recommend 
documentation of exercise- or stress-induced ischemia in patients with stable angina who are 
evaluated for revascularization1,2. Patients with a positive exercise-ECG test will be further eval-
uated by diagnostic CCA to determine further management with percutaneous intervention, 
bypass surgery, or pharmacological treatment. Patients with a negative exercise-ECG require 
(depending on the level of clinical suspicion of the presence of CAD based upon history, physi-
cal examination, and rest-ECG), either further non-invasive diagnostic work-up, or referral for 
CCA, or a regular clinical follow-up on an outpatient basis. 
In our study, we evaluated the diagnostic value of exercise-ECG alone, of CTCA alone, and 
in particular the additional value of CTCA after exercise-ECG in 62 consecutive patients with 
typical angina and an intermediate-to-high pre-test probability of significant CAD. We only 
included patients with typical symptoms of stable angina pectoris. The prevalence of signifi-
cant CAD in our patient cohort was 74%, which is in line with the estimated pre-test likelihood 
of 81 ± 17% using clinical variables such as age, gender, symptoms, and cardiovascular risk 
factors3,16,17. Our results show that exercise-ECG was able to correctly predict the presence 
or absence of significant CAD in 65% (40/62) of patients, whereas CTCA correctly classified 
all patients with significant CAD (n = 46), but misclassified 19% (3/16) of patients without 
significant CAD.
 
Figure 5. Example of CT vs. 
CCA in a patient with single ves-
sel disease and an inconclusive 
exercise-ECG test. A volume ren-
dered CT image (coloured image) 
suggests the presence of a sig-
nificant stenosis of the proximal 
circumflex coronary artery. More 
detailed analyses using maxi-
mum intensity projected (MIP) 
curved multiplanar reconstructed 
(cMPR) post-processing tech-
niques confirm these findings, 
which was also found on the con-
ventional angiogram (CCA).
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The post-test probability of significant CAD after a negative exercise-ECG test was 58%, which 
represents such a high diagnostic uncertainty level that further diagnostic work-up is required. 
In this context, CTCA proved particularly useful; a positive CTCA increased the probability of 
significant CAD to 91% whereas a negative CTCA decreased it to 0%. Thus, the additional 
diagnostic information provided by CTCA is of particular use in patients with an intermediate 
likelihood of having significant CAD (e.g. patients with typical angina and a negative stress-
test).
The estimated post-test probability of significant CAD after a positive exercise-ECG test was 
91%. The subsequent step in such patients, where indicated, is conventional diagnostic an-
giography, as the high probability of significant CAD in patients with typical angina pectoris 
and a positive stress test makes further non-invasive diagnostic work-up unhelpful. However, 
despite this high probability of disease, CTCA was able to even further perfect this to a preva-
lence of 100% in case of a positive CT-scan and to 0% in case of a negative CT-scan. 
The question remains what would be the role of CTCA in the diagnostic work-up of patients 
with a (very) high pre-test likelihood of significant CAD. According to the guidelines, the ma-
jority of patients with a high pre-test likelihood should undergo non-invasive testing, followed 
by diagnostic CCA to refer these patients for appropriate therapy. Some investigators sug-
gest that these patients should immediately be referred for a diagnostic coronary angiogram, 
followed in the same session by percutaneous intervention, thereby obviating the need for 
further non-invasive diagnostic tests including CTCA. In keeping with current guidelines, such 
an ad-hoc approach has important disadvantages when compared to a staged approach, 
which allows time to inform the patient about risks, benefits, and alternatives of the selected 
therapy as well as optimal hydration and pre-treatment with oral anti-platelet agents before 
coronary intervention4. This immediate approach does not allow general discussion between 
the general cardiologist, interventional cardiologist, and cardiac surgeon to reach consensus 
about the most optimal treatment strategy. In addition, a single session approach may result 
in a considerable kidney contrast burden and associated contrast induced nephrotoxicity4. 
Moreover, such approach may result in a high diagnostic workload with a significant burden 
on the availability of percutaneous interventional laboratories. In fact, the majority of patients 
who undergo elective percutaneous revascularization procedures in the Netherlands -as in 
many other European countries- are being sent to referral hospitals after a complete diag-
nostic work-up including CCA in a community hospital without percutaneous intervention 
facilitations. The findings of our pilot study suggest that CTCA may be used as an “intermedi-
ate” step to guide referral for diagnostic angiography followed by percutaneous intervention 
in the same session (patients with one- or two-vessel disease) or bypass surgery (left main or 
three-vessel disease). Our results also indicate that CTCA may even function as a “gatekeeper" 
for diagnostic coronary angiography in patients with an intermediate-to-high likelihood of 
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significant CAD. For these reasons, CTCA may still be of use in patients with a high pre-test 
likelihood of significant CAD. 
We have studied a relatively small number of patients who are at high risk of having significant 
CAD and excluded a significant number of patients because of logistic inability to perform 
CTCA before the conventional angiogram. The main reason was the short interval between 
exercise-ECG and conventional angiography (3-7 days) which in some cases did not allow 
timely CT examination (e.g. no available time slots, CT maintenance, or not able to contact 
the patient). It is of note that these patients could have been examined by CT in a clinical set-
ting because of the elective nature of diagnostic angiography in stable patients. Moreover, we 
did not find significant differences in patient characteristics between included and excluded 
patients (Table 1). Larger prospective studies are needed evaluating the diagnostic value of 
CTCA in addition to stress testing in patients with a low or intermediate pre-test likelihood of 
significant CAD (e.g. patients with atypical angina or non-anginal chest pain). These patients 
may potentially benefit more from CTCA whereas the impact of CT as “gatekeeper” for diag-
nostic coronary angiography may be higher. If such studies would confirm our initial results, 
CTCA may become a routinely used technique in the diagnostic work-up of patients suspected 
of having CAD. 
Limitations
We have classified stenoses with a mean lumen diameter reduction of ≥50% as determined by 
QCA as “significant”. It is known that this threshold is the best-chosen anatomical threshold 
that correlates with myocardial ischemia18. However, it is of note that some ≥50% stenoses 
on the conventional angiogram may have been haemodynamically non-significant, and that 
a negative stress-test in these patients incorrectly was classified as false negative, thereby 
stressing that the cut-off values of anatomy and function do not always result in concordant 
outcomes.
CTCA has specific limitations; it is only reliable in selected patients with a slow (<70 beats/
min, spontaneous or ¯-blocker induced) and regular heart rhythm, who are able to breath 
hold for at least 20 s. Furthermore, the high radiation exposure associated with CTCA [11.8-
16.3 (male/female) mSv] is a matter of concern and significantly higher when compared to 
diagnostic conventional angiography (3-6 mSv).
ConCluSionS
While exercise-ECG testing provides important information that aids in the management of 
patients with typical angina, it is of limited diagnostic value for the detection of significant 
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coronary disease. A combined diagnostic work-up of exercise-ECG testing and CTCA mark-
edly improved the post-test probability of the presence or absence of significant CAD. 
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aBSTraCT
Objectives
We sought to determine the diagnostic accuracy of noninvasive visual computed tomography 
coronary angiography (CTCA) and quantitative computed tomography coronary angiography 
(QCT) to predict the hemodynamic significance of a coronary stenosis, using intracoronary 
fractional flow reserve (FFR) as the reference standard.
Background
It has been demonstrated that CTCA provides excellent diagnostic sensitivity for identifying 
coronary stenoses, but may lack accurate delineation of the hemodynamic significance
Methods
We investigated 79 patients with stable angina pectoris who underwent both 64-slice  or dual-
source CTCA and FFR measurement of discrete coronary stenoses. CTCA and conventional 
coronary angiography (CCA), and QCT and quantitative coronary angiography (QCA), were 
performed to determine the severity of a stenosis that was compared with FFR measurements. 
A significant anatomical or functional stenosis was defined as ≥ 50% diameter stenosis or an 
FFR < 0.75. Stented segments and bypass grafts were not included in the analysis. 
Results
A total of 89 stenoses were evaluated of which 18% (16 of 89) had an FFR < 0.75. The diag-
nostic accuracy of CTCA, QCT, CCA and QCA to detect a hemodynamic significant coronary 
lesion was 49%, 71%, 61% and 67%, respectively. Correlation between QCT and QCA with 
FFR measurement was weak (R values of -0.32 and -0.30, respectively). Correlation between 
QCT and QCA was significant, but only moderate (R = 0.53; p <  0.0001).
Conclusions
The anatomical assessment of the hemodynamic significance of coronary stenoses deter-
mined by visual CTCA, CCA or QCT or QCA does not correlate well with the functional assess-
ment of FFR. Determining the hemodynamic significance of an angiographically intermediate 
stenosis remains relevant before referral for revascularization treatment.  
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inTroduCTion
Currently available 64-slice cardiac computed tomography (CT) scanners and recently intro-
duced dual-source scanners have the ability to completely assess the entire coronary tree and 
have been demonstrated to have good diagnostic accuracy for the identification of anatomi-
cally important coronary artery disease (CAD), generally defined as coronary artery stenoses 
with a lumen diameter reduction of at least 50 % (1-11). However, the anatomical significant 
appearance of a coronary stenosis does not always equate with functional significance, and 
this is particularly true for intermediate type coronary lesions (12-16). According to the guide-
lines (European Society of Cardiology, American College of Cardiology/American Heart As-
sociation), the decision to perform angioplasty or bypass surgery should integrate anatomical 
information with a test that provides objective proof of ischemia (17,18).
Only few reports have studied the relationship between the significance of a stenosis in a 
coronary vessel as defined by computed tomography coronary angiography (CTCA) and the 
functional importance of this stenosis in that particular coronary vessel territory (19-22). This 
study evaluates the relationship between the anatomy and functional significance of a coro-
nary stenosis in patients who both underwent CTCA and conventional coronary angiogram 
(CCA) using the lesion-specific intracoronary fractional flow reserve (FFR) measurement. 
meThodS
Study population
We retrospectively analyzed all patients who in the period between July 2004 and March 
2007 underwent both a cardiac CT scan and invasive CCA and a subsequent measurement 
of the FFR. The decision to measure FFR was based entirely on the appearance of a coro-
nary narrowing on CCA and was performed at the interventional cardiologist’s discretion. 
All patients were assessed by either a 64-slice CT scanner (period July 2004 to March 2006) 
or dual-source CT scanner (period April 2006 to March 2007). Contra-indications for a CT 
scan included impaired renal function (creatinine clearance < 60 ml/min as defined with the 
Cockroft formula), irregular heart rhythm and known contrast allergy. Patients with previous 
percutaneous coronary intervention using stents or coronary artery bypass surgery were ex-
cluded from further analysis. Due to the hemodynamic interaction between 2 or more stenoses 
in series (23,24), we only included patients in whom FFR of a single discrete lesion had been 
performed. In total, 89 segments in 79 patients were included in the study. Sixteen segments 
were excluded due to CTCA-related artefacts and 1 because of inability to obtain a good an-
giographic view to perform quantitative coronary angiography (QCA).
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For this retrospective analysis, all patients gave their informed consent to undergo CTCA as 
part of research protocols approved by the institutional review board. FFR was carried out as 
part of routine clinical management. 
CCA.
All patients underwent CCA through the femoral approach, using a 6- or 7-F guiding catheter. 
After intracoronary injection of 2 mg isosorbide dinitrate, an angiogram of the right and left 
coronary artery was performed in multiple projections using standard techniques. All angio-
grams were analyzed off-line by 2 cardiologists who were not involved in the patient’s medical 
care. They independently analyzed the selected coronary artery stenosis where FFR had been 
informed using visual estimation and quantitative assessment, the latter using an automated 
edge contour detection system (Cardiovascular Angiographic Analysis System, Pie Medical 
Equipment, Maastricht, the Netherlands)(25). Qualitative and quantitative analysis was based 
on the angiographic projection showing the most severe narrowing. A coronary stenosis was 
defined as significant based on visual inspection or when the degree of stenosis as measured 
with QCA was ≥ 50%.
 
FFR measurement.
Fractional flow reserve was measured with a sensor-tipped 0.014-inch guide wire (Pressure 
Wire, Radi Medical Systems, Uppsala, Sweden). After positioning of the pressure sensor just 
distal to the stenosis, maximal myocardial hyperemia was induced by a continuous intrave-
nous infusion of adenosine in a femoral vein at an infusion rate of 140 µg/kg body-weight per 
minute for minimum of 2 min. During maximum hyperemia, FFR was calculated as the ratio 
of mean distal pressure measured by the pressure wire divided by the mean proximal  pressure 
measured by the guiding catheter (26). A coronary stenosis with an FFR value  <0.75 was 
considered functionally significant (27-29).
CTCA. Patient preparation.
Patients scanned with the 64-slice scanner who had a heart rate exceeding 65 beats/min 
received additional oral and/or intravenous beta-blockers (metoprolol) before the CT scan in 
order to obtain a heart rate below 65 beats/min. Patients scanned with dual-source CT did not 
receive pre-medication irrespective of the heart rate.
Scan protocol. 
Thirty-eight patients were scanned with a 64-slice CT scanner (Sensation 64, Siemens, Forch-
heim, Germany). Angiographic scan parameters were: 32 x 2 x 0.6 mm collimation with 
z-flying focal spot, 330 ms rotation time, temporal resolution 165ms, 120 kV tube voltage, 
900 mAs tube current, 3.8 mm/rotation table feed. Prospective X-ray tube modulation was 
not applied. 
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Forty patients were scanned using a dual-source CT scanner (Somatom Definition, Siemens, 
Forcheim, Germany). Dual-source CT angiographic scan parameters were: 120 kV, 330 ms 
rotation time, temporal resolution 83ms and 32x 2 X 0.6 mm collimation with z-flying focal 
spot for both detectors. Pitch values were adapted to heart rate based on the average of the 
last 10 heartbeats preceding the scan. Each tube provided 412 mAs/rot. Prospective tube 
modulation was applied with full dose radiation only given during 25% to 70% of the RR-
interval. 
With the 64-slice scanner, a bolus of 100 ml of contrast material (400 mgI/mL; Iomeron, Brac-
co, Milan, Italy) was injected intravenously in an antecubital vein at 5 ml/s. With dual- source 
CT, the volume of iodinated contrast material (Ultravist 370 mgl/ml, Schering AG, Germany) 
was adapted to the scan time, which varied between 5 and 13 s. A bolus of contrast material 
(60 to 90 ml) was injected in an antecubital vein at a flow rate of 5 ml/s followed by a saline 
chaser of 40 ml at 5 ml/s. In both scanners a bolus-tracking technique was used to synchro-
nize the arrival of contrast in the coronary arteries, and the scan was started once the contrast 
material in the ascending aorta reached a predefined threshold of +100 Hounsfield units.
 
Image reconstruction
Images were reconstructed with electrocardiogram gating to obtain near motion-free image 
quality. Optimal datasets were reconstructed in the mid- to end-diastolic phase and in the 
end- systolic phase. 
Qualitative evaluation of the CTCA.
Two experienced observers unaware of the results of CCA evaluated the CTCA data sets on an 
offline workstation (Leonardo, Siemens, Forchheim, Germany). Initially the specific lesion was 
evaluated with axial slices for the presence of significant disease, and additionally (curved) 
multiplanar reformatted reconstructions were used.
 
Quantitative evaluation of the CTCA.
Two experienced observers performed the quantification manually. After positioning the planes 
orthogonal to the course of the coronaries , cross-sectional images were obtained in the most 
severe narrowing and in the proximal and distal reference site. In these 3 images, the mini-
mal lumen diameter was measured. The reference diameter was calculated by averaging the 
proximal and distal minimal lumen diameters. The percent diameter stenosis was calculated 
by subtracting the reference diameter from the minimal lumen diameter, which was divided by 
the reference diameter. The average of both measurements by the 2 observers was reported. 
A 50% diameter stenosis measured with quantitative computed tomography coronary angiog-
raphy (QCT) was described as significant. 
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Statistical analysis
The diagnostic performance of qualitative and quantitative CCA and CTCA for the detection 
of significant stenoses in the coronary arteries with FFR as the standard of reference is pre-
sented as sensitivity, specificity and diagnostic accuracy (true positives + true negatives/ true 
positives + true negatives + false positives + false negatives), with the corresponding 95% 
confidence intervals. The relation between anatomical (QCA and QCT) and functional param-
eters (FFR) were analyzed with correlation statistics. The Pearson correlation-coefficient was 
used because QCA, QCT, and FFR were normally distributed. Bland-Altman analysis was per-
formed by plotting the difference of QCA and QCT versus QCA (30). Interobserver variability 
for the detection of significant coronary stenosis and agreement between techniques to clas-
sify segments as having a functional 
significant lesion was determined by 
∙-statistics.
reSulTS
Patients’ characteristics and angio-
graphic data are shown in Table 1. A 
total of 17 segments were excluded 
due to the presence of heavy calcifica-
tions (11 segments), motion artifacts 
(2 segments), breathing artifacts (2 
segments), low contrast opacification 
(1 segment) and absence of a good 
angiographic view to perform QCA 
(1 segment). Average heart rate dur-
ing CT data acquisition was 60 ± 9 
beats/min for 64-slice CT and 68 ±11 
beats/min for dual-source CT. 
Overall, 89 discrete stenoses in 79 patients 
were included for comparison with FFR. Sev-
enty-one percent (63 of 89) of these stenoses 
were of angiographic intermediate severity 
(between 40 and 70% diameter stenosis as de-
termined by QCA), 29 stenoses were less than 
40%, and 1 stenosis was measured as more 
than 70%. Of these 89 coronary stenoses, 35 
Table 1.  Patient and lesion characteristics
Patients (n=79)
    Segments, n 89
    Gender, male/ female 64/15
    Mean age, yrs 60 ± 9
    Body mass index, mean (kg/m2) 26.6 ± 3.9
    Prior myocardial infarction 10
Angiographic data
  Affected artery
    Left main coronary artery 5
    Left anterior descending coronary artery 41
    Circumflex coronary artery 19
    Right coronary artery 24
  Reference diameter (mm) 2.82 ± 0.67
  Percent diameter stenosis (%) 44 ± 11
  Minimal luminal diameter (mm) 1.57 ± 0.50
Table 2. Patient management
FFR = fractional flow reserve; IVUS = intravascular ul-
trasound
Therapeutic decision, n
    Medical therapy 57
    Percutaneous coronary intervention 29
    Coronary artery bypass grafting 3
Revascularized segments, n 
    ffR < 0.75 16
    0.75 < ffR < 0.80 11
    ffR > 0.80, IVuS obstructive plaque 5
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had a diameter stenosis of more than 50% by QCA, but only 16 lesions were hemodynamically 
significant (FFR <0.75). Patient management is shown in Table 2.
 
Diagnostic performance of CTCA and CCA versus FFR: visual assessment
The diagnostic performance of CTCA and CCA for the assessment of a functionally important 
coronary stenosis (FFR < 0.75) is detailed in Table 3 and Figure 1. Agreement between visual 
CT and FFR assessment was present in 49% (44 of 89) of the evaluated segments; 15 of the 
16 hemodynamically significant stenoses were identified correctly. One functionally important 
lesion in the mid left anterior descending coronary artery was underestimated and classified 
as nonsignificant by CTCA (44% diameter stenosis by QCA) (Fig. 2). Overestimation of hemo-
dynamic severity occurred in 44 cases (Fig. 3). Corresponding sensitivity and specificity were, 
respectively, 94% and 40%. Interobserver variability for detection of a functionally important 
coronary stenosis was good (kappa value of  0.76). Agreement between CTCA and FFR was 
poor (kappa value of 0.16).
By comparison, visual lesion assessment by CCA showed an agreement with FFR in 61% (54 of 
89) of the segments. Visual scoring identified 10 of the 16 functionally important lesions and 
44 of the 73 functionally insignificant lesions. Six functionally important lesions were underes-
timated (Fig. 2). In 29 lesions, the hemodynamic severity was overestimated (Fig. 3). Conse-
quently, the sensitivity was 63% and the specificity 60% for CCA to detect a functionally signifi-
Figure 1. Scatter plots of FFR 
versus QCA, QCT, CCA, and 
CTCA
Quantitative coronary angiog-
raphy (QCA), quantitative com-
puted tomography coronary 
angiography (QCT), CCA, and 
CTCA are plotted versus FFR. 
There was a weak, but signifi-
cant, negative correlation be-
tween QCA and FFR (r = -0.30) 
and between QCT and FFR (r 
= -0.32). Coronary arteries 
smaller than 3.5 mm are de-
picted as solid circles, coronary 
arteries larger than 3.5 mm as 
open circles.
Chapter 11
198
cant lesion. Interobserver variability 
for the detection of a functionally 
important coronary stenosis was 
moderate (kappa value of  0.61). 
Agreement between CCA and FFR 
was poor (kappa value of 0.15). 
Furthermore, the diagnostic perfor-
mance of CTCA and CCA for the 
assessment of a functionally impor-
tant coronary stenosis, defined as a 
FFR <0.80, is detailed in Table 3 
and Figure 1.
Diagnostic performance of 
QCT and QCA versus FFR: 
quantitative assessment 
The diagnostic accuracy of QCT 
and QCA for detecting function-
ally relevant coronary stenoses is 
described in Table 3 and Figure 1. 
Overall, the diagnostic accuracy 
for both quantitative measures was 
slightly better than when performed 
with visual estimation. 
Agreement between QCA and FFR 
as well as between QCT and FFR 
(Table 3) was only fair (kappa value 
of 0.25 and 0.20, respectively). The 
interobserver variability for QCA 
(kappa value of 0.58) and QCT 
(kappa value of 0.69) was moder-
ate. 
The correlation between QCT and 
FFR was R= -0.32 and between 
QCA and FFR was R= -0.30. Cor-
relation of the percent diameter 
stenosis as determined by QCT and 
QCA was significant, but only mod-
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erate (R = 0.53; p< 0.0001) (Fig. 4). The Bland-Altman analysis 
plot revealed important variability: the mean difference between 
QCA and QCT was +2% with 95% limits of agreement ranging 
from – 21% to + 25% (Fig. 4). 
 
Figure 2. CTCA and CCA with 
FFR measurement of interme-
diate coronary lesion
Patient showing a coronary 
artery stenosis (arrow) in the 
left anterior descending coro-
nary artery, as visualized with 
computed tomography coro-
nary angiography (CTCA) (A, 
volume-rendered image; B 
and C, 2 orthogonal curved 
multiplanar reconstructions) 
and conventional coronary an-
giography (CCA) (D). By visual 
assessment, the coronary le-
sion was estimated as less than 
50% diameter stenosis, both by 
CTCA and CCA. By quantitative 
analysis, the diameter stenosis 
was measured as 44% by quan-
titative coronary angiography 
and 40% by quantitative CTCA. 
The fractional flow reserve 
(FFR) was 0.71 (E). Based on 
the functional assessment, the 
patient underwent a successful 
percutaneous coronary inter-
vention for this anatomically 
intermediate stenosis. (A full 
color version of this illustration 
can be found in the color sec-
tion).
Figure 3.  CTCA and CCA with 
FFR measurement of interme-
diate coronary lesion 
Patient with a coronary artery 
stenosis (arrow) in the proximal 
part of the right coronary artery, 
as visualized with CTCA (A, 
volume-rendered image; B and 
C, 2 orthogonal curved mul-
tiplanar reconstructions) and 
CCA (D). Visually, the diameter 
stenosis was estimated as more 
than 50%, both by CTCA and 
CCA.  Also, after quantifica-
tion (56% diameter stenosis by 
quantitative coronary angiog-
raphy, 70% diameter stenosis 
by quantitative CTCA), the le-
sion appeared to be anatomi-
cally significant. The FFR was 
0.78 (E). In the distal segments, 
a step artefact can be seen (A 
and C, arrowhead). (A full color 
version of this illustration can 
be found in the color section).
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diSCuSSion
Fractional flow reserve is a lesion-specific technique to determine the functional importance 
of a coronary stenosis and is correlated with non-invasive tests that demonstrate ischemia 
(27,31-34). It has been shown to be a useful guide for decision making regarding the revas-
cularisation of a specific lesion. In lesions where the FFR is ≥ 0.75, revascularization can be 
safely deferred (35-37). 
Limitations of anatomical imaging. Previous reports have demonstrated that the anatomi-
cal assessment of a coronary stenosis as determined by CCA correlates poorly with the he-
modynamic significance of the stenosis in particular in intermediate severity lesions (12-16). 
Although QCA is accurate and reproducible, it does not reflect the hemodynamic impairment 
of coronary flow. The QCA does not account for the effects of factors such as collateral cir-
culation, mass of viable myocardium, shape and length of stenosis, inflow and outflow con-
figuration, and transient vasoconstriction with resulting dynamic changes in the diameter of 
a stenosis (38). The diffuseness of the atherosclerotic process often results in disease in the 
reference segments proximal and distal to the site of maximal diameter reduction and as a 
result leads to underestimation of extent and severity of  coronary atherosclerosis (39).
Integrating anatomy with functional information. These findings were also demonstrated in 
this study, not only for CTCA, but also when assessing the severity of a coronary artery stenosis 
with CCA. Using visual assessment, CTCA had high sensitivity to detect lesions with functional 
significance (FFR < 0.75). However, it had poor specificity due to frequent false positives; 
Figure 4. Scatter plot and Bland-Altman analysis of QCT versus QCA
 In the left panel, QCT is plotted versus QCA. A significant correlation is seen between both anatomical techniques (r =  0.53). In 
the right panel, Bland-Altman analysis showed a bias of +2% with 95% limit of agreement ranging from -21% to 25%. 
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CTCA overestimated the functional severity of a coronary stenosis, even when excluding seg-
ments with extensive calcifications or coronary motion. Quantification of stenosis severity by 
QCT and QCA improved the prediction of a functional relevant coronary stenosis slightly.
Previous studies have compared the anatomical findings of CTCA with functional imaging 
using nuclear stress testing (19,20,22). These studies also showed a poor correlation be-
tween anatomy and function with only ~ 50% of patients with significant coronary stenosis 
as demonstrated by CTCA having ischemia demonstrated by nuclear stress testing. Besides 
methodological limitations, these noninvasive tests measure the effect of impaired coronary 
perfusion at the level of the myocardium and thus do not discriminate between epicardial flow 
impairment and microvascular perfusion abnormalities. Intracoronary measurement of the 
FFR has the disadvantage of being invasive, but has the benefit of determining the ischemic 
potential of a specific epicardial coronary stenosis.
Clinical implementation. Given the previously discussed findings, and the consistently high 
negative predictive value of CTCA in different population groups, CTCA appears best suited 
as an effective rule out test for significant CAD. Those patients with suspected CAD and no 
or minimal coronary atherosclerosis on CTCA would not need further investigation (40,41). 
However patients with obstructive CAD on CTCA may best be investigated using a combined 
approach with a subsequent functional test such as nuclear stress testing, stress echocardiog-
raphy or magnetic resonance perfusion imaging.
Anatomical evaluation of CAD has limitations and makes functional assessment necessary. 
Comprehensive non invasive anatomical and functional imaging may best identify patients 
who are likely to benefit most from secondary preventive measures and medical therapy (coro-
nary atherosclerosis without ischemia) or who may be candidates for coronary revasculariza-
tion (coronary atherosclerosis with ischemia). All-in-one approaches, such as single-photon 
emission CT-CTCA or positron-emission tomography-CTCA, that provide integrated evalua-
tion of anatomy and physiology in a noninvasive way might theoretically solve these diagnostic 
problems.
Now that we are able to noninvasively access coronary anatomy, we should be remindful of 
the limitations of noninvasive functional tests, especially in patients with multivessel disease or 
significant left main stenosis on CTCA, without evidence of ischemia of a noninvasive function-
al test (42,43). In case of doubt, it seems prudent to refer such a patient to the catheterization 
laboratory for further invasive assessment and definitive exclusion of the functional severity of 
a specific epicardial stenosis using FFR.
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Study limitations.
Patient inclusion was not performed in a prospectively designed study, but as a retrospective 
analysis. Consecutive patients were enrolled based on the access to the 64-slice or dual-source 
CT scanner. Seventeen segments in 15 patients had to be excluded due to the presence 
of heavy calcifications, motion artifacts, breathing artifacts, low contrast opacification and 
absence of a good angiographic view which made it, both visually as well as quantitatively, 
impossible to reliably estimate stenoses severity.
Quantification of coronary artery stenoses with CTCA continues to be a challenge due to 
the difficulty in ascertaining the normal reference segment of the coronary artery because 
of atherosclerotic involvement of the vessel wall proximal and distal to the stenosis (2,3,44). 
Especially in the presence of extensive calcifications of the artery it becomes impossible to 
accurately define the reference vessel diameters. Further improvement in spatial resolution 
will enhance the ability to accurately grade stenosis severity. However, particularly in coronary 
stenoses of intermediate severity, this may not improve the ability to predict functional signifi-
cance, as is also observed with invasive CCA. 
ConCluSion
The correlation between stenosis severity as determined by CTCA or CCA and ischemia mea-
sured by FFR in coronary lesions of intermediate severity is poor. Functional information, 
whether provided by FFR or a noninvasive stress test, is essential in these circumstances for 
appropriate clinical decision making.   
reFerenCeS
1. Leschka S, Alkadhi H, Plass A, et al. Accuracy of MSCT coronary angiography with 64-slice 
technology: first experience. Eur Heart J 2005; 26(15):1482-7.
2. Raff GL, Gallagher MJ, O'Neill WW, Goldstein JA. Diagnostic accuracy of noninvasive 
coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol 
2005;46:552-7.
3. Leber AW, Knez A, von Ziegler F, et al. Quantification of obstructive and nonobstructive 
coronary lesions by 64-slice computed tomography: a comparative study with quantitative 
coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005;46:147-54.
4. Mollet NR, Cademartiri F, van Mieghem CA, et al. High-resolution spiral computed 
tomography coronary angiography in patients referred for diagnostic conventional 
coronary angiography. Circulation 2005;112:2318-23.
203
Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus 
conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina
5. Ropers D, Rixe J, Anders K, et al. Usefulness of multidetector row spiral computed 
tomography with 64- x 0.6-mm collimation and 330-ms rotation for the noninvasive 
detection of significant coronary artery stenoses. Am J Cardiol 2006;97:343-8.
6. Schuijf JD, Pundziute G, Jukema JW, et al. Diagnostic accuracy of 64-slice multislice 
computed tomography in the noninvasive evaluation of significant coronary artery disease. 
Am J Cardiol 2006;98:145-8.
7. Nikolaou K, Knez A, Rist C, et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart 
disease. AJR Am J Roentgenol 2006;187:111-7.
8. Fine JJ, Hopkins CB, Ruff N, Newton FC. Comparison of accuracy of 64-slice cardiovascular 
computed tomography with coronary angiography in patients with suspected coronary 
artery disease. Am J Cardiol 2006;97:173-4.
9. Ehara M, Surmely JF, Kawai M, et al. Diagnostic accuracy of 64-slice computed tomography 
for detecting angiographically significant coronary artery stenosis in an unselected 
consecutive patient population: comparison with conventional invasive angiography. Circ 
J 2006;70:564-71.
10. Leber AW, Johnson T, Becker A, et al. Diagnostic accuracy of dual-source multi-slice CT-
coronary angiography in patients with an intermediate pretest likelihood for coronary 
artery disease. Eur Heart J 2007;28:2354-2360.
11. Weustink AC, Meijboom WB, Mollet NR, et al. Reliable high-speed coronary computed 
tomography in symptomatic patients. J Am Coll Cardiol 2007;50:786-94.
12. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram 
predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-
24.
13. Kern MJ, Lerman A, Bech JW, et al. Physiological assessment of coronary artery disease 
in the cardiac catheterization laboratory: a scientific statement from the American Heart 
Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council 
on Clinical Cardiology. Circulation 2006;114:1321-41.
14. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the 
catheterization laboratory. J Am Coll Cardiol 2007;49:839-48.
15. Christou MA, Siontis GC, Katritsis DG, Ioannidis JP. Meta-analysis of fractional flow reserve 
versus quantitative coronary angiography and noninvasive imaging for evaluation of 
myocardial ischemia. Am J Cardiol 2007;99:450-6.
16. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between 
myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 
1994;330:1782-8.
17. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. 
The Task Force for Percutaneous Coronary Interventions of the European Society of 
Cardiology. Eur Heart J 2005;26:804-47.
Chapter 11
204
18. Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., et al. ACC/AHA/SCAI 2005 guideline update 
for percutaneous coronary intervention: a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing 
Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). 
Circulation 2006;113:e166-286.
19. Schuijf JD, Wijns W, Jukema JW, et al. Relationship between noninvasive coronary 
angiography with multi-slice computed tomography and myocardial perfusion imaging. J 
Am Coll Cardiol 2006;48:2508-14.
20. Hacker M, Jakobs T, Hack N, et al. Sixty-four slice spiral CT angiography does not predict 
the functional relevance of coronary artery stenoses in patients with stable angina. Eur J 
Nucl Med Mol Imaging 2007;34:4-10.
21. Rispler S, Keidar Z, Ghersin E, et al. Integrated single-photon emission computed 
tomography and computed tomography coronary angiography for the assessment of 
hemodynamically significant coronary artery lesions. J Am Coll Cardiol 2007;49:1059-
67.
22. Hacker M, Jakobs T, Matthiesen F, et al. Comparison of spiral multidetector CT angiography 
and myocardial perfusion imaging in the noninvasive detection of functionally relevant 
coronary artery lesions: first clinical experiences. J Nucl Med 2005;46:1294-300.
23. De Bruyne B, Pijls NH, Heyndrickx GR, Hodeige D, Kirkeeide R, Gould KL. Pressure-
derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and 
animal validation. Circulation 2000;101:1840-7.
24. Pijls NH, De Bruyne B, Bech GJ, et al. Coronary pressure measurement to assess the 
hemodynamic significance of serial stenoses within one coronary artery: validation in 
humans. Circulation 2000;102:2371-7.
25. Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-
term variations in arterial dimensions from computer-assisted quantitation of coronary 
cineangiograms. Circulation 1985;71:280-8.
26. Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. A useful index 
to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. 
Circulation 1995;92:3183-93.
27. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional 
flow reserve calculated from coronary pressure measurements and exercise-induced 
myocardial ischemia. Circulation 1995;92:39-46.
28. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the 
functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8.
29. Kern MJ. Coronary physiology revisited : practical insights from the cardiac catheterization 
laboratory. Circulation 2000;101:1344-51.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods 
of clinical measurement. Lancet 1986;1:307-10.
205
Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus 
conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina
31. De Bruyne B, Baudhuin T, Melin JA, et al. Coronary flow reserve calculated from pressure 
measurements in humans. Validation with positron emission tomography. Circulation 
1994;89:1013-22.
32. Bartunek J, Marwick TH, Rodrigues AC, et al. Dobutamine-induced wall motion 
abnormalities: correlations with myocardial fractional flow reserve and quantitative 
coronary angiography. J Am Coll Cardiol 1996;27:1429-36.
33. Costa MA, Shoemaker S, Futamatsu H, et al. Quantitative magnetic resonance perfusion 
imaging detects anatomic and physiologic coronary artery disease as measured by 
coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007;50:514-22.
34. Rieber J, Huber A, Erhard I, et al. Cardiac magnetic resonance perfusion imaging for the 
functional assessment of coronary artery disease: a comparison with coronary angiography 
and fractional flow reserve. Eur Heart J 2006;27:1465-71.
35. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention 
of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll 
Cardiol 2007;49:2105-11.
36. Legalery P, Schiele F, Seronde MF, et al. One-year outcome of patients submitted to routine 
fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J 
2005;26:2623-9.
37. Wongpraparut N, Yalamanchili V, Pasnoori V, et al. Thirty-month outcome after fractional 
flow reserve-guided versus conventional multivessel percutaneous coronary intervention. 
Am J Cardiol 2005;96:877-84.
38. Gould KL, Kelley KO, Bolson EL. Experimental validation of quantitative coronary 
arteriography for determining pressure-flow characteristics of coronary stenosis. Circulation 
1982;66:930-7.
39. de Feyter PJ, Serruys PW, Davies MJ, Richardson P, Lubsen J, Oliver MF. Quantitative 
coronary angiography to measure progression and regression of coronary atherosclerosis. 
Value, limitations, and implications for clinical trials. Circulation 1991;84:412-23.
40. Gilard M, Le Gal G, Cornily JC, et al. Midterm prognosis of patients with suspected coronary 
artery disease and normal multislice computed tomographic findings: a prospective 
management outcome study. Arch Intern Med 2007;167:1686-9.
41. Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multidetector coronary computed 
tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 
2007;50:1161-70.
42. Ragosta M, Bishop AH, Lipson LC, et al. Comparison between angiography and fractional 
flow reserve versus single-photon emission computed tomographic myocardial perfusion 
imaging for determining lesion significance in patients with multivessel coronary disease. 
Am J Cardiol 2007;99:896-902.
Chapter 11
206
43. Lima RS, Watson DD, Goode AR, et al. Incremental value of combined perfusion and 
function over perfusion alone by gated SPECT myocardial perfusion imaging for detection 
of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70.
44. Hoffmann MH, Shi H, Schmitz BL, et al. Noninvasive coronary angiography with multislice 
computed tomography. Jama 2005;293:2471-8.
INTERLUDE 3
Combining Non-Invasive Coronary 
Anatomical Imaging with 
Invasive functional Information. 
An unconventional but 
Appropriate Hybrid Approach.
Carlos A.G. Van Mieghem1,2 and Pim J. de Feyter1,2  
From the departments of Cardiology1 and Radiology2, 
Erasmus MC, Rotterdam, the Netherlands
Submitted
Interlude 3
208
aBSTraCT
CT coronary angiography (CTCA) allows accurate non-invasive imaging of the coronary arter-
ies. As illustrated by this case report, the 3-dimensional information provided by this technique 
might be of value to resolve complex coronary anatomy encountered in the cathlab. However, 
the limitations inherent to an anatomical test also apply for CTCA, and bring in the need for 
functional information to ensure adequate patient management. 
 
inTroduCTion
Catheter-based coronary angiography (CCA) is considered the gold-standard technique to 
assess the presence of coronary artery disease. It has become the essential diagnostic tool for 
the interventional cardiologist and cardiac surgeon to decide upon the most optimal revas-
cularization strategy. The catheter-based approach allows an ad-hoc percutaneous coronary 
intervention or the acquirement of additional morphologic or functional information, using 
intravascular ultrasound or measurement of the fractional flow reserve, in case of intermediate 
coronary stenosis. 
The last decade, computed tomography coronary angiography (CTCA) has developed into 
a robust non-invasive alternative providing detailed anatomical information of the coronary 
arteries. Difficult coronary anatomy can easily be resolved due to the 3-dimensional nature of 
the technique. However, for clinical decision making, functional information remains essential 
and complementary in addition to accurate anatomical data.
This report describes a case highlighting the limitations of CCA and documents the advan-
tages of CTCA. Invasively obtained functional information was necessary to reach a correct 
therapeutic decision.
CaSe reporT
A 56-year-old man was referred to undergo aortic valve replacement because of severe symp-
tomatic aortic valve stenosis. Before final acceptance for surgery, all cases are preoperatively 
discussed in our daily heart team conference, which is attended by a cardiac surgeon, inter-
ventional cardiologist and a staff member of general cardiology.  The patient received medical 
treatment for hypercholesterolemia and arterial hypertension. Otherwise he had no significant 
medical history. He recently underwent further investigation in the cardiology service of a 
community hospital because of anginal symptoms. On transthoracic echocardiography a se-
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vere aortic valve stenosis was di-
agnosed based on severe calcifi-
cations of the valve with a mean 
gradient of 60 mmHg. Left ven-
tricular systolic function was nor-
mal.  Invasive coronary angiog-
raphy revealed a left dominant 
coronary system. The right and 
left coronary artery were con-
sidered normal by the referring 
cardiologist (Figure.1). However, 
due to poor contrast opacifica-
tion the left coronary artery was 
difficult to assess. Although the angiographic report did not mention the presence of pressure 
dampening when the left coronary system was cannulated, the absence of backward contrast 
filling into the left sinus of Valsalva, suggested the presence of an ostial left main abnormality. 
To clarify this issue, we performed a dual-source cardiac CT scan with a specific emphasis on 
evaluating the left main coronary artery. The cardiac CT scan revealed a large noncalcified 
plaque at the origin of the left main 
stem causing a narrowing of the 
vessel lumen of at least 50% (Figure. 
2). Because of these findings the 
patient was scheduled again for a 
repeat invasive coronary angiogram 
in combination with measurement 
of the fractional flow reserve across 
the stenosis. Using a 0.014" pres-
sure sensor wire and intravenous 
adenosine (140 mcg/kg/min during 
2 minutes) the obtained fractional 
flow reserve was 0.68, confirming 
the functional severity of the coro-
nary narrowing. Instead of isolated 
cardiac valve surgery with implanta-
tion of a St.Jude mechanical valve 
prosthesis, the patient also received 
a venous jumpgraft to the interme-
diate branch and obtuse marginal 
branch of the circumflex artery and 
Figure 1. Conventional coronary angiogram of the right (A) and left coronary 
artery (B). The left coronary system is difficult to evaluate due to poor contrast 
opacification.
Figure 2. Cardiac CT scan showing a large non-calcified plaque (arrow) 
with accompanying significant lumen narrowing of the left main coronary 
ostium (inset, arrow).  The aortic valve is severely calcified (arrowheads). 
The CT image provides the physician the coordinates of the projection 
(encircled) in which the coronary narrowing is clearly visible, in this case an 
RAO 141 projection with 25 degrees of caudal inclination.
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a left internal mammary graft anastomosis to the left anterior descending artery. He made an 
uneventful recovery and remains symptom-free at one year follow-up.
diSCuSSion 
Currently, CTCA is preferably used as a rule-out-test for the presence of clinically relevant 
coronary artery disease (CAD), generally defined as a coronary stenosis with more than 50% 
diameter obstruction. For the purpose of exclusion of CAD, CTCA is most effective when used 
for symptomatic patients who are at low or intermediate pre-test risk of CAD.1 By contrast, 
patients with typical angina in general are not referred to diagnose CAD, but rather undergo 
the test with the aim to provide information who best to treat medically or by revascularization. 
These patients usually present with an advanced stage of atherosclerosis that is hallmarked by 
calcifications. Severe vessel wall calcifications are the main obstacle for the use of CTCA today 
as it prevents assessment of the integrity of the underlying coronary lumen or leads to overes-
timation of coronary stenosis severity. A major role in the assessment of patients with a high 
pre-test likelihood of CAD is therefore not to be expected. However, CCA has limitations that 
sometimes result in an incomplete assessment of the coronary anatomy. As illustrated by this 
case, CTCA offers a useful alternative especially in patients with complex coronary anatomy.2,3 
The accurate three-dimensional visualization of cardiac structures with CTCA explains the 
phenomenon of so-called “reverse referrals”, i.e. patients who initially underwent a CCA are 
sometimes referred for a CTCA to complement the catheter-based angiographic findings. 
Both CCA and CTCA are anatomical imaging techniques that provide detailed information of 
the location and severity of possible coronary artery stenoses. Quantification of lesion severity 
using quantitative coronary angiography has limited value for predicting the hemodynamic 
impact of a coronary stenosis, especially for an intermediately severe luminal narrowing (ap-
proximately 40% to 70% diameter narrowing).4 Recently, this disconcordance between ana-
tomical based assessment of lesion severity and its functional importance has been reported 
in patients who undergo CTCA.5 The documentation of myocardial ischemia is essential infor-
mation to guide the therapeutic management of patients with anatomically important CAD.6 
It is therefore advisable to clarify the physiological relevance of obstructive CAD on a cardiac 
CT scan by using a combined approach with a functional test. For the patient who is referred 
to the cathlab, invasive measurement of the FFR is the recommended test as it provides func-
tional information about an angiographic stenosis.
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aBSTraCT
Aims
To compare the performance of 64-slice computed tomography coronary angiography (CTCA) 
and invasive coronary angiography (ICA) in the detection and classification (according to the 
Medina  system) of bifurcation lesions (BL).
Methods and results
We studied 323 consecutive patients undergoing 64-slice CTCA prior to ICA. All coronary seg-
ments ≥ 2 mm in diameter were evaluated for the presence of a significant (≥50% diameter 
reduction on quantitative coronary angiography) BL. Evaluation of BL by CTCA included the 
assessment of significant lumen obstruction in both main and side branch vessels. Forty-one 
out of 43 patients (46/48 lesions) with significant BL were identified by CTCA. Excluding 
coronary segments with non-diagnostic image quality (5%), the sensitivity, specificity, positive 
and negative predictive values of CTCA for detecting significant BL was 96, 99, 85 and 99% 
respectively. In 39 of these 41 patients, CTCA assessment was concordant with the Medina 
lesion classification on ICA.
Conclusion
64-slice CTCA allows accurate assessment of complex BL.
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inTroduCTion
Invasive coronary angiography is regarded as the reference standard for the diagnosis of 
significant coronary artery disease and to plan and guide percutaneous coronary intervention 
(PCI). However, coronary angiography has major limitations. Factors such as vessel overlap 
and foreshortening may make it difficult to accurately assess the severity and extent of coro-
nary artery lesions.1 Furthermore, as angiography only visualizes the lumen, it cannot identify 
plaque accumulation related to positive remodeling, a ubiquitous phenomenon at bifurcation 
sites.2 
The high diagnostic accuracy of computed tomography coronary angiography (CTCA) in the 
non-invasive detection of significant coronary artery disease (CAD) is well established.3,4 How-
ever, the potential role of CTCA in the detection and characterisation of coronary bifurcations 
is unclear. CTCA allows 3-dimensional evaluation of both the lumen and the wall of the vessel; 
thus, it has potential to provide a more comprehensive assessment of the complex geometry 
of bifurcation lesions (BLs). The purpose of the present study is to evaluate the diagnostic 
accuracy of CTCA in patients with bifurcation pathology. Furthermore, we provide a detailed 
comparison with conventional angiographic data by categorizing each BL according to a sim-
plified classification system (Medina).5 
meThodS
Patient selection
The study population comprised 323 consecutive patients who underwent 64-slice CTCA, 
within a 2-week period prior to invasive coronary angiography (ICA) between March and De-
cember 2005. In patients with prior PCI or coronary artery bypass graft surgery (CABG), only 
the nonintervened coronary artery segments were included in the analysis. Contra-indications 
for CTCA were: an irregular heart rhythm, inability to breath hold for 15 seconds, renal dys-
function (creatinine clearance < 60 ml/min), and known contrast allergy. The institutional 
ethical review board approved the study protocol, which complied with the declaration of 
Helsinki. All patients gave written informed consent.
MSCT protocol, radiation dose calculation and image reconstruction
Patients with a resting heart rate above 65 beats per minute (bpm) received oral beta-blockers 
(metoprolol 50-100 mg) or a non-dihydropyridine calcium-antagonist (diltiazem 60-120 mg) 
together with 0.5-1 mg lorazepam 1 hour before the scan. An additional IV bolus of metoprolol 
(5-10 mg) was occasionally administered where the heart rate remained above 65 bpm. The 
examination was performed using previously reported methodology.4 In brief, CTCA data were 
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acquired using a 64-slice CT scanner (Sensation 64, Siemens, Germany). A non-enhanced 
calcium-scoring scan was only obtained in patients without previous PCI or CABG using the 
following parameters: collimation 64 x 0.6 mm, tube rotation time 330 ms, table feed 3.8 
mm per rotation, tube current 150 mAs at 120 kV, and prospective x-ray tube modulation. 
Angiographic scan parameters were identical aside from a tube current that ranged between 
850 and 960 mAs without the use of dose pulsing. The effective radiation dose was calculated 
separately for patients with and without previous CABG using dedicated software (ImPACT 
CT Patient Dosimetry Calculator, version 0.99x), as described in the European Guidelines 
on Quality Criteria for Computed Tomography (Available at: http://www.drs.dk/guidelines/ct/ 
quality/index.htm).6
A bolus of 100 ml of contrast (iomeprol, 400 mg iodine/ml, Iomeron®, Bracco, Milan, Italy) 
was administered in all patients. The standard injection rate was 5 ml/sec, but was decreased 
to 4 ml/sec in patients who had previous CABG. We did not use a saline chaser after contrast 
administration. A bolus tracking technique was used to monitor the appearance of contrast 
material in the aortic root cranial to the origin of the left coronary artery. Once the signal in 
the ascending aorta reached a predefined threshold of 100 Hounsfield units, CT data were 
acquired during an inspiratory breath-hold. 
All scans were analyzed off-line using a Leonardo workstation (Siemens Medical Solutions) by 
2 independent observers who were blinded to the results of ICA. Images were reconstructed 
using ECG-gating to obtain optimal, motion free image quality. Datasets were routinely ob-
tained during the mid-to-end diastolic phase (–300, -350, -400,  –450 ms before the next 
R-wave or at 60 to 70% of the R-R interval). Additional reconstruction windows in systole (in 
general at 25% to 35% of the R-R interval) were explored when image quality was suboptimal 
on the standard reconstructions. In 31% of the cases the end-systolic dataset was used for 
image analysis. 
Image quality was evaluated on a per segment basis and classified as good (defined as ab-
sence of any image-degrading artefacts related to motion, calcification, or insufficient contrast 
enhancement), adequate (presence of image-degrading artefacts, but evaluations possible 
with moderate confidence), or poor (presence of image-degrading artefacts and evaluation 
only possible with low confidence). Coronary artery segments with poor image quality were 
judged to be “unevaluable”. 
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CTCA analysis 
All evaluable coronary segments were visu-
ally scored for the presence of significant 
BLs (diameter reduction of ≥50%) by careful 
axial scrolling and using (curved) multiplanar 
reconstructions. A bifurcation lesion was de-
fined as a stenosis that involved the origin of a side branch, equal to or more than 2.0 mm in 
diameter.7 The presence or absence of side branch pathology was determined by evaluating 
the first 10 mm of the side branch for the presence of significant lumen narrowing. Disagree-
ment between observers was resolved by a third observer, and the consensus reading was 
subsequently compared with the ICA.
High-resolution thin slab multiplanar reconstructions (reconstructed slice thickness of 0.75 
mm) were used for assessment of bifurcation angles. The 3 orthogonal planes as provided 
when opening a CT dataset were carefully orientated according to the geometrical orientation 
of the main vessel and side branch at the bifurcation point (Figure 1A). To determine the angle 
of bifurcation, we depicted 2 lines (in the centre of each vessel lumen) along the initial course 
of the distal part of the main branch (MBd) and side branch (SB) using the MPR view in which 
the angulation between the proximal parts of these 2 vessels was maximal (Figure 1B). We 
only used diastolic datasets to measure bifurcation angles. Subsequently, BL with significant 
Figure 1a. Visualization of the circumflex  obtuse marginal 
bifurcation by invasive coronary angiography (a) and volume-
rendered computed tomography coronary angiography (b). 
The three-dimensional representation of the heart, as shown 
in (b), can be obtained by summation of the ‘raw’ axial com-
puted tomography images that have a defined x-y-z dimension. 
The conventional planes that are used for visualization of this 
volume data set are the axial plane (axial), the coronal plane 
(coronal) and the sagittal plane (sagittal).  CX, circumflex cor-
onary artery; LAD, left anterior descending coronary artery; 
OM, obtuse marginal branch. (A full color version of this illus-
tration can be found in the color section).
Figure 1b. Scrolling of axial images provides a quick view of 
the data set to assess crudely the main features of the coronary 
anatomy. To obtain a precise view of the structure of interest, 
in this example the circumflex-obtuse marginal bifurcation, 
the planes of visualization need to be orientated to the geo-
metrical orientation of the coronary structures. As a first step, 
the three conventional image planes are centered at the level 
of the branching point (a-c). The three-dimensional nature of 
the CT data allows to subsequently tilt these image planes in 
any orientation. The resulting multiplanar reconstruction (d) 
precisely shows the relationship of the main vessel with the 
side branch and is used to assess the angle between the initial 
course of distal portion of the main vessel and side branch (in 
this example, 31°). Also shown is a maximum intensity pro-
jection computed tomography image (e) to demonstrate the 
anatomical correlation with the angiographic view. We did 
not use this maximum intensity projection  reconstruction to 
determine bifurcation angles. CX, circumflex coronary artery; 
LAD,  left anterior descending coronary artery; OM, obtuse 
marginal branch. (A full color version of this illustration can be 
found in the color section).
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lumen narrowing were categorized using a recently introduced classification scheme, known 
as the MEDINA bifurcation classification (Figure 2).5 The Medina classification is a simple 
binary system whereby significant lumen narrowing is classified as present (1) or absent (0) 
in the proximal MB, distal MB, and SB. Modification and scrolling of MPR images originating 
from the bifurcation site was used to confirm the exact spatial relation of the lumen obstruc-
tion in relation to the branching point. 
Quantitative coronary angiography 
Coronary angiograms were obtained in multiple projections after intracoronary nitrate ad-
ministration with standard techniques. Two experienced cardiologists blinded to CTCA results 
identified all available coronary segments using a 17-segment modified American Heart As-
Figure 2. Medina binary classification of coronary bifurcation lesions.
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sociation (AHA) classification and classified all coronary segments as < 2 and ≥ 2 mm in 
diameter using validated, automated, edge detection software (CAAS II, Pie Medical, Maas-
tricht, The Netherlands).8 Only segments classified as ≥ 2 mm in reference diameter were 
considered for comparison with CTCA. In the presence of an occluded coronary artery, we 
only assessed the segments that were located proximal to the occlusion. Standard measure-
ments were made for the MB analysis; the proximal border of the SB was depicted manually 
by extending the reference point into the main vessel, as previously reported.9 Significant lu-
men narrowing was defined as a lumen diameter reduction of ≥50% in the MB and/ or SB. 
Identified BLs were subsequently classified according to the Medina classification system.5 All 
measurements, including bifurcation angles, were determined using end-diastolic frames.
Statistical analysis
Continuous variables are presented as mean ± standard deviation and compared by Stu-
dent’s t-test.  A two-sided p-value of <0.05 was considered to be significant. Categorical vari-
ables are presented as counts and percentages. The diagnostic performance of CTCA for the 
detection of significant BL, when compared with quantitative coronary angiography (QCA), 
is presented as sensitivity, specificity, positive and negative predictive value and reported with 
associated 95% confidence intervals based on binomial probabilities. Diagnostic performance 
indices are presented separately for all “evaluable” segments and for the overall population, 
including coronary segments with poor image quality. These “unevaluable” segments were 
classified as having a stenosis on CTCA. Because of potentially interdependent observations, 
i.e. multiple bifurcations in the same patient, an additional measurement of diagnostic ac-
curacy was performed for a random selection of single observations per patient. Statistical 
analysis was performed with SPSS, version 11.5 (SPSS Inc., Chicago, USA).
reSulTS
All 323 patients tolerated the CTCA procedure well and no complications occurred. The aver-
age time required for the cardiac CT examination, including patient preparation for scanning, 
image acquisition and reconstruction of the appropriate datasets was 20 to 25 min. Evalua-
tion of the CT coronary angiogram took on average about 5-10 min; the extra time needed to 
specifically assess the bifurcations was about 5 min. 
Patient characteristics are summarized in Table 1. Mean periscan heart rate was 58 ± 7.2 
bpm. Of the theoretically available 5491 segments, 582 were excluded because the diameter 
was <2 mm and 161 because they were distal to an occluded segment. In addition, 470 
segments were absent on CCA. After exclusion of 189 stented segments and 74 grafted ves-
sels (267 segments), 3822 segments (1218 bifurcations) were available for further analysis. 
Poor image quality was present in 5% (211/ 3822; 88 bifurcations) of coronary segments and 
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was related to a technically inad-
equate scan (breathing artifacts 
or fast or irregular heart rate, 
n=53), severe calcification 
(n=62), cardiac motion artifacts 
(n=58), or insufficient contrast 
enhancement (n=38). The effec-
tive radiation dose was calculated 
as 19 mSv (1.6 mSv for the calci-
um score scan and 17.4 mSv for 
the contrast-enhanced scan) in 
patients without previous CABG 
and 22 mSv in patients with pre-
vious CABG.
Table 2 summarizes the diagnos-
tic accuracy of 64-slice CT com-
pared with QCA for the evaluation 
of coronary bifurcations. A total 
of 1130 evaluable bifurcations 
were available for analysis. Fifty-
four BL in 49 patients were identi-
fied on CTCA. QCA identified 48 
BL in 43 patients. Thus, CTCA in-
correctly classified the severity of 
BL in 10 patients. In 8 patients, a 
significant BL on CTCA was not 
confirmed on ICA; in 6 of these 8 
patients this misclassification was 
related to the presence of calcifi-
cation. In two patients the severity 
of the lesion was underestimated: 
one patient had a calcified lesion 
of the left main/ left anterior de-
scending bifurcation; the second 
had a short lesion of the distal 
right coronary artery-posterolateral branch bifurcation. When the 88 bifurcations with poor 
image quality were arbitrarily scored as having significant lumen narrowing on CTCA, the 
sensitivity and specificity for detection of significant BL was 95% (41/43; 95% CI: 85-99) 
Table 1. Patient characteristics (n= 323).
Categorical data are presented as numbers (%) and continuous data as mean 
values ±SD.
ACS, acute coronary syndrome; CABG, coronary artery bypass graft surgery; 
CAD, coronary artery disease; CTCA, computed tomography coronary an-
giography; CTDIvol , volume computed tomography dose index; MI, myocar-
dial infarction; PCI, percutaneous coronary intervention.
a The estimated radiation dose is higher in bypass patients because of the 
longer scan length.
Characteristic Value
Age 61.3 ± 10.4
Male (%) 72
Body mass index (kg/m2) 27.2 ± 4.3
Clinical presentation
    Stable angina (%) 60
    ACS (%) 14
    Other (%) 26
Current smoker (%) 27
Hypertension (%) 53
Dyslipidemia (%) 81
Diabetes mellitus (%) 16
Creatinin (mg/dl) 0.97 ±0.2
Prior MI (%) 33
Prior PCI (%) 32
Prior CABG (%) 10
Vessel disease (%)
   Non-significant disease 28
   1-vessel disease 38
   2-vessel disease 18
   3-vessel disease 8
   Left main disease 5
   Graft disease 3
Basal heart rate 68.5 ± 10.2
Heart rate during CTCA 58 ± 7.2
CTDIvol no previous CABG (Gy) 70.5 
CTDIvol previous CABG (Gy) 61
Dose estimate (no previous CABG) (mSv)a 19
Dose estimate (previous CABG) (mSv)a 22
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and 95% (266/280; 95% CI: 92-
97) on a “patient-level” and 96% 
(46/48; 95% CI: 86-99) and 92% 
(1074/1170; 95% CI: 90-93) on a 
lesion level (1218 bifurcations).
The angiographic and CTCA 
characteristics of the patients with 
identified BL are shown in Table 
3. Lesions were predominantly 
located in the left main or at the 
left anterior descending / first or 
second diagonal bifurcation. The 
angle between MV and SB dif-
fered significantly when assessed 
by CTCAwhen compared with ICA 
(60 ± 19 versus 51 ± 18° respec-
tively, P<0.0001).
Table 4 describes in detail the le-
sion distribution in coronary bi-
furcations, as assessed by CTCA 
and ICA. In all but 2 patients, the 
bifurcation classification on CTCA 
was concordant with that on ICA 
(agreement between CTCA and 
ICA in 44/46 BLs). In one patient, 
ICA underestimated the severity of 
stenosis in the left main bifurca-
tion and the patient was referred 
Table 2. Diagnostic accuracy of 64-slice CTCA for the detection of significant coronary bifurcation lesions (≥ 50% lumen diameter 
stenosis as defined by quantitative coronary angiography) in evaluable segments.
Values are n (%, with 95 percent confidence interval). CI, confidence interval; CTCA, computed tomography coronary angiogra-
phy; NPV, negative predictive value; PPV, positive predictive value.
evaluable Sensitivity Specificity PPV NPV
Patients (n 
= 317)
317/323 
98%
41/43 
(95%, CI: 85-99)
266/274 
(97%, CI: 94-98)
41/49 
(84%, CI: 71-91)
266/268 
(99%, CI: 97-100)
Bifurcations 
(n = 1149)
1149/1218 
94%
46/48 
(96%, CI: 86-99)
1074/110 
(97%, CI: 96-98)
46/73 
(63%, CI: 52-73)
1074/1076 
(99%, CI: 99-100)
Table 3. Angiographic and computed tomography characteristics of patients 
(n= 41) with bifurcation lesions (n= 46)
CABG, coronary artery bypass graft surgery; CTCA, computed tomography 
coronary angiography; CX, circumflex coronary artery; ICA, invasive coro-
nary angiography; MLD, minimal lumen diameter; OM, obtuse marginal 
branch; PCI, percutaneous coronary intervention; PD, posterior descendens 
coronary artery; PL, posterolateral branch; RCA, right coronary artery; SB, 
side branch.
aAgatston-score.
Variables
Bifurcation lesions (n) 46
Location of bifurcation lesion
   Left main, n (%) 17 (37)
   LAD/ diagonal, n (%) 22 (48)
   CX/ OM, n (%) 6 (13)
   RCA-PD/ RCA-PL, n (%) 1 (2)
Angiographic variables, main branch
   Lesion length (mm) 11.8 ± 6.6
   Reference diameter (mm) 2.82 ± 0.53
   MLD (mm) 1.14 ± 0.49
   % diameter stenosis 59 ± 19
Angiographic variables, side branch
   Lesion length 6.54 ± 4.2
   Reference diameter (mm) 2.34 ± 0.5
   MLD (mm) 1.38 ± 0.64
   % diameter stenosis 41 ± 24
Previous heart rate lowering medication (%) 82
Additional heart rate lowering drugs (%) 58
Angulation by CTCA (degrees) 60 ± 19
Angulation by ICA (degrees)   51 ± 18
Calcium score (mean ± SD)a 704 ± 955
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Table 4. Medina bifurcation classification: comparison of invasive coronary angiography with computed tomography coronary 
angiography.
Medina classification Conventional angiography CTCA
Medina: 1.0.0 n=10 n=10
Medina: 0.1.0 n=8 n=7
Medina 1.1.0: n=1
Medina: 1.1.0 n=8 n=8
Medina: 1.1.1 n=5 n=4
Medina 1.1.0: n=1
Medina: 0.0.1 n=5 n=5
Medina: 1.0.1 n=8 n=8
Medina: 0.1.1 n=2 n=2
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for CABG, based on the CTCA assessment (Figure 3). In the second patient, significant in-
volvement of the ostium of the first diagonal branch was not detected on CTCA and the lesion 
was classified as Medina type 1.1.0 instead of type 1.1.1. 
diSCuSSion
Bifurcation lesions provide a challenge in terms of both assessment and management. Vessel 
overlap, foreshortening, beam attenuation (particularly in obese patients), and underopacifi-
cation may hinder accurate assessment of the anatomy, particularly with respect to the assess-
ment of ostial side branch involvement. Errors in diagnosis may have significant consequences 
for patient management.10 When CABG is the treatment strategy, underestimation of a side 
branch lesion may inadvertently result in the side branch not being grafted. Where PCI is the 
preferred option, accurate anatomic information is crucial in planning the treatment strategy, 
to anticipate plaque shift with resulting lumen compromise.11,12 In this study we demonstrated 
that in selected patients the use of 64 slice-CTCA accurately detected angiographically signifi-
cant BL when compared to ICA, which is in keeping with the diagnostic accuracy of 64-CTCA 
to detect significant non-bifurcation coronary lesions with reported sensitivity values in the 90 
to 95% range.4,13-16
Figure 3. CT coronary angiogram 
and corresponding conventional 
angiogram in a patient presenting 
with unstable angina. The volume-
rendered CT image (A) suggests the 
presence of a significant ostial nar-
rowing (arrow) of the LAD. On ICA 
(B) the stenosis (arrow) was classi-
fied as Medina type 0.1.0. Maximal 
intensity projected (C) and multi-
planar reconstructed (D and E) CT 
images however showed additional 
significant involvement of the distal 
LM (arrow) and thus reclassified the 
lesion as Medina type 1.1.0. 
CX: circumflex coronary artery, 
LAD: left anterior descending coro-
nary artery, LM: left main coronary 
artery. (A full color version of this il-
lustration can be found in the color 
section).
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For the purpose of percutaneous treatment of BL, several BL classifications have been used, 
with the aim to better define treatment strategies.17,18 Such classifications may lead to initial 
treatment involving stenting of both the main and side branches (e.g. crush or culotte tech-
nique) rather than main branch stenting first, followed by provisional balloon angioplasty with 
or without stenting of the side branch. We have demonstrated that 64-slice CTCA accurately 
classified BLs when compared to ICA. Furthermore, the 3-dimensional nature of the data 
provided by CTCA has the potential to allow for evaluation of lesion anatomy without vessel 
overlap or foreshortening and hence allows detailed evaluation of BLs. Calcified BLs remain 
problematic due to blooming artefacts that may lead to overestimation of stenosis severity and 
subsequent misclassification.
The general consensus with regard to the treatment of BLs is that, ideally, the MV only should 
be stented, with provisional stenting of the SB where the ostium is severely compromised.19 
In situations where both branches need to be stented, the interventional approach (i.e. selec-
tion of stenting technique) is determined by the angle between the MV and SB. In our study, 
assessment of the bifurcation angle on CTCA was relatively straightforward. The angle deter-
mined by the 3-dimensional assessment on CTCA differed significantly from that measured on 
ICA. These findings are consistent with the results of a recent study demonstrating that bifur-
cation angles measured by CTCA were more accurate when compared with invasive angiog-
raphy.16  
Current 64-slice CT scanners are sufficiently reliable to exclude the presence of significant 
coronary artery stenoses. CTCA therefore seems most useful for the assessment of symptom-
atic patients who have a low-to-intermediate probability of significant coronary artery steno-
sis. A recent meta-analysis of all major published studies on 16- and 64-slice CT technology, 
showed that in patients with high prevalence of coronary artery disease the specificity of CT is 
still insufficient to allow its implementation as an alternative to ICA.20 ICA should continue to 
be the preferred option in patients with typical angina and/or previously known CAD because 
it allows ad hoc PCI to be performed, where appropriate, and because the high prevalence 
of calcification in this population would hamper accurate assessment by CTCA. In the current 
study, the prevalence of pre-existing CAD was relatively high (50%) and severe calcifications 
were the main reason for uninterpretable coronary artery segments (39%, 62/158 segments) 
after exclusion of the 6 patients (53 segments) who had a technically inadequate CT scan. 
Our preliminary study provides proof of concept for the potential of CTCA to accurately detect 
coronary artery lesions, even in the presence of complex anatomy such as BLs.
Limitations
Although our report concerns a large consecutive series of patients who were scanned prior 
to ICA during a 9-month period, the retrospective nature of the study is a limitation. However, 
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even with a prospectively conducted study it would be difficult to prove the clinical benefit of 
a ‘pre-interventional’ CT evaluation since the optimal approach to PCI for a BL is currently 
unknown.
General limitations of CTCA are the additional contrast load and the considerably higher ra-
diation exposure compared with ICA. However, these drawbacks should be balanced against 
the additional costs and risks of a prolonged angiographic procedure with, in general, the use 
of more contrast, catheters and additional invasive tools such as IVUS for assessment of dif-
ficult lesion subsets such as bifurcations.
In this study we demonstrated the feasibility of CTCA to accurately assess coronary bifurca-
tions for the presence or absence of significant disease and we found CTCA to be more ac-
curate than ICA for the measurement of bifurcation angles. Whether the information provided 
by a CT exam would influence the therapeutic strategy when attempting PCI for a BL remains 
unproven and needs further study.
The results of this study are only applicable to a selected patient population (patients in sinus 
rhythm, who are relatively young, with coronary arteries that do not contain severe calcifica-
tions) and were obtained in a center with experienced investigators. 
Observations (bifurcations) within the same patient are not statistically independent. We re-
calculated the diagnostic accuracy parameters after random selection of a single bifurcation 
per patient. Sensitivity and specificity for detection of significant BLs was respectively 100% 
(10/10; 95% CI, 72 to 100) and 95% (296/313; 95% CI, 91 to 97). Fewer observations re-
sulted in wider confidence intervals. 
 Finally, current studies reporting on the diagnostic accuracy of 64-slice CTCA in general in-
cluded vessels with a reference size up to 1,5 mm. This is a reasonable threshold since smaller 
sized vessels usually do not constitute targets for revascularization. In this study, we limited 
the assessment of BL to branches with a reference diameter ≥ 2mm for two reasons: (i) this 
cut-off value is a generally accepted criterion to define clinically relevant side branches, and 
(ii) current spatial resolution is not sufficient for accurate plaque imaging in vessels with a 
reference size <2 mm. 17,21-24
ConCluSionS
Sixty four-slice CTCA provides an accurate and comprehensive assessment of coronary bifur-
cation pathology in a selected patient population. These preliminary data support the poten-
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tial of CTCA to replace coronary angiography as the preferred diagnostic tool for coronary 
imaging in this setting.
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aBSTraCT
Objectives
We investigated angiographic and computed tomography coronary angiography (CTCA) pre-
dictors of success and measured the amount of the radiation exposure in patients with chronic 
total occlusion (CTO), treated by percutaneous  coronary intervention (PCI).
Background
There is no mention -in current appropriateness criteria for CTCA- of the need of CTCA inves-
tigation prior to an attempt at recanalization of a CTO. 
Methods
Symptomatic patients due to a CTO, suitable for percutaneous treatment were included.
Results
One hundred and thirty nine (142 CTOs) patients were studied. Overall success rate was 
62.7%. By CTCA, the occlusion length was 24.9±18.3 vs. 30.7±20.7mm in successful and 
failure cases (p=0.1), but the frequency of patients with an occlusion length >15 mm was 
different, ie, 63.2% vs. 82.7%, respectively (p=0.02). Severe calcification, (> 50% of the ves-
sel cross sectioneal area) was more prevalent in failure cases (54.7% vs. 35.9%, p=0.03). 
Calcification at the entry of the occlusion was present in 58.5% of the failure cases vs. 41.6% 
of the successful cases (p=0.04), while calcium at the exit was not different.
The length of calcification was 8.5±8.4 vs. 5.5±6.6mm in the failure and successful cases re-
spectively (p=0.027). By multivariable analysis, the only independent predictor of procedural 
success was the absence of severe calcification as defined by CTCA.
The mean effective radiation dose of the PCI was 39.3±30.1mSv. The mean effective radia-
tion dose of the CT scan was 22.4 mSv: 19.2 ± 6.5 mSv for CTCA, 3.2 ± 1.7 mSv for the 
calcium scoring scan.
Conclusion
More severe calcified patterns, as assessed by CTCA, are seen in failure cases. The radiation 
exposure during a CT scan prior to PCI for a CTO is considerable, and further studies are re-
quired to determine whether this extra diagnostic study is warranted.
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inTroduCTion
Since success rate has remained unchanged over the last few years, there has been a de-
crease in the number of attempted percutaneous coronary interventions (PCI) in patients with 
chronic total occlusions (CTO)(1). In the search for new therapeutic approaches to reopen 
the occluded vessel many new CTO-dedicated guidewires and devices have become avail-
able(2). Until recently, innovative imaging tools to provide the operator guidance during the 
most exacting phase of the procedure, i.e. crossing the lesion, have been lacking. Commonly, 
in angiography these lesions appear as missing segments within two vessel ends. In addition, 
the angiogram does not provide reliable  information with regard to the trajectory of the oc-
cluded segment, its length and tissue composition, variables that have been correlated with 
low procedural success rate(3). Computed tomography coronary angiography (CTCA) has 
developed into a reliable noninvasive technique to evaluate a patient for the presence of 
obstructive coronary artery disease(4). Although, preliminary data suggest that CTCA might 
be of beneficial guidance in attempting revascularization of a CTO (5), there is no mention 
-in current appropriateness criteria for CTCA, of the need of a CTCA investigation prior to an 
attempt at recanalization of a CTO. 
To better define the role of CTCA in the treatment of patients with CTOs, we performed CTCA 
in a consecutive cohort of eligible patients who were scheduled for percutaneous recanaliza-
tion of a CTO. We investigated angiographic and computed tomographic predictors of suc-
cess and measured the amount of contrast material used during PCI and CTCA as well as the 
radiation exposure for both techniques.
maTerial and meThodS
Study population
Between April 2002 and March 2007, those eligible for this study included all consecutive pa-
tients presenting with symptomatic coronary artery disease due to a CTO. Specifically, patients 
without contra-indications for CTCA, suitable for percutaneous treatment who had provided 
written informed consent, were included. CTCA was considered contra-indicated in following 
situations: irregular heart rhythm, inability to sustain a sufficiently long breath hold (20 sec-
onds with the 16-slice CT scanner, 15 seconds with the 64-slice or dual-source CT scanner), 
renal dysfunction (creatinine clearance < 60 ml/min as defined with the Cockroft formula)(6), 
hearing disability, and known contrast allergy.
A CTO was defined as either an occlusion on angiography with no antegrade filling of the 
distal vessel other than via collaterals or minimal antegrade flow (TIMI flow 0 or 1)(7,8). All in-
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cluded patients had a native vessel occlusion estimated to be at least of three months duration 
based on either a history of sudden chest pain, a previous acute myocardial infarction in the 
same target vessel territory, or the time between the diagnosis made on coronary angiography 
and PCI. The type of CTO was either de novo or due to in-stent restenosis.
The protocol was approved by the local ethics committee and is in accordance with the prin-
ciples of Good Clinical Practice for Trials of Medicinal Products in the European Community 
and the Declaration of Helsinki. All patients signed a written informed consent.
All the CT scans were discussed between the operator of CTO procedure and someone trained 
to interpreting CTCA prior to the interventional procedure. 
All interventional procedures were performed by operators who were highly experienced in the 
treatment of CTOs, with the interventional strategy left to the discretion of the operator. Wires 
were used in a stepwise progression, starting with a wire that had a relatively less traumatic 
tip (Graphix Intermediate, Boston Scientific Corporation, Miami, Florida) or a hydrophilic wire 
(Choice PT Plus, Boston Scientific Corporation, or Crosswire NT, Terumo Corporation, Tokyo, 
Japan) and progressing to stiffer wires (Miracle, Asahi Intec, Nagoya, Japan) and special-
ized technologies (Safe-Cross, Intraluminal Therapeutics, Carlsbad, New Mexico; The CROS-
SERTM CTO Recanalization System (FlowCardia Inc, CA; Laser Guidewire, Spectranetics, 
Colorado Springs, CO, USA). Detailed description of these devices and explanation of our 
approach to treat CTO patients has been previously reported(2).
Procedural failure was defined as the inability to cross the occlusion with a guidewire. 
All patients were pretreated with 300mg of clopidogrel, which was continued at a dose of 75 
mg/day for 6 months. All patients were advised to maintain aspirin (≥ 80 mg/day) lifelong.
Definitions
Procedural success: defined as successful opening of the chronic occlusion and restoration of 
flow (<50% residual stenosis and TIMI 2-3 flow).
Type of CTO: defined according to two characteristics, location (native vessel vs. graft) and 
quality (de novo or in-stent restenosis).
Occluded length: defined as the non-contrast enhanced segment of the vessel from the proxi-
mal to the distal end of the occlusion in the least foreshortened view on angiography or the 
3-dimensional measurement of the occlusion using a dedicated software program (Circula-
tion®, Siemens, Germany) of the CT workstation (Leonardo).
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Stump morphology: defined as the entry site of the occlusion that has either a tapered-  (cen-
tral or eccentric) or a blunt appearance.
Side branch at the entry site: defined as the presence of any side branch, irrespective of the 
size, within 3 mm proximal to the entry of the occlusion.
Bridging collaterals: presence of multiple small collaterals connecting the proximal and distal 
lumens of the vessel by spanning through or around the occluded segment. This characteristic 
can only be measured by conventional angiography (CA).
Occlusion ends in bifurcation: the presence of a side branch larger than 1.5 mm within 3 mm 
distally to the distal end of the occlusion.
Rentrop classification(9): grading of collateral filling was as follows: 0 = none, 1 = filling of 
side branches only, 2 = partial filling of the epicardial segment, 3 = complete filling of the epi-
cardial segment. This classification only applies for conventional angiography since in CTCA 
the distal part of the vessel is almost always filled with contrast and thus can be regarded as 
Rentrop class 2 or 3.
Figure 1. Assessment of tor-
tuosity by computed tomog-
raphy coronary angiography. 
(a) Angiographic image show-
ing an occlusion (arrow) of the 
right coronary artery (RCA). (b) 
Volume-rendered CT image of 
the RCA, showing the occlusion 
(arrow) distal to the origin of the 
margo acutis. (c) 3-dimensional 
CT angiographic view of the 
coronary vasculature, illustrat-
ing the tortuosity of the vessel 
before the occlusion, with 4 con-
secutive bends. (d) same image 
as panel c but looking at the ves-
sel from posterior; the final bend 
before the start of the occlusion 
is marked (43 degrees). (A full 
color version of this illustration 
can be found in the color sec-
tion).
Chapter 13
234
Calcification: was defined as follows:
- By conventional angiography, defined as mild, moderate or severe.
- By CTCA, the number of separate calcium spots was counted and their length measured. 
The presence of calcium at the entry and exit side of the occlusion was annotated. All the 
spots were evaluated in a cross-sectional view to assess whether the calcification occupied 
more than 50% of the cross-sectional vessel area at any location within the occluded 
vessel segment. Finally, the amount of calcium in the occluded segment was quantified, 
using dedicated software. 
Tortuosity: was defined as the presence of bends proximal to the lesion. By angiography, this 
feature was only scored in a binary fashion (yes/no), i.e. < or > than 45 degrees, while by CT, 
the angle of all the separate vessel bends was measured. (Figure 1). 
Angulation: was defined as the presence of bends within the occluded segment. By angiogra-
phy, only a binary scoring system was used (yes/no), while by CT, the angle was measured in 
subsequent bends within the occlusion. (Figure 2). 
Conventional coronary angiography (CCA)
Two experienced observers who were unaware of the results of the CT scans analyzed each 
film; consensus was needed for each assessed parameter. Quantitative angiographic analysis 
(CAAS II, Pie Medical, Maastricht, The Netherlands) was performed to measure the vessel 
diameter prior to the occlusion side. The length of the occluded vessel segment was also 
quantified. The other variables, i.e. location of the occlusion, morphology of the stump, the 
Figure 2. (a) Assessment of angulation by computed tomography coronary angiography.
Maximal intensity projection of the right coronary artery (RCA) showing the vessel with the entry (arrow) and exit side (arrowhead) 
of the occlusion in one plane. (b) 3-dimensional CT angiographic view, illustrating the angulation within the occlusion; in this case 
2 bends are visible.
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presence of a side branch in the vicinity of the entry (<3 mm), collaterals and calcification 
were reported qualitatively.
Conventional coronary angiography: calculation of effective dose(10). 
The Axiom study reports for each PCI procedure the used projections, the geometrical gantry 
settings and the generator settings for each digital cinematography (DCM), the used fluoros-
copy time and the total dose-area product (DAP). The DAP is measured by an integral device 
in the x-ray tube, placed after the filters and the collimator and takes into account the quality, 
quantity, size and duration of the used x-ray beam.
A PC-based X-ray Monte Carlo program, from the Radiation and Nuclear Safety Agency – 
Helsinki – Finland, PCXMC, (reference Tapiovaara M, Lakkisto M, Servomaa A. A PC-Based 
Monte Carlo Program for calculating Patient Doses in Medical X-Ray Examinations. STUK-
A139. Radiation and Nuclear Safety Agency, Helsinki, 1997) was used to estimate effective 
doses from conventional angiography. We did not correct for each gantry setting. We assumed 
all radiation was given in the Left Anterior Oblique 30 (LAO 30) projection, while the effective 
dose with careful simulation of all used gantry settings during DCM and fluoroscopy differed 
<2%. The focus-skin distance was 65 cm and the estimated entrance field size was 95 cm2 
with a quality of 70 kV.
CT patient selection, scan protocol and image reconstruction
A cardiac CT scan was performed in the fortnight before PCI. During the described study 
period 3 successive scan generations were used in our center. Up to July 2004, CT data were 
acquired using a 16-slice CT scanner (Sensation 16, Siemens, Germany). From August 2004 
to March 2006, CT data were acquired using a 64-slice CT scanner  (Sensation 64, Siemens, 
Germany) and from April 2006 on the latest dual-source CT scanner (Somatom Definition, 
Siemens, Germany) was used. In the period until March 2006 we systematically slowed down 
the heart rate in patients with a heart rate above 65 bpm, using 100 mg metoprolol or a non-
dihydropyridine calcium-antagonist (diltiazem 60-120 mg) orally 1 hour before the scan. An 
additional IV bolus of metoprolol (5-10 mg) was occasionally administered where the heart 
rate remained above 65 bpm. After that period we did not use extra medication to slow down 
the heart rate. Instead, nitrates were systematically given as a sublingual spray (0.4 mg) to all 
patients 5 minutes before initiation of the scan provided the systolic blood pressure was above 
100 mmHg.
Scan parameters for each of the 3 scanner types were the following:
- 16-slice CT scanner: collimation 16 x 0.75 mm, tube rotation time 375 ms, tube voltage 
of 120 kV, table feed 3 mm per rotation. For the non-enhanced scan we used a tube 
current of 150 mAs and applied prospective x-ray tube modulation. For the angiographic 
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scan we used a tube current that ranged between 500 and 600 mAs without the use of 
dose pulsing. 
- 64-slice CT scanner: collimation 64 x 0.6 mm, tube rotation time 330 ms, tube voltage 
of 120 kV, table feed 3.8 mm per rotation. For the non-enhanced scan we used a tube 
current of 150 mAs and applied prospective x-ray tube modulation. For the angiographic 
scan we used a tube current that ranged between 850 and 960 mAs without the use of 
dose pulsing. 
- dual-source CT scanner: collimation 64 x 0.6 mm, tube rotation time 330 ms, tube voltage 
of 120 kV. For the non-enhanced scan we used a tube current of 84 mAs per tube and full 
X-ray tube current was given during 50-70% of the RR interval. For the angiographic scan 
we used a tube current of 412 mAs per tube and limited this amount of tube current to 
25-70% of the RR-interval. Pitch values were adapted to heart rate (minimal pitch value of 
0.2 for slow heart rates, up to a maximal pitch value of 0.45 with higher heart rates).
The contrast-enhanced scan was obtained after the intravenous injection of 70-100 ml of con-
trast material (iomeprol, 400 mg iodine/ml, Iomeron® with the 16- and 64-slice CT scanner 
or iopromide, 370 mg iodine/ml,  Ultravist® with the dual source CT scanner) through a large 
antecubital vein at a flow rate of 4-5 ml/sec, followed by 40ml of saline flush at 4 ml/s. A bolus 
tracking technique was used to monitor the appearance of contrast material in the ascending 
aorta. Once the signal in the ascending aorta reached a predetermined density level of 100 
Hounsfield units, CT acquisition was automatically started during an inspiratory breath hold. 
Images were reconstructed using ECG-gating to obtain optimal, motion free image quality.
The scan data were reconstructed at various phases of the cardiac cycle using medium-to-
smooth (B26f) and sharp (B46f) convolution kernel. Image reconstruction was retrospectively 
gated to the ECG. The position of the reconstructed window within the cardiac cycle was 
individually optimized to minimize motion artifacts. Datasets containing no or minimal mo-
tion artifacts were transferred to a remote workstation (Leonardo workstation, Siemens).  for 
further evaluation.
CT coronary angiography: calculation of effective dose.
The effective radiation dose was calculated from the scan parameters using dedicated soft-
ware (ImPACT CT Patient Dosimetry Calculator, version 0.99x), as described in the European 
Guidelines on Quality Criteria for Computed Tomography (Available at: http://www.drs.dk/
guidelines/ct/ quality/index.htm).
CT data analysis
Two experienced observers independently evaluated the CT data sets on both the original 
axial images and on multiplanar reformatted reconstructions for the presence of an occluded 
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vessel. This initial assessment was per-
formed blinded to the angiographic 
data. Subsequently, the observer was 
provided with the angiographic in-
formation, i.e. the occluded vessel in 
which PCI was performed, without hav-
ing access to the angiographic images. 
After confirmation of the right vessel, 
the further CT analysis was performed 
without knowledge of the angiographic 
characteristics of the occluded vessel. 
In a few occasions, especially in case 
of heavy calcifications of the vessel, an-
giographic information on the start and 
end of the occlusion was provided to al-
low calculation of the occlusion length. 
To measure the length of the occlusion 
on CT we used a dedicated software 
program (Circulation®, Siemens, Ger-
many), which allows creating a central 
lumen line through the vessel. By rotat-
ing the vessel around this line the exact 
entry- and exit point of the occlusion 
can be visualized, thus allowing to mea-
sure the length of the occlussion along 
the 3-dimensional vessel path without 
foreshortening. (Figure 3).
Statistical analysis 
Assumptions for normality were checked by Kolmogorov-Smirnov test and by visual assessment 
of Q-Q plots of residuals. Accordingly, log transformation was performed on the variables with 
skewed distribution. Continuous variables are presented as mean ± 1SD and differences were 
compared using Student t test or Mann Whitney test. Categorical variables are presented as 
counts and percentages and differences were assessed by Fisher exact test or chi-square test, 
as appropriate. A two-sided p value of less than 0.05 indicated statistical significance. 
The following variables were included in the multivariable analysis dataset: baseline char-
acteristics (gender, age, diabetes mellitus, previous myocardial infarction, family history of 
coronary artery disease, smoking, hypertension, hypercholesterolemia, previous PCI and 
Figure 3. Measurement of the length of the occlusion by computed 
tomography coronary angiography. CT images showing an occlusion 
of the left anterior descending coronary artery (LAD). (a) Volume-
rendered image showing the proximal part of the occlusion (arrow). 
(b) Using the Circulation® software the entire coronary tree can be 
extracted from the dataset. The start and end points for the vessel 
to be examined, in this example the LAD, are marked and a cen-
terline through the middle of the vessel is displayed and labeled be-
tween these 2 points. (c) Maximal intensity projection showing the 
approximate length and composition, in this case non-calcified, of 
the occlusion. (d) After defining the centerline of the vessel, features 
of the occlusion such as length and composition can be evaluated. 
The markers Q1a and Q1b set the boundary marker at the beginning 
and end of the occlusion, which in this case measures 14mm. The 
proximal part of the occlusion shows a small amount of calcium (ar-
rowhead).(A full color version of this illustration can be found in the 
color section).
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previous coronary artery bypass surgery, ves-
sel disease and target vessel), conventional 
angiographic characteristics (ostial location, 
stump morphology, presence of bridging col-
laterals, presence of sidebranch at the entry 
of the occlusion, degree of calcification and 
tortuosity (yes/no); and CTCA characteristics 
(ostial location, stump morphology, presence 
of sidebranch at the entry of the occlusion, 
calcification - at entry, at exit, >50% CSA, 
length of the calcification –,  angulation – as 
continuous variable -, tortuosity – as continu-
ous variable- and length of the occlusion – as 
continuous variable). Due to collinearity prob-
lems some variables were removed from the 
model. On the remainder of the variables we 
ran a backward selection procedure.
Statistical analyses were performed with use 
of SAS V8.02.
reSulTS
One hundred and thirty nine (142 CTOs) consecutive patients were enrolled in this prospective 
registry of patients treated for a chronic total occlusion.
The mean age was 60.7±10.8 years, most of the patients being male (87.3%) (Table 1). For 
the majority of the patients (95.1%) this was the first attempt to open the CTO. Most of the 
occlusions were de novo lesions and the most frequently treated coronary artery was the left 
anterior descending (Table 2). Overall success rate was 62.7%.
CTO characteristics by conventional coronary angiography and CTCA 
By conventional coronary angiography, the mean vessel diameter was larger in successful 
procedures (2.9±0.4 vs 2.1±0.7, p=0.02) as compared to procedural failures. Overall the 
length of the occlusion was 16.6±12.8mm and there was no difference in successful vs. un-
successful cases (16.0±12.7 and 18.0±13.4, p=0.5). The presence of a sidebranch at the 
entry was more frequently seen in failure cases (84.9 vs. 69.7%, p=0.03). Conversely, the 
presence of bridging collaterals was more frequently seen in successful cases (59.5 vs. 43.4%, 
Table 1. Baseline characteristics, n=139
SD, standard deviation; CHD, cardiovascular heart disease; 
ACS, acute coronary syndrome; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass graft.
Age, yrs (mean+1SD) 60.7±10.8
Male (%) 87.3
Diabetes mellitus (%) 13.4
Hypertension (%) 40.1
Family history of CHD (%) 33.8
Current smoking (%) 23.9
Hypercholesterolemia (%) 50.0
Previous ACS (%) 40.8
Previous PCI (%) 20.4
Previous CABG (%) 7.7
Vessel disease (%)
One vessel disease 51.4
Two vessel disease 31.7
Three vessel disease 16.9
Attempts to reopen the CTO (%)
First 95.1
Second 4.9
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Table 2. Morphologic CTO characteristics, n=142 leasions
Total failure, 
n=53
Success, 
n=89
p value 
Conventional Angiography characteristics
Type of CTO (%)
De novo 94.4 92.5 95.5 0.6
Target vessel (%) 0.5
Left anterior descending  42.3 50.9 37.1  
Left circumflex 13.4 11.3 15.7  
Right coronary artery 42.3 35.9 46.1  
Occluded length (mean±1SD) 16.6±12.8 18.0+13.4 16.0+12.7 0.5
Ostial location (Y/N) (%) 17.8 20.8 15.7 0.4
Stump morphology (%) 0.8
Central 28.2 28.3 28.1  
Eccentric 26.1 24.5 34.8  
Blunt 37.3 41.5 34.8  
Side branch at entry (Y/N) (%) 75.4 84.9 69.7 0.03
Bridging collaterals (Y/N) (%) 53.5 43.4 59.5 0.04
Collateral filling [Rentrop Classification (%)] 0.45
0/1 21.5 22.7 13.5  
2 31.0 30.1 31.5  
3 42.3 37.7 44.9  
Angiographic calcification (%) 0.05
None/mild 40.1 39.6 40.4  
Moderate 32.4 22.6 38.5  
Severe 19.7 28.3 14.6  
Tortuosity (>45), (%) 45.8 43.4 47.2 0.58
Occlusion ends in bifurcation (Y/N) 23.2 17.0 27.0 0.18
  
Computed tomography angiographic characteristics
Occluded length (mean±1SD) 27.1±19.4 30.7+20.7 24.9+18.3 0.1
Ostial location (Y/N) (%) 14.8 15.0 14.6 0.9
Stump morphology (%) 0.28
Central 16.4 17.0 15.7  
Eccentric 22.1 15.1 25.8  
Blunt 61.4 67.9 56.2  
Side branch at entry (Y/N) 42.3 43.4 41.6 0.8
Collateral filling [Rentrop Classification (%)]  
0/1  
2  
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p=0.04). Severe calcification, as defined qualitatively, was more prevalent in failure cases 
(28.3 vs. 14.6%, p=0.05). (Table 2)
By CTCA, the occlusion length was widely dispersed, mean 27.1±19.4mm (range 2.6 to 93.4 
mm) and longer as compared with CA.  Although the occlusion length did not differ in suc-
cessful as compared to failure cases (24.9±18.3 and 30.7±20.7, p=0.1), the frequency of 
patients with an occlusion length >15 mm was significantly different, i.e. 63.2% in those with 
procedural success vs. 82.7% in those with procedural failure (p=0.02).
CTOs without calcification were present in 27.5% of the treated lesions. The presence of 
severe calcification, defined as calcium that occupies more than 50% of the vessel cross-
sectional area, was more prevalent in failure cases (54.7%) as compared to patients with a 
successful PCI procedure (35.9%) (p=0.03). The length of the calcified segments was longer 
in failure cases as compared to success cases (8.5±8.4 vs. 5.5±6.6mm, p=0.027).
3 100 100 100 1
Number of spots of calcium (%) 0.69
No 27.5 22.6 30.3  
One spot 43.0 46.2 40.4  
Two spot 19.0 18.9 19.1  
Three o more 10.5 11.3 10.1  
Calcium at the entry (%) 52.1 58.5 41.6 0.04
Calcium at the exit (%) 35.9 39.6 33.7 0.6
Calcium >50% CSA (Y/N) (%) 43.0 54.7 35.9 0.03
Calcium score of the occluded segment
 Volume (mm3) 123.6±323.8 142.5±224.4 112.0±373.7 0.7
 Equivalent mass (g) 25.0±81.0 24.5±33.4 25.4±100.1 0.9
 Score (Agatston) 139.0±411.5 142.6±258.1 136.9±484.9 0.9
Tortuosity (%) 0.8
No 8.5 11.3 6.7  
One bend 43.3 41.5 43.8  
Two bends 31.2 26.4 33.7  
Three o more bends 12.8 15 11.2  
Angulation (%) 0.04
No 65.2 53.8 72.1  
One bend 29.7 40.4 23.3  
Two bends 1.4 0 2.3  
Three o more bends 3.6 5.7 2.3  
CTO, chronic total occlusion; CSA, cross-sectional area.
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When calcifications were present in the CTO, it was especially located at the entry side of the 
occlusion. Interestingly,  calcification at the entry of the occlusion was present in 58.5% of the 
failure cases as compared to 41.6% of the successful cases (p=0.04), while the frequency of 
calcium at the exit was not different between the two patient groups. The absence of angu-
lation in the occlusion was also a predictor of favourable outcome: procedural success was 
72.1% in CTOs without angulation as compared to 53.8% in angulated CTOs (p=0.04) (Table 
2).
 
Of note, the calcification patterns are affected by age but similar between genders (data not 
shown). Patients with severe calcification (>50% VCSA) were older than their counterparts 
(63.9±9.0 vs. 58.3±11.4, p=0.002). Patients with longer calcification segments (cut-off set 
on >4.3mm – median of the length of calcified segments in this population) were also older 
(63.4±9.7 vs. 55.8±11.2, p=0.005). Patients with calcification at the entry of the occlusion 
segment were 61.4±10.2 vs. 55.4±10.6 year old, p=0.0007, and also patients with calcifica-
tion at the exit were older 62.6±9.5 vs. 55.9±10.7 year old, p<0.0001.
In table 3, a comparison between CCA and CTCA for the detection of calcium in the occlusion 
is shown. Conventional CA appears to be imprecise when assessing the presence and amount 
of calcium within the occlusion since the qualitative angiographic score did not correlate with 
the different CT calcium score indices (i.e. volumetric score, equivalent mass or Agatston 
calcium score).
Table 3. Comparison between CT calcium score and angiographic calcification score
CTCA, computed tomography coronary angiography; SD, standard deviation; Min, minimum; Max, maximum
CTCA calcium scoring Angiographic scoring Mean SD Min Max
Volume (mm3) None or mild 69.7 ±103.1 1.9 462
 moderate 207.7 ±546.0 3.3 2712.5
 Severe 122.9 ±123.5 7.5 578
 p value 0.3  
Equivalent mass (g) None or mild 12.6 ±16.6 0 60.16
 moderate 39.5 ±138.1 0 726.95
 Severe 31.7 ±40.2 1.64 179.5
 p value 0.4  
Agatston score None or mild 70.3 ±97.5 0.8 371.2
 moderate 263.1 ±707.7 1.1 3515.8
 Severe 111.2 ±63.9 8.5 223.4
 p value 0.2  
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In the multivariable analysis the only variable that 
remained a significant predictor of procedural 
success, was the absence of severe calcification, 
i.e. calcium occupying >50% of the vessel CSA, 
as defined by CTCA (table 4 and figure 4). 
Procedure related characteristics and effective radiation dose (Table 5)
Overall, the mean amount of contrast used was 455.4 ± 202 ml and was not different be-
tween the patient treatment groups. The fluoroscopic time was higher in the failure cases 
as compared to the successful cases, 72.5 versus 53.1 minutes respectively, p=0.007. The 
mean effective radiation dose of the PCI procedure was 39.3±30.1mSv. The mean effective 
radiation dose of the preprocedural CT scan was 22.4 mSv: 19.2±6.5 mSv for the contrast-
enhanced scan, 3.2±1.7 mSv for the calcium scoring scan. The mean effective radiation dose 
per scanner type was: 14.4±5.7mSv for 16-slice CTCA (n= 34 patients), 20.1±1.6 mSv for 
64-slice CTCA (n=42 patients) and 21.8±6.5 mSv for dual-source CTCA (n= 63 patients).
Table 4. Angiographic and tomographic predictors of success: multivariate analysis
CCA, conventional coronary angiography; CI, confidence interval; CTCA, computed 
tomography coronary angiography; OR, odds ratio; PCI, percutaneous coronary intervention; 
VCSA, vessel cross sectional area. 
Figure 4.  Assessment of calfication by computed tomography coro-
nary angiography. Failed percutaneous coronary intervention in a 
patient with a chronic total occlusion of the left anterior descending 
coronary artery (LAD). (a) The angiographic borders of the occlusion 
are marked by arrows. (b) Final angiographic image showing persis-
tent occlusion of the LAD. Insets show the wiring through the occlu-
sion (inset 1) that appears to be in the false lumen as illustrated by the 
presence of contrast extravasation (arrows) once the wire is removed. 
(c) The volume-rendered CT image clearly shows heavy calcifications 
within the occluded segment (arrowheads). (d) Curved multiplanar re-
construction again highlighting the large calcifications (arrowheads) 
within the occlusion. D1, first diagonal branch. S1, septal branch. (A 
full color version of this illustration can be found in the color section).
Coefficient OR 95% CIs p value
Previous PCI -1.6 0.2 0.034 1.215 0.08
Side branch at the entry (CCA) -1.9 0.15 0.02 1.184 0.07
Tortuosity (CTCA) -0.01 0.99 0.969 1.002 0.09
Calcification >50% VCSA (CTCA) -1.8 0.17 0.036 0.747 0.02
243
Computed tomography in total coronary occlusions (CTTO registry): radiation 
exposure and predictors of successful percutaneous intervention
diSCuSSion
In this registry of 139 patients we evaluated the possible role of CTCA when attempting PCI 
of CTOs. We found that the distribution rather than the amount of calcium impacts on the 
procedural outcome of this particular group of patients. Not unexpectedly, CTCA was more 
accurate than CCA for defining the morphological features of CTOs. In particular, we found 
that the assessment of calcification by CTCA was more predictive of success than CCA in the 
multivariate model. It is difficult to prove the added value of a preprocedural CT scan in terms 
of procedural outcome. However, it is fair to say that a better understanding of the anatomical 
features of an occluded vessel can modify our intentional treatment strategy (11). Dedicated 
CTO wires and new treatment strategies have been developed recently and appear to be use-
ful in selected cases (12). However, these new tools need to be used judiciously and in our 
view in the right anatomical context. A promising new strategy to treat CTOs, is the retrograde 
approach which has been introduced as an alternative route for recanalization of otherwise 
difficult or impossible lesions and is gaining acceptance among interventionalists due to its 
high success rate (13). A possible explanation is the fact that calcium is more prevalent at the 
entry of the occlusion, so a higher chance to cross/break the distal cap and make progress 
retrograde would encourage the operator to continue until success is achieved (figures 5a and 
5b). Our data corroborate what intuitively was written in the consensus document from the Eu-
roCTO club (14): “the distal fibrous cap is often less resistant than the proximal cap”. Another 
Table 5. Procedure related characteristics and radiation parameters, n=142 lesions
Total failure, n=53 Success, n=89 p value 
Number of stents in the target vessel 1.8±1.4 0.7±0.9 2.9±1.3 <0.001
Average target vessel stent length (mm) 23.2±5.2 19.9±6.1 24.4±4.6 0.002
Average target vessel stent 
diameter (mm)
3.0±0.5 3.3±0.6 3.1±0.7 0.46
Biplane use (%) 70.8 76.6 68.8 0.4
Contrast used (ml) 455.4±201.9 457.8±214.7 454.2±195.8 0.93
Procedure time (min) 132.2±57.3 143.9±60.3 125.3±54.7 0.06
Fluoroscopic time (min) 60.3±40.1 72.5±41.9 53.1±37.5 0.007
Dose area product PCI (cGy*cm2) 16171.6±11539.0 17598±13765 15240±9814 0.3
Effective dose PCI (mSv) 39.26±30.1 42.5±36.5 37.1±25.1 0.34
Calcium scoring ctdi 10.5±5.1 10.1±5.8 10.7±4.8 0.6
Calcium scoring dlp 159.6±80.3 153.9±88.1 162.7±76.2 0.6
Effective dose calcium scoring (mSv) 3.2±1.7 3.1±1.8 3.3±1.6 0.5
CT ctdi 62.9±18.6 64.1±20.7 62.4±17.4 0.6
CT dlp 938.0±316.6 977.7±335.9 917.6±305.3 0.3
Effective dose CT (mSv) 19.2±6.5 20±7.1 18.8±6.2 0.3
CT, computed tomography; ctdi, computed tomography dose index; dlp, dose length index; mSv, milliesievert;
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anatomical factor that favors the retrograde approach is the presence of a sidebranch at the 
entry side of the occlusion that in our series was related to failure cases (figures 5a and 5b).
The location of calcification is not only a strong determinant for crossing the lesion with 
the guidewire, but also influences the balloon selection. In severely calcified lesions small 
diameter balloons, ie, 1.0, 1.1 and 1.25 mm, with a lubricious coating and acceptable shaft 
pushability are usually required (14). Calcification of the coronary arteries has been related to 
age in several publications (15,16). In our study, CTOs with longer and more severe calcified 
patterns were present in older patients. Also the mean age of patients with calcifications at the 
entry and exit sides of the occlusion was significantly higher.
Undoubtedly, this is a high-risk subset of patients in different aspects and the decision to 
choose for a percutaneous intervention should envisage a maximal chance of success at a 
minimal patient risk. The amount of contrast used and the radiation dose a patient receives 
are important variables that have an impact on patient’s safety. The contrast load during a 
CTO recanalization attempt is higher as compared to non-CTO procedures (17,18). In this 
study, the average amount of contrast used was 455.4 ml. In addition, a PCI of a CTO is 
Figure 5a. (a) Retrograde approach. Angiographic image, 
showing proximal occlusion (arrowhead) of the right coro-
nary artery (RCA). (b)  Angiographic image of the left coro-
nary artery, showing a large septal branch (arrowheads). (c) 
Corresponding CT image of the RCA showing 2 consecutive 
non-calcified occlusions of the vessel. (d) Corresponding CT 
image of the left coronary artery, also showing the large septal 
branch.
Figure 5b. Retrograde approach. Same patient as in 5a. Il-
lustration of the percuteneous retrograde technique. (a)  3-di-
mensional CT angiographic view, showing he occlusion of the 
RCA (arrow) and the large septal branch (arrowhead). (b) Wir-
ing of the septal branch (arrowhead). (c) The wire is introduced 
through the guiding catheter that is engaged in the left coro-
nary artery (arrow) and was successfully advanced through the 
septal branch and finally retrograde through the RCA ending 
into the ascending aorta (arrowheads). (d) Balloon
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often characterized by a long procedural time and a high radiation dose. Usually during the 
procedure one view is maintained, or two orthogonal views in case of biplane use, which leads 
to an intense exposition of the same skin areas (10) and body segments (14). The average 
radiation dose of a PCI procedure in this study was 39.26 mSv. This is 8 times higher than the 
dose received during a CCA(20). In addition, patients received a mean radiation dose during 
the preprocedural cardiac CT scan of 22.4 mSv.
Clinical implications
In experienced centres the success rate of a percutaneous CTO recanalization attempt is on 
average 70% (8,14). Knowing beforehand in which patients the chances of success are rea-
sonably high appears to be worthwhile, as it has been shown that a failed recanalization is 
associated with a worse outcome and a higher rate of major cardiac events (21). The current 
study shows that CTCA is more precise than CCA for assessing the anatomical features of a 
CTO. At the cost of a significant additional amount of contrast and radiation, it would not 
be reasonable to propose a cardiac CT scan before each PCI attempt of a CTO. Instead, a 
cardiac CT scan seems most useful in patients in whom the angiographic features look unfa-
vourable or in patients in whom a second PCI attempt is contemplated. The decision whether 
or not to perform a contrast-enhanced scan after the calcium scoring scan depends on the 
information one wants to obtain: if the question is to have an idea of the amount of calcium 
in the occluded segment, a calcium scoring scan might be sufficient considering the fact that 
most of the radiation exposure derives from the contrast-enhanced scan. Pursuing a “com-
plete scan”, including the administration of contrast, might be preferred in case of a suspected 
long occlusion where one aims to obtain information on the 3-dimensional course of the oc-
clusion, including the distribution of calcium. In addition, the contrast- and radiation exposure 
of the patient should become less of an issue in the near future: new scanning protocols are 
dramatically reducing the radiation dose of a contrast-enhanced scan to less than 3mSv (22) 
and scheduling the cardiac CT scan at least a few days before the PCI would not increase the 
risk of contrast nephropathy. 
The radiation from a PCI is considerable, but necessary to do the procedure. Good arguments 
are needed before embarking on a percutaneous recanalization attempt and this decision 
process in general should incorporate the symptomatic status of the patient, documentation 
of myocardial ischemia and if possible data with regard to the pre-procedural chances of 
success. The latter argument would be in favour of performing a cardiac CT scan in selected 
cases: patients in whom the CT characteristics of a CTO are unfavourable for PCI might be 
considered for an alternative therapeutic modality, i.e. medical treatment or bypass surgery.
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Limitations of the study
Despite the fact that we failed to provide with accurate data for occlusion duration, which is 
an important marker of procedure failure (5), we performed a detailed and selective quan-
tification of the calcium present in the occluded segment, for which occlusion duration is a 
surrogate marker as shown in a pathological study where fibrocalcific plaque increased with 
CTO age (p = 0.008) (23). 
Although all the CTCA scans were discussed between the operator and someone trained to 
interpreting CTCA prior to the interventional procedure, there was no formal documentation 
of the changes in approach for treating the CTO in light of the CTCA findings. Thus, it was dif-
ficult to measure to what extent this knowledge on the CTO characteristics by CTCA impacts 
on the success rate. In order words, a severely calcified and long lesion might have discour-
aged the operator from a longer attempt.
In case of severe calcifications of the vessel, we relied on angiographic data to determine 
the length of the occlusion by CTCA. Although a limitation in this study, the repercussion 
in clinical practice would be minor as the angiographic data are an essential component of 
the therapeutic decision process for a given patient. As mentioned in the discussion part, we 
would only recommend a cardiac CT scan in selected cases to complement the angiographic 
information. 
ConCluSion
Evaluation of CTOs by means of CTCA offers a better description of its anatomical features as 
compared to conventional angiography and predicts procedural success in patients referred 
for PCI. More specifically, the presence of severe calcification, ie, calcium occupying >50% 
of the VCSA, as determined by CTCA is an independent predictor of procedural failure. The 
radiation exposure and amount of contrast used during a PCI attempt is considerable. The 
judicious use of a preprocedural cardiac CT scan makes sense and might modify the approach 
in case PCI is attempted or could drive the physician’s preference to an alternative therapeutic 
modality, ie, medical treatment or bypass surgery. 
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A 50-year-old man with increasing anginal complaints was referred for percutaneous coro-
nary intervention (PCI) of an occluded right coronary artery (RCA) (panel A, white arrows 
show distal filling of the vessels through collaterals from the left coronary artery). He had 
had an inferior myocardial infarction in 1998 and two previous attempts to open the RCA 
percutaneously had been unsuccessful. To appreciate fully the length and composition of the 
occlusion a preprocedural 64-slice CT coronary angiogram was performed. This showed a 
long occlusion (panel E, 82.4mm) up to the crux of the RCA (panel C, arrow), which mainly 
consisted of non-calcified tissue, except for the entry point that disclosed a dense but relatively 
short rim of calcium (panels B and C, arrowhead). With this information, we used a different 
strategic approach: after ablation of the calcified initial part of the occlusion using a therapeu-
tic ultrasound device, we were easily able to cross the remainder of the lesion with a conven-
tional guidewire and revascularise the vessel using three overlapping drug-eluting stents. The 
angiographic result at 6 months’ follow-up remained perfect (panel D).
Chronic total occlusions are a common reason for referral to bypass surgery because of the 
relatively high failure rates when attempting a PCI. Unlike conventional coronary angiography, 
cardiac multislice CT provides an accurate assessment of the length and composition of the 
occluded segment, which are important predictors of procedural success. Preprocedural mul-
tislice CT guidance therefore has potential to identify which patients are most likely to benefit 
from attempted PCI. 
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(A full color version of this illustration can be found in the color section).
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aBSTraCT
Magnetic navigation is the use of adjustable magnetic fields to precisely direct wires and 
equipment for clinical applications. It is a recently developed option that is now available for 
Interventional Cardiology. Procedures are based on the production of a three-dimensional 
reconstruction of the vessel lumen from standard angiographic images. Knowledge of the 
positions of the table and image intensifier during angiography allows calculation of the ves-
sel coordinates in real space within the patient’s chest. The applied magnetic field can be 
changed at any time to redirect the wire tip in order to improve navigation through complex 
and tortuous anatomy.
The digital information of the coronary reconstruction can be used in further novel ways. 
Firstly, the integration of multi-slice computerised tomography images adds information about 
the path of the previous lumen of chronic total occlusions. Secondly, the computed center-line 
of the reconstructed vessel can be superimposed onto the live fluoroscopy images as a three-
dimensional guide. The combination of improved navigation together with the other available 
system features may improve time, contrast, and material usage in a range of coronary le-
sions. Future potential developments include improvements in equipment and software and 
potential therapeutic strategies under consideration include the use of equipment to perform 
remote control procedures, and the integration of the system to improve bone-marrow derived 
stem cell delivery.
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inTroduCTion 
The field of interventional cardiology has been characterized by the rapid introduction and 
uptake of new treatments and devices such as stents,1 clopidogrel,2 drug eluting stents,3 biva-
lirudin,4 and new guidewire technology. These new technologies have driven the continuously 
increasing total number of percutaneous coronary interventions (PCI).5 
A recent promising development is the use of a magnetic navigation system (MNS) to steer a 
guidewire through coronary arteries. This technology is already accepted for the performance 
of electrophysiological studies6–9 and has tested favorably in neurosurgery both in animal 
models10 and in humans.11 Interventional coronary procedures present more of a moving 
target when compared with neurosurgery and requires smaller magnets when compared with 
electrophysiology. The combination of smaller wire tip magnets together with new software 
and imaging features has made the MNS available as a new platform for PCI. 
Magnetic navigation allows a magnetically enabled wire tip to be pointed in any orientation. 
This allows the adjustment and readjustment of the direction of the wire tip in vivo whenever 
needed. In addition, the system produces three-dimensional images, integrates information 
with multislice computerized tomography (MSCT), and is able to use this three-dimensional 
information superimposed on live fluoroscopy. The potential areas where such a system pro-
vides new options include challenging and tortuous anatomy, chronic total occlusions (CTOs), 
reduction in time, contrast and materials, and remote control PCI. This article reviews a brief 
history of magnetic procedures, the current status, some future possibilities, and some limita-
tions within the area of non-electrophysiological cardiac interventions.
The SySTem
The magnetic navigation system (Niobe®, Stereotaxis, St Louis, Missouri) has been developed 
for use with digital coronary angiography. The system consists of two permanent magnets, 
mounted on mechanical positioners, on either side of the fluoroscopy table (see Fig. 1). These 
magnets produce an interacting magnetic field to produce an approximately spherical 15 cm 
uniform magnetic field of 0.8 T. The magnets move along three different coordinates and 
rotate about the z axis, move toward or away from the navigation volume along he z axis, 
and tilt about an axis located just behind the magnet. This allows the direction of the applied 
magnetic field vector to be orientated in 360° in all planes. The three-dimensional location of 
the X-ray image is known from the positions of the image intensifier, angiography system, and 
table. A three-dimensional reconstruction is created from the angiographic images using dedi-
cated reconstruction software (CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel). This 
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reconstruction is used by the MNS to give three-dimensional coordinates that are localized 
in real space (within the Figure 1. Magnetic navigation system is shown with the magnets in 
position on either side of the patient. chest in a patient during a procedure). This provides two 
new abilities. Firstly, the three-dimensional model allows the computation of the orientations 
of the magnetic field needed for alignment with the center-line at every point of the virtual 
coronary artery. Secondly, the three-dimensional coordinates are known in real space and this 
provides the data for the MNS to change the magnetic field vector, and therefore the resulting 
magnetic moment on the wire tip, at every location in the vessel.
The magnetic moment is equal to the product of the strength of the applied magnetic field, 
the crosssectional area of the tip magnet, and the sine of the angle of the magnet direction 
relative to the applied magnetic field. The result is control of the direction of the wire tip, in 
vivo, without the need for a preshaped wire tip angle.
There is a recently introduced and broadened range of dedicated, magnetically enabled wires 
(TitanTM series) for PCI available for use with the MNS.
Figure 1. Magnetic navigation system is shown with the magnets in position on either side of the patient.
257
Magnetic Navigation in Percutaneous Coronary Intervention
hiSTory
The use of magnets to control an intravascular catheter was first reported in 195112 while the 
first human use was a neonatal heart catheterization in 1991 for the diagnosis of anomalous 
congenital cardiac drainage.13 The current MNS has been developed over the past 15 years. 
Previous systems were only suitable for relatively large vessels because of the size of the cath-
eter magnets required. The current system now has tiny magnets (≤0.014) and is the most 
widely used. This system received regulatory approval for human clinical use in cardiac elec-
trophysiology and interventional neuroradiology in 2000, and for interventional cardiology in 
2003. It has been shown to be feasible in neurosurgery10,11 and is a well-accepted technique 
in electrophysiology.6–9
CurrenT STaTuS
Navigation. The core feature of the system is the ability to alter the direction of the wire tip 
within a patient during a procedure to give improved wire tip control compared to conven-
tional procedures. First, the ability to precisely direct the wire tip means that the wire can be 
redirected and readjusted throughout the procedure to configurations that exactly suit the 
angulations and direction of the vessel, or alternatively used in a precisely defined probing pat-
tern to interrogate the vessel ahead. This ability is not affected by friction on the shaft of the 
wire that can impair manipulation in tortuous vessels. Second, it overcomes the problem of a 
conventional tip that can become damaged and misshapen during a procedure and so impair 
manipulation. Finally, the passage of the wire is guided by the magnetic vector rather then 
rotational manipulation and this may reduce wire entanglement. This problem sometimes oc-
curs in bifurcation procedures where wires can become intertwined with manual manipulation 
and prevent passage of materials. These abilities mean that the lesion can be approached, 
and navigated through, with a straight tip. A straight tip may reduce the chance of the wire tip 
impacting against the vessel wall or unintentionally navigating into sidebranches. 
Figure 2. This shows the three-
dimensional reconstruction in 
the left panel and the endolu-
minal view of the LAD/diagonal 
bifurcation in the right panel. 
Note that these are live, mov-
ing, real-time images during a 
procedure.
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A major goal in the development of this system has been to enable the successful passage 
of the wire through vessels that prove challenging to conventional guidewires. In this context, 
two situations are particularly relevant. Firstly tortuous and/or heavily calcified vessels where 
a conventional guidewire loses manipulability as described above. Secondly, CTOs where the 
path of the vessel is not visible and the required tip direction is unclear.
Difficult Anatomy. This technology has been examined in a number of different situations 
with regards to difficult lesions. Passage of a wire to distal segments of in vitro phantoms was 
not only successful but, in addition, fluoroscopy times were found to be significantly reduced.14 
This potentially reduces radiation exposure both to patients and personnel. The system has 
been shown to be feasible for PCI in vivo15,16 and furthermore, both of these studies showed 
that the magnetically enabled wire was capable of crossing lesions where a conventional 
wire had failed. In addition to normal PCI, MNS can support other specialist specialist in-
tracoronary procedures such as percutaneous alcohol septal ablation.17 These navigational 
advantages are enhanced by a range of imaging possibilities including the three-dimensional 
lumenogram, the bullseye view, and the endoluminal view (see Figs. 2 and 5). In addition, the 
MNS has dedicated ranges of magnetically enabled guide wires (the TitanTM and Cronus R 
ranges) that vary in stiffness, magnet length, and tip angulation to tailor the system to each 
individual coronary artery. These 0.014 wires are entirely compatible with all current stan-
dard PCI equipment and standard access sites, both radial and femoral. The combination of 
precise navigation, together with the additional imaging options available, may reduce time, 
contrast, fluoroscopy, and material use.
Figure 3. The left panel shows 64 slice cardiac MSCT with vessels, a tissue attenuation line is seen in the RCA after the RV branch. 
The right panel shows a post-processed image of the vessel that more clearly shows the 30 mm occlusion.
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CTOs and MSCT Integration. A second lesion type that continues to be vexing is the CTO. 
Success rates for PCI of CTOs are around 65% to 80%, depending on the technique used and 
presence of other diseases such as diabetes.18–21 A number of strategies have been suggested 
to facilitate the treatment of CTOs, e.g., in tracoronary thrombolytic infusion,22 the use of 
tapered-tip guidewires,20 imaging with (16 slice) MSCT,23 and the use of a laser guidewire.24 
The ability to precisely steer and change the orientation of the wire tip may be crucially impor-
tant in avoiding wire exit, and may hold a major advantage in comparison with a conventional 
Figure 4. The fluoroscopy im-
age is marked on the system 
with dots ready for three-di-
mensional integration in the left 
panel with the MSCT marked 
with dots for integration in the 
right panel. These give the spe-
cific three-dimensional coordi-
nates that allow integration of 
the two modalities (see Fig. 5).
Figure 5. The Stereotaxis screen is shown with the integrated MSCT image and reconstruction made. In the upper panels the green 
dots indicate where attenuated tissue of previous vessel was seen on the MSCT, while the lower panels show fluoroscopy images 
with a superimposed three-dimensional reconstruction that follows the path identified by the MSCT. 
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wire that has afixed, unchangeable angulation. However, with regard to CTOs, the MNS has 
a further major advantage as it can also integrate 64 slice MSCT images (see Figs. 3–5). This 
imaging technique can identify both a distal vessel that is filled via collaterals and also show a 
tissue attenuation line (the scarred tissue of the original vessel lumen). This imaging allows a 
path to be visualized and then synchronized with the MNS (see Figs. 3–5) to direct the wire tip 
along the previous vessel lumen (or at least the scar tissue) to the distal vessel. These features 
have helped the success of the MNS in the initial experience of CTO procedures.25
FuTure developmenTS 
The MNS is a flexible system and, as well as improvements in the areas described above, it 
can be expected that the current capabilities will be extended and further potential strate-
gies will be discovered. This system is a platform that adds new abilities to conventional PCI. 
Some possibilities in both strategy and equipment currently under consideration are described 
below. 
Newer and Improved equipment. The newest system available offers tilting magnets for bet-
ter imaging (the older system limits RAO and LAO projections to approximately 30° because 
of the magnets) and software upgrades. In addition, the current range of wires is being in-
creased. A new intermediate grade wire will increase the range of stiffness of the wires and 
a new blended nitinol-stainless steel wire may offer improved flexibility with memory. Further 
potential wire developments include coil magnet and multi-magnet configurations of the wire 
tip that may offer increased flexibility within tortuous anatomy and better deformation in ex-
tremely tortuous segments.
Contrast Reduction. A further feature of the MNS is the ability to project a white line overlay 
onto the fluoroscopy screen. This can be used as a guide for wire passage and enables the op-
Figure 6. The left panel shows 
the endoluminal view that is 
synchronized with the position 
of the marker on the fluoros-
copy screen. The right panel 
shows the fluoroscopy screen 
with the white line overlay, 
the dashed line is the desired 
vector, and the solid line is the 
applied vector (in this example 
the desired vector has just been 
moved and the applied vector 
is in the process of moving to 
that position). Note that these 
are live, moving, real-time im-
ages during a procedure.
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erator to pass the wire with minimal or no use of contrast26 (see Fig. 6). Contrast-induced renal 
dysfunction, and the dialysis needed in some cases, remains a cause of morbidity and mortal-
ity in procedures involving intravascular contrast.27 While some medical maneuvers, such as 
fluid,28 N-acetyl-cysteine,29 and theophylline30 administration, may confer some protection, 
evidence suggests that limiting intravascular contrast load to 100 mL may be a cut-off dose for 
the development of acute renal failure requiring dialysis.27 The ability to pass the wire without 
contrast may allow such a goal to be reached in patients with preexisting renal problems.
Chronic Total Occlusions. In addition to the advantages described above for the treatment of 
CTOs, the ongoing development of a magnetically enabled radiofrequency ablating wire may 
be highly advantageous. This will combine the current advantages of highly adjustable steer-
ing, the identification of the missing section of the vessel (shown by MSCT integration),
and the ability to ablate intervening scar tissue.
Remote Control. A further new concept in PCI is the ability to remotely control the delivery 
system. remote control equipment (see Fig. 7) in the form of the Remote Navigation System® 
Figure 7. The Remote Navigation System® is shown in a catheterization suite. (courtesy of T. Wenderow, CEO, Navicath Ltd). 
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(Navicath Ltd, Haifa, Israel) has been successfully tested in both in vitro and in vivo models.31 
This successful testing in models was mirrored by the successful use in the majority of a series 
of clinical PCI cases.32 Remote control procedures have already been shown to be possible
in electrophysiology.6 Such remote control procedures have the advantages of more exact 
movement of wires. Wire advancement by a remote system could potentially be integrated with 
the MNS to advance the wire and change the magnetic vector in tandem thereby enabling 
robotic procedures. Theoretically such movements could even be gated to the ECG to ad-
vance the tip and this might overcome some of the limitations of the static three-dimensional 
reconstruction. This combination would add the advantages of improved wire control to those 
of remote control procedures with reduction of irradiation of personnel and the reduction of 
collateral problems such as back pains from wearing lead coats.
Stem Cell Therapy. Stem cell therapy presents another possibility for MNS that may give both 
precisely directed delivery and also utilize integration with other forms of imaging. Intramyo-
cardial injections of bonemarrow derived stem cells have been shown to have a potential for 
improving regional and global left ventricular function.33 However, delivery of stem cells to
the correct areas has remained inexact with relatively crude methods of identifying where 
the injections are to be placed on delivery and where they have been placed on restudy. The 
identification of infarcted areas onMSCT34 mayadd a further tool that can be integrated into 
the MNS for such target localization. The MNS gives highly precise three-dimensional control 
and, with the possible development of a magnetically enabled injection catheter, the current 
MSCT integration may help localization of the infarct area to give a more tailored delivery. 
The combination of such localization techniques with the mapping abilities of systems like he 
recently developed NOGA® XP Cardiac Navigation System (BiosenseWebster Inc./Biologics 
Delivery Q1 System Group, Cordis Corporation) may give complementary information and 
result in more exact delivery. Integration of other digitized information from sources such as 
three-dimensional intracardiac echocardiography or magnetic resonance imaging could give 
functional data on improvements in wall segment motion.
limiTaTionS
This new system has a number of weaknesses that may be considered in terms of software, 
hardware, strategy, and general limitations.
Software. The Navigant software has many useful features however, some aspects remain 
limited. Reconstructions are static images with no variation with respiration and heart mo-
tion, there is a restricted range of forward advancement along the virtual vessel to 1–5 mm 
per touch of the screen, and the alignment can be problematic. Vessel reconstructions are 
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restricted to two branches and are based on angiography films alone resulting in limited reso-
lution. Reconstructions of the exact vessel borders and hazy lesions may have poor definition 
leading to underestimation of stenoses and difficulty with sharp, short lesions.
Hardware. The equipment has some physical limitations such as the length of the wire tip 
magnet that, with a standard of 3 mm, may hinder advancement in extremely tortuous and 
narrowed segments. In addition the integration of other imaging modalities directly into the 
system remains incompletely explored.
Strategy. Strategies for using this system in the performance of PCI are under development 
and these will depend on the indication for the procedure. The system remains relatively new 
with limited operator experience and current strategies utilize ad hoc reconstruction of the 
vessel that may be time consuming during a procedure. The timing of the reconstruction may 
have an impact on image quality and readiness for use in procedures. The usefulness of the 
center-line overlay for the minimization of the contrast load is not yet clarified.
General. As a whole, currently, the system functions well. However this system is still in further 
development and further refinements are expected. Furthermore, this system is an aid in the 
performance of PCI so should problems occur or, in the worst case scenario, the system fails 
then standard PCI can be performed.
ConCluSion
The MNS is a new platform for PCI that gives the operator more precise control of wire tip 
direction as well as the broadening imaging and integration abilities. This system facilitates 
navigation for difficult vessels and CTOs, it gives useful control of direction derived from MSCT 
integration and it may lead to a reduction in irradiation and discomfort to operators, person-
nel, and patients. For the future, the versatility of the system indicates further possible avenues 
for investigation such as reductions in contrast and irradiation, and navigable ablation and 
injection capabilities. Further investigation and development is underway.
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aBSTraCT 
Whereas the clinical diagnosis of in-stent thrombosis is straightforward, that of in-stent rest-
enosis remains a problem, because although many patients experience chest pain after coro-
nary stent placement, that symptom is secondary to ischemia in only a few.
The use of a noninvasive technique to identify such patients for early invasive intervention 
versus more conservative management is thus highly desirable. Multidetector computed to-
mography (CT) performed with 16-section scanners recently emerged as such a technique 
and has overtaken modalities such as electron-beam CT and magnetic resonance imaging as 
an alternative to conventional angiography for the assessment of in-stent restenosis.
The improved hardware design of the current 64-section CT scanners allows even better delin-
eation of stent struts and lumen. The more reliable criterion of direct lumen visualization thus 
may be substituted for the presence of distal runoff, which lacks specificity for a determination 
of in-stent patency because of the possibility of collateral pathways.
However, the capability to accurately visualize the in-stent lumen depends partly on knowl-
edge of the causes of artifacts and how they can be compensated for with postprocessing and 
proper image display settings. In addition, an understanding of the major stent placement 
techniques used in the treatment of lesions at arterial bifurcations is helpful.
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inTroduCTion
Over the past 25 years, catheter-based intervention has become the dominant form of coro-
nary revascularization. Percutaneous coronary interventions are increasingly performed in-
stead of coronary artery bypass graft surgery, even in patients with three-vessel disease or 
left main coronary artery disease. The most important advance in the field of percutane-
ous coronary interventions was the introduction of coronary stent implantation in the 1990s, 
which led to reductions in both the risk of acute major complications and the incidence of 
restenosis, compared with the risks after balloon angioplasty (1,2). Although the use of re-
cently introduced drug-eluting stents has resulted in even further reductions in the occurrence 
of restenosis, in-stent thrombosis and neointimal hyperplasia may still occur and cause partial 
or complete obstruction. 
Whereas the clinical diagnosis of stent occlusion due to thrombosis is usually straightforward 
in patients with a recent stent implantation and with a subsequent onset of acute myocardial 
ischemia leading to acute myocardial infarction, the assessment of in-stent restenosis is more 
challenging. Restenosis occurs in approximately 10%–20% of patients with complex lesion 
characteristics (3).
Moreover, although several characteristics of high-risk populations have been described as 
clinical predictors, the likelihood of restenosis in a particular patient remains largely unpre-
dictable (4 –7). For these reasons, conventional coronary angiography is still the technique of 
choice for the diagnosis of in-stent restenosis, although cardiac catheterization may involve 
major complications and is associated with moderate to high costs. Magnetic resonance (MR) 
angiography also can depict the coronary anatomy and help detect stenoses in the proximal 
segments of coronary arteries (8). However, metallic stents cause magnetic susceptibility ar-
tifacts that may prevent visualization of the lumen (9). Electron-beam computed tomography 
(CT) has been used more successfully to visualize coronary stents (10,11). Electron-beam CT 
is the modality with the shortest image acquisition times, namely 100 msec for a 3-mm-thick 
section suitable for morphologic interpretation and 50 msec for an 8-mm-thick section used 
for flow analysis without direct visualization of the in-stent lumen.
However, image noise is extremely high with the first technique, and only severe, flow-limiting 
stenoses can be detected by using the flow technique. Thus, the occurrence of nonobstruc-
tive neointimal hyperplasia remains unnoticed at electron-beam CT. In addition, patients who 
undergo percutaneous coronary intervention may experience a progression of atherosclerosis 
in native coronary vessels without a stent implant, but electron-beam CT is suboptimal for 
monitoring such progression, because it requires the sequential triggered acquisition of mul-
tiple 3-mm-thick sections.
\
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Hence, the latest generation of multidetector (multisection) CT scanners, which offer a smaller 
voxel size, faster gantry rotation speed, and reconstruction of 64 sections per gantry rotation, 
provide an appealing alternative for noninvasive luminal assessment in patients with chest 
pain after coronary stent placement (12). The improved hardware configuration of 64-sec-
tion CT scanners allows direct visualization of the stent struts and lumen for a more reliable 
assessment of in-stent patency than is allowed by the visualization of distal runoff. In symp-
tomatic patients, multidetector CT may be used as a complement or a substitute for treadmill 
testing; because the latter lacks specificity, additional noninvasive investigations such as stress 
echocardiography and scintigraphy often are required before cardiac catheterization is un-
dertaken. Multidetector CT also can be useful to assess the condition of the whole coronary 
tree, as it provides information about the number, severity, and location of coronary lesions. 
In the follow-up of asymptomatic patients after stent implantation, multidetector CT might 
help overcome the limited accuracy of treadmill testing to rule out restenosis and thus enable 
a reduction in the number of further examinations (ie, stress echocardiography, scintigraphy) 
needed because of a positive or inconclusive test result.
In this article, the capability of 64-section CT coronary angiography for the evaluation of in-
stent patency is discussed. The authors provide explanatory illustrations of the major stent im-
plantation techniques used to treat lesions at or near arterial branching points. They describe 
the CT features and artifacts that may be observed in or near stent implants on multiplanar 
reformatted images and volume-rendered images, the causes of those visual characteristics, 
and the postprocessing and image display methods that may be used to avoid or minimize 
artifacts.
perCuTaneouS Coronary inTervenTion 
and STenT plaCemenT 
Indications and outcomes
The clinical indications for percutaneous coronary interventions cover the spectrum of isch-
emic heart disease, from unstable angina pectoris and acute myocardial infarction to silent 
ischemia, as summarized in the guidelines of the American College of Cardiologists and the 
American Heart Association (13). In patients with significant narrowing of a single coronary 
artery, the main benefit of revascularization is the relief of angina rather than an improvement 
of the already good prognosis with medical therapy. In contrast, in patients with significant left 
main coronary artery stenosis or multiple-vessel disease, revascularization may both relieve 
angina and improve long-term survival.
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Epidemiology
An estimated 1,204,000 inpatients underwent percutaneous coronary interventions in the 
United States in 2002, and coronary stent placement accounted for 537,000 of such proce-
dures (14–16). More than 80% of percutaneous interventions that were performed in 2004 
involved the placement of a drug-eluting stent coated with sirolimus or paclitaxel (17). The 
procedural success rate of percutaneous revascularization is higher than 90%, and the risk of 
sudden arterial occlusion and subsequent myocardial infarction is low (13). Despite contradic-
tory reports (18), there is evidence that the long-term survival of patients who have undergone 
percutaneous revascularization for two- or three-vessel disease is no worse than that achieved 
with bypass graft surgery (19). Thus, percutaneous coronary intervention has become the 
preferred coronary revascularization strategy in many countries.
Coronary Stents
Coronary stents are expandable devices that are delivered to the coronary artery via cath-
eter and then expanded to preserve the luminal diameter. The currently available stents are 
pre-mounted on dedicated delivery systems. Occurrences that may limit the success of stent 
implantation include in-stent restenosis and thrombosis, which may obstruct the flow through 
the stent.
Thrombosis
The frequency of in-stent thrombosis is low, with a cumulative incidence of 1.3%–1.7% at 
9-month follow-up (20). However, even this incidence is clinically important because in-stent 
thrombosis is associated with high mortality and morbidity due to acute myocardial infarction. 
In the era of uncoated metallic stents, in-stent thrombosis typically occurred acutely (less than 
48 hours after stent implantation) or sub-acutely (2–30 days after implantation). One of the 
current concerns about drug-eluting stents is the occurrence of delayed in-stent thrombosis 
that is manifested more than 30 days after stent implantation. This late manifestation may be 
related to delayed endothelialization of the stent and typically occurs when antiplatelet therapy 
is discontinued (21,22). In patients with additional risk factors (eg, renal failure, diabetes 
mellitus, or low ejection fraction), stents implanted at the level of coronary artery bifurcations 
are considered to present a higher risk of thrombosis (23). The same applies when very long 
stents are used, with a reported 1.03 relative risk of thrombosis for each 1-mm increase in 
length (20).
Restenosis
Restenosis, the major limitation to the long-term outcome of percutaneous coronary interven-
tion, is defined as vessel lumen narrowing of more than 50% after angioplasty, with the resul-
tant recurrence of angina. Restenosis is an iatrogenic process caused by an excessive arterial 
healing response to vessel injury associated with dilation. It results from the combined effects 
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of elastic recoil (24), vascular remodeling (25), and neointimal hyperplasia (26). Coronary 
stents represent a mechanical approach to the prevention of restenosis by virtually eliminat-
ing elastic recoil and negative remodeling of the vessel after balloon dilation (26). The oc-
currence of neointimal hyperplasia is mainly responsible for the observed rates of restenosis, 
which range from less than 10% with a drug-eluting stent to 40% with an uncoated metallic 
stent (1,2,27,28). For both stent types, excess stent length is associated with an increased risk 
of in-stent restenosis (29); thus, the arbitrary use of stents much longer than the actual lesion 
length is not advisable (30). 
Drug-eluting Stents
Drug-eluting stents were developed to help prevent in-stent restenosis. Coating of a conven-
tional metallic stent with an antiproliferative agent helps preserve the mechanical scaffolding 
properties of the stent; the drug is released locally, at the site of the vascular injury (31). The 
most extensive accumulated clinical experience to date is that with polymer-coated siroli-
mus- and paclitaxel-eluting stents. Favorable safety profiles and decreased restenosis rates 
have resulted in the widespread use of percutaneous coronary interventions and drug-eluting 
stents since their release in early 2003 (32–34). Ongoing developments in stent design in-
clude the creation of biodegradable, nonmetallic, and MR-compatible devices. Theoretically, 
a biodegradable drug-eluting stent may be the ideal solution to prevent in-stent restenosis. 
The response to vessel wall damage can be suppressed by the drug, while elastic recoil and 
negative remodeling are prevented by the stent. Eventually, the stent degrades, and chronic 
vessel injury related to the metal or polymer is thereby prevented (35).
mulTideTeCTor CT For viSualizaTion 
oF Coronary STenTS 
Four– and 16–detector row CT scanners 
The diagnostic accuracy of electron-beam CT and multidetector CT performed with different 
generations of scanners is summarized in the Table. Whereas in-stent lumen evaluation with 
CT was almost impossible with four–detector row scanners (36–38), the introduction of 16– 
detector row scanners (in combination with dedicated convolution filters) made CT a much 
more viable modality for the detection of significant in-stent restenosis, with reported sensitivity 
and specificity values in the ranges of 54%–100% and 88%–100%, respectively (12,39–44) 
(Table). It is worth noting that the observation of distal runoff cannot be considered an ab-
solute indicator of patency, since the presence of vessel enhancement distal to a stent could 
also be secondary to retrograde filling. Indeed, whereas in conventional coronary angiography 
the contrast agent is selectively injected into the coronary artery, CT requires injection into a 
peripheral vein instead. This allows retrograde flow via collateral branches to the vessel seg-
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Diagnostic accuracy of electron-beam CT and multi–detector row CT in the evaluation of coronary stents
CT Technique 
and Study
No.  
Patients
No.  
Stents
Stent 
Location
Stent 
Caliber 
(mm)
No. As-
sessable 
Stents
Criteria for 
Patency
Sens 
(%)
Spec 
(%)
Electron beam CT
Pump et al (10) 202 321 
(221 
vessels) 
LM, RCA, 
LAD, LCX, 
Bypass grafts
(216 
vessels) 
Dynamic 
study distal 
runoff
78 98
Knollman et al (11) 117 152 2.5–3.0 144 Dynamic 
study distal 
runoff
72 60
Four–detector CT
Kruger et al (36) 20 32 RCA, LAD, 
LCX
32 Distal runoff
Maintz et al (37) 29 47 3–5 38 Distal runoff 100 100
Ligabue et al (38) 48 72 RCA, LAD, 
LCX
53 Distal runoff 100 100
15 ≥3.5 14 Lumen 
visualization
45 3.0–3.4 35
12 <3 4
16–detector CT
Schuijf et al (12) 22 68 2.25–5 50 Distal runoff 78 100
Cademartiri 
et al (39)
51 76 >2 74 Lumen 
visualization
84 99
Gilard et al (40) 29 29 LM 27 Lumen 
visualization
100 92
Gilard et al (41) 143 232 LM, RCA, 
LAD, LCX
122 Lumen 
visualization
1 4.5 1 86 100
42 4.0 28
61 3.5 41
86 3.0 40 56 100
42 2.5 12
Kitagawa et al (42) 42 61 42 Lumen 
visualization
15 4.0 14
22 3.5 17
19 3.0 11
5 2.5 0
Hong et al (43) 19 26 2.25–5 26 Contrast 
enhancement 
measurement
Ohnuki et al (44) 16 20 >3 19 Pixel count 
method
75 88
Sens = sensitivity, Spec = specificity,  LAD = left anterior descending artery, LCX = left circumflex artery, LM = left main coronary 
artery, RCA = right coronary artery.
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ment distal to an occluded or diseased stent. Attempts also have  een made to assess coronary 
artery stent patency with 16–detector row CT scanners on the basis of contrast enhancement 
measurements (43) or pixel count methods (44). However, the detection of more subtle de-
grees of in-stent neointimal hyperplasia was beyond the capabilities of that generation of CT 
scanners.
Multidetector 64-section CT systems
Although the calibers of coronary stents are no smaller than those of the major native coro-
nary arteries and their branches, the depiction of the in-stent coronary lumen at CT is a 
greater challenge than is that of the native coronary artery lumen because of high-attenuation 
artifacts secondary to the metallic stent struts. High in-plane and through-plane spatial resolu-
tion, optimal contrast resolution, and minimization of high attenuation artifacts are paramount 
in order to overcome the technical challenges. The superiority of 64-section CT systems over 
earlier generations of CT scanners with regard to the detection of coronary artery stenoses in 
native vessels has been demonstrated in recent investigations (45–47). Improvements in CT 
hardware technology, such as high x-ray output, isotropic voxel size of 0.4 x 0.4 x 0.4 mm 
(48), acquisition times of 6–14 seconds, and the capability of rendering 64 sections per rota-
tion, can play a valuable role also in the evaluation of the intra–coronary artery stent lumen. 
Indeed, advances in multidetector CT technology mean that thinner sections can be obtained 
in a shorter time, with resultant increased spatial resolution along the z-axis and with almost 
motion-free data sets (49). Temporal resolution depends primarily on a gantry rotation speed 
faster than those available with earlier scanners. The reduced breath-holding time is better 
tolerated by patients and contributes to the minimization of motion-related artifacts. Coupled 
with these improvements in hardware design, electrocardiography (ECG)-based gating tech-
niques and specialized methods of image reconstruction are used. Depending on the patient’s 
heart rate, data acquired during one cardiac cycle (monosegmental) or multiple cardiac cycles 
(multisegmental) can be used for section reconstruction. With these combined advantages, 
current 64-section CT systems provide better spatial and temporal resolution than do earlier 
generations of multidetector CT scanners, and higher spatial resolution and a better signal-
to-noise ratio than do electron-beam CT scanners (50). In the clinical evaluation of coronary 
stents, better delineation of the graft struts and of the presence of instent restenosis is possible 
with 64-section CT technology. 
STenT imaging wiTh mulTideTeCTor CT  
General issues
In addition to the specifications of scanner hardware, scanning technique, and dedicated 
postprocessing (ie, convolution filter), variables such as stent diameter, material, and design as 
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well as patient characteristics may heavily affect the visibility of the in-stent lumen. The earliest 
experiments to assess the feasibility of coronary stent imaging with multidetector CT were per-
formed in vitro with varying collimations, contrast material concentrations, stent calibers, and 
stent positions within the gantry (51–53). When imaging is performed in vivo, stent-related 
beam hardening artifacts are a constant phenomenon, and assessment is further complicated 
by vessel wall calcifications, poor contrast-to-noise ratios in obese patients, and motion.
Beam hardening and blooming effect
Metallic struts cause a severe CT artifact known as blooming effect. Blooming effect results 
from beam hardening and causes the stent struts to appear thicker than they are (51) and, 
often, to overlap the vessel lumen. The result is an underestimation of the in-stent luminal 
diameter (Figure 1A). The energy spectrum of the x-ray beam as it passes through a hyperat-
tenuating structure increases because lower-energy photons are absorbed more rapidly than 
are higher-energy photons, with the result that the beam is more intense when it reaches the 
detectors. Calcified spots of the vessel wall near or at the outer surface of an implanted stent 
also contribute to beam hardening, which further erodes the assessability of the stent lumen 
(Figure 1B, 1C). Depending on the type of metal and the design of the stent, the magnitude of 
the artifact varies (Figure 2) (53). As a rule, the depiction of stents with the slimmest profile is 
least affected by blooming artifacts. Beam hardening is counterbalanced mainly by increasing 
the spatial resolution (decreasing the voxel size) and performing dedicated data filtering. 
Tube voltage is usually a constant pa-
rameter in cardiac protocols, but the 
contrast between structures on images 
also depends on the amount of x-ray 
energy. At lower-voltage settings, which 
correspond to lower energy of the x-ray 
beam, the CT number of metal increas-
es substantially, and, hence, beam 
hardening artifacts are more likely to 
occur. Beam hardening artifacts also 
may be exacerbated by motion or by in-
appropriate selection of the reconstruc-
tion window (54). Conversely, they may 
be minimized by reducing the amount 
of motion inherent in the data set and 
optimizing the reconstruction window.
Figure 1. Blooming effect on follow-up images obtained with 64-sec-
tion CT in a patient who underwent stent implantation in the left cir-
cumflex coronary artery. (A) Longitudinal multiplanar reformatted 
image shows, at the outer edge of the stent, a calcified spot that con-
tributes to beam hardening and hampers visualization of the in-stent 
lumen. Note the insufficient dilation of the stent proximal to the bulky 
calcification. (B, C) Sharp-kernel-filtered cross-sectional image (B), 
obtained at the level indicated in A (line), is less affected by blooming 
than is the smooth-kernel-filtered cross-sectional image (C).
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Partial volume averaging and interpolation
Another obstacle to coronary stent imaging is related to partial volume averaging and interpo-
lation. Inherent in all digital tomographic imaging techniques, partial volume averaging yields 
a CT number that represents the average attenuation of the materials within a voxel. At stent 
imaging in vessels with a large diameter, such as the aorta or iliac arteries, beam hardening 
and partial volume averaging effects are present but are limited to the proximity of the vessel 
wall. In coronary arteries with smaller diameters, the artifacts are of the same magnitude, but 
a reliable assessment of the lumen is much more problematic. The smaller the stent, the more 
detrimental the effect of partial volume averaging on the assessability of the in-stent lumen 
(Figure 2A).
Figure 2. Variation in the severity of metal-related artifacts at 
64-section CT with variations in metallic content, design, and 
luminal diameter of the stent. (A) Curved multiplanar refor-
matted image obtained in a patient with a 4-mm-caliber stent 
in the proximal right coronary artery (arrow) and 2.50-mm-
caliber (arrowhead) and 2.25-mm-caliber stents in the poste-
rolateral artery. Although all three stents consist of the same 
material, the in-stent lumen in the two stents in the posterolat-
eral artery is not visible because of the small stent caliber.
Note the gap between the stents implanted in the posterolat-
eral artery. (B) Image obtained in another patient, who under-
went stent implantation (different stent type, 5-mm caliber) 
in the proximal circumflex artery, shows a more pronounced 
metal-related artifact than is visibel in A.
Figure 3. Residual cardiac motion exacerbates metal-related 
artifacts at 64-section CT in a patient with a stent in the 
midportion of the right coronary artery and with a premature 
heartbeat recorded at ECG during scanning. (A, B) Images 
obtained from data acquired during gating with the original 
ECG tracing. On the volume-rendered image (A), a steplad-
der artifact (arrowheads) is visible at the level of the midpor-
tion of the right coronary artery. On the multiplanar reformat-
ted image (B), a blurring of contours is visible. (A’, B’) Images 
obtained with cardiac gating after editing of the ECG tracing. 
To avoid a gap in the image data, the reconstruction window 
during the premature heartbeat was deleted and another was 
added to the subsequent cardiac cycle. This step eliminated 
the abrupt heart rate change related to the premature beat 
and allowed a more coherent reconstruction of the data set. 
On the volume-rendered image (A’), the appearance of the 
stent (arrow) is unaffected by motion artifacts. Likewise, the 
in-stent lumen is well depicted on the multiplanar reformat-
ted image (B’).
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The thinner detector width on 64-section CT scanners partly solves this problem by reducing 
the voxel size and thereby the general assessability of the stent lumen (48,55,56).
Optimization of contrast enhancement
Prominent contrast enhancement in the lumen is a prerequisite for robust coronary CT an-
giography (57). It is achieved not only by optimizing the contrast material injection parameters 
(ie, using a high-concentration contrast agent and a fast injection rate) but also by accurately 
synchronizing the CT data acquisition with the passage of the contrast agent by means of bo-
lus tracking or a test bolus. Edge-enhancing convolution filters, which may be used for better 
delineation of stents, have the drawback of producing noisier data sets. If such a convolution 
filter is used, the assessability of the in-stent lumen particularly benefits from the presence of 
a high degree of intraluminal contrast enhancement, which somewhat compensates for the 
kernel-related noise. A high degree of intraluminal enhancement is recommended especially 
for the investigation of stent patency in vessels that have a small diameter and thus contain 
less blood.
Residual cardiac motion
Residual cardiac motion is of the utmost importance as a cause of vessel non assessability at 
multidetector CT coronary angiography. Residual cardiac motion also plays a role in exacer-
bating metal-related artifacts such as beam hardening and partial volume averaging effects 
(Figure 3).
The use of high gantry rotation speeds, multisegmental reconstruction techniques, and 
¯-blockers to lower the heart rate consistently improves the interpretability of multidetector CT 
coronary angiograms. ECG-based editing techniques allow an improvement of image quality 
for patients with mild irregularities in sinus rhythm, such as premature beats, and for those 
with bundle-branch block.
ConvoluTion FilTerS 
Once the technical requirements and acquisition parameters for adequate coronary CT an-
giography have been fulfilled, additional dedicated postprocessing can be performed to opti-
mize the visualization of the stent. The use of a dedicated edge-enhancing convolution kernel 
allows a significant decrease in the severity of blooming artifacts at the edges of high-attenua-
tion structures. Indeed, the in-stent contrast-enhanced attenuation measured on sharp-kernel 
images is closer to that measured in the proximal or distal lumen than is the in-stent attenua-
tion measured on smooth-kernel images (43).
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According to the authors of a recently published article about the effects of reconstruction ker-
nels on the delineation of coronary stents (58), when a medium-smooth filter is applied, as a 
consequence of the blooming effect an average in-stent lumen narrowing of 37% is observed 
in comparison with the diameter of the untreated vessel segment, and the measured in-stent 
attenuation exceeds the aortic attenuation by more than 100 HU because of the partial vol-
ume averaging effect. In contrast, the in-stent lumen narrowing is 29% of the diameter of the 
normal vessel segment on sharp-filtered images, and the in-stent attenuation exceeds the at-
tenuation in the aorta by only 60 HU.
The results of such studies support the superior depiction of the stent lumen with dedicated 
edge-enhancing convolution kernels in comparison with conventional medium-smooth ker-
nels. While spatial resolution is increased and blooming artifact is reduced by the application 
of edge-enhancing filters, an increase in image noise has to be accepted as a trade-off. Thus, 
the most appropriate filter must be chosen so that an advantageous balance is achieved 
Figure 4. Visibility of low-contrast structures with different convolution filters. The most appropriate filter must be chosen so that 
an advantageous balance is achieved between the visibility of low-contrast structures and the quantity of image noise. (A) Conven-
tional coronary angiogram shows nonsignificant neointimal hyperplasia in the distal portion
of the right coronary artery (arrowheads). (B–F) Multidetector 64-section CT angiograms obtained in a patient with multiple stents 
in the right coronary artery. On the image reconstructed with a smooth convolution filter (B20f) (B), the luminal defect (*) is hardly 
visible. On the image reconstructed with a medium-smooth convolution filter (B30f) (C), the defect (*) is visible but quite blurred. 
The image reconstructed with a dedicated edge-enhancing kernel (B46f) (D) allows visualization of in-stent neointimal hyperpla-
sia (*), with good contrast between the defect and the surrounding structures (stent scaffold, enhanced lumen). On the images 
reconstructed with sharp (B60f) (E) and very sharp (B70f) (F) convolution filters, the edge enhancement does not provide clearer 
depiction of the defect (*) but, instead, greater amounts of image noise.
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between the visualization of low contrast structures and image noise (Figure 4). In these in-
stances, high intraluminal contrast enhancement is also very helpful to counterbalance the 
increased image noise. Additional “intelligent” noise-reduction filters may prove beneficial 
for the depiction of low-contrast structures within the in-stent lumen and therefore may help 
detect in-stent restenosis (58).
inTerpreTaTion oF mulTideTeCTor CT daTa
Display techniques and windowing
The clinical evaluation of coronary arteries on CT angiograms is routinely performed by us-
ing multiplanar reformation of the data volume. Curved multiplanar reformation, maximum 
intensity projection, and volume rendering techniques also are often used. The same tech-
niques are applied for the evaluation of coronary stents on CT angiograms. Multiplanar re-
formatted images and cross-sectional images of the stent are the most useful views on which 
to assess patency, restenosis, or a minor degree of neointimal hyperplasia. Advances in CT 
technology have provided 64-section CT scanners with submillimeter spatial resolution of 0.4 
x 0.4 x 0.4 mm (43,48). With the very small isotropic voxel size, the assessability of the stent 
lumen on multiplanar reformatted images remains unaffected by angulation in relation to the 
z-axis. 
CT window settings affect image contrast and noise. If the window is set too narrow, image 
noise may be significantly increased, and grayscale differentiation of fine structural details 
may be lost. Wide window settings are necessary for accurate evaluation of the in-stent lumen 
at CT angiography (window width, 1500 HU; window center, 300 HU) (Figure 5). Although 
they are not routinely used to assess CT scans in the clinical setting, other three-dimensional 
volume rendering techniques are available with current CT scanners.
After suitable threshold ranges or transparency settings are selected, an endoscopic view of 
the internal surface of the vessel can be simulated (Figure 6). This technique may allow 
visualization of different stent designs (eg, slotted tube and corrugated ring stents) (59). In 
stents with small diameters, though, the amount of image noise may be too great for such 
techniques to be reproducibly applied.
In-stent lumen evaluation
As mentioned earlier (39), the direct visualization of the in-stent lumen is important for as-
sessing patency, because collateral vessels may be feeding the vessel segment distal to the 
occluded stent in a retrograde direction.
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Figure 6. Selection of suitable thresh-
old ranges and opacity settings allows 
simulation of an endoscopic view of 
the inner vessel surface and makes it 
possible to recognize different designs 
of the metal scaffold in stents. A slot-
ted tubular stent (A) and a corrugated 
ring stent (B) are currently used for 
the treatment of most coronary le-
sions. Both stents have a diameter of 3 
mm. The amount of image noise may 
prevent successful application of this 
technique for depiction of the lumen 
in stents with very small diameters. 
Figure 5. Combined effects of the selected filter and window settings on image contrast and noise at 64-section CT coronary 
angiography. (A–C) Images obtained with a medium-smooth convolution kernel (B30f). (D–F) Images obtained with a dedicated 
sharp convolution kernel (B46f). Note that D–F more clearly depict the in-stent lumen than do A–C. The standard soft-tissue win-
dow width (W) (A, D) is too narrow and accentuates blooming artifacts. On the
image filtered with a medium-smooth convolution kernel (A), the blooming effect totally obscures the in-stent lumen. With exag-
gerated widening of the window (B, E), the blooming effect is decreased, but this occurs at the expense of overall image contrast. 
Setting the window center (C) at approximately 300 HU and choosing a width (W) of approximately
1500 HU allows a more favorable balance between image contrast and noise (C, F). However, the window settings alone are not 
sufficient to ensure optimal depiction of the inner lumen (C). The combined use of a dedicated edge-enhancing convolution kernel, 
which increases image spatial resolution, and appropriate window settings to compensate for filter-related noise allows the most 
favorable in-stent lumen visualization (F).
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An accurate intraluminal evaluation can 
best be performed by means of multiplanar 
reformation of the CT data volume. The 
stent may be considered to be occluded if 
the lumen inside the device appears darker 
than the contrast-enhanced vessel lumen 
proximal to the stent. 
Unless severe artifacts affect the CT data set, stent evaluation may proceed beyond a judg-
ment of patency or occlusion. Nonocclusive in-stent neointimal hyperplasia is characterized by 
the presence of a darker rim between the stent and the contrast-enhanced vessel lumen (Fig-
ure 4) and is secondary to the healing response to procedure-related vessel injury. If neointi-
mal hyperplasia exceeds a luminal diameter reduction of 50%, the process is consistent with 
hemodynamically significant in-stent restenosis (Figure 7) (39).
In-stent restenosis typically occurs as a localized nonenhancing lesion, often (but not invari-
ably) associated with complex lesion anatomy (ie, ostial lesions) and discontinuity in lesion 
coverage. It occurs with higher frequency in patients with diabetes mellitus (26). Restenosis 
may occur either within or adjacent to the stent (within 5 mm of the stent extremities). Edge 
restenosis might occur because of a decrease in local drug availability, incomplete lesion cov-
erage due to a gap between two stents, procedure-related trauma, or damage to the polymer 
coating of a stent from calcifications or an overlapping stent (33).
Bifurcation lesions
Arterial branching points are particularly vulnerable to the atherosclerotic process and its 
complications. The treatment of lesions located at coronary artery bifurcations, including the 
left main artery bifurcation, currently accounts for approximately 15% of all percutaneous 
Figure 7. In-stent occlusion in a patient with recurrent an-
gina pectoris 18 months after implantation of two stents in 
the right coronary artery. CT was performed after conven-
tional angiography failed to depict the right coronary artery. 
(A) Multiplanar reformatted image shows lower attenuation 
inside the stent lumina than in the proximal untreated tract 
of the right coronary artery, a gap between the occluded 
stents, and collateral filling (*). (1–3) Cross-sectional im-
ages obtained at the proximal end of the stent (1), in the 
middle portion (2), and at the distal end (3) show the ap-
pearances of patency, occlusion, and patency, respectively. 
(B, C) Conventional angiograms provide information about 
the presence of collateral filling (* in B) and the length of 
the occlusion. This information enabled planning for percu-
taneous revascularization, which was successful, as evident 
from a comparison of the pre-treatment image (B) and the 
post-treatment image (C).
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coronary artery interventions 
(20,60,61). Stent implanta-
tion at coronary artery bifur-
cations remains technically 
challenging and is associated 
with higher restenosis rates 
than is stent placement for 
simple lesions (62). An accu-
rate and noninvasive coronary 
imaging tool thus is highly 
desirable for the follow-up of 
these patients. 
Numerous techniques of stent 
deployment in bifurcation le-
sions have been described 
(63–72). The preferred stent 
implantation strategy de-
pends on the bifurcation 
anatomy and takes into ac-
count the plaque location in 
relation to the side branch (63–65). In accordance with the strategy applied, different stent 
configurations may be observed on CT images. 
If the lesion anatomy allows it, the provisional stent implantation technique is preferred. This 
technique consists of stent placement in the main branch first, with subsequent implantation 
of a second stent in the side branch only if residual stenosis or dissection is present (66). How-
ever, in many patients, both the main branch and the side branch are severely diseased. In 
such cases, the simultaneous implantation of a stent in both branches is favored. 
The “T” stent technique (Fig 8) was developed for the treatment of vessels with a bifurcation 
angle close or equal to 90°. Side branches that originate with a narrower angle (less than 
70°) are preferably treated by using one of many available “Y” stent techniques, since incom-
plete coverage of the side-branch ostium may lead to the recurrence of stenosis at that spot 
(67,68). 
Another variant, the “V” stent technique, involves the implantation of two stents together: one 
stent is advanced into the side branch; the other, into the main branch. The two stents are in 
direct contact proximally and form a new bifurcation angle (69). If this angle extends a con-
Figure 8. T stent implantation at the left main coronary artery bifurcation. (A) Vol-
ume-rendered image obtained with 64-section CT shows the left main coronary 
artery and circumflex artery (arrow), which constitute the main branch, and the an-
terior descending artery (arrowhead), the side branch for stent implantation. (B–E) 
T-stent cross-sectional diagram (B), curved multiplanar reformatted image (C), and 
cross-sectional images (D, E) obtained in the planes indicated in C show overlap of 
the metal struts only at the bifurcation point. 
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siderable distance (usually, 5 
mm or more) into the proxi-
mal part of the main branch, 
the technique is referred to 
as “simultaneous kissing 
stents” (3,69). V stents and 
simultaneous kissing stents 
are suitable for proximal le-
sions, such as lesions located 
at the left main coronary ar-
tery bifurcation (Figure 9), 
provided that the part of the 
main branch that is proximal 
to the bifurcation is free of 
disease.
The “culottes” or “trousers” 
technique (Figure 10) is an-
other well-known Y stent 
variant that ensures full cov-
erage of the side-branch os-
tium. First, a stent is deployed 
across the branch that has the greatest an-
gulation, usually the side branch. Next, a 
balloon catheter is passed through the struts 
of the stent, into the other branch, and di-
lated; a second stent is then delivered into 
that branch (usually the main branch). This 
technique is suitable for use at bifurcations of 
any angulation. The bifurcation itself is fully 
covered, albeit at the expense of an excess 
of metal at the proximal end (70,71). 
Figure 10. Y stent implantation at the bifurcation of the left 
main coronary artery. (A) Volume-rendered image shows the 
point of bifurcation, at which two stents were implanted in a 
configuration resembling a pair of trousers or culottes. Cx = 
left circumflex artery, LAD = left anterior descending artery. 
(B) Multiplanar reformatted image shows stent patency at the 
level of the bifurcation. (C) Diagram shows the concentrically 
deployed stents, which overlap near the point of bifurcation. 
(D, E) Cross-sectional images, obtained in the planes shown in B, depict a thicker stent profile in 
the parent vessel (D) at a level near the side-branch ostium (E).
Figure 9. V stent implantation in the left coronary artery. (A, B) Volume-rendered 
image (A) and multiplanar reformatted image (B) show the left main artery and the 
anterior descending, intermediate, and circumflex branches, in which stents were 
placed to provide full coverage of the branching point. (C) Diagram of the V stent 
technique shows overlap of the metal struts only at the trifurcation. (D, E) Cross-
sectional images, obtained in the planes shown in B, show the slim and symmet-
ric profiles of the stents, both proximally (D) and at the level of the carina (E). (F) 
Volume-rendered image obtained for visualization of the vessel lumen provides a 
simulated endoscopic view of the origin of the three branches (1–3).
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This excess of metal produces marked hyper-
attenuation at the bifurcation on the CT im-
age, an effect that may prevent visualization 
of the lumen.  The “crush” technique, like 
the V technique, involves the simultaneous 
insertion of two stents (Figure 11) (72). he 
side-branch stent, which protrudes minimally 
into the main branch, is deployed at the bifurcation. Subsequently, the main-branch stent is 
deployed across the ostium of the side-branch vessel and causes the protruding side-branch 
stent to be flattened against the vessel wall (hence the term crush). As a result, three layers 
of metal are applied to the vessel wall of the main branch immediately upstream of the side-
branch ostium, a stent configuration that results in an area of hyperattenuation on one side of 
the vessel on multidetector CT angiograms.
Summary
Considering the high number of percutaneous coronary interventions that involve stent im-
plantation, the development of relatively inexpensive and noninvasive methods for assessing 
stent patency is an issue of growing interest. Multidetector CT has recently emerged above 
competing modalities such as electron-beam CT and MR imaging as a practical alternative 
to invasive coronary angiography. Despite image-degrading effects caused by the metallic 
scaffold of the stent, recent experience with the current generation of 64-section scanners sug-
gests improved assessability of the in-stent lumen with the capability to appreciate more subtle 
degrees of in-stent neointimal hyperplasia. Knowledge of the different types of artifacts and 
how they can be compensated for with dedicated postprocessing and appropriate image views 
and window settings is a prerequisite for reliable depiction of the in-stent lumen and leads to 
a more robust application of CT findings in the clinical context. In future, the development of 
biodegradable stents may create optimal conditions for noninvasive post-implantation follow-
up with multidetector CT.
Figure 11. Crush stent placement at the circumflex-marginal ar-
tery bifurcation. (A, B) Volume rendered image (A) and curved 
multiplanar reformatted image (B) allow assessment of the stent 
configuration. (C) Diagram shows the multiple layers of metal 
that produce an asymmetric appearance of the cross-sectional 
stent profile. (D, E) Cross-sectional images, obtained in the 
planes shown in B, show asymmetric high attenuation where 
the layers of metal overlap, both proximal to the bifurcation (D) 
and across the ostium of the side-branch vessel (E). 
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Background 
Surveillance conventional coronary angiography (CCA) is recommended 2 to 6 months after 
stent-supported left main coronary artery (LMCA) percutaneous coronary intervention due to 
the unpredictable occurrence of in-stent restenosis (ISR), with its attendant risks. Multislice 
computed tomography (MSCT) is a promising technique for noninvasive coronary evaluation. 
We evaluated the diagnostic performance of high-resolution MSCT to detect ISR after stenting 
of the LMCA.
Methods and Results
Seventy-four patients were prospectively identified from a consecutive patient population 
scheduled for follow-up CCA after LMCA stenting and underwent MSCT before CCA. Until 
August 2004, a 16-slice scanner was used (n= 27), but we switched to the 64-slice scanner 
after that period (n=43). Patients with initial heart rates > 65 bpm received beta-blockers, 
resulting in a mean periscan heart rate of 57±7 beats/min. Among patients with technically 
adequate scans (n=70), MSCT correctly identified all patients with ISR (10/70), but misclas-
sified 5 patients without ISR (false positives). Overall, the accuracy of MSCT for detection of 
angiographic ISR was 93%. The sensitivity, specificity, positive and negative predictive value 
were 100%, 91%, 67%, and 100%, respectively. When analysis was restricted to patients with 
stenting of the LMCA with or without extension into a single major side branch, accuracy was 
98%. When both branches of the LMCA bifurcation were stented, accuracy was 83%. For the 
assessment of stent diameter and area, MSCT showed good correlation with IVUS (r = 0.78 
and 0.73, respectively). An IVUS threshold value ≥1mm was identified to reliably detect in-
stent neointima hyperplasia with MSCT.
Conclusions  
Current MSCT technology, in combination with optimal heart rate control, allows reliable non-
invasive evaluation of selected patients after LMCA stenting. CT is safe to exclude left main 
ISR and may therefore be an acceptable first-line alternative to CCA.
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inTroduCTion
Multislice computed tomography coronary angiography (MSCTA) is a promising non-invasive 
coronary imaging modality.1,2 Although several reports have shown that it may be used to 
evaluate stent patency, more precise evaluation of the lumen within the stent is markedly hin-
dered by artificial enlargement of the metallic stent struts caused by blooming artefact.3 The 
impact of blooming artefact on the evaluation of structures inside stents is inversely related to 
stent diameter.4 In large-diameter coronary stents, such as those implanted in the left main 
coronary artery (LMCA) or proximal left anterior descending artery (LAD), neointimal hyper-
plasia (NIH) within the stent can be visualized on multislice computed tomography (MSCT), 
demonstrating its potential for the detection of in-stent restenosis (ISR), in addition to stent 
patency, in specific lesion subsets.5 
Although coronary artery bypass graft (CABG) surgery is still the recommended treatment 
for significant left main (LM) disease, the introduction of drug-eluting stents (DES) with much 
lower restenosis rates has increasingly resulted in the alternative use of percutaneous coronary 
intervention (PCI).6,7 However, LM ISR still occurs with DES and may result in fatal myocardial 
infarction or sudden death.8-10 Careful surveillance, including routine coronary angiography at 
2 to 6 months after PCI, is therefore strongly recommended.11 A noninvasive method to detect 
ISR and to potentially preempt its clinical consequences would be of evident clinical value. In 
the present study, we evaluated the potential of MSCT for detecting LM ISR. 
meThodS
Patient selection
Between March 2004 and November 2005, we screened 91 consecutive patients scheduled 
for follow-up coronary angiography after LMCA stenting for inclusion in a protocol to compare 
MSCT with conventional angiography. In addition, most patients also underwent intravascular 
ultrasound (IVUS) evaluation of the LMCA. All patients in sinus rhythm who were able to hold 
their breath for 20 seconds were eligible for inclusion. We excluded patients with the following: 
previous allergic reaction to contrast, impaired renal function (serum creatinine >1.6 mg/dl), 
contra-indication to ¯-blockers (high-degree heart block, poor left ventricular function, asth-
ma, or severe chronic obstructive pulmonary disease), obesity (body mass index >30 kg/m2 
for patients scanned with the 16-row MSCT scanner), and those who had an acute coronary 
syndrome at the time of scheduled angiography. The institutional review board of Erasmus MC 
Rotterdam approved the study, and all subjects gave informed consent. 
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MSCT protocol and image acquisition
MSCT was performed in the fortnight before conventional angiography. Patients with a heart 
rate >65 bpm received 100 mg of metoprolol orally 1 hour before the scan. Up to July 2004, 
MSCT data were acquired with a 16-slice MSCT scanner (Sensation 16, Siemens, Germany). 
From August 2004 on, all scans were performed with a 64-slice MSCT scanner (Sensation 
64, Siemens, Germany). A bolus of 100 ml of contrast (iodixanol, 320 mg of iodine per 1 ml 
[mgI/mL]; Visipaque, Nycomed, Inc, Princeton, NJ) was injected intravenously at 4 to 5 ml/
sec. MSCT data were acquired during a single breath hold once the contrast material in the 
ascending aorta reached a predefined threshold of 100 Hounsfield units. The 16-slice MSCT 
scanner had the following scan parameters: detector collimation 16 x 0.75 mm, table feed 
3.0 mm per rotation, gantry rotation time 420 ms, tube voltage 120 kV, and tube current 400 
to 450 mA. The parameters for the 64-slice MSCT scanner were: detector collimation 64 x 
0.6 mm, table feed 3.8 mm per rotation, gantry rotation time 330 ms, tube voltage 120 kV, 
and tube current of 900 mA. With dedicated software (WinDose, Institute of Medical Physics, 
Erlangen, Germany), the average radiation exposure was calculated as 11.8 to 16.3 mSv for 
the 16-slice MSCT scanner and 15.2 to 21.4 mSv for the 64-slice MSCT scanner. All data 
were reconstructed using a field of view of 50x50 mm, image matrix of 512x512 pixels, and 
a sharp heart view (B46f) convolution kernel. Image reconstruction was retrospectively gated 
to the ECG. The position of the reconstructed window within the cardiac cycle was individually 
optimized to minimize motion artifacts. Datasets containing no or minimal motion artifacts 
were transferred to a remote workstation for further evaluation.
MSCT data analysis
Two experienced observers, unaware of the results of convential angiography, evaluated the 
MSCT data sets on both the original axial images and on multiplanar reformatted recon-
structions rendered orthogonal and perpendicular to the vessel course. In the case of LM 
bifurcation stenting, each of the three segments (LM, left anterior descending artery (LAD), 
and circumflex artery [CX]) was evaluated individually. To assess significant restenosis (≥50% 
decrease of lumen diameter as defined by angiography), we evaluated the stent in the LMCA 
and, where applicable, in related branches, including the 5-mm borders proximal and distal 
to the stent. The stent lumen was visually evaluated as (1) patent with no visible NIH, (2) 
patent with non-obstructive (<50% lumen diameter) NIH, (3) patent with obstructive (>50% 
lumen diameter) NIH, ie, restenosis, and (4) occluded. Disagreements were resolved by con-
sensus. Where a single stent was placed across the LM bifurcation into the LAD or CX, with 
no intervention, or solely with balloon dilatation in the other branch, we also evaluated the 
proximal 5 mm of the untreated side branch unless a functional bypass graft was attached to 
the nonstented branch. 
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For comparison with IVUS, stent area and diameter at the proximal and distal stent edge and 
at the ostium of LAD and CX were measured in cross-sectional orthogonal image planes. The 
degree of luminal narrowing was quantified in the cross section with maximum stenosis as 
percent diameter and area stenosis by calculating the ratio of the minimal lumen diameter or 
area by the stent diameter or area.
Angiographic analysis
Conventional x-ray coronary angiography was performed with standard techniques after in-
tracoronary injection of 2 mg of isosorbide dinitrate. Care was taken to ensure that the same 
views of the LM were obtained as at the time of intervention. An experienced cardiologist, 
unaware of the results of MSCT, analyzed all angiographic data quantitatively, using validated, 
automated, edge detection software (CAAS II, Pie Medical, Maastricht, Netherlands). With 
the outer diameter of the catheter tip, not filled with contrast, as the calibration standard, we 
measured from multiple projections in diastole the minimal lumen diameter, the reference 
diameter, and the percentage diameter stenosis of the LMCA and, where indicated, the LAD 
and CX; the averaged results were recorded. Binary angiographic restenosis was defined as 
percentage diameter stenosis ≥50% anywhere within the stent or within the 5 mm segments 
proximal or distal to the stent margins. This definition also applied to the proximal 5mm ves-
sel segment of the untreated LAD or CX, where a stent was placed over the distal left main 
bifurcation. 
IVUS imaging 
IVUS was performed with a 2.9F, 40-MHz or a 3.2F, 30-MHz single-element mechanical trans-
ducer (Boston Scientific, Natick, Mass). After intracoronary injection of 2 mg of isosorbide 
dinitrate, the IVUS catheter was positioned at least 1 cm distal to the stent in the LMCA; 
for patients with bifurcation stenting a sufficiently distal starting point in the LAD or CX was 
chosen. IVUS images were recorded after initiation of automated pullback at 0.5 mm/s. In 
case of bifurcation stenting, only one of the 2 major branches, preferentially the LAD, was 
investigated. IVUS images of the entire pullback were recorded on both S-VHS videotape and 
CD-ROM for off-line analysis. 
IVUS analysis
In our institution all IVUS pullbacks are retrospectively gated with a program that selects images 
recorded in the end-diastolic phase.12 Two experienced observers, blinded to the angiography 
and MSCT results, analyzed and reviewed the IVUS image data sets using an off-line semi-
automated software package (Curad, version 3.1, Wijk bij Duurstede, the Netherlands).13 The 
stented portion of the LMCA, including the stented parts of the side branches, was evaluated 
for the presence of NIH. For each of the 3 coronary segments (ie, stented part of LM, LAD, 
and CX), the following IVUS parameters were measured: (1) minimal lumen cross sectional 
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area (CSA, mm2), (2) mean stent CSA (mm2), (3) minimal lumen diameter (mm), (4) mean 
stent diameter (mm), and (5) maximal NIH thickness (mm). Similar to the MSCT measure-
ments, stent area and diameter at the proximal and distal stent edge and at the ostium of LAD 
or CX were determined. The percent diameter and area stenosis were comparably to MSCT 
determined in cross-sections with maximal in-stent lumen obstruction.
Statistical analysis
Continuous variables are presented as mean ± SD or median with 25% and 75% interquartile 
ranges. Categorical variables are presented as counts and percentages. Continuous variables 
were compared by Student t test for normally distributed values; otherwise the Mann-Whitney 
U test was used. All tests were 2-tailed, and a probability value of <0.05 was considered 
significant. Accuracy (percentage of patients correctly classified), sensitivity, specificity, and 
positive and negative predictive value of MSCT for the detection of ≥50% ISR, as determined 
by quantitative coronary angiography, was calculated on a per-patient basis. Diagnostic test 
results are reported with associated 95% CIs based on binomial probabilities.
Quantitative IVUS and MSCT data were correlated by means of Bland-Altman and linear 
regression analysis and by calculating the Pearson correlation coefficient.14 Mean values were 
compared with the 2-tailed t-test. The degree of agreement between IVUS and MSCT was 
also measured by the ∙-statistic and expressed as a function of NIH thickness, as determined 
by IVUS. The intraobserver and interobserver variability for the detection of ISR and NIH was 
determined with the ∙-statistic. Statistical analysis was performed with SPSS, version 12.1 
(SPSS Inc., Chicago, Ill).
The authors had full access to the data and take full responsibility for its integrity. All authors 
have read and agree to the manuscript as written.
reSulTS
Seventeen of the 91 potentially eligible patients (ie, those scheduled for conventional an-
giography during the inclusion period) had exclusion criteria as outlined in Table 1; 4 of the 
74 patients included had a technically inadequate scan. One of those 4 patients had ISR on 
conventional angiography. The remaining 70 patients constitute the study population. The 
baseline clinical characteristics of these patients are summarized in Table 2. The median inter-
val between stent placement and computed tomography (CT) imaging was 259 days (range 
89 to 758 days), and the average interval between MSCT and conventional coronary angiog-
raphy (CCA) was 14±16 days. Mean basal heart rate was 68±10 bpm; 49 patients (70%) 
received additional ¯-blockers, which resulted in a mean periscan heart rate of 57±7 beats/
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min. Mean scan time with the 
64-row detector MSCT (n=43, 
11.1±1.2 seconds) was signifi-
cantly (p < 0.001) shorter than 
with the 16-row detector MSCT 
(n=27, 15.9±1.5 seconds). 
 
Anatomic characteristics 
and procedural details 
of index interventions
Table 3 presents the anatomic 
characteristics of the lesions 
treated and the procedural de-
tails of the index interventions. 
The vast majority of patients 
(83%, 58/70) underwent PCI of 
unprotected LM stem lesions, 
and DES were used in all but 3 
patients (96%). Two groups of 
patients were defined, according to the characteristics of the PCI procedure. The first group 
(n=46) was defined as a “simple stenting group” and comprised patients in whom single or 
Table 2. Clinical characteristics (n=70 patients)
IQR indicates interquartile range.
Protected left main indicates LM disease with at least 1 patent arterial or ve-
nous conduit to the LAD or CX.
*Blood pressure > 160/95 mmHg or treatment for hypertension. †Total choles-
terol >200 mg/dl or treatment for hypercholesterolemia.
Age, y, mean±SD 61.2±10.7
Male, % 83
Cardiac risk factors
   Hypertension, %* 44
   Hypercholesterolemia, %† 90
   Diabetes mellitus, % 19
   Current smoking, % 29
   family history of coronary artery disease, % 54
Body mass index (kg/m2), median (IqR) 26.2 (24.2-28.6)
Previous PCI, % 29
Protected left main, % 17
Serum creatinine, mg/dl, mean±SD 1±0.23
Previous heart rate-lowering medication, % 87
Table 1. Reasons to exclude performance of MSCT (n=21 patients)
* This exclusion criterion only applied to patients analyzed with the 16-slice MSCT scanner. 
† Other reasons for exclusion were: patient refusal, hearing disability, and presence of an implantable cardioverter defibrillator. 
Reason for exclusion No. of patients
Patients with exclusion criteria 17
   Renal insufficiency 2
   Respiratory insufficiency 1
   Contra-indication to ¯-blocker (poor left ventricular function) 4
   Obesity (BMI> 30 kg/m2)* 3
   Atrial fibrillation 3
   Acute coronary syndrome 1
   Other† 3
Technically inadequate MSCT scan 4
   Arrhythmia during the scan 1
   Breathing artifact 1
   Heart rate >70 bpm 1
   Scan failure 1
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overlapping stents were implant-
ed in the LM stem alone (n=14) 
or in whom they extended from 
the LM stem into only the LAD 
or the CX (n=32). The second 
group was defined as a “com-
plex bifurcation stenting group” 
and comprised patients in whom 
the LM stem and both the LAD 
and LCX were stented (n=24). 
Further details are presented in 
Table 3.
 
Overall MSCT results
The diagnostic accuracy of 
MSCT is summarized in Table 4. 
On the basis of conventional an-
giography, ISR occurred in 14% 
of the patients (10/70). In the 
overall population, MSCT iden-
tified all patients with restenosis 
and correctly classified 55 pa-
tients as having no ISR (Figures 
1 and 2). In the group of pa-
Table 3. Procedural Characteristics (n=70 patients)
IQR indicates interquartile range.
* Express stent (Boston Scientific).† Bx Velocity stent (Cordis).
‡ Additional balloon dilatation of the other branch vessel in 3 patients. 
§ Kissing balloon postdilatation in 14 of the 15 patients.
No. and type of stents n=162
  Stents per patient, median (IQR) 2 (1-3)
  Paclitaxel-eluting stent, n (%)* 123 (76%)
  Sirolimus-eluting stent, n (%)† 31 (19%)
  Bare metal stent, n (%)† 8 (5%)
Stent and balloon size
  Nominal stent diameter, mm, median (IQR) 3 (3-3.5)
  Postdilatation with bigger balloon, % 63
  Balloon size for postdilatation, mm, median (IQR) 4 (3.5-4)
Stenting technique 
  Simple stenting, n (%) 46 (66%)
    Stent only in LM, n 14 
    Stent from LM to LAD/ LCX, n‡ 25/ 7 
  Complex Bifurcation Stenting, n (%) 24 (34%)
    Culotte stenting, n§ 13
    Crush stenting, n§ 2
    T-stenting or V-stenting, n 9
Table 4. Diagnostic accuracy of MSCT to detect ISR as defined by CCA
Simple stenting group includes patients who underwent stenting of the LM stem only or stenting of the distal LM extending into a 
single major side branch. The complex bifurcation stenting group comprises patients in whom the LM stem and both the LAD and 
CX were stented. Values in parentheses are 95% CIs.
All patients Simple stenting Complex bifurcation stenting
Total No. 70 46 24
No. of true negatives 55 39 16
No. of true positives 10 6 4
No. of false negatives 0 0 0
No. of false positives 5 1 4
Sensitivity, % 100 (72-100) 100 (61-100) 100 (51-100)
Specificity, % 91 (82-96) 97 (87-99) 80 (58-92)
Accuracy, % 93 (84-97) 98 (89-99) 83 (64-93)
Positive predictive value, % 67 (42-85) 86 (49-97) 50 (22-78)
Negative predictive value, % 100 (93-100) 100 (91-100) 100 (81-100)
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tients (n=46) in whom simple stenting was 
performed, only 1 patient was incorrectly 
scored (false-positive) on MSCT.  By contrast, 
in the complex bifurcation stenting group 
(n=24), 4 patients who did not have rest-
enosis were scored as having ISR on MSCT. 
In 3 of the 5 false-positive scans, stent-relat-
ed high density artifacts at the level of the 
CX ostium, due to the complex stenting strategy used, precluded correct assessment of the 
lumen within the stent. Three false-positives occurred among those evaluated with the 16-slice 
scanner; the other 2 occurred with the 64-slice scanner. Numbers were too small to support 
a statistical comparison among the 2 scanner types. The characteristics of the patients with 
restenosis and the 5 patients with a false-positive scan are reported in table 5. Seven of the 
10 patients presented with restenosis in the ostium of the CX or intermediate branch. Three 
Figure 1. No evidence of ISR 5 months after culotte stenting 
(all DES) of the distal LM coronary artery: 3 overlapping stents 
toward the LAD (total stent length 60 mm, each stent with a 
diameter of 3.5mm) and 2 overlapping stents toward the CX 
(3.5x20 mm proximal and 3x32 mm distal). A, 64-slice MSCT 
coronary angiogram (volume-rendered 3D image), with stents 
in LM, LAD, and CX (arrows). B, Corresponding conventional 
coronary angiogram. C and D, The curved multiplanar recon-
structions show stent patency of LM, LAD and CX and confirm 
the findings on CCA. C, Struts overlapping the ostium of the 
CX (arrowhead). (A full color version of this illustration can be 
found in the color section).
Figure 2. Restenosis of the ostium of the CX 6 months after 
stenting of the distal LM (crush technique): 3 overlapping stents 
had been placed from the LM to mid-LAD (3.5x24, 3.5x8 and 
2.75x28 mm) and 2 overlapping stents toward the CX (each 
with a dimension of 3x20mm). A, 64-slice MSCT coronary an-
giogram (volume-rendered 3D image). The stents in LM, LAD 
and CX are clearly delineated (arrows). B, Corresponding CCA 
with restenosis in proximal CX (arrow). C and D, Curved multi-
planar reconstructions of CX and LAD with ISR of the proximal 
CX. Cross-section 2, with inset, illustrates the ISR which ap-
pears as hypoattenuating tissue within the stent reducing the 
stent lumen diameter by >50%. The proximal stent edge in 
the LM shows non-obstructive plaque with <50% reduction of 
the normal contrast-enhanced lumen (C, cross section 1, with 
inset). The cross section discloses a large plaque (between the 
arrowheads) with a calcified (outer rim) and noncalcified (inner 
rim) component. The bright zone represents the lumen. This 
was confirmed by CCA (B, arrowhead). (A full color version of 
this illustration can be found in the color section).
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patients were revascularized; 2 patients underwent re-PCI, and the third patient underwent 
CABG.
Ten patients presented with 11 de novo lesions in a previously untreated vessel segment, 
which required revascularization by PCI in 2 patients. All 11 lesions were correctly identified on 
MSCT; overestimation of lesion severity by MSCT occurred in 2 additional calcified lesions. In 
12 patients, the presence of nonsignificant (<50% stenosis) NIH in the LM (n=5), LAD (n=5) 
and CX (n=2) on diagnostic coronary angiography was correctly classified as nonobstructive 
on MSCT (Figure 3). 
Quantitative coronary angiography (QCA), IVUS, and MSCT
Quantitative coronary angiography (QCA) and IVUS data are shown in Table 6. The reference 
diameter and minimal lumen diameter of the patients who were wrongly classified did not dif-
fer from those who were correctly analyzed by MSCT (data not shown). Fifty-six nonconsecu-
tive patients (90 segments) had technically adequate IVUS examinations. NIH was present in 
Figure 3. 63-year-old as-
ymptomatic man under-
went invasive and noninva-
sive coronary imaging 19 
months after placement 
of 4 overlapping stents 
from LM toward LAD. A, 
CCA and C, correspond-
ing 16-slice MSCT coro-
nary angiogram (curved 
multiplanar reconstruc-
tion of LM and LAD). NIH 
presenting as a dark ec-
centric rim (C, arrow) was 
documented within the 
LM portion of the stent. D, Cross-sectional MSCT image confirms its nonobstructive nature (arrowhead). Although hardly visible 
with conventional angiography (A, arrowheads), NIH was clearly present on IVUS at the level of the proximal LM (arrowheads in B, 
longitudinal view, and in cross section 1). Cross section 2 is at the level of the origin of the CX and shows no signs of NIH.
Figure 4. Maximal value of NIH 
thickness as measured by IVUS 
as a function of degree of agree-
ment (expressed by the ∙-value) 
between IVUS and MSCT. This 
analysis includes all patients 
with technically adequate IVUS 
examinations (n= 56). Values 
of NIH thickness <0.4 mm are 
not related to a ∙-value, because 
values below this threshold are 
beyond the spatial resolution of 
currently available MSCT scan-
ners.
0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60
Maximal NIH thickness (mm)
0.00
0.20
0.40
0.60
0.80
1.00
A
gr
ee
m
en
t 0.58
0.63
0.75
0.74
0.78 0.77 0.81
0.85 0.84 0.83
A
gr
ee
m
en
t 
Chapter 16
304
31 patients (38 segments). On the 
basis of a ∙-value >0.8, which indi-
cates very good agreement between 
the 2 imaging techniques, ie, MSCT 
and IVUS, a cutoff value of 1 mm 
was identified in which NIH could be 
identified with good confidence by 
MSCT (Figure 4). This corresponded 
to a 30% diameter obstruction as de-
termined by QCA. 
Quantitative IVUS and MSCT stent 
data were available for comparison 
in 50 patients (Figures 5 and 6). The 
mean stent diameter was 3.4 ± 0.70 
mm with MSCT compared with 3.6 
± 0.6 mm with IVUS. The correla-
tion coefficient was significant (r = 
0.78, p < 0.001), but the Bland-
Altman analysis showed a systematic 
overestimation of the stent diameter 
by MSCT (mean difference 0.22 ± 
0.44 mm, p<0.0001). Mean stent 
area of MSCT compared to IVUS 
was 10 ± 3.3 mm2 versus 10.3 ± 
3.5 mm2. Bland-Altman analysis for 
stent area demonstrated good cor-
relation between both imaging tech-
niques (mean difference 0.35 ± 2.53 mm2, P=0.13; r = 0.73, P < 0.001). Only 11 patients 
presented sufficient lumen narrowing to compare IVUS with MSCT. As shown in Figure 7, 
correlations were moderate for quantifying the degree of diameter and area stenosis (r = 0.65 
and 0.55, respectively). 
Observer variability 
To assess internal validity, all MSCT datasets were analyzed twice by 2 observers. Interob-
server agreement for the detection of ISR or NIH was good to moderate (∙- value of 0.74 and 
0.6, respectively), whereas intraobserver agreement was very good in both situations (∙-value 
0.82).
Table 6. Quantitative angiographic and IVUS characteristics at follow-up
Values are mean±SD. CSA indicates cross-sectional area.  
*In nine patients entire analysis of the LM was not possible due to a deeply 
intubated guiding catheter.  
QCA, n 70
   Reference diameter LAD, mm 2.57±0.51
   Minimal lumen diameter LAD, mm 2.1±0.44
   Reference diameter CX, mm 2.11±0.63
   Minimal lumen diameter CX, mm 1.74±0.55
   Reference diameter LM, mm 3.29±0.6
   Minimal lumen diameter LM, mm 2.88±0.62
Quantitative IVUS
   Technically adequate IVUS pullback, n (%) 56 (80%)
   LAD, n 31
       Minimal lumen CSA, mm2  6.2 ± 2.54
       Stent CSA, mm2  9.23 ± 2.53
       Minimal lumen diameter, mm  2.76 ± 0.54
       Stent diameter, mm  3.39 ± 0.47
   CX, n 16
       Minimal lumen CSA, mm2  5.24 ± 2.35
       Stent CSA, mm2  7.67 ± 2.74
       Minimal lumen diameter, mm  2.54 ± 0.47
       Stent diameter, mm  3.1 ± 0.52
   LM, n* 47
       Minimal lumen CSA, mm2  9.40 ± 2.85
       Stent CSA, mm2  12 ± 2.62
       Minimal lumen diameter, mm 3.42 ± 0.52
       Stent diameter, mm 3.89 ± 0.44
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diSCuSSion  
Stent implantation in the LM and proximal LAD/CX provides the "best case scenario" for the 
use of MSCT in the detection of ISR for several reasons. First, stents implanted in the LM and 
proximal LAD/CX are relatively large; second, the LM and proximal LAD are usually running 
in an axial plane that corresponds to the scan direction, whereas the proximal CX generally 
runs in a slightly less favourable craniocaudal longitudinal plane; finally, this part of the coro-
nary tree is relatively protected from motion artefact.
Recent technical improvements, including improved z-resolution, faster tube rotation, and the 
development of dedicated filters for image reconstruction in the presence of stents, have also 
significantly improved the potential of MSCT to assess coronary stent patency. Furthermore, 
preliminary experience with 16-detector row CT scanners showed promise for the evaluation 
of stents in the LMCA.4,15 
The present study demonstrates that evaluation of stent patency in the LMCA is feasible with 
16-slice and the latest 64-slice MSCT scanners. The technique is reliable (accuracy of 98%) 
for the evaluation of patients with stenting of the LM and for those patients with distal left 
main bifurcation lesions, in whom only 1 of the major branch vessels (ie, the LAD or the CX) 
is stented. However, in patients who required complex bifurcation stenting, ie, treatment of 
the LM and both major side branches, reliability was significantly less (accuracy of 83%). The 
most obvious explanation is the large quantity of metal, involving up to 3 layers of struts for 
Figure 7. Correlation between MSCT and IVUS to quantify degree of in-stent area stenosis (A, Pearson correlation coefficient 0.55) 
and in-stent diameter stenosis (B, Pearson correlation coefficient 0.65).
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crush bifurcation stenting, at and around the ostium of the branch vessels, which is a major 
source of artifact on MCST. 
A few studies reported reasonable accuracy of MSCT to quantify the degree of coronary artery 
stenosis in untreated coronary arteries.16,17 This study reports on the quantification of stent 
dimensions and the amount of lumen narrowing within LMCA stents. Quantitative assessment 
by MSCT of stent diameter and area showed good correlation with IVUS. Not unexpectedly, 
metal-related artefacts, referred to as “blooming” effect, impair optimal visualization of the 
stent lumen and thus accurate quantification of lumen narrowing within the stent, especially 
for minor to moderate degrees of NIH. Nevertheless, NIH of > 1 mm thickness is recognized 
with sufficient sensitivity to allow the detection of clinically relevant restenosis in patients after 
LMCA stenting.  
LMCA stent implantation traditionally represented a relatively small proportion of PCIs. Until 
recently, more widespread applicability of this revascularization modality had been hampered 
by the high occurrence of ISR.9,18,19 The advent of DES has both significantly reduced resteno-
sis rates and improved long-term clinical outcome; this has already resulted in an increasing 
proportion of patients with LM disease being treated percutaneously.6,7 However, restenosis 
still occurs and when located in the LMCA may cause severe myocardial ischemia with po-
tential fatal consequences.19, 20 A noninvasive method for its detection, before clinical events 
occur, would be of major clinical value. The results of the present study indicate that current 
MSCT scanners may provide a reliable alternative to CCA. The low number of false-positive 
scans leading to “unnecessary” diagnostic coronary angiograms should in the light of poten-
tial serious consequences of LM ISR be acceptable.
Limitations of the study
The use of 2 different MSCT scanners in the present study might be criticized. However, the 
spatial resolution of the 16- and 64-slice scanner in the x- and y-axes has remained identical 
(0.4 mm) and only the resolution in the z-axis has improved with the 64-slice scanner. Because 
the LM and proximal LAD generally course in an axial plane, only the resolution in the x- and 
y-axes play a major role in the high-resolution visualization of these segments.
The rather high radiation dose of MSCT is a general limitation of the technique. However, new 
developments such as the recent introduction of dual-source CT scanners, systematically al-
low using ECG-pulsing, thereby significantly reducing patient dose. On the other hand, many 
physicians underestimate the radiation exposure of widely accepted imaging techniques such 
as CCA or technetium sestamibi scans that produce a dose as high as 5 to 20 mSv respec-
tively.21, 22 
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The rather low positive predictive value (67%) is related to the low prevalence of ISR in pa-
tients treated with DES and reflects the limitations of current CT technology. New technical 
advances, such as the development of flat panel detectors and the general trend in interven-
tional cardiology to use stents with thinner struts, will be beneficial for CT imaging of stents 
and reduce the number of false-positive scans.
The present study was limited by the relatively low number of patients with complex bifurcation 
stenting, because this group importantly affects the reported diagnostic accuracy data. None-
theless, it is unlikely that this proportion will increase in the near future given the tendency to 
treat bifurcation lesions through a more simple approach and use a second stent towards the 
side branch only when strictly necessary.23
Finally, only 2 stent types with similar strut dimensions were used in this study. These results 
do not necessarily apply to different stent types since parameters such as strut thickness and 
stent design importantly influence the amount of blooming effect and thus assessability of the 
lumen inside. 
ConCluSionS 
In combination with optimal heart rate control, current MSCT technology allows reliable non-
invasive evaluation of selected patients after LMCA stenting. A negative MSCT scan virtually 
rules out the presence of LM ISR and may therefore be an acceptable first-line alternative to 
CCA.
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A 39-year-old man underwent a complex percutaneous coronary intervention of the left main 
trifurcation due to unstable angina. Five paclitaxel-eluting stents were implanted success-
fully in the 3 major branches and left main trunk (Figure 1, panels A and B). Three months 
later follow-up 64-slice computed tomographic (MSCT) coronary angiography demonstrated 
excellent stent patency without signs of neointimal hyperplasia (Figure 2). Invasive coronary 
angiography and intravascular ultrasound (IVUS) confirmed these findings (Figure 1, panels 
C and D).
Current MSCT scanners provide a promising non-invasive alternative to conventional coronary 
angiography in the follow-up of patients after stenting of the left main coronary artery.
Figure 1. Two paclitaxel eluting stents (PES) were positioned simultaneously within the intermediate branch and circumflex artery 
(CX) together with balloon dilatation of the left anterior descending artery (LAD) to prevent plaque shift (panel A). The stent in 
the CX overlapped with a more distal stent in the same branch implanted at the start of the procedure.  Due to dissection of the 
LAD ostium another PES was positioned in the proximal LAD and a fifth stent was deployed in the left main trunk (not shown). 
The procedure was completed with kissing balloon inflations of the 3 branches using 2 guiding catheters (one 5 and one 6 French 
guiding catheter), as indicated by the arrowhead and arrow (panel B). Invasive coronary angiography showed perfect patency of 
the 3 branches (panel C). Intravascular ultrasound confirmed the absence of neointimal hyperplasia, as shown by the IVUS cross-
sectional image of the LMCA (panel D). b indicates balloon; CX, circumflex coronary artery; IB, intermediate branch; LAD, left 
anterior descending coronary artery; and s, stent.
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Figure 2. 64-slice CT coronary angiogram. Volume-rendered (panel A) and multiplanar reconstructed image (panel B) showing 
the stented left main trifurcation. The proximal stent edge in the left main trunk is well delineated (arrow). The lumen within the 
stents is clearly visible along the 3 branches of the trifurcation (panels C, D and E). It is obvious that the 4 stents, including the stent 
edges, are perfectly patent without signs of neointima hyperplasia.
Ao indicates ascending aorta; CX, circumflex coronary artery; IB, intermediate branch; LAD, left anterior descending coronary 
artery; RVOT,  right ventricular outflow tract.  (A full color version of this illustration can be found in the color section).
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aBSTraCT
Objective
To evaluate the performance of dual source CT coronary angiography (DSCT-CA) in the de-
tection of in-stent restenosis (≥50% luminal narrowing) in symptomatic patients referred for 
conventional angiography (CA).
 
Design/patients 
100 patients (78 males, age 62 (SD  10)) with chest pain were prospectively evaluated after 
coronary stenting. DSCT-CA was performed before CA. 
Setting
Many patients undergo coronary artery stenting; availability of a non-invasive modality to 
detect in-stent restenosis would be desirable. 
Results
Average heart rate (HR) was 67 (SD 12) (range 46-106) bpm. There were 178 stented le-
sions. The interval between stenting and inclusion in the study was 35 (SD 41) (range 3-140) 
months. 39/100 (39%) patients had angiographically proven  restenosis. Sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value (NPV) of DSCT-CA, calculated in 
all stents, were 94%, 92%, 77% and 98%, respectively.
Diagnostic performance at HR <70 bpm (n = 69; mean 58 bpm) was similar to that at HR 
≥70 bpm (n = 31; mean 78 bpm); diagnostic performance in single stents (n = 95) was 
similar to that in overlapping stents and bifurcations (n = 83). In stents ≥3.5 mm (n = 78), 
sensitivity, specificity, PPV, NPV were 100%; in 3 mm stents (n = 59), sensitivity and NPV were 
100%, specificity 97%, PPV 91%; in stents ≤2.75 mm (n = 41), sensitivity was 84%, specificity 
64%, PPV 52%, NPV 90%.
Nine stents ≤2.75 mm were uninterpretable. Specificity of DSCT-CA in stents ≥3.5 mm was 
significantly higher than in stents ≤2.75 mm (OR = 6.14; 99%CI: 1.52 to 9.79).
Conclusion
DSCT-CA performs well in the detection of in-stent restenosis. Although DSCT-CA leads to 
frequent false positive findings in smaller stents (≤2.75 mm), it reliably rules out in-stent rest-
enosis irrespective of stent size.
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inTroduCTion
Computed tomography angiography is a non-invasive diagnostic tool to visualize coronary 
arteries.1 The evaluation of stents is, however, hampered by the occurrence of high-density 
artifacts (‘blooming effect’) caused by the stent struts. These artifacts cause an apparent en-
largement of the stent and preclude appropriate assessment of the in-stent lumen.
In particular, the lumens of small stents, overlapping stents and bifurcation stents are difficult 
to assess.2 Motion artifacts may further hinder the evaluation of stents.3 Several investigations 
have evaluated the diagnostic performance of computed tomography in assessing stent pat-
ency or the presence of in-stent restenosis; 4-16  these studies have included patients with low 
heart rates and pre-scan preparation with ¯-blockers. 
The introduction of dual source 64-slice computed tomography scanners, with an improved 
temporal resolution,17 may be helpful to more accurately assess coronary stents.
In this study we evaluated the diagnostic performance of dual source computed tomography 
coronary angiography (DSCT-CA) for the detection of in-stent restenosis in patients with angi-
nal symptoms after stent implantation.
meThodS
Population 
From April 2006 to January 2007, 133 patients with chest pain and prior stent implantation 
were considered for inclusion in this prospective study. All patients were scheduled for diag-
nostic conventional angiography. Serum creatinine >120 µmol/l, irregular heart rhythm and 
known allergy to iodinated contrast agents were exclusion criteria. The recruitment procedure 
is described in figure 1. The institutional review board approved the study protocol and all the 
included patients gave informed consent. 
DSCT-CA protocol
All patients were examined with a dual source CT scanner (Somatom Definition, Siemens, 
Forchheim, Germany). The scanner design consists of two x-ray tubes and two detector arrays 
mounted at an angle of 90°. Scan parameters were: 120 kV, 330 ms gantry rotation time, 2 
x 32 x 0.6 mm collimation with z-flying focal spot for both detectors. Using this scan protocol, 
spatial resolution was 0.4x0.4x0.4 mm3.17 Pitch values were automatically adapted to the 
heart rate after an estimation based on the last 10 heartbeats preceding the scan, and varied 
between 0.20 and 0.43. Current x-ray tube modulation was used at full current for 25-70% of 
the R-R interval. Each tube provided a maximum of 412mAs/rotation. In patients with heart 
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rates <70bpm, x-ray exposure was (mean (SD)) 15.0 (4.1) mSv in men and 16.7 (5.0) mSv in 
women; in patients with heart rates ≥70bpm, x-ray exposure was 12.1 (2.6) mSv in men and 
13.7 (4.7) in women (values calculated  using ImPACT®, version 0.99x, St. George’s Hospital, 
Tooting, London, UK).
All patients received sublingual nitroglycerin just before scanning. Contrast agent (Iomeron® 
400 mgl/ml, Bracco, Italy) was injected into the antecubital vein at a flow rate of 5.0 ml/s, fol-
lowed by a saline chaser (40 ml). We calculated the contrast volume with the following equa-
Figure 1. inclusion procedure.
Inclusion procedure for the study (from April 2006 to January 2007). 
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tion: estimated scan time + scan delay (7s). The contrast volume varied between 60 and 100 
ml depending on the scan time, which in turn varied between 5 and 13 seconds. We used a 
bolus-tracking technique to synchronise the start of the scan with the arrival of contrast agent 
in the coronary arteries. A circular region-of-interest (ROI) was positioned in the ascending 
aorta and the scan was automatically started when a threshold of +100 Hounsfield Units was 
reached inside the ROI
 
Image reconstruction
Given the scanner geometry, a monosegmental algorithm using data from a single heartbeat 
obtained during a quarter gantry rotation was used for reconstruction. This translated into a 
temporal resolution equal to one-fourth of the gantry rotation time, that is, 330/4 = 83 ms.
First, 0.75 mm-thick images were retrospectively reconstructed during the mid-diastolic to 
end-diastolic phase. The position of the reconstruction window within the R-R interval varied 
according to the heart rate (from -400 ms before the R wave for low heart rates to -175 ms for 
high heart rates). Additional data sets were reconstructed during the end-systolic phase (from 
+400 ms after the R wave for low heart rates to +200 ms for high heart rates). The recon-
struction increment was 0.4 mm. The data set with the fewest motion artifacts was chosen for 
analysis and reconstructed using a dedicated sharp convolution kernel (B46f, ‘Heart View’). 
Quantitative coronary angiography (QCA)
A single observer unaware of the CT results examined the angiograms before contrast injection 
to identify the sites of stent implantation. The stents were then located within the coronary tree 
following a 17-segment modified AHA model, as previously described 18,19. Stents and stent 
edges, the latter defined as 5 mm-long coronary segments proximal and distal to the stents, 
were evaluated on multiple projections; luminal narrowing ≥50% was classified as significant 
(restenosis). A validated quantitative coronary angiography software (CAAS II®, Pie Medical, 
Maastricht, the Netherlands) was used to determine the minimal lumen diameter and derive 
the per cent diameter stenosis by means of the user-independent method of the interpolated 
reference diameter, using the angiographic catheter diameter as reference for calibration.20
DSCT-CA analysis 
Two experienced readers evaluated the DSCT-CA studies independently; the readers were 
unaware of the findings of conventional angiography. In the event of diverging opinions, a 
consensus was reached and used in the final analysis.  
Using axial images, multiplanar reconstructions (MPR) and curved MPR, the stents were vi-
sually screened for the presence of in-stent restenosis (≥50% lumen diameter reduction). 
When multiple stents were implanted contiguously to treat one lesion, they were considered as 
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one single lesion. The assessment of 
restenosis was based exclusively on 
the visualisation of the in-stent lu-
men. The presence of distal run-off 
was not considered as an indica-
tor of patency because retrograde 
or collateral filling in an occluded 
stent can also give distal contrast 
enhancement (figure 2). All stent edges, defined as 5 mm-long coronary segments proximal 
and distal to the stents, were also included in the evaluation. In the event of bifurcation stent-
ing, each of the three branches was evaluated. When the stent lumen was uninterpretable 
(e.g., obscured by high-density artifacts), and in-stent restenosis could not be excluded by 
DSCT-CA, stents were considered to have restenosis (worst case scenario) 6,7 for the purpose 
of the analysis. 
Statistics 
The statistical analysis was performed with SPSS, version 12.1 (SPSS Inc., Chicago, Illinois, 
USA.). Results are reported in accordance with the STARD criteria.21 Continuous variables are 
expressed as mean (standard deviation). Categorical variables are presented as counts and 
percentages. 
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 
DSCT-CA for the detection of ≥50% in-stent restenosis, as determined by QCA as reference 
standard, were computed in two subgroups defined as low heart rate and high heart rate; 
Figure 2. distal run-off as a criterion of pat-
ency.
The presence of distal run-off is not always asso-
ciated with stent patency. (A)A DSCT-CA curved 
multiplanar reconstruction shows a stented lesion 
consisting of 2 BX Velocity stents plus three Taxus 
stents (stent-in-stent) in the left anterior descend-
ing artery (LAD). In spite of the presence of distal 
run-off (asterisk), in-stent total occlusion is seen. 
(C-D) Stent cross-sections obtained as indicated in 
(A’) (magnification of (A)) show the appearances 
of a patent stent (C) and of a totally occluded stent 
(D), respectively.(B)  the corresponding conven-
tional angiogram demonstrates that, distally to the 
stents (empty arrowheads), the LAD (asterisk) is 
fed by collateral flow (solid arrowheads). Direct vi-
sualisation of the stent lumen is therefore manda-
tory to rule-out in-stent restenosis with DSCT-CA.
DSCT-CA, dual source coronary computed tomog-
raphy angiography.
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the definition of the two groups was based on a cut-off heart rate of 70 bpm as previously 
described by Leber et al22 and Mollet et al19. The low heart rate subgroup comprised patients 
with heart rates <70 bpm, the high heart rate subgroup comprised patients with heart rates 
≥70bpm.
Sensitivity, specificity, PPV and NPV were then computed in two subgroups defined as simple 
configuration and complex configuration: the simple configuration subgroup comprised le-
sions treated with the deployment of one single stent; the complex configuration subgroup 
comprised overlapping stents and bifurcation stenting. 
We also computed sensitivity, specificity, PPV and NPV in three subgroups defined by stent 
diameters, that is, ≥3.5mm, 3mm and ≤2.75mm. When multiple stents were employed to 
treat one lesion, the diameter of the proximal stent determined the diameter subgroup. This 
criterion for subclassifying lesions with multiple stents was based on the expectation that small 
stents were more difficult to evaluate than large stents; we preferred to underestimate the di-
agnostic performance in the larger stent subgroups rather than overestimating the diagnostic 
performance in the smaller stent subgroup. 
Sensitivity, specificity, PPV and NPV were also computed separately for the right coronary 
artery (RCA), left main (LM) stem, left anterior descending (LAD) and left circumflex (LCx) ar-
teries.  Because the accuracy of DSCT-CA to detect occluded stents might be greater than the 
accuracy to detect restenosis, we performed separate analyses after excluding totally occluded 
segments. Diagnostic test results are presented with corresponding 95% confidence intervals 
based on binomial probabilities. The Â2 test was used to compare the frequency of occurrence 
of restenosis in the different subgroups. The Mann-Whitney U test was used to compare the 
mean stent diameters in the heart rate subgroups and in the configuration subgroups.
We determined the effect of heart rate, stent configuration and stent diameter on sensitivity, 
specificity, PPV, and NPV using logistic regression analysis including patient identification to 
correct for possible correlation within the individuals who had multiple stents.23 To compen-
sate for multiple testing, we used a significance level of 0.01 and computed 99% confidence 
intervals (CI).  
Interobserver and intraobserver agreement for the detection of restenosis were determined by 
∙-statistics. 
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Table 1. Baseline characteristics, angiographic findings and stent types
Patient number 100
Age and gender
Age (years) (mean (SD)) 62 ± 10
Men/women 78/22
Cardiovascular risk factors: (number)  
Obesity (Body Mass Index ≥ 30 Kg/m2) 23
Smoking 25
Hypertension (≥160/95 mmHg or ongoing treatment) 45
Serum cholesterol >200 mg/dL (5.18 mmol/L) 51
Diabetes mellitus 21
Family history 29
Total number of stents used and types 247
Drug-eluting stents 157
Bare metal stents 90
frequency of individual diameters and types (number (%))
2.25 21/247 (9%)
2.5 31/247 (13%)
2.75 17/247 (7%)
3.0 82/247 (33%)
3.5 63/247 (25%)
4.0 20/247 (8%)
4.5 8/247 (3%)
5.0 5/247 (2%)
Taxus 136/247 (55%)
Cypher 21/247 (8%)
BX Velocity 32/247 (14%)
R Evolution 21/247 (8%)
NIR 7/247 (3%)
Multilink 4/247 (1.5%)
Palmaz-Schaz 4/247 (1.5%)
Other BMS* 22/247 (9%)
Number of lesions and stent types ( number (%)) † 178
Drug-eluting stents 113 (63%)
Bare metal stents 65 (37%)
Vessel implanted: number (%)
RCA 60 (34%)
LM stem 11 (6%)
LAD 58 (32%)
LCx 49 (28%)
323
Dual source coronary computed tomography angiography for detecting in-stent restenosis
*Type not available (implanted before 2003)
†One stent-in-stent implantation consisting of 2 BX Velocity plus 3 Taxus stents was classified as BMS; all other complex 
lesions consisted of stents of the same type.
Patients diagnosed with ≥50% restenosis (number) 39
Lesions with ≥50% restenosis (number (%)) 39/178 (22%)
Restenosis 22/39 (56%)
Total occlusion 17/39 (44%)
Stent types with restenosis (number (%))
Drug-eluting stents 12/113 (11%)
Bare metal stents 27/65 (42%)
reSulTS
Baseline characteristics and angiographic findings
Of the 133 patients screened for inclusion in our study, 33 were excluded because of serum 
creatinine level >120 µmol/l (n= 4 ), known contrast allergy (n = 3), irregular heart rate (n 
= 6) and refusal to undergo DSCT-CA (n = 20), so that 100 patients underwent DSCT-CA 
(figure 1).
DSCT-CA and conventional angiography were performed 35 (SD 41) months after stenting 
(range 3-140 months). Seventy patients were on treatment with ¯-blockers; none of the pa-
tients received additional ¯-blockers before the scan. The average heart rate during the scan 
was 67 (SD 12) (range 42-106) bpm. Sixty-nine patients had heart rates <70 bpm and were 
included in the low heart rate subgroup (the average heart rate in this subgroup was 58 (SD 
6) (range 42-69) bpm); 31 patients had heart rates ≥70 bpm and were included in the high 
heart rate subgroup (the average heart rate in this subgroup was 78 (SD 9) (range 70-106) 
bpm).
We examined 178 stented lesions (247 stents used, 1.4 (SD 0.8) stents per lesion); 95 lesions 
consisted of single stents (simple configuration subgroup); the remaining 83 lesions consisted 
of overlapping stents (n = 62) and bifurcations (n = 21) (complex configuration subgroup). 
All but one complex lesions consisted of stents of the same type. One complex lesion was a 
stent-in-stent implantation consisting of two partially overlapped BX Velocity stents plus three 
Taxus stents implanted 1 year later (figure 2); this lesion was classified as a bare metal stent 
(BMS) lesion. BMS accounted for 37% (65/178) of the stented lesions, drug-eluting stents 
(DES) accounted for 63% (113/178) of the stented lesions. Restenosis was diagnosed angio-
graphically in 39/178 (22%) stented lesions in 39/100 (39%) patients. Restenosis was found in 
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27/65 (42%) BMS and in 12/113 (11%) DES. Table 1 summarises patient baseline character-
istics, main angiographic findings and stent types.
The frequency of in-stent restenosis was 23% (29/124) in the low heart rate subgroup and 
19% (10/54) in the high heart rate subgroup. In the simple and complex configuration sub-
groups, frequencies were 18% (17/95) and 26% (22/83), respectively. In the ≥3.5 mm, 3 mm 
and ≤2.75 mm subgroups, frequencies of restenosis were 19% (15/78), 20% (12/59) and 
31% (13/41), respectively. All p-values were not significant (p > 0.05).
The mean stent diameter in the entire sample was 3.15 (SD 0.58). The mean stent diameters 
in the simple and complex configuration subgroups were 3.16 (SD 0.60) mm and 3.15 (SD 
0.61) mm, respectively. The mean stent diameters in the low and high heart rate subgroups 
were 3.17 (SD 0.61) mm and 3.15 (SD 0.66) mm, respectively. All p-values were not signifi-
cant (p > 0.05). 
Diagnostic performance of DSCT-CA
All 178 stented lesions were detected by DSCT-CA. The stent lumen was judged interpretable 
in 169/178 (95%) stents. In the remaining nine stents (5%), all of which were ≤2.75mm in 
diameter, the lumen was uninterpretable due to high-density artifacts obscuring the in-stent 
lumen; these stents were scored as having in-stent restenosis. However, these nine small stents 
were angiographically normal (no in-stent restenosis, DSCT-CA false positives). 
Sensitivity, specificity, PPV and NPV in detecting ≥50% restenosis, calculated on all stents, 
were 94%, 92%, 77% and 98%, respectively. The diagnostic performance of DSCT-CA at 
heart rates <70bpm did not differ significantly from that obtained at heart rates ≥70bpm, as 
witnessed by widely overlapping confidence intervals. The diagnostic performances obtained 
in simple stents and overlapping stents/bifurcations were also similar. Likewise, no significant 
differences were seen between the four major coronary vessels. Table 2 gives sensitivity, speci-
ficity, PPV and NPV obtained in the heart rate subgroups, in simple and complex configuration 
subgroups and in the four major coronary vessels. 
In the diameter-based subanalysis, we found that NPV was in the range 90-100% in all sub-
groups. Sensitivity was 100% in ≥3.5 mm stents and in 3 mm stents, but it dropped to 84% in 
≤2.75 mm stents. Specificity and PPV were both 100% in the ≥3.5 mm subgroup; the values 
for specificity and PPV were 97% and 91%, respectively, in the 3 mm subgroup, and 64% and 
52%, respectively, in the ≤2.75 mm subgroup. Table 2 gives the diagnostic performance of 
DSCT-CA in detecting ≥50% luminal narrowing in the different diameter subgroups.
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In the logistic regression analysis predicting specificity, a stent diameter of ≥3.5 mm had an 
odds ratio of 6.14 (99%CI 1.52 to 9.79). In predicting the PPV, a stent diameter of ≥3.5 mm 
had an odds ratio of 3.70 (99%CI 0.98 to 8.90). All other variables were not significant. 
The interobserver agreement in detecting restenosis was good (∙- value = 0.78). The intrao-
bserver agreement was very good (∙- value = 0.87).
diSCuSSion
Cardiac catheterization is the technique of choice for the detection of in-stent restenosis. How-
ever, it may involve life-threatening complications and is relatively expensive. The diagnostic 
accuracy of non-invasive techniques such as exercise testing is known to be suboptimal;24 
therefore an alternative non-invasive ‘gatekeeper’ to invasive coronary angiography would be 
desirable. The reliability of such a technique would have to be demonstrated in various clinical 
situations (i.e., various stent sizes and configurations, higher heart rates) before it could be 
routinely used in patients with prior coronary artery stenting. 
Feasibility of DSCT-CA at high heart rates
This study showed that DSCT-CA was accurate in detecting in-stent restenosis without the 
use of pre-scan ¯-blockers. Although the rate of false positives was slightly higher at high 
heart rates (PPV = 69%) than at low heart rates (PPV = 80%), the number of false negatives 
was low in both subgroups (NPV in the range 97-98%). In addition, the capability to perform 
DSCT-CA at higher heart rates without the use of ¯-blockers may be advantageous in terms 
of reducing radiation exposure. Table speed increases with increasing heart rates in DSCT-CA, 
which in turn translates into shorter scan times and reduced radiation exposure. 
Stent configurations
To the best of our knowledge, the population evaluated in the present study is the largest 
available in the literature on coronary CT angiography including overlapping and bifurcation 
stenting (n = 83). Although the differences were not statistically significant, we found that 
specificity and PPV of DSCT-CA in bifurcation stenting and overlapping stents were slightly 
lower than those obtained in single stents, probably due to the large amount of metal at the 
ostium of side branches and at overlapping sites. This excess of metal is a major source of 
high-density artifacts in CT and may lead to lesion overestimation (figure 3). 
It may be argued that restenosis occurs more frequently in patients with complex lesion char-
acteristics than in patients with simple lesions.25 This might have led to an overestimation of 
sensitivity in our complex configuration subgroup. However, the difference between the fre-
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quency of restenosis in our simple and complex configuration subgroups was not statistically 
significant. 
Stent diameters
We found that stent diameter was the most important feature influencing the diagnostic per-
formance of coronary CT angiography. This is in keeping with the findings of Gilard et al. 8 and 
of Rixe et al.13, who performed 16-slice CT coronary angiography and 64-slice CT coronary 
angiography, respectively, in patients with low heart rates. In those studies though, up to 50% 
of the stents were judged unevaluable. With DSCT-CA, we judged unevaluable only 5% (n = 
9) of the stents, and found a low rate of false negatives irrespective of stent diameter (NPV 
in all stents = 98%, NPV in stents ≤2.75mm = 90%). When stent diameter was ≤2.75mm, 
DSCT-CA had a high rate of false positives (specificity = 64%; PPV = 52%) and could not 
predict with certainty the presence of restenosis; in particular, the specificity of DSCT-CA in this 
subgroup was significantly lower than that obtained in stents ≥3.5mm (OR = 6.14; 99%CI: 
1.52 to 9.79). Therefore our study confirms that DSCT-CA is not a suitable gatekeeper to 
conventional angiography in symptomatic patients with ≤2.75mm stents.
Figure 3. Bifurcations
Patient with in-stent restenosis 6 
months after crush-stenting. (A)
A volume-rendered DSCT-CA im-
age shows bifurcation stenting of 
the left anterior descending artery 
(LAD) and second diagonal branch. 
The stent in the diagonal branch 
(side branch) has a diameter of 
2.25 mm; the stent in the LAD 
(main branch) has a diameter of 4 
mm. (B) MPR image (C) MPR cross-
section obtained at the level of the 
carina, and (D) corresponding con-
ventional angiogram demonstrate 
restenosis in the diagonal branch 
(arrowhead); the main branch is 
patent. In (B), note the typical CT 
appearance of the crush technique, 
characterized by three layers of 
metal crushed against the ostium of 
the side branch.
MPR, multiplanar reconstruction 
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In a recent study, Cademartiri et al.4 reported the relationship between diagnostic accuracy 
of 64-slice CT and stent size in terms of the rate of false diagnosis (false positives and false 
negatives). In contrast with our findings, the rate of false diagnosis reported in that study did 
not decrease with increasing stent diameters. In stents <3mm, the rate of false diagnosis was 
6.1%; in 3mm stents, the rate of false diagnosis was 1.6% and surprisingly, in stents >3mm, 
the rate of false diagnosis was 12%. An explanation of these findings compared to our study is 
that only patients with stents larger than 2.5mm were included. Secondly, complex stent con-
figurations such as overlapping stents and bifurcation stenting were not included in that study, 
which may have led to an overestimation of the diagnostic performance in smaller stents. 
Lastly, a 64-slice CT scanner was used, rather than the dual source CT scanner in this study.
It is conceivable that future developments in CT technology might further increase the diag-
nostic performance in patients with stents by improvements in spatial (eg, flat panel technol-
ogy) and temporal resolution.
Totally occluded stents
Totally occluded stents might be easier to recognize on DSCT-CA. In our sample, 17 stents 
were totally occluded. Overall, the analysis after exclusion of totally occluded segments yielded 
similar sensitivity, specificity and NPV but lower PPV (Table 2). 
Study limitations
We examined a selected symptomatic patient cohort; applicability to a wider population may 
therefore yield different results. This limitation was inevitable in order to compare DSCT-CA to 
the reference technique, i.e., conventional coronary angiography. 
X-ray radiation exposure is a general limitation of multi-slice CT coronary angiography.26,27 
However, using x-ray tube modulation, full dose radiation may be given for a shorter duration 
of the cardiac cycle than used in this study. Radiation dose is further reduced by automated 
pitch adaptation with higher heart rates. Other widely accepted imaging techniques, such as 
technetium sestamibi scans, may deliver radiation doses as high as 20mSv.26,27
Conclusions
This study shows that, in patients with recurrent chest pain after stent implantation, DSCT-CA 
performs well in the detection of in-stent restenosis. Stent diameter is an important predictor 
of DSCT-CA diagnostic performance; when stent diameter is ≤2.75mm, the technique is as-
sociated with frequent false positives. However, due to the high NPV, DSCT-CA reliably rules-
out in-stent restenosis irrespective of stent size.
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aBSTraCT
Objectives
We sought to evaluate the diagnostic performance of a traditional work-up as compared to CT 
coronary angiography (CTCA) in symptomatic patients after previous percutaneous coronary 
stent implantation.
Background
Patients with recurrent chest pain after percutaneous coronary intervention (PCI) are tradition-
ally investigated using exercise electrocardiography (ex-ECG), myocardial perfusion imaging 
(MPI) and dobutamine-stress echo (DSE) or by direct referral for a conventional coronary 
angiogram (CCA).
 
Methods
Fifty-one consecutive symptomatic patients underwent dual-source cardiac CT and CCA in 
addition to a traditional work-up consisting of ex-ECG, MPI, DSE. All angiograms were evalu-
ated for in-stent restenosis and the presence of disease progression at non-PCI sites. 
Significant disease was defined by quantitative coronary angiography (QCA) as the presence 
of ≥ 50% lumen diameter stenosis. 
Results
According to QCA, 40/51 patients (78%) presented with restenosis (11 patients) or progres-
sion of native vessel disease (29 patients). On a patient level, the sensitivity of CTCA (98%, 
95%CI  93-100%) was significantly higher (P <0.05) than that of the traditional work-up (65%, 
95%CI  50-80%) whereas specificity was identical (55%, 95%CI  25-84%; P=NS). 
Revascularization was performed in 36 of the 40 patients with angiographically significant 
disease.
A negative CTCA reliably excluded the need for revascularization. By contrast, in the presence 
of a negative or inconclusive functional test, the probability of revascularization was as high 
as 60%. 
Conclusions
CTCA improves the traditional diagnostic work-up of symptomatic patients with previous per-
cutaneous coronary stent implantation. Ideal candidates for CTCA prior to CCA are patients 
with a negative or inconclusive stress test.
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after previous percutaneous coronary stent implantation.
inTroduCTion
Percutaneous coronary intervention (PCI) for symptomatic patients with coronary artery dis-
ease is a well established therapy.(1) Currently, more than 90% of PCIs involve the implanta-
tion of a coronary stent.(2) Drug-eluting stents are increasingly being used and actually com-
prise ~50% of the stenting procedures because of their increased efficacy to reduce in-stent 
restenosis (ISR).(3) The recurrence of symptoms in patients, requiring additional coronary 
intervention at 5 years follow-up in 20%, after an initial successful PCI may either be caused 
by progression of atherosclerotic disease in non-stented segments or from ISR.(4)  
Current ACC/ AHA guidelines advocate exercise stress testing, preferably combined with 
nuclear or echocardiographic imaging, for the initial work-up of symptomatic patients after 
previous PCI.(5) Due to its costs and invasive nature, catheter-based coronary angiography 
(CCA) is ideally restricted to patients with an abnormal functional test result. CT coronary an-
giography (CTCA) has emerged as a potentially useful alternative for CCA to assess coronary 
anatomy and larger stents (≥ 3mm). (6,7)  
In a consecutive cohort of 51 symptomatic patients after previous stent-based PCI, we sought 
to evaluate the diagnostic performance of CTCA as compared to a traditional approach us-
ing either: exercise electrocardiography (ex-ECG), myocardial perfusion imaging (MPI), dob-
utamine-stress echocardiography (DSE), or direct referral for CCA. We also compared the 
therapeutic decision based on this traditional work-up with CTCA. 
meThodS
Patient population
Between August 2006 and December 2007, we prospectively enrolled 51 consecutive patients 
who experienced recurrence of anginal symptoms after previously successful PCI and who 
were scheduled to undergo a CCA. The majority of the patients was recruited in referring 
community hospitals and underwent most of the diagnostic work-up, including CCA, in the 
referring hospital. The CTCA was performed in our institution on an outpatient basis, within a 
3-week period prior to CCA. Patients with prior coronary artery bypass graft surgery, previous 
PCI using small-diameter stents (stent diameter < 3mm), previous PCI for ISR with a resulting 
double layer of stents, and previously implanted tantalum, titanium or gold-coated stents were 
excluded, as well as women of childbearing age. Exclusion criteria for CTCA were: an irregular 
heart rhythm, inability to breath hold for 15 seconds, contraindications for heart-rate lowering 
drugs and IV contrast media (history of prior contrast allergy, renal insufficiency defined as 
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the presence of a creatinine clearance < 60 ml/min, as calculated with the Cockroft formula), 
and the presence of an implanted pacemakers or defibrillator. A flow diagram of the study is 
presented in Figure 1. The institutional ethical review board approved the study protocol. All 
participating patients gave informed consent.
CT based strategy: CT scan protocol and image reconstruction
Patients with a resting heart rate above 80 beats per minute (bpm) received oral beta-blockers 
(metoprolol 50-100 mg) 1 hour before the scan. For patients with astma we used an oral cal-
cium-antagonist (diltiazem 60-120 mg). An additional IV bolus of metoprolol (5-10 mg) was 
administered where the heart rate remained above 80 bpm. Nitrates were given sublinguallu 
(0.4 mg) to all patients 5 to 10 minutes before initiation of the scan.
The examination was performed using previously reported methodology.(8) In brief, all pa-
tients were scanned using a dual-source CT (DSCT) scanner (Somatom Definition, Siemens, 
Forcheim, Germany). A non-contrast-enhanced scan was not performed. The angiographic 
scan parameters were: individual detector collimation 32 x 2 x 0.6mm, gantry rotation time 
330 ms, tube voltage 120 kV, current of 412 mAs per tube. Pitch values were adapted to heart 
Figure 1. Flow diagram of the study.
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rate and estimated based on the last 10 heartbeats preceding the scan. Full x-ray tube cur-
rent was limited to 25-70% of the RR-interval. The tube current was reduced to 20% of the 
maximum tube current outside the ECG pulsing window.
Contrast material (Ultravist® 370 mg of iodine per ml, Schering AG, Germany) was delivered 
intravenously with a flow rate of 5.5 ml/sec, followed by 40 ml of saline flush at 5.5 ml/s. A 
bolus tracking technique was used to monitor the appearance of contrast material in the aortic 
root cranial to the origin of the left coronary artery. Once the signal in the ascending aorta 
reached a predetermined density level of +100 Hounsfield units, CT acquisition was automat-
ically started during an inspiratory breath hold. Images were reconstructed using ECG-gating 
to obtain optimal, motion free image quality.
The scan data were reconstructed with 0.75 mm slice thickness and 0.4 mm increment at vari-
ous phases of the cardiac cycle using medium-to-smooth (B26f) and sharp (B46f) convolution 
kernel. Datasets with least motion artefact were selected for further analysis. The non-stented 
vessel segments were evaluated using images generated with medium-smooth kernel. The 
segments that contained stents were evaluated using both medium-smooth and sharp kernel 
datasets.  
The effective radiation dose was calculated from the scan parameters using dedicated soft-
ware (ImPACT CT Patient Dosimetry Calculator, version 0.99x), as described in the European 
Guidelines on Quality Criteria for Computed Tomography (Available at: http://www.drs.dk/
guidelines/ct/ quality/index.htm). 
CTCA image interpretation 
Two experienced investigators (CVM, ACW), who were blinded to the patients’ clinical history 
as well as the angiographic data, interpreted each CT study independently, and subsequently 
a consensus reading was performed. Cardiac CT data were analyzed off-line using a Leon-
ardo workstation (Siemens Medical Solutions). All coronary segments, regardless of image 
quality, were visually scored for the presence of significant disease, which was defined as a di-
ameter reduction of ≥ 50%, by evaluating the original transaxial images and by using oblique 
and curved multiplanar reconstructions. A significant narrowing within the stent, including 
the 5mm vessel borders proximal and distal to the stent, was considered as ISR. A significant 
stenosis outside these borders was considered as progression of native vessel disease. Vessel 
segments with poor image quality that precluded reliable assessment were considered as hav-
ing significant disease.(9) Different window settings, including a window width/ window level 
setting of 1500 by 300 HU, were used for optimal stent assessment.
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Traditional work-up
The traditional work-up was defined as referral to CCA on the basis of typical clinical symp-
toms and/or a positive result on functional testing, including ex-ECG, MPI or DSE (Figure 1). 
The decision whether or not to use a functional stress test before proceeding to CCA was left 
to the discretion of the treating physician. In general, direct referral to CCA is considered a 
valid option for patients with typical anginal symptoms that substantially limit exertion or when 
presenting with unstable symptoms.(10)
Exercise electrocardiography (ex-ECG)
The exercise test was performed on a bicycle ergometer beginning at a workload of 25W and 
increasing by 25W every 2 minutes. Heart rate and blood pressure were recorded at rest and 
at the end of each stage of exercise. A 12-lead electrocardiogram was obtained each minute 
and 3-channel monitoring of cardiac rhythm was performed continuously. The exercise test 
was considered ‘positive’ when one of the following events occurred: ≥1mm horizontal or 
downsloping ST-segment depression or elevation measured 80 ms after the J-point during ex-
ercise or recovery, or occurrence of typical angina.(11) An exercise test without accompanying 
ST-segment changes or anginal symptoms was classified as inconclusive when the patient did 
not reach at least 85% of the maximum predicted heart rate.
 
Dobutamine-stress echocardiography (DSE)
Dobutamine was used as the stress agent for this examination and was administered through 
a peripheral vein starting at a dose of 5 µg/kg/min, followed by a dose of 10 µg/kg/min and 
further increasing by 10 µg/kg/min every 3 minutes to a maximum of 40 µg/kg/min. The 
infusion was stopped when 85% of age-predicted heart rate was achieved. Otherwise, dobu-
tamine infusion was continued and supplemented by atropine (up to a maximal dose of 1 mg). 
Echocardiographic images were acquired using the standard views at rest and during stress 
and recovery. The test was considered positive for significant coronary artery disease (CAD) if 
new or worsening wall motion abnormalities developed during stress.(12)
Myocardial perfusion imaging (MPI)
Myocardial perfusion single photon emission CT (SPECT) was carried out with symptom-lim-
ited bicycle exercise or pharmacologic (adenosine or dobutamine) stress. A two-day protocol 
was used with rest and stress images acquired on subsequent days. An intravenous dose of 
370 MBq technetium-99m tetrofosmin was administered approximately 1 minute before the 
termination of the stress test. For resting studies, 370 MBq technetium-99m tetrofosmin was 
injected at least 24 hours after the exercise study. Images were obtained with a triple-head 
gamma camera system without attenuation or scatter correction. The interpretation of the 
scan was performed by visual analysis. A reversible perfusion defect was defined as a perfu-
sion defect on stress images that partially or completely resolved at rest. A fixed perfusion 
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defect was defined as a perfusion defect on stress images that persisted on rest images. An 
abnormal study was indicated by the presence of a fixed or reversible perfusion defect (or 
both).(13) This was considered diagnostic of significant CAD.
Quantitative coronary angiography (QCA)
Invasive coronary angiograms were obtained in multiple projections after intracoronary nitrate 
administration with standard techniques. One experienced cardiologist (WBM), unaware of the 
results of the CT examination, identified all available coronary segments using a 17-segment 
modified American Heart Association classification.(14) All vessel segments with a reference 
diameter of at least 1.5mm were included for comparison with CTCA, except for segments 
distal to an occlusion. Stenoses were evaluated in the angiographic projection showing the 
most severe narrowing using validated, automated, quantitative software (CAAS II, Pie Medi-
cal, Maastricht, the Netherlands), and classified as significant if the lumen diameter reduction 
was ≥ 50%. 
Statistical analysis
Continuous variables are presented as mean ± standard deviation. Categorical variables are 
presented as counts and percentages. The diagnostic performance of CTCA for the detection 
of a significant coronary artery stenosis was calculated per patient, per segment, and per stent 
using QCA as the reference test and is presented as sensitivity, specificity, and positive- and 
negative predictive values. The diagnostic performance of the traditional work-up was calcu-
lated per patient using QCA as reference test with a positive test defined as a positive result 
on a non-invasive functional test or the presence of typical symptoms.(15,16) Precision of the 
diagnostic parameters is presented using 95% confidence intervals. The pairwise McNemar’s 
test was used to compare per-patient sensitivity and specificity of the traditional work-up and 
CTCA. For the analysis with revascularization versus no revascularization as outcome, the 
reference test used was a combination of QCA, fractional flow reserve and intravascular ultra-
sound. The predictive values of typical symptoms or the functional test result (i.e. the tradition-
al work-up) versus CTCA for predicting the need for revascularization (revasc) were calculated. 
Interobserver variability in the interpretation of CTCA was calculated using kappa-statistics. 
A two-sided p-value of <0.05 was considered statistically significant. Statistical analysis was 
performed with SPSS, version 11.5 (SPSS Inc., Chicago, USA).
reSulTS
Patient characteristics are summarized in Table 1. Twenty percent of the patients received ad-
ditional heart-rate lowering drugs resulting in an average heart rate of 64 ± 8.2 beats per min-
ute during CT data acquisition. The mean effective CT radiation dose was estimated as 18.1 
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± 4 mSv. The amount of contrast media 
used for the CT scan was on average 80.3 
± 10 ml. All 51 patients successfully under-
went CTCA without untoward side effects. 
The median time interval between CTCA 
and CCA was 1 day (range 0 to 20 days). 
The median time interval between PCI and 
CTCA was 522 days (range 16-2350 days).
A noninvasive functional test was available in 
35 patients: 25 patients underwent a symp-
tom-limited bicycle stress test, 7 patients 
underwent nuclear SPECT imaging and in 
3 patients a dobutamine stress echocardio-
gram (DSE) was performed. Sixteen patients 
were directly referred for CCA because of 
severe stable angina (n=8), residual angina 
after primary percutaneous coronary inter-
vention for myocardial infarction (n=5), or 
other forms of unstable angina (n=3). 
Traditional work-up versus 
CT coronary angiography. 
Diagnostic performance.  
According to QCA, 78% (40/51) of the 
patients presented with in-stent restenosis 
(11/51) or progression of native vessel dis-
Table 1.  Patient characteristics (n=51).
Values are mean ± SD, or number with percentage in paren-
theses. ACE denotes angiotensin converting enzyme, and ARB 
angiotensin-receptor blocker.
Variable Value
Age, yrs 61.4 ± 9.5
Men, n (%) 41 (80)
Body mass index, kg/m2    23.2 ± 3.7
Clinical presentation, n (%) 
   - stable angina 47 (92)
   - acute coronary syndrome 4 (8)
Hyperlipidemia, n (%) 47 (92)
Arterial hypertension, n (%) 23 (45)
Diabetes mellitus, n (%) 7 (14)
Current cigarette smoking, n (%) 5 (10)
Medication, n (%)
   - Aspirin 51 (100)
   - Beta-blocker 39 (76)
   - Calcium-channel blocker 15 (29)
   - Nitrates 18 (35)
   - Statin 45 (88)
   - ACE inhibitor or ARB 33 (65)
Creatinin clearance, ml/min 90.1 ± 26.7
Heart rate during CT scan, bpm 64 ± 8.2
Contrast amount during scan, ml 80.3 ± 9.9
Radiation dose estimate CTCA, mSv 18.1 ± 4 
Figure 2. Diagnostic performance of CTCA versus a tra-
ditional work-up (functional test or clinical symptoms) for 
the detection of significant coronary artery disease (n= 51 
patients).
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ease (29/51). Five of the 11 patients with ISR also showed significant disease in non-PCI 
sites. The diagnostic performance of CTCA versus a traditional work-up is shown in Figure 2. 
The sensitivity of CTCA (98%, 39 of 40 patients, 95%CI  93-100%) was significantly higher 
(P<0.05) compared to the traditional work-up (65%, 26 of 40 patients, 95%CI  50-80%); 
specificity was identical (55%, 6 of 11 patients, 95%CI  25-84%; P=NS). 
When we restrict the data to those 35 patients who had a functional test available before CCA, 
we found the following results (data not shown): sensitivity of 100% (28 of 28 patients, 95%CI 
94-100%) versus 50% (14 of 28 patients, 
95%CI  31-69%), specificity of 57% (4 of 7 
patients, 95%CI  20-94%) versus 86% (6 of 7 
patients, 95%CI  60-100%), for respectively 
CTCA and the traditional work-up. 
Figure 3. Patient with a 47% di-
ameter stenosis in the LAD (A, 
arrowheads). Corresponding 
CTCA (B, arrowheads). Nuclear 
SPECT stress image showing a 
reversible perfusion defect in 
the anteroapical region (C). 
The stents in the RCA (D and 
E, arrows) and CX (F, arrows) 
were patent both on CCA (D) 
and CTCA (E and F). Measure-
ment of the fractional flow re-
serve (FFR) across the lesion 
was within normal limits (value 
of 0.81). (A full color version of 
this illustration can be found in 
the color section).
Figure 4a. Patient with a significant stenosis (52% by QCA, A, 
arrow) in the distal RCA.   Corresponding CTCA showing a non-
significant narrowing at the corresponding spot (B, arrow). 
Figure 4b. The previously implanted stent in the CX artery 
was patent both on CCA(C) and CTCA (D, arrows). The take-
off of the RCA is also visible on the CTCA (D, arrowhead).
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Among the 15 patients with an incorrect functional test result, 10 were due to a false negative 
(n=7) or inconclusive (n=3) bicycle stress test, 4 were due to a false negative nuclear SPECT 
(n=2) or DSE (n=2), and 1 was due to a false positive nuclear SPECT (Figure 3). Six of the 
51 patients were incorrectly classified by CTCA: 1 patient, in whom the severity of disease was 
underestimated, showed a significant stenosis distal to the take-off of the posterior descending 
branch of the right coronary artery (Figures 4a and 4b). Five patients with angiographically 
nonsignificant disease were classified as having significant disease by CTCA (Figure 5). The 
interobserver agreement in the interpretation of CTCA on a patient level was very good (kappa 
value of 0.81). 
Diagnostic accuracy of DSCT coronary 
angiography: segment-based analysis.
Overall, 687 (of 867 theoretically available) segments were included for comparison with 
QCA. Sixty-nine segments were anatomically absent, 46 segments were located distal to an 
occlusion and 65 segments were smaller than 1.5mm. The sensitivity, specificity, positive and 
negative predictive values were 85% (71 of 84, 95% CI 77-92%), 96% (578 of 603, 95% CI 94-
97%), 74% (71 of 96, 95% CI 65-83%) and 98% (578 of 591, 95% CI 97-99%), respectively. 
The severity of 13 significant coronary stenoses was underestimated or missed and classified as 
non-significant by CTCA. All of these false negative interpretations were due to lesions located 
in distal segments (n=5) or in side branches (n=8). The severity of 25 non-significant lesions 
Figure 5. Patient with a 
functionally non-significant 
(fractional flow reserve value 
of 0.88 ) narrowing of the 
proximal LAD. The CCA shows 
minimal lumen narrowing 
(A, arrowhead). Correspond-
ing CTCA showing a calcified 
plaque at this spot (C, arrow-
heads), which was evaluated 
as causing significant lumen 
narrowing. The previously im-
planted stent in the RCA was 
patent both on CCA (B, arrows) 
and CTCA (D, arrows).
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was overestimated by CTCA: 
false positive interpretations 
were mainly related to severe 
vessel wall calcifications (n=14) 
or stent related artefacts (n=2). 
The interobserver agreement in 
the interpretation of CTCA on a 
segment level was good (kappa 
value of 0.71). 
Coronary stent analysis.
The stent characteristics are 
shown in Table 2. Seven differ-
ent stent types were evaluated, 
most of them (69%) being drug-
eluting stents. All stents had a 
diameter of ≥ 3mm (range 3 to 
4.5mm) and the majority of the 
patients (82%) had undergone 
single-vessel PCI. By QCA, ISR 
was present in 22% (6 of 27) of 
the bare metal stents and in 13% (8 of 60) of the drug-eluting stents. The diagnostic perfor-
mance of DSCT to detect ISR is summarized in Figure 6. The sensitivity, specificity, positive 
and negative predictive values were 100% (14 of 14, 95% CI 88-100%), 97% (71 of 73, 95% 
CI 94-100%), 87% (14 of 16, 95% CI 71-100%) and 100% (71 of 71, 95% CI 97-100%), re-
spectively. All 14 stents with ISR were identified by CTCA, whereas two stents were incorrectly 
considered as having significant 
disease.
 
Therapeutic decision.
Of the 40 patients with angio-
graphically significant coronary 
artery disease (CAD), 36 under-
went a repeat revascularization: 
1 patient received coronary ar-
tery bypass graft surgery, the 
other 35 underwent PCI. In 10 
patients additional information 
obtained by fractional flow re-
Table 2.  Stent characteristics (n=87).
# Drug-eluting stents that were implanted were the paclitaxel-eluting stent 
(n=51) using the Express 2 or Liberté stent platform, the sirolimus-eluting stent 
(n=4) using the Bx velocity stent platform, the everolimus-eluting stent (n=4) 
using the Multi-link Vision stent platform and the tacrolimus-eluting stent (n=1) 
using the S-stent platform. 
* Material: stainless steel, strut thickness: 0.091-0.14 mm. § Material: Cobalt-
chromium, strut thickness: 0.081 mm.
Variable Value
Stents per patient, mean (range) 1.7 (1-6)
Single- / multi-vessel PCI, number of patients (%) 42 (82)/ 9 (18)
Stent diameter, mm (range) 3.3 (3-4.5)
Drug-eluting stent, n (%)# 60 (69)
Stent type, n (%)
   - Express 2* 18 (21) 
   - Liberté* 37 (42)
   - Bx velocity* 11 (13)
   - R-stent* 9 (10)
   - NIR* 7 (8)
   - Multi-link Vision§ 4 (5)
   - S-stent* 1 (1)
Figure 6. Diagnostic performance of CTCA to detect in-stent restenosis. (n= 
87 stents)
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serve (n=9) or intravascular ultrasound (n=1) was necessary to guide the final therapeutic 
decision. A stratification of the CTCA data and those of the traditional work-up according to 
the final therapeutic decision, i.e. revascularization versus no revascularization, is shown in 
Tables 3 and 4. Importantly, a negative CTCA reliably excluded the need for revasculariza-
tion (Table 3), or put in other words, all ultimately revascularized patients were identified by a 
CTCA based approach. Of the 8 patients in whom the CT-based result did not match with the 
therapeutic decision, 5 had a functional test available that in all cases did not show signs of 
ischemia (4 tests negative, 1 test inconclusive). By contrast, in the presence of a negative or 
inconclusive functional test, the probability of revascularization was as high as 60% (12/20) 
(Table 4). All these 12 patients were correctly identified based on CTCA. The presence of an 
abnormal functional test (n=15) was almost always indicative of angiographically significant 
CAD and sufficient reason to revascularize: only one of the patients with an abnormal nuclear 
test did not show anatomically important epicardial CAD. 
Table 3. Stratification of the CTCA data according to the final therapeutic decision.
A negative/ positive CTCA is determined as: the absence or presence of significant coronary artery disease.
CTCA
Positive Negative Total
Therapeutic decision
   Revascularization 36 0 36
   No revascularization 8 7 15
   Total 44 7 51
Table 4. Stratification of the noninvasive functional and clinical data according to the final therapeutic decision.
A positive result on a “noninvasive functional test or typical clinical symptoms” is determined as: the presence of an abnormal 
functional test or typical anginal symptoms (in those patients in whom a functional test was not available). A negative result is 
determined as the presence of a normal or inconclusive functional test.
Noninvasive 
typical
functional test/ 
clinical symptoms
Positive Negative Total
Therapeutic decision
   Revascularization 24 12 36
   No revascularization 7 8 15
   Total 31 20 51
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diSCuSSion
Recent 64-slice CT technology has shown to be a robust non-invasive diagnostic modality to 
visualize the coronary arteries.(8,17) CTCA is recommended for symptomatic patients at inter-
mediate pre-test risk of having CAD in whom the presence of significant CAD can reliably be 
excluded.(7) Today, firm evidence is lacking that CTCA may be clinically useful in patients who 
have undergone coronary stent implantation, because the stent lumen is often obscured by 
significant blooming effects of the stent struts. This artefact is less cumbersome in large-sized 
stents and hence CTCA is indicated only in selected patients. 
The present study evaluated the value of dual-source CTCA in patients with recurrent angina 
after previous percutaneous coronary stent implantation. To provide a useful answer to this 
clinically relevant topic, we chose a study design that differed from previous reports by provid-
ing an assessment of the stented as well as the non-stented coronary artery segments and by 
comparing the diagnostic performance of CTCA with a traditional work-up that is currently 
used in routine clinical practice. Several conclusions can be drawn from this study. 
First, after a median follow-up of 1.4 years post PCI, 67% of patients had symptom recurrence 
related to progression of native CAD. Second, the diagnostic performance of CTCA was bet-
ter as compared to a traditional work-up. CTCA had high sensitivity to detect anatomically 
significant CAD in stented as well as non-stented segments, however non-invasive functional 
tests had better specificity. Third, CTCA correctly identified all patients who needed a repeat 
revascularization, however the low specificity resulted in 18% of patients in whom revascular-
ization eventually was not deemed necessary. By contrast, the rather poor sensitivity of non-
invasive functional tests resulted in significant underestimation of clinically relevant CAD and 
revascularization was deemed necessary in a fair number of patients who had a negative or 
inconclusive functional test result. Fourth, CTCA appears useful as it provides an alternative 
to CCA whenever further work-up is deemed necessary in case of a negative or inconclusive 
functional test. 
Advancements in CT technology have improved stent assessability, but even when using cur-
rent state-of-the-art 64-slice DSCT- technology, which provides the most optimal spatial and 
temporal resolution, factors such as stent size and material as well as strut thickness still have 
an important impact on the visualization of the stent lumen.(6,18-20) However, these studies 
have shown that diagnostic in-stent lumen visibility can be obtained for the majority of stents 
with a diameter of ≥ 3mm. Additional factors such as x-ray scattering in patients with high 
body-mass index, severe vessel wall calcifications and artefacts related to cardiac or respira-
tory motion, further hamper in-vivo imaging of coronary stents and are an important cause of 
non-diagnostic image quality.(21) 
Limitations.
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The current study only applies to a selected group of patients as we used stringent selection 
criteria: patients were only considered appropriate in case of a large stent diameter (≥ 3mm), 
with a relatively low metal density, and were treated with heart-rate lowering drugs despite the 
use of DSCT technology, to ensure optimal image quality. The decision to reduce the heart 
rate below 80 bpm, was based on our earlier experience with DSCT, where we demonstrated 
a higher proportion of non-diagnostic scans in patients with a heart rate above 80 bpm.(22) 
The effective radiation dose in our study was relatively high compared with previous reports, 
because we used a wide pulsing window (25% to 70% of the RR interval) in combination with 
the ¯-blocker induced lower heart rate, which results in a lower pitch and thus longer scan 
time.(23) A significant reduction in dose, well below 5 mSv, with preservation of optimal image 
quality can be achieved with newer 64-slice CT technology and also with very recent updated 
DSCT technology.(24) The design of our study could be criticized since not all patients had a 
functional test available before referral for a CCA. Some patients were instead referred to CCA 
because of the presence of typical symptoms, which in itself can be considered a positive test 
result given its high likelihood ratio.(16) In addition, most patients with a functional test were 
evaluated using ex-ECG instead of a functional imaging test, which may have caused the rela-
tively low diagnostic performance of the traditional work-up. We chose not to select patients 
on the basis of the availability of a functional imaging test because of potential selection bias. 
Furthermore, we believe that the enrolment of a consecutive patient group fits most closely 
with current medical practice and therefore contributes to the generalizability of the results. 
Note that referral to CCA was based on the traditional work-up and not on the CTCA result 
implying that verification bias (=post-test referral bias) may have overestimated the sensitivity 
of the traditional work-up but not of CTCA.(25) In spite of this potential bias we still showed 
that the sensitivity of CTCA was far higher than that of the traditional work-up.
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Ten years after its introduction as a new diagnostic technique, computed tomography coro-
nary angiography (CTCA) is still undergoing technical improvements underscoring the need 
to further improve image quality of the coronary arteries. From a technical point of view, high 
temporal and spatial resolution are the key factors determining the validity of CTCA as a 
non-invasive alternative to conventional coronary angiography (CCA). This thesis uses as a 
foundation the optimisations in technique that have been achieved so far and focuses on the 
clinical applications that appear reasonable at the current stage.
Interventional cardiology is a discipline that relies on accurate imaging of the heart and coro-
nary vasculature. The interventional cardiologist uses as a medium CCA, a catheter-based 
technique that allows selective contrast injection of the coronary arteries and “ in the same 
run” a targeted therapeutic intervention where appropriate. Contrary to the general belief, 
CCA does not always prove to be the gold standard technique for the visualization of the coro-
nary anatomy even in the hands of an expert angiographer. Indeed, the intrinsic limitations of 
an imaging technique that is inherently 2-dimensional make it sometimes impossible to ac-
curately assess the presence or severity of a coronary narrowing especially where the anatomy 
is complex. Furthermore, the “catheter-handling” itself needs to be performed with attention 
for detail in order to obtain an adequate and reliable visualisation of the coronary arteries. In 
chapter 2, we comment on the limitations of CCA and demonstrate that the 3-dimensional 
properties of CTCA help to resolve complex coronary pathology. In addition, the unique infor-
mation that is provided on the trajectory of a coronary artery or the composition of an athero-
sclerotic lesion may prove valuable in planning and guiding interventional procedures.
The emergence of CTCA is changing the basic image format we are using in daily practice 
to discuss on the subject of coronary artery disease (CAD). Instead of looking at the lumino-
graphic impact of atherosclerosis, we are now able to directly visualize the disease process in 
the vessel wall. As a result, the metrics we are using to describe CAD are being modified: a 
“significant coronary stenosis in the proximal LAD” is being rephrased as “the proximal LAD 
shows a noncalcified plaque causing significant lumen narrowing” or “the RCA has a normal 
appearance” becomes “the RCA shows a small calcified plaque in segment 2 without lumino-
graphic involvement”. In this thesis we report on the Integrated Biomarker and Imaging Study 
(IBIS), which evaluates the feasibility to detect subclinical atherosclerosis using 16-slice CTCA 
in combination with the assessment of changes in plaque characteristics using invasive imag-
ing modalities (Chapter 3 and 4). Compared with intravascular ultrasound (IVUS), CTCA can 
identify atherosclerotic plaque, in vessels with only minimal angiographic disease, with high 
sensitivity and moderate specificity. After 6 months of standard medical therapy, conventional 
imaging with quantitative coronary angiography and IVUS did not show significant changes in 
lumen or plaque dimensions of the atherosclerotic disease process. Similarly, plaque composi-
tion as assessed with IVUS echogenicity did not show temporal changes. However, significant 
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changes in plaque deformability or strain were evident on  IVUS palpography. Studies like 
IBIS are indicative of the paradigm shift that has recently occurred linking the occurrence of 
acute coronary syndromes to plaque disruption of non-flow-limiting stenoses rather than to 
gradual progression to complete occlusion of fixed, high-grade stenoses. As a noninvasive 
imaging modality, CTCA has potential to facilitate the identification at a preclinical stage of 
those individuals that harbour atherosclerotic plaques that are deemed to carry a high risk 
for rupture and ensuing acute coronary event. These so-called vulnerable plaques are most 
often characterized by positive remodelling of the vessel wall, a large lipid-rich necrotic core 
covered by a thin fibrous cap and surrounding intense inflammatory activity. Preliminary clini-
cal studies have reported on the feasibility to demonstrate compensatory vessel wall remod-
elling and plaque composition with CTCA. Novel invasive imaging modalities such as IVUS 
palpography, IVUS radiofrequency analysis and optical coherence tomography, have been 
developed to assess in more detail plaque biomechanical and compositional characteristics. 
Although promising, limitations in spatial resolution restrict the ability of CTCA to identify non-
calcified plaques to larger advanced lesions that are located in proximal and middle coronary 
segments. Furthermore, the plaque density measurements obtained with CTCA are only a 
rough estimate of the true plaque composition as they correlate linearly with the amount of 
attenuation derived from intracoronary contrast material: this phenomenon is a consequence 
of partial volume and interpolation artefact. Both artefacts combined result in averaging of 
the different attenuation profiles of the various tissues present within one voxel, in stead of 
preserving and showing the attenuation profile of each tissue type separate. It remains to 
be demonstrated whether these new approaches to assess vulnerable plaques will impact 
on the occurrence of acute coronary events in patients at highest risk. Chapter 5 illustrates 
the coronary plaque characteristics as assessed by CTCA in comparison to optical coherence 
tomography. Interlude 1 demonstrates the feasibility of CTCA to visualize noninvasively the 
angiographic visible and non-visible aspects of native CAD as well as to evaluate the bypass 
grafts in the revascularized patient.  
The assessment of coronary artery stenoses with CTCA was already demonstrated to be fea-
sible with the early 4-slice and 16-slice CT scanners. In this thesis we report on the diagnostic 
accuracy with 64-slice CT, which was introduced in 2004 (Chapters 6 and 7). The increase in 
spatial and temporal resolution that accompanies this new generation of CT scanner, results 
in an improved diagnostic performance while at the same time reducing the percentage of 
unevaluable coronary segments to less than 5%. These results remain valid in patients pre-
senting with acute coronary syndromes without ST-segment elevation (Chapter 7). 
Conventional coronary angiography should remain the preferred imaging technique for symp-
tomatic patients with a high pretest likelihood of significant coronary artery disease in whom 
anatomical assessment of the coronary vasculature is deemed necessary. As a new diagnostic 
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test, each new CT scanner version has been systematically validated against CCA, to assess for 
the presence or absence of obstructive CAD. By default, the patients that have been included 
in these validation studies almost invariably had a high pretest probability of significant CAD 
as all of them had an indication for CCA based on clinical grounds. Not unexpectedly, the 
value of a “normal” or “nonobstructive” scan result appears not rewarding in patients who 
based on clinical grounds already have a high pre-test probability of harbouring anatomically 
significant CAD, as the post-test probability of significant CAD in case of a negative CT scan 
remains as high as 17%. By contrast, the same CT scan result in symptomatic patients with 
a low-to-intermediate pre-test likelihood reveals a post-test probability of 0% and thus reli-
ably rules out the presence of significant CAD (Chapter 8). A well defined patient group who 
may benefit from this “CTCA-first” approach before referral for CCA are those patients who 
need to undergo cardiac valve surgery. Obstructive CAD that is left untreated at the time of 
cardiac valve surgery worsens prognosis. As a result most patients above the age of 35 cur-
rently undergo a CCA to preoperatively assess coronary anatomy. The pre-test odds of having 
significant CAD is relatively low in this patient population, averaging around 30%. We found 
that CTCA could effectively be implemented as a gatekeeper for CCA in this patient group, 
as most of them turned out to have normal coronary arteries or non-obstructive CAD and the 
post-test odds of significant CAD were zero in case of a negative CTCA (Chapter 9).
 
The addition of CTCA, a noninvasive anatomical test, to the current armamentarium of di-
agnostic tests creates the need for a reassessment of currently used diagnostic algorithms in 
patients with suspected CAD. We made a first attempt to assess the possible value of 16-slice 
CTCA within the diagnostic work-up of patients presenting with stable angina who under-
went an exercise stress test and subsequent CCA (Chapter 10). As expected the  prevalence 
of significant CAD was high (74%) in this patient group. We demonstrated a much higher 
diagnostic accuracy with CTCA as compared to exercise electrocardiography, which in addi-
tion turned out to be inconclusive in 15% of the patients studied. The purpose of a test in this 
population entails more than just diagnosing the presence of significant CAD, which is highly 
likely already based on the clinical symptomatology. More important is how the diagnostic test 
result would impact on the subsequent management of the patient. An exercise stress test 
showing severe ST-segment changes or an important drop in systolic blood pressure carries a 
poor prognosis for the patient and is a clear indication for coronary angiography and eventual 
subsequent revascularization. Although not proven in the current study, CTCA might be useful 
for those patients with a negative or inconclusive exercise stress test result: considering its high 
diagnostic accuracy, particularly in large-calibre coronary segments, CTCA could become a 
useful tool towards the exclusion of high-risk coronary anatomy such as left main- or triple 
vessel CAD. 
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Coronary artery disease can be evaluated from an anatomical and/ or functional perspec-
tive. Both approaches are not mutually exclusive but are rather complementary since both 
ways of assessment have test-related limitations. Today, even the most advanced dual-source 
CT scanners still have suboptimal spatial resolution as compared to catheter-based coronary 
angiography (0.4mm versus 0.2mm). When quantifying the degree of coronary artery lumen 
narrowing in percent diameter stenosis for lesions with at least 50% diameter reduction, the 
limits of agreement vary by 27% when comparing 16-slice CTCA with quantitative coronary 
angiography, the reference standard. Indeed, considering a 3mm coronary artery the dif-
ference between a 50% and 70% diameter stenosis would not be evident for a 16-slice CT 
scanner that features a spatial resolution of 0.6mm in optimal circumstances. This difference 
in spatial resolution explains the relatively low specificity of CTCA as compared to CCA. More 
than a decade ago, it was demonstrated that the angiographic interpretation, using QCA, of 
intermediate type severity coronary artery stenoses, usually reported in the range of 40% to 
70% narrowing, did not predict well the functional consequence of this type of stenosis, in 
other words whether a coronary narrowing significantly impairs coronary blood flow thereby 
causing myocardial ischemia. Using the same methodology, we demonstrated that an ana-
tomically significant coronary stenosis as determined by CTCA poorly predicts its hemody-
namic relevance (Chapter 11). Based on our observation and those of other investigators we 
recommend to use a combined approach with a functional test to decide upon further patient 
management whenever obstructive CAD is diagnosed on CTCA. In certain circumstances, 
invasively obtained functional information may be appropriate for this purpose (Interlude 3).  
The angiographic assessment by CCA of patients with anatomically complex CAD some-
times yields insufficient diagnostic information to confidently decide upon further appropriate 
therapy. Often a repeat CCA, with the associated risks of an invasive procedure, is performed 
to determine the exact lesion anatomy. We demonstrated that CTCA might be an excellent 
alternative for CCA in patients presenting with coronary bifurcation lesions or chronic total 
occlusions (Chapters 12 and 13, Interlude 4). Chronic total occlusions (CTOs) are a frequent 
observation in patients found to have significant CAD on CCA. Because of failure rates as high 
as 40%, percutaneous coronary intervention (PCI) is often not attempted in this type of lesion. 
We demonstrated that evaluation of CTOs by means of CTCA offers a better description of its 
anatomical features as compared to CCA and predicts procedural success in patients referred 
for PCI. More specifically, the presence of severe calcification, i.e. calcium occupying >50% 
of the vessel cross-sectional area, as determined by CTCA is an independent predictor of 
procedural failure. We also showed that the radiation exposure and amount of contrast used 
during a PCI attempt is considerable (Chapter 13). The judicious use of a preprocedural CTCA 
therefore makes sense and might modify the approach in case PCI is attempted or could drive 
the physician’s preference to an alternative therapeutic modality, i.e. medical treatment or 
bypass surgery. Magnetic navigation represents a novel technology that has been introduced 
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within the field of interventional cardiology with the aim to improve procedural success in 
coronary lesions with tortuous vessel anatomy and/or complex morphology. The incorporation 
of CT data into the magnetic navigation software allows to generate a detailed preprocedural 
pathway of the coronary artery to be treated, which facilitates the precise control of the direc-
tion of a guidewire in three-dimensional space (Chapter 14). 
Percutaneous coronary intervention (PCI) using stents has become the dominant form of 
revascularization. Although the advent of drug-eluting stents significantly reduced the occur-
rence of in-stent restenosis (ISR), symptoms still recur as a result of ISR or more often due 
to progression of atherosclerotic disease in non-stented segments. Improvements in CT scan 
technology and utilisation of dedicated filters and window settings have progressively improved 
the assessability of the lumen inside the stent (Chapter 15). Still, ISR evaluation continues to 
be difficult with CTCA due to the extreme blooming effect of the stent material. The bloom-
ing effect is a fairly constant phenomenon and therefore less evident in large diameter stents 
(Chapter 17). We demonstrated that for stents implanted in the left main coronary artery, 
CTCA may be useful to exclude the presence of ISR (Chapter 16, Interlude 5). To be useful 
in clinical practice, the overall patient-related diagnostic performance including stented and 
non-stented segments needs to be sufficiently high. Using dual-source CTCA in symptomatic 
patients with previously implanted large-diameter stents (≥ 3.0 mm), we found CTCA to be 
clinically useful for patients with a negative or inconclusive stress test (Chapter 18).
Conclusions and future perspective
Current 64-slice and dual-source 64-slice CT coronary angiography has a high diagnostic 
performance and in particular, is highly reliable to rule out CAD. It is now recommended for 
use in symptomatic patients with a low-to-intermediate pre-test likelihood of CAD, where a 
negative CT scan reliably rules out the presence of CAD and prevents patients from referral 
to CCA. CTCA overcomes the limitations of 2-dimensional CCA and justifies its use in patients 
with coronary anomalies. The transition to the broader group of patients with complex CAD is 
already happening in cathlab centres that provide PCI facility as it avoids performing a repeat 
CCA in case the initial angiographic assessment is deemed to be suboptimal. In patients with 
CTOs, CTCA helps to predict the chances of success of a PCI attempt and therefore might be 
useful in deciding upon the most appropriate therapeutic modality. In the post-revasculariza-
tion setting, CTCA currently provides only a niche application: after previous bypass surgery 
CTCA is useful to rule out obstructive disease in venous and arterial bypass grafts, evaluation 
of stenotic disease in native coronary arteries remains problematic. Post-PCI, CTCA may be 
useful in patients with larger stents (≥3.0 mm diameter); smaller stents cannot be reliably 
evaluated. Finally, the emergence of CTCA creates the need to reassess currently applied 
work-up strategies for patients with suspected CAD. Noninvasive access to coronary anatomy 
has become feasible and reinforces the importance of functional evaluation as a guide for 
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selection of therapy. Both approaches are not mutually exclusive but become rather comple-
mentary.
The clinical applications will benefit from further developments in CT technology. In particular, 
the challenges posed by extensive calcification or irregular cardiac rhythms will require novel 
technical approaches probably taking many years to be implemented in the in-vivo setting. 
For the time being, consolidating and conveying the knowledge already in existence, will help 
to embrace this fascinating new technology on a broader scale. We eagerly await the data of 
ongoing multi-center studies to see whether the results of highly performing research centres 
can be reproduced. Cost-effectiveness studies will be essential to establish the value of CTCA 
as compared to other diagnostic tests. The radiation risk is a matter of concern and is provid-
ing impetus for the development of dose-saving algorithms and new scanning protocols aim-
ing at reducing the effective radiation dose to the level of CCA. Finally, the fast development 
of CTCA has been the result of a successful interaction between 2 specialties, the cardiology 
and radiology community. To maintain this high level of expertise, is critical to ensure that 
those performing it have adequate training in the technique and adhere to guidelines issued 
by professional societies.

Samenvatting en Conclusies
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Tien jaar na haar introductie als een nieuwe diagnostische techniek, ondergaat CT coronair 
angiografie (CTCA) nog steeds technische verfijningen ten behoeve van verdere verbetering 
van de beeldkwaliteit van de coronair arteries. Een hoge temporele en spatiele resolutie zijn 
de voornaamste technische vereisten om CTCA te kunnen aanbieden als een niet-invasief 
alternatief voor conventionele coronair angiografie (CCA). Deze thesis bouwt voort op de ver-
beteringen in CT technologie die tot op heden werden gerealiseerd en focust op meest voor 
de hand liggende klinische toepassingen anno 2009. 
Interventionele cardiologie is een discipline die steunt op accurate beeldvorming van het hart 
en de coronaire vasculatuur. De interventiecardioloog maakt als medium gebruik van CCA, 
een catheter-gebaseerde techniek waarbij contrastvloeistof selectief in de coronair arteries 
wordt geïnjecteerd en waarbij indien geïndiceerd in dezelfde sessie een therapeutische in-
terventie kan worden gedaan. In tegenspraak met de gangbare opvatting is CCA niet de on-
omstreden “gouden-standaard” techniek voor visualisatie van de coronair arteries, zelfs wan-
neer ze wordt uitgevoerd door een expert in coronair angiografie. Het is inderdaad zo dat de 
2-dimensionele eigenschappen van CCA soms een beperkende factor zijn om een coronaire 
stenose en de ernst ervan goed in beeld te brengen, zeker wanneer de coronair anatomie 
complex is. Ook de cathetermanipulatie dient omzichtig en precies te gebeuren zodat de coro-
nair arteries adequaat en betrouwbaar in beeld worden gebracht. In hoofdstuk 2 bespreken 
wij de beperkingen van CCA en tonen wij aan dat de 3-dimensionele eigenschappen van 
CTCA toelaten om complexe coronair pathologie precies in beeld te brengen. Bovendien geeft 
CTCA unieke informatie aangaande het verloop van een coronair arterie of de samenstelling 
van een coronaire stenose, hetgeen waardevolle informatie is bij de keuze van het type revas-
cularizatie en de uitvoering van de revascularizatieprocedure zelf.
De implementatie van CTCA gaat gepaard met een verandering van het beeld “format” dat 
wij in de dagelijkse praktijk gebruiken bij discussie over het onderwerp coronaire atheroscle-
rose. In plaats van te kijken naar de impact van coronaire atherosclerose op het lumen, is 
het nu mogelijk geworden het primaire ziekteproces in de vaatwand te visualiseren. Bijgevolg 
is ook de terminologie die wij gebruiken om coronaire atherosclerose te beschrijven aan ve-
randering onderhevig: een “significante stenose in de proximale LAD” wordt nu omschreven 
als “de proximale LAD vertoont een niet-verkalkte plaque gepaard gaande met significante 
vernauwing van het lumen” of  “de RCA heeft een normaal angiografisch aspect” wordt  “de 
RCA vertoont een kleine gecalcifieerde plaque in segment 2 niet gepaard gaande met ver-
nauwing van het lumen”. In dit proefschrift bespreken wij de Integrated Biomarker and Imag-
ing Study (IBIS). Deze studie onderzoekt de diagnostische accuraatheid van 16-slice CTCA 
voor de detectie van subklinische atherosclerose en evalueert de verandering in plaque kara-
kteristieken over de tijd daarbij gebruik makende van invasieve beeldvormingsmodaliteiten 
(Hoofdstuk 3 en 4). In vergelijking met intravasculaire echografie (IVUS) heeft CTCA een 
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hoge sensitiviteit en matige specificiteit voor het aantonen van atherosclerotische plaque in 
bloedvaten met minimale angiografische afwijkingen. Na een standaard medicamenteuse 
therapie van 6 maanden, waren er geen veranderingen in lumen of plaque dimensies. Ook 
de plaque samenstelling bleef dezelfde bij evaluatie met IVUS “echogenicity”. Er traden wel 
significante veranderingen op in de biomechanische eigenschappen van de plaque zoals met 
IVUS “palpography” kan worden aangetoond. Studies zoals IBIS zijn een verdere uitwerking 
de huidige nieuwe inzichten in de pathogenese van atherosclerose, namelijk dat een acuut 
coronair syndroom meestal optreedt als gevolg van plaque ruptuur ter plaatse van niet-sig-
nificante vernauwingen in de vaatwand, in plaats van het progressief verder vernauwen van 
een significante stenose totdat er een occlusie optreedt. Mede omwille van haar niet-invasieve 
karakter, is CTCA een veelbelovende techniek om in het pre-klinische stadium individuen te 
identificeren die plaque karakteristieken vertonen die gecorreleerd zijn aan een hoger risico 
voor ruptuur en daaraan geassocieerd optreden van een acuut coronair syndroom.
Deze “vulnerabele plaques” worden meestal gekenmerkt door: positieve remodelling van de 
bloedvatwand, een grote vet-rijke kern die overdekt wordt door een dunne fibreuse laag, en de 
aanwezigheid van veel inflammatoire cellen voornamelijk in de rand van de lipidenrijke kern. 
In een aantal preliminaire klinische studies werd aangetoond dat het mogelijk is met CTCA 
de remodelling van de bloedvatwand en de samenstelling van de plaque in beeld te brengen. 
IVUS palpography, IVUS radiofrequentie analyse en “optical coherence tomography” zijn vrij 
nieuwe invasieve beeldvormingstechnieken die werden ontwikkeld om de biomechanische ei-
genschappen en samenstelling van de plaque te kunnen bestuderen. CTCA heeft beperkin-
gen in spatiële resolutie met als gevolg dat de techniek in hoofdzaak kan worden gebruikt 
voor de evaluatie van niet-verkalkte plaques in het proximale- of midden segment van de 
coronair arteries. Bovendien is het zo dat de densiteitsmetingen van de plaque door middel 
van CTCA slechts een ruwe inschatting toelaten van de reëele plaque compositie, aangezien 
de gemeten densiteitswaarde een lineaire correlatie vertoont met de mate van contrastvloe-
istofattenuatie:  dit fenomeen is een gevolg van 2 artefacten die optreden met CT, namelijk 
“partial volume” artefact en interpolatie artefact. De combinatie van beide artefacten result-
eert in een densiteitsmeting per voxel dat een gemiddelde is van elk van de weefselspecifieke 
attenuatieprofielen die in deze voxel aanwezig zijn, in plaats van ieder weefsel met zijn eigen 
densiteitsprofiel afzonderlijk weer te geven. Het dient nog te worden aangetoond dat deze 
nieuwe methoden om vulnerabele plaques te bestuderen het optreden van acute coronaire 
syndromen bij hoog-risico patiënten op een gunstige manier kunnen beïnvloeden. In hoofd-
stuk 5 vergelijken we de plaque karakteristieken van CTCA met deze van “optical coherence 
tomography”. Tussenhoofdstuk 1 is een illustratie van de mogelijkheid om met CTCA bij een 
gerevasculariseerde patient de angiografisch zichtbare- en niet-zichtbare aspecten van natief 
coronarialijden evenals de bypass greffen niet-invasief in beeld te brengen. 
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Reeds met de 4-slice en 16-slice CT scanners was het mogelijk om met CTCA coronair stenos-
es te beoordelen. In dit proefschrift rapporteren wij de diagnostische accuraatheid van de 
64-slice CT scanner, die werd geïntroduceerd in 2004 (Hoofdstukken 6 en 7). Deze scanner 
zorgde voor een belangrijke verbetering van de spatiële en temporele resolutie met als gevolg 
een betere diagnostische performantie en een afname van het percentage niet-beoordeelbare 
coronair segmenten, tot minder dan 5%. Dezelfde resultaten worden bekomen bij evaluatie 
van patiënten die zich presenteren met een acuut coronair syndroom, zonder ST-segment 
elevatie (Hoofdstuk7). 
Conventionele coronair angiografie blijft de voorkeurstechniek bij symptomatische patiënten 
met een hoge vooraf-kans op significant coronarialijden wanneer anatomische evaluatie van 
de coronair arteries noodzakelijk is. Aangezien het een nieuwe techniek betreft werd iedere 
nieuwe CT-scanner versie steeds opnieuw gevalideerd ten opzichte van CCA, de referenti-
etechniek, voor de beoordeling van de aanwezigheid of afwezigheid van significant coronari-
alijden. Per definitie hadden al de patiënten die werden geïncludeerd in deze validatiestudies 
een hoge vooraf-kans op significant coronarialijden aangezien er voor iedere patiënt een 
klinische indicatie bestond voor het uitvoeren van een CCA. Het is bijgevolg geen verrassing 
dat een CT scan die als “normaal” of “niet-significant” wordt geprotocolleerd relatief weinig 
waardevol is bij patiënten die puur op basis van klinische symptomatologie reeds een hoge 
vooraf-kans op anatomisch significant coronarialijden vertonen, aangezien de waarschijnlijk-
heid van significant coronarialijden in geval van een “normale of niet-significante CT scan” 
nog steeds 17% bedraagt. Dezelfde CT scan uitslag bij symptomatische patiënten met een 
lage-tot-intermediaire vooraf-kans gaat gepaard met een post-test waarschijnlijkheid van 0% 
en sluit bijgevolg op betrouwbare wijze significant coronarialijden uit (Hoofdstuk 8). Een ges-
chikte doelgroep voor een initiële benadering met CTCA in plaats van CCA zijn patiënten die 
hartklepchirurgie dienen te ondergaan. Obstructief coronarialijden dat niet wordt behandeld 
op het moment van hartklepchirurgie heeft een nadelige invloed op de prognose van de 
patiënt. Dientengevolge ondergaat de meerderheid van de patiënten die ouder zijn dan 35 
jaar en in aanmerking komen voor hartklepchirurgie een CCA om pre-operatief de coronair 
anatomie te beoordelen. De vooraf-kans op significant coronarialijden is evenwel laag in deze 
patiëntengroep en bedraagt ongeveer 30%. CTCA zou in deze patiëntengroep effectief als 
sluitstuk kunnen worden geïmplementeerd vooraleer over te gaan tot CCA, aangezien het 
merendeel van de patiënten normale coronair arteries of niet-significant coronarialijden blijkt 
te vertonen en de post-test waarschijnlijkheid van significant coronarialijden 0 is in het geval 
van een “negatieve” CT scan (Hoofdstuk 9).
De beschikbaarheid van CTCA als een niet-invasieve anatomische test binnen het bestaande 
arsenaal van diagnostische modaliteiten, maakt het noodzakelijk de diagnostische algoritmes 
die actueel worden gebruikt voor de evaluatie van patiënten met vermoeden van coronariali-
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jden te herevalueren. In hoofdstuk 12 evalueren wij de mogelijke waarde van 16-slice CTCA 
bij de diagnostische work-up van patiënten met stabiele angina pectoris die een inspannings 
stress test en vervolgens een CTCA ondergingen. Zoals verwacht was de prevalentie van sig-
nificant coronarialijden hoog (74%) in deze patiëntengroep. De diagnostische accuraatheid 
van CTCA was hoger in vergelijking met inspanningselectrocardiografie, die bovendien incon-
clusief was bij 15% van de patiënten. Het doel van een diagnostische test in deze populatie 
behelst evenwel meer dan enkel de diagnose van significant coronarialijden, aangezien deze 
reeds zeer waarschijnlijk is voortgaande op de symptomatologie van de patiënt. Belangrijker 
is de impact van de diagnostische test op het therapeutisch beleid van de patiënt. Een ins-
panningselectrocardiogram dat gepaard gaat met uitgesproken deviatie van het ST-segment 
of belangrijke daling van de systolische bloeddruk is van slechte prognostische waarde voor 
de patiënt en vormt een duidelijke indicatie voor het uitvoeren van een coronair angiografie 
en eventueel revascularisatie. Hoewel dit niet wordt aangetoond in de huidige studie, is het 
uitvoeren van een CTCA mogelijks zinvol voor de evaluatie van patiënten met een negatief of 
inconclusief inspanningselectrocardiogram: de hoge diagnostische accuraatheid van CTCA, 
in het bijzonder voor de grotere segmenten van de coronair arteries, maakt deze techniek 
mogelijks waardevol voor het uitsluiten van significant hoofdstam- en/of 3-vatslijden, met an-
dere woorden prognostisch relevante coronair pathologie. 
Ziekte van de kransslagaders kan geëvalueerd worden vanuit een anatomische en functio-
nele invalshoek. De ene benadering sluit de andere niet uit maar zijn eerder complemen-
tair aangezien beide evaluatiemethoden beperkingen hebben. De meest performante CT 
technologie die actueel beschikbaar is, met name de dual-source CT scanner, vertoont een 
spatiële resolutie die inferieur is aan CCA (0.4mm versus 0.2mm). Bij quantificatie van de 
hoeveelheid diameter reductie in geval van een coronaire lesie met minstens 50% diameter 
stenose, bestaat er een variatie van 27% wanneer 16-slice CTCA wordt vergeleken met de 
referentietest, namelijk quantitatieve coronair angiografie.  Met een 16-slice CT scanner is 
het inderdaad niet mogelijk in een coronair arterie met een referentiediameter van 3mm het 
onderscheid te maken tussen een stenose die varieert tussen 50% en 70% diameter reduc-
tie, aangezien de spatiële resolutie van deze scanner in optimale omstandigheden 0.6mm 
bedraagt.  Dit verschil in spatiële resolutie verklaart de relatief lage specificiteit van CTCA in 
vergelijking met CCA. Reeds meer dan 10 jaar geleden werd aangetoond dat de quantitatieve 
angiografische evaluatie van een coronaire stenose met een diameter reductie die varieert 
tussen 40 en 70% geen goede predictie toelaat van de functionele weerslag van deze graad 
van stenose, met andere woorden of deze stenose de coronaire flow op significante wijze 
beïnvloedt en als gevolg hiervan leidt tot myocardischemie. Uitgaande van dezelfde method-
ologie hebben wij aangetoond dat een stenose die bij CTCA als anatomisch significant wordt 
ingeschat geen goede inschatting toelaat van de hemodynamische weerslag ervan (Hoofd-
stuk 11). Uitgaande van onze bevindingen en deze van andere onderzoekers, stellen wij voor 
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een functionele test uit te voeren wanneer obstructief coronarialijden wordt gediagnosticeerd 
door middel van CTCA om zodoende het verder therapeutisch beleid te kunnen bepalen. In 
een aantal omstandigheden is invasief verkregen functionele informatie hiervoor het meest 
aangewezen (Tussenhoofdstuk 3).
Voornamelijk bij patiënten met anatomisch complex coronarialijden, levert CCA soms onvol-
doende diagnostische informatie op om een gefundeerde therapeutische beslissing  beleid 
te kunnen nemen. Niet onfrequent wordt een nieuwe CCA uitgevoerd, hetgeen opnieuw een 
risico voor de patiënt inhoudt omwille van het invasieve karakter van de procedure, om de 
anatomische kenmerken van de stenose beter te kunnen beoordelen. Bij patiënten met bifur-
catiepathologie of chronische totale occlusies biedt CTCA een uitstekend alternatief voor CCA 
(Hoofdstukken 12 en 13, Tussenhoofdstuk 4). Chronische totale occlusies (CTOs) zijn een 
frequente bevinding bij patiënten die significant coronarialijden vertonen bij CCA. Aangezien 
het succes percentage van een percutane coronaire interventie (PCI) voor CTOs niet optimaal 
is, met name tot 40% ervan kunnen percutaan niet gerevasculariseerd worden, wordt een PCI 
dikwijls niet uitgevoerd bij dit type van coronair pathologie. CTCA laat een betere beschrijving 
toe van de anatomische karakteristieken van een CTO in vergelijking met CCA en voorspelt 
bij welke patiënten de kans op een succesvolle PCI het hoogst is. In het bijzonder blijkt dat 
de aanwezigheid van ernstige calcificaties op CTCA, met name calcium dat >50% van het 
cross-sectionele oppervlak van het bloedvat in beslag neemt, een onafhankelijke voorspeller 
is van een niet-succesvolle procedure. Bovendien is de stralingsbelasting voor de patiënt en 
de gebruikte hoeveelheid contrastvloeistof aanzienlijk bij het uitvoeren van een PCI (Hoofd-
stuk 13). Het oordeelkundig gebruik van een CTCA vóór het uitvoeren van een eventuele 
PCI lijkt daarom zinvol en kan de behandelstrategie bijsturen in het geval dat een PCI wordt 
ondernomen of kan een argument voor de behandelend arts zijn om te kiezen voor een an-
dere therapeutische optie, met name medicamenteuse therapie of coronaire bypass chirurgie. 
Magneet navigatie is een nieuwe technologische ontwikkeling die recent binnen het domein 
van interventiecardiologie werd geïntroduceerd. Met behulp van deze techniek beoogt men bij 
coronair stenoses met tortueuse bloedvat anatomie of andere complexe coronair pathologie 
de kansen op succes van de PCI te vergroten. De incorporatie van CT data in de magneet 
navigatie software biedt de mogelijkheid vóór de procedure een gedetailleerd pad van de te 
behandelen coronair arterie uit te werken: in combinatie met het magnetisch veld dat rondom 
de patiënt wordt gecreëerd, wordt het zodoende mogelijk de richting van de draad heel pre-
cies in 3 dimensies te sturen(Hoofdstuk 14).
Percutane coronaire interventies waarbij gebruik wordt gemaakt van stents is de meest fre-
quent toegepaste vorm van coronaire revascularisatie. Het beschikbaar worden van drug-
eluting stents is gepaard gegaan met een significante reductie van het voorkomen van in-
stent restenose (ISR), doch niet tot een volledige eliminatie van dit probleem. Patiënten die 
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opnieuw klachten ontwikkelen na een eerdere succesvolle PCI vertonen inderdaad soms ISR, 
doch meer frequent progressie van ziekte in bloedvat segmenten die nog niet werden gestent. 
Verbeteringen in CT scan technologie en het gebruik van speciale filters en “window settings” 
hebben de visualisatie van het lumen binnenin de stent progressief beter gemaakt (Hoofdstuk 
15). Het aantonen van de aanwezigheid van ISR blijft evenwel moeilijk met CTCA als gevolg 
van de metaal component van de stent die gepaard gaat met artefact vorming, het “blooming 
effect”, waardoor het stent materiaal in belangrijke mate wordt uitvergroot. Het “blooming 
effect” is een relatief constant fenomeen en bijgevolg minder uitgesproken in stents met een 
relatief grote diameter (Hoofdstuk 17). CTCA kan worden gebruikt voor het uitsluiten van 
ISR bij patiënten die gestent werden in de hoofdstam (Hoofdstuk 16, Tussenhoofdstuk 5). 
Toepassing van CTCA in de dagelijkse praktijk is evenwel enkel mogelijk indien de diagnos-
tische accuraatheid op “patiënt-niveau”, waarbij zowel de gestente als niet-gestente bloedvat 
segmenten worden geïncludeerd, voldoende hoog is. Bij patiënten die opnieuw symptomen 
vertonen na eerdere implantatie van stents met grote diameter (≥ 3.0 mm) en geëvalueerd 
worden met een dual-source CT scanner, blijkt CTCA klinisch waardevol te zijn in de patiën-
tengroep met een negatieve of inconclusieve stress test (Hoofdstuk 18).
Conclusies en toekomstperspectief
De huidige 64-slice en dual-source 64-slice CT scanner vertoont een hoge diagnostische 
performantie en is met name uiterst geschikt voor het uitsluiten van de aanwezigheid van 
kransslagaderziekte. CTCA kan worden gebruikt als diagnostische modaliteit bij de evaluatie 
van symptomatische patiënten met een lage-tot-intermediaire vooraf-kans op coronarialijden: 
een “negatieve” CT scan sluit op betrouwbare wijze coronarialijden uit en doet de noodzaak 
voor het uitvoeren van een CCA afnemen. CTCA is niet onderhevig aan de 2-dimensionele 
beperkingen van CCA en is bijgevolg een waardevolle techniek voor de evaluatie van patiënten 
met coronaire anomaliëen. In hartcatheterisatiecentra met PCI faciliteiten wordt CTCA meer 
en meer gebruikt voor evaluatie van de bredere groep van patiënten met complexe vormen 
van coronair lijden: CTCA laat een goede beoordeling toe van patiënten waarbij de initiële 
angiografische evaluatie suboptimaal was en maakt een nieuwe CCA overbodig. Bij patiënten 
met CTOs biedt CTCA de mogelijkheid de slaagkans van een PCI op voorhand in te schatten 
en kan deze informatie zinvol zijn bij de uiteindelijke therapiekeuze.  Bij patiënten die voorheen 
werden gerevasculariseerd biedt CTCA op dit moment enkel een niche applicatie: na bypass 
chirurgie is CTCA waardevol ter uitsluiting van obstructief vaatlijden in de veneuse en arteriële 
greffen, de evaluatie van stenotisch vaatlijden in de natieve bloedvaten blijft problematisch. Bij 
patiënten na PCI is CTCA waardevol voor evaluatie van stents met een relatief grote diameter 
(≥3.0 mm diameter); kleine stents kunnen niet betrouwbaar worden beoordeeld. De beschik-
baarheid van CTCA maakt het noodzakelijk de diagnostische algoritmes die actueel worden 
gebruikt voor de evaluatie van patiënten met vermoeden van coronaria lijden te herevalueren. 
De niet-invasieve toegang tot coronair anatomie is nu mogelijk en bekrachtigt het belang van 
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functionele evaluatie om de meest geschikte therapiekeuze te kunnen maken. Beide benader-
ingswijzen sluiten elkaar niet uit maar zijn eerder complementair. 
Nieuwe ontwikkelingen in CT technologie zullen de klinische toepassingen van CTCA verder 
verbreden. Uitgesproken calcificaties en een onregelmatig hartritme zijn momenteel een be-
langrijke beperking voor CTCA en vereisen unieke technische oplossingen die wellicht versc-
heidene jaren in beslag zullen nemen vooraleer implementatie mogelijk is in de in-vivo setting. 
De belangrijkste uitdaging op dit moment is de consolidatie en overdracht van de kennis die 
reeds voorhanden is. Dit zal bijdragen tot een implementatie op bredere schaal van deze 
nieuwe fascinerende technologie. De data van een aantal lopende multi-center studies zullen 
aantonen of de resultaten van hoog-performante research centra kunnen worden gerepro-
duceerd. Studies die de kosten-effectiviteit van CTCA beoordelen zijn noodzakelijk om de 
waarde van CTCA te kunnen vergelijken met andere diagnostische tests. De stralingsbelast-
ing van CTCA is een nadeel maar tegelijkertijd een krachtige impuls die actueel leidt tot de 
ontwikkeling van protocollen en algoritmes die de stralingsdosis in belangrijke mate reduceren 
tot op het niveau van CCA. Tot slot dient vermeld te worden dat de snelle ontwikkeling van 
CTCA heeft kunnen plaats vinden door een succesvolle interactie tussen de deelspecialismen 
cardiologie en radiologie. Om dit hoge niveau van expertise te kunnen behouden is het essen-
tieel dat de specialisten die zich met deze techniek zullen bezig houden op een goede manier 
worden opgeleid en zich houden aan de richtlijnen die worden opgesteld door de betreffende 
beroepsgroepen. 
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